© 2000-2025 QIAGEN. All rights reserved.

Analysis Details for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Workspace	My Projects
Project	Nasal_TB
Analysis	nasal_5k_ipa - 2025-12-01 12:15 PM
Date	Mon Dec 01 09:15:07 PST 2025
Analysis ID	43063910

Analysis Settings
Cutoff before duplicate resolution	true
Resolve duplicate on	Expression logfoldchange
Color using	Expression logfoldchange
Cutoff for Expression logfoldchange	--
Cutoff for Expression pvalue	--
Cutoff for Expression qvalue	0.1
Reference set	Ingenuity Knowledge Base (Genes Only)
Relationship to include	Direct and Indirect
Includes Endogenous Chemicals	Yes
Optional Analyses	My Pathways My List
Filter Summary	
Consider only molecules and/or relationships where
(species = Human) AND
(confidence = High (predicted) OR Experimentally Observed)

Canonical Pathways for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Ingenuity Canonical Pathways	 -log(p-value)	zScore	Ratio	Molecules
3-phosphoinositide Degradation	-0E00		5.00E-03	PPP1R16B	
Acetylcholine Receptor Signaling Pathway	-0E00		5.21E-03	ADAM19	
Adrenomedullin signaling pathway	-0E00		5.15E-03	MAP2K6	
Allograft Rejection Signaling	-0E00		4.00E-03	GZMB	
Autoimmune Thyroid Disease Signaling	-0E00		3.98E-03	GZMB	
B Cell Receptor Signaling	-0E00		2.70E-03	MAP2K6	
CLEAR Signaling Pathway	-0E00		3.57E-03	RRAGB	
Cachexia Signaling Pathway	-0E00		2.78E-03	PHGDH	
Calcium Signaling	-0E00		4.69E-03	TNNC2	
Cell Cycle Checkpoints	-0E00		3.44E-03	WEE1	
Chaperone Mediated Autophagy Signaling Pathway	-0E00		2.35E-03	MMP12	
Cilia Biogenesis Signaling Pathway	-0E00		5.05E-03	TUBB4B	
Class I MHC mediated antigen processing and presentation	-0E00		2.62E-03	ZBTB16	
Cohesin Chromatin Regulation Pathway	-0E00		3.51E-03	PCDHA12	
Colorectal Cancer Metastasis Signaling	-0E00		3.77E-03	MMP12	
Communication between Innate and Adaptive Immune Cells	-0E00		2.15E-03	CCR7	
Cyclophilin Signaling Pathway	-0E00		4.17E-03	CD44	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00		4.46E-03	GZMB	
Dendritic Cell Maturation	-0E00		5.17E-03	CCR7,CD1B	
Eicosanoid Signaling	-0E00		3.64E-03	MAPKAPK3	
Estrogen Receptor Signaling	-0E00		2.48E-03	MMP12	
Expression and translocation of olfactory receptors	-0E00		2.46E-03	OR52M1	
GAIT Translation Signaling Pathway	-0E00		4.03E-03	CCR3	
Generic Transcription Pathway	-0E00		2.34E-03	ZNF157	
Glutaminergic Receptor Signaling Pathway (Enhanced)	-0E00		3.13E-03	SLC1A7	
Graft-versus-Host Disease Signaling	-0E00		4.12E-03	GZMB	
Hematoma Resolution Signaling Pathway	-0E00		3.97E-03	MMP12	
Hepatic Cholestasis	-0E00		4.63E-03	FABP6	
Hepatic Fibrosis Signaling Pathway	-0E00		4.88E-03	CCN2,MAP2K6	
Human Embryonic Stem Cell Pluripotency	-0E00		5.10E-03	MAP2K6	
ID1 Signaling Pathway	-0E00		4.95E-03	CCN2	
IL-12 Signaling and Production in Macrophages	-0E00		4.42E-03	MAP2K6	
IL-15 Signaling	-0E00		3.77E-03	GZMB	
ILK Signaling	-0E00		5.13E-03	MAP2K6	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00		4.94E-03	CD1B,SIGLEC6	
Insulin Secretion Signaling Pathway	-0E00		3.60E-03	SCNN1B	
Intra-Golgi and retrograde Golgi-to-ER traffic	-0E00		4.90E-03	TUBB4B	
Lipid Antigen Presentation by CD1	-0E00		4.69E-03	CD1B	
Mitotic Metaphase and Anaphase	-0E00		4.22E-03	TUBB4B	
Mitotic Prometaphase	-0E00		4.88E-03	TUBB4B	
Multiple Sclerosis Signaling Pathway	-0E00		4.76E-03	IRF4	
NRF2-mediated Oxidative Stress Response	-0E00		4.65E-03	MAP2K6	
Neurovascular Coupling Signaling Pathway	-0E00		4.50E-03	ENTPD4	
OX40 Signaling Pathway	-0E00		4.08E-03	TRAF5	
Orexin Signaling Pathway	-0E00		4.27E-03	PIP4K2A	
Pulmonary Healing Signaling Pathway	-0E00		5.05E-03	MMP12	
RAF/MAP kinase cascade	-0E00		3.80E-03	RASGRP3	
RAR Activation	-0E00		4.85E-03	HOXA3,ZBTB16	
RHO GTPase cycle	-0E00		2.22E-03	UBXN11	
Role of NFAT in Cardiac Hypertrophy	-0E00		4.46E-03	MAP2K6	
SLAMF Signaling Pathway	-0E00		3.90E-03	DOK2,TRAF5	
Sperm Motility	-0E00		4.03E-03	MAP2K6	
Stress Granule Signaling Pathway	-0E00		4.05E-03	MAP2K6	
T Cell Receptor Signaling	-0E00		2.62E-03	MAP2K6	
TCF dependent signaling in response to WNT	-0E00		4.26E-03	SFRP1	
TRIM21 Intracellular Antibody Signaling Pathway	-0E00		3.27E-03	IRF4	
Th17 Activation Pathway	-0E00		3.47E-03	IRF4	
GNRH Signaling	1.99E-01		5.26E-03	MAP2K6	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	2E-01		5.29E-03	PPP1R16B	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	2E-01		5.29E-03	PPP1R16B	
Acute Phase Response Signaling	2.07E-01		5.43E-03	MAP2K6	
Hepatitis B Chronic Liver Pathogenesis Signaling Pathway	2.08E-01		5.46E-03	CCN2	
PPARα/RXRα Activation	2.08E-01		5.46E-03	MAP2K6	
Macrophage Alternative Activation Signaling Pathway	2.13E-01		5.56E-03	IRF4	
NOD1/2 Signaling Pathway	2.14E-01		5.59E-03	MAP2K6	
Tight Junction Signaling	2.14E-01		5.59E-03	CLDN3	
Signaling by the B Cell Receptor (BCR)	2.22E-01		5.75E-03	RASGRP3	
Xenobiotic Metabolism PXR Signaling Pathway	2.25E-01		5.81E-03	HS3ST3A1	
Ribonucleotide Reductase Signaling Pathway	2.26E-01		5.85E-03	WEE1	
Gαq Signaling	2.33E-01		5.99E-03	RGS18	
NF-κB Signaling	2.38E-01		5.42E-03	MAP2K6,TRAF5	
Coronavirus Replication Pathway	2.43E-01		6.21E-03	TUBB4B	
Preeclampsia Signaling Pathway	2.43E-01		6.21E-03	CCN2	
HMGB1 Signaling	2.46E-01		6.29E-03	MAP2K6	
Microautophagy Signaling Pathway	2.48E-01		6.33E-03	COL28A1	
Ovarian Cancer Signaling	2.48E-01		6.33E-03	CD44	
HEY1 Signaling Pathway	2.5E-01		6.37E-03	MMP12	
IL-10 Signaling	2.61E-01		6.62E-03	MAP2K6	
PTEN Regulation	2.61E-01		6.62E-03	RRAGB	
Dilated Cardiomyopathy Signaling Pathway	2.63E-01		6.67E-03	TNNC2	
Type II Diabetes Mellitus Signaling	2.63E-01		6.67E-03	SLC27A3	
Glucocorticoid Receptor Signaling	2.64E-01		5.51E-03	IL22RA2,IL31RA,PDK4	
Endocannabinoid Neuronal Synapse Pathway	2.67E-01		6.76E-03	CNR2	
PIP3 activates AKT signaling	2.69E-01		6.80E-03	PIP4K2A	
Hedgehog 'on' state	2.72E-01		6.90E-03	GAS1	
NAD Signaling Pathway	2.79E-01		7.04E-03	NMNAT2	
Xenobiotic Metabolism General Signaling Pathway	2.79E-01		7.04E-03	MAP2K6	
RHO GTPases Activate Formins	2.83E-01		7.14E-03	TUBB4B	
DHCR24 Signaling Pathway	2.87E-01		7.25E-03	CYP51A1	
Hereditary Breast Cancer Signaling	2.91E-01		7.35E-03	WEE1	
CCR3 Signaling in Eosinophils	2.96E-01		7.46E-03	CCR3	
Iron homeostasis signaling pathway	2.96E-01		7.46E-03	HEPH	
SNARE Signaling Pathway	2.96E-01		7.46E-03	SYT2	
Centrosomal KIAA0586 Signaling Pathway	2.98E-01		7.52E-03	CD44	
Epigenetic regulation of gene expression by MLL3 and MLL4 complexes	2.98E-01		7.52E-03	PDK4	
Gα12/13 Signaling	2.98E-01		7.52E-03	CDH26	
Mitotic G1 phase and G1/S transition	3E-01		7.58E-03	WEE1	
Role of PKR in Interferon Induction and Antiviral Response	3E-01		7.58E-03	MAP2K6	
Interleukin-1 family signaling	3.05E-01		7.69E-03	MAP2K6	
TR/RXR Activation	3.05E-01		7.69E-03	SYT2	
Clathrin-mediated endocytosis	3.07E-01		7.75E-03	SYT2	
IL-6 Signaling	3.07E-01		7.75E-03	MAP2K6	
Synaptogenesis Signaling Pathway	3.09E-01		6.37E-03	CDH26,SYT2	
MHC class II antigen presentation	3.1E-01		7.81E-03	TUBB4B	
14-3-3-mediated Signaling	3.14E-01		7.94E-03	TUBB4B	
IL-27 Signaling Pathway	3.14E-01		7.94E-03	GZMB	
Axonal Guidance Signaling	3.15E-01		6.04E-03	ADAM19,MMP12,TUBB4B	
Insulin Receptor Signaling	3.17E-01		8.00E-03	SCNN1B	
Ferroptosis Signaling Pathway	3.19E-01		8.06E-03	FDFT1	
GP6 Signaling Pathway	3.19E-01		8.06E-03	COL28A1	
RHOA Signaling	3.19E-01		8.06E-03	PIP4K2A	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	3.19E-01		8.06E-03	CTSG	
L1CAM interactions	3.22E-01		8.13E-03	TUBB4B	
Type I Diabetes Mellitus Signaling	3.23E-01		6.56E-03	GZMB,MAP2K6	
Activation of anterior HOX genes in hindbrain during early embryogenesis	3.27E-01		8.26E-03	HOXA3	
IL-15 Production	3.27E-01		8.26E-03	MAP2K6	
Regulation of lipid metabolism by PPARalpha	3.32E-01		8.40E-03	FDFT1	
Fc Epsilon RI Signaling	3.35E-01		8.47E-03	MAP2K6	
Th1 Pathway	3.35E-01		8.47E-03	MAP2K6	
Parkinson's Signaling Pathway	3.35E-01		6.73E-03	CNR2,TUBB4B	
Cholecystokinin/Gastrin-mediated Signaling	3.37E-01		8.55E-03	MAP2K6	
Bladder Cancer Signaling	3.4E-01		8.62E-03	MMP12	
Hedgehog 'off' state	3.43E-01		8.70E-03	TUBB4B	
Sleep NREM Signaling Pathway	3.46E-01		8.77E-03	MAP2K6	
Regulation of Actin-based Motility by Rho	3.51E-01		8.93E-03	PIP4K2A	
Interleukin-4 and Interleukin-13 signaling	3.54E-01		9.01E-03	IRF4	
Phase II - Conjugation of compounds	3.54E-01		9.01E-03	GGT5	
MITF-M-dependent gene expression	3.57E-01		9.09E-03	IRF4	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	3.57E-01		9.09E-03	MAP2K6	
Irritable Bowel Syndrome Signaling Pathway	3.63E-01		7.12E-03	ITLN1,MMP12	
Factors involved in megakaryocyte development and platelet production	3.63E-01		9.26E-03	WEE1	
Membrane Repair Signaling Pathway	3.63E-01		9.26E-03	SYT2	
Opioid Signaling Pathway	3.64E-01		7.14E-03	MAP2K6,RGS18	
Egg-Sperm Fusion Signaling Pathway	3.66E-01		9.35E-03	SYT2	
Extracellular matrix organization	3.66E-01		9.35E-03	ADAM19	
Signaling by VEGF	3.66E-01		9.35E-03	MAPKAPK3	
Xenobiotic Metabolism Signaling	3.66E-01		7.17E-03	HS3ST3A1,MAP2K6	
Phase I - Functionalization of compounds	3.69E-01		9.43E-03	CYP51A1	
Cargo recognition for clathrin-mediated endocytosis	3.72E-01		9.52E-03	SYT2	
IGF-1 Signaling	3.72E-01		9.52E-03	CCN2	
PD-1, PD-L1 cancer immunotherapy pathway	3.75E-01		9.62E-03	PDCD1LG2	
COPI-mediated anterograde transport	3.82E-01		9.80E-03	TUBB4B	
S Phase	3.85E-01		9.90E-03	WEE1	
mRNA 3 Prime End Processing Signaling Pathway	3.88E-01		1.00E-02	CD44	
Signaling by Rho Family GTPases	3.91E-01		7.52E-03	CDH26,PIP4K2A	
Protein folding	3.92E-01		1.01E-02	TUBB4B	
Apelin Cardiomyocyte Signaling Pathway	3.95E-01		1.02E-02	SLC9A3	
IL-1 Signaling	3.98E-01		1.03E-02	MAP2K6	
Salvage Pathways of Pyrimidine Ribonucleotides	3.98E-01		1.03E-02	MAP2K6	
TGF-β Signaling	3.98E-01		1.03E-02	MAP2K6	
Transcriptional regulation by RUNX3	3.98E-01		1.03E-02	CCN2	
Circadian Rhythm Signaling	3.99E-01		7.63E-03	MAP2K6,PER1	
Small Cell Lung Cancer Signaling	4.02E-01		1.04E-02	TRAF5	
Cardiac Hypertrophy Signaling	4.11E-01		7.81E-03	MAP2K6,MAPKAPK3	
ERBB Signaling	4.12E-01		1.08E-02	MAP2K6	
Cell junction organization	4.16E-01		1.09E-02	CLDN3	
Acute Myeloid Leukemia Signaling	4.24E-01		1.11E-02	MAP2K6	
RAB GEFs exchange GTP for GDP on RABs	4.24E-01		1.11E-02	DENND2D	
Unfolded protein response	4.24E-01		1.11E-02	CEBPE	
ABRA Signaling Pathway	4.31E-01		1.14E-02	CCN2	
NAP1L1 Transcription Regulation Signaling Pathway	4.31E-01		1.14E-02	TUBB4B	
Transcriptional regulation of granulopoiesis	4.31E-01		1.14E-02	CEBPE	
Tuberculosis Latent Signaling Pathway	4.31E-01		1.14E-02	TRAF5	
Neddylation	4.32E-01		8.13E-03	CISH,ZBTB16	
Docosahexaenoic Acid (DHA) Signaling	4.39E-01		8.23E-03	FABP6,SYT2	
FGF Signaling	4.39E-01		1.16E-02	MAP2K6	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	4.43E-01		7.35E-03	CD44,IRF4,MAP2K6	
Activation of NMDA receptors and postsynaptic events	4.43E-01		1.18E-02	TUBB4B	
Cyclins and Cell Cycle Regulation	4.43E-01		1.18E-02	WEE1	
Integrin cell surface interactions	4.43E-01		1.18E-02	CD44	
LPS-stimulated MAPK Signaling	4.43E-01		1.18E-02	MAP2K6	
Immunogenic Cell Death Signaling Pathway	4.47E-01		1.19E-02	GZMB	
PI Metabolism	4.47E-01		1.19E-02	PIP4K2A	
Transport of bile salts and organic acids, metal ions and amine compounds	4.47E-01		1.19E-02	HEPH	
Superpathway of Inositol Phosphate Compounds	4.48E-01		8.37E-03	PIP4K2A,PPP1R16B	
Wound Healing Signaling Pathway	4.48E-01		8.37E-03	COL28A1,MAP2K6	
JAK/STAT Signaling	4.56E-01		1.22E-02	CISH	
Chemokine Signaling	4.6E-01		1.23E-02	CCR3	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	4.6E-01		1.23E-02	ISG15	
Role of MAPK Signaling in the Pathogenesis of Influenza	4.6E-01		1.23E-02	MAP2K6	
Signaling by NTRK1 (TRKA)	4.6E-01		1.23E-02	MAPKAPK3	
Osteoarthritis Pathway	4.64E-01		8.62E-03	ITLN1,MMP12	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	4.64E-01		8.62E-03	CLDN3,MAP2K6	
Neurotrophin/TRK Signaling	4.78E-01		1.30E-02	MAP2K6	
Toll-like Receptor Signaling	4.78E-01		1.30E-02	MAP2K6	
Angiopoietin Signaling	4.82E-01		1.32E-02	DOK2	
GDNF Family Ligand-Receptor Interactions	4.82E-01		1.32E-02	DOK2	
HIPPO signaling	4.82E-01		1.32E-02	CD44	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	4.82E-01		1.32E-02	MAP2K6	
Nuclear Cytoskeleton Signaling Pathway	4.89E-01		9.01E-03	CDH26,TUBB4B	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	5.01E-01		1.39E-02	TUBB4B	
Cell surface interactions at the vascular wall	5.02E-01		9.22E-03	CD44,DOK2	
Glioma Invasiveness Signaling	5.06E-01		1.41E-02	CD44	
Heparan Sulfate Biosynthesis	5.06E-01		1.41E-02	HS3ST3A1	
Melatonin Signaling	5.06E-01		1.41E-02	MAP2K6	
GM-CSF Signaling	5.12E-01		1.43E-02	CISH	
3-phosphoinositide Biosynthesis	5.13E-01		9.39E-03	PIP4K2A,PPP1R16B	
Sensory processing of sound by inner hair cells of the cochlea	5.17E-01		1.45E-02	OTOF	
Cardiac Hypertrophy Signaling (Enhanced)	5.2E-01	-2.0	7.55E-03	IL22RA2,IL31RA,MAP2K6,MAPKAPK3	
Macroautophagy	5.22E-01		1.47E-02	RRAGB	
Collagen biosynthesis and modifying enzymes	5.27E-01		1.49E-02	COL28A1	
Remodeling of Epithelial Adherens Junctions	5.27E-01		1.49E-02	TUBB4B	
Mitotic G2-G2/M phases	5.3E-01		9.66E-03	TUBB4B,WEE1	
T Cell Exhaustion Signaling Pathway	5.31E-01		8.29E-03	GZMB,IRF4,PDCD1LG2	
HIF1α Signaling	5.33E-01		9.71E-03	MAP2K6,MMP12	
Glutamate Receptor Signaling	5.33E-01		1.52E-02	SLC1A7	
Pyridoxal 5'-phosphate Salvage Pathway	5.33E-01		1.52E-02	MAP2K6	
Cilium Assembly	5.38E-01		9.80E-03	IFT74,TUBB4B	
D-myo-inositol-5-phosphate Metabolism	5.38E-01		9.80E-03	PIP4K2A,PPP1R16B	
Superpathway of Melatonin Degradation	5.38E-01		1.54E-02	CYP51A1	
Activin Inhibin Signaling Pathway	5.41E-01		9.85E-03	CCN2,MAP2K6	
Collagen degradation	5.44E-01		1.56E-02	MMP12	
Heparan Sulfate Biosynthesis (Late Stages)	5.44E-01		1.56E-02	HS3ST3A1	
Mitotic Roles of Polo-Like Kinase	5.44E-01		1.56E-02	WEE1	
Role of Tissue Factor in Cancer	5.44E-01		9.90E-03	CCN2,MAP2K6	
Degradation of CRY and PER proteins	5.56E-01		1.61E-02	PER1	
Kinesins	5.56E-01		1.61E-02	TUBB4B	
PI3K/AKT Signaling	5.59E-01		1.02E-02	IL22RA2,IL31RA	
Melatonin Degradation I	5.68E-01		1.67E-02	CYP51A1	
Nicotine Degradation II	5.68E-01		1.67E-02	CYP51A1	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	5.68E-01		1.03E-02	CLDN3,MAP2K6	
Regulation of the Epithelial-Mesenchymal Transition Pathway	5.72E-01		1.04E-02	CLDN3,MAP2K6	
GADD45 Signaling	5.74E-01		1.69E-02	MAP2K6	
Iron uptake and transport	5.74E-01		1.69E-02	HEPH	
Polyamine Regulation in Colon Cancer	5.74E-01		1.69E-02	MAP2K6	
Dermatan Sulfate Biosynthesis	5.8E-01		1.72E-02	HS3ST3A1	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	5.87E-01		1.75E-02	TUBB4B	
Neurexins and neuroligins	5.87E-01		1.75E-02	SYT2	
Role of IL-17A in Arthritis	5.87E-01		1.75E-02	MAP2K6	
Chondroitin Sulfate Biosynthesis	5.94E-01		1.79E-02	HS3ST3A1	
NLR signaling pathways	5.94E-01		1.79E-02	MAP2K6	
Amino acids regulate mTORC1	6E-01		1.82E-02	RRAGB	
Intrinsic Pathway for Apoptosis	6E-01		1.82E-02	GZMB	
IL-17 Signaling	6.01E-01		1.09E-02	MAP2K6,TRAF5	
Lymphotoxin β Receptor Signaling	6.07E-01		1.85E-02	TRAF5	
Nicotine Degradation III	6.07E-01		1.85E-02	CYP51A1	
SPINK1 Pancreatic Cancer Pathway	6.07E-01		1.85E-02	MMP12	
Neutrophil degranulation	6.17E-01	-1.0	8.37E-03	CD44,CLEC12A,CTSG,TUBB4B	
Xenobiotic Metabolism CAR Signaling Pathway	6.21E-01		1.12E-02	HS3ST3A1,MAP2K6	
FXR/RXR Activation	6.25E-01		1.13E-02	FABP6,FETUB	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	6.29E-01		1.96E-02	WEE1	
Gap junction trafficking and regulation	6.29E-01		1.96E-02	TUBB4B	
NR1H2 and NR1H3-mediated signaling	6.29E-01		1.96E-02	FABP6	
Epithelial Membrane Protein Signaling Pathway	6.39E-01		1.16E-02	CD44,EMP3	
PFKFB4 Signaling Pathway	6.44E-01		2.04E-02	MAP2K6	
Pyruvate metabolism	6.44E-01		2.04E-02	PDK4	
WNT/β-catenin Signaling	6.5E-01		1.18E-02	CD44,SFRP1	
Chondroitin Sulfate Biosynthesis (Late Stages)	6.52E-01		2.08E-02	HS3ST3A1	
DNA Damage Bypass	6.52E-01		2.08E-02	ISG15	
Aldosterone Signaling in Epithelial Cells	6.54E-01		1.18E-02	PIP4K2A,SCNN1B	
Serotonin Receptor Signaling	6.55E-01	-1.0	8.70E-03	CCR7,CD44,MAP2K6,SLC9A3	
Sensory perception of taste	6.6E-01		2.13E-02	SCNN1B	
Germ Cell-Sertoli Cell Junction Signaling	6.62E-01		1.20E-02	MAP2K6,TUBB4B	
Arachidonate metabolism	6.68E-01		2.17E-02	GGT5	
DNA damage-induced 14-3-3σ Signaling	6.68E-01		2.17E-02	WEE1	
M-decay: degradation of maternal mRNAs by maternally stored factors	6.68E-01		2.17E-02	TUBB4B	
Carboxyterminal post-translational modifications of tubulin	6.77E-01		2.22E-02	TUBB4B	
Dermatan Sulfate Biosynthesis (Late Stages)	6.77E-01		2.22E-02	HS3ST3A1	
Aggrephagy	6.85E-01		2.27E-02	TUBB4B	
Assembly and cell surface presentation of NMDA receptors	6.85E-01		2.27E-02	TUBB4B	
BER (Base Excision Repair) Pathway	6.85E-01		2.27E-02	MAP2K6	
Bile acid and bile salt metabolism	6.85E-01		2.27E-02	FABP6	
Collagen chain trimerization	6.85E-01		2.27E-02	COL28A1	
HOTAIR Regulatory Pathway	6.89E-01		1.25E-02	CD44,MMP12	
B Cell Activating Factor Signaling	6.94E-01		2.33E-02	TRAF5	
Senescence Pathway	6.99E-01		1.02E-02	MAP2K6,MAPKAPK3,PDK4	
April Mediated Signaling	7.03E-01		2.38E-02	TRAF5	
Pyrimidine Ribonucleotides De Novo Biosynthesis	7.13E-01		2.44E-02	ENTPD4	
RET signaling	7.13E-01		2.44E-02	DOK2	
Signaling by Retinoic Acid	7.13E-01		2.44E-02	PDK4	
Neurotransmitter release cycle	7.22E-01		2.50E-02	SLC1A7	
Estrogen Biosynthesis	7.32E-01		2.56E-02	CYP51A1	
Interleukin-7 signaling	7.32E-01		2.56E-02	CISH	
WNT/SHH Axonal Guidance Signaling Pathway	7.36E-01		1.34E-02	SFRP1,SHISA2	
Inhibition of Matrix Metalloproteases	7.42E-01		2.63E-02	MMP12	
Pyrimidine Ribonucleotides Interconversion	7.42E-01		2.63E-02	ENTPD4	
Triglyceride metabolism	7.42E-01		2.63E-02	FABP6	
Semaphorin Neuronal Repulsive Signaling Pathway	7.45E-01		1.36E-02	CD44,MAP2K6	
Endocannabinoid Cancer Inhibition Pathway	7.5E-01		1.37E-02	CNR2,MAP2K6	
Detoxification of Reactive Oxygen Species	7.53E-01		2.70E-02	PRDX5	
Fatty acyl-CoA biosynthesis	7.53E-01		2.70E-02	SLC27A3	
Metabolism of steroid hormones	7.64E-01		2.78E-02	HSD11B2	
Striated Muscle Contraction	7.64E-01		2.78E-02	TNNC2	
IL-9 Signaling	7.75E-01		2.86E-02	CISH	
Nucleotide catabolism	7.75E-01		2.86E-02	ENTPD4	
Signaling by NOTCH2	7.75E-01		2.86E-02	GZMB	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	7.78E-01		1.43E-02	CEBPE,MMP12	
RAC Signaling	7.92E-01		1.46E-02	CD44,PIP4K2A	
Fatty Acid β-oxidation I	8.1E-01		3.12E-02	SLC27A3	
RHO GTPases activate IQGAPs	8.1E-01		3.12E-02	TUBB4B	
Th2 Pathway	8.13E-01		1.50E-02	CCR3,PTGDR2	
Co-inhibition by PD-1	8.36E-01		3.33E-02	PDCD1LG2	
Regulation of CDH11 Expression and Function	8.36E-01		3.33E-02	ADAM19	
Neutrophil Extracellular Trap Signaling Pathway	8.36E-01		1.03E-02	COL28A1,CTSG,MAP2K6,VSTM1	
Atherosclerosis Signaling	8.39E-01		1.56E-02	CCR3,TPSAB1	
Warburg Effect Signaling Pathway	8.39E-01		1.56E-02	PHGDH,PRDX5	
Endocannabinoid Developing Neuron Pathway	8.44E-01		1.57E-02	CNR2,MAP2K6	
Glycosaminoglycan metabolism	8.44E-01		1.57E-02	CD44,HS3ST3A1	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	8.5E-01		3.45E-02	CYP51A1	
Energy dependent regulation of mTOR by LKB1-AMPK	8.5E-01		3.45E-02	RRAGB	
Myogenesis	8.5E-01		3.45E-02	MAP2K6	
Nicotinate metabolism	8.5E-01		3.45E-02	NMNAT2	
Paracetamol ADME	8.5E-01		3.45E-02	GGT5	
Oxidative Stress Induced Senescence	8.61E-01		1.61E-02	MAP2K6,MAPKAPK3	
MTOR signalling	8.64E-01		3.57E-02	RRAGB	
LXR/RXR Activation	8.67E-01		1.63E-02	CYP51A1,FDFT1	
Sertoli Cell-Sertoli Cell Junction Signaling	8.76E-01		1.24E-02	CDH26,CLDN3,TUBB4B	
p38 MAPK Signaling	8.78E-01		1.65E-02	MAP2K6,MAPKAPK3	
Pyroptosis	8.79E-01		3.70E-02	GZMB	
D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis	8.94E-01		3.85E-02	PIP4K2A	
Interleukin-20 family signaling	8.94E-01		3.85E-02	IL22RA2	
Bupropion Degradation	9.27E-01		4.17E-02	CYP51A1	
Growth hormone receptor signaling	9.27E-01		4.17E-02	CISH	
IL-22 Signaling	9.27E-01		4.17E-02	IL22RA2	
Interleukin-6 family signaling	9.27E-01		4.17E-02	IL31RA	
Tumoricidal Function of Hepatic Natural Killer Cells	9.27E-01		4.17E-02	GZMB	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	9.29E-01		1.32E-02	CTSG,MMP12,SFRP1	
Airway Pathology in Chronic Obstructive Pulmonary Disease	9.33E-01		1.79E-02	CTSG,GZMB	
LPS/IL-1 Mediated Inhibition of RXR Function	9.41E-01		1.33E-02	FABP6,HS3ST3A1,SLC27A3	
Apelin Cardiac Fibroblast Signaling Pathway	9.44E-01		4.35E-02	CCN2	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	9.45E-01		1.34E-02	MAP2K6,SFRP1,TRAF5	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	9.62E-01		4.55E-02	OTOF	
NAD Salvage Pathway II	9.62E-01		4.55E-02	NMNAT2	
Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes	9.62E-01		4.55E-02	PER1	
RHOGDI Signaling	9.67E-01		1.37E-02	CD44,CDH26,PIP4K2A	
Pathogen Induced Cytokine Storm Signaling Pathway	9.84E-01		1.18E-02	CCL18,CCR3,COL28A1,GZMB	
WNK Renal Signaling Pathway	9.93E-01		1.94E-02	CLCNKB,SCNN1B	
ISGylation Signaling Pathway	1E00		1.96E-02	IRF4,ISG15	
Methylglyoxal Degradation III	1E00		5.00E-02	HSD11B2	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	1E00		5.00E-02	RSAD2	
Mitochondrial L-carnitine Shuttle Pathway	1.02E00		5.26E-02	SLC27A3	
Modulation of host responses by IFN-stimulated genes	1.02E00		5.26E-02	ISG15	
γ-linolenate Biosynthesis II (Animals)	1.02E00		5.26E-02	SLC27A3	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	1.04E00	-2.0	1.10E-02	IFIT2,IFIT3,ISG15,RASGRP3,TRAF5	
Pulmonary Fibrosis Idiopathic Signaling Pathway	1.05E00	0.0	1.24E-02	CCN2,COL28A1,MAP2K6,MMP12	
Gustation Pathway	1.05E00		1.49E-02	P2RY10,P2RY13,SCNN1B	
Gap Junction Signaling	1.05E00		1.25E-02	GZMB,P2RY10,P2RY13,TUBB4B	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	1.06E00	-1.0	1.25E-02	CEBPE,MAP2K6,SFRP1,TRAF5	
Crosstalk between Dendritic Cells and Natural Killer Cells	1.07E00		2.15E-02	CCR7,CD69	
Metabolism of Angiotensinogen to Angiotensins	1.07E00		5.88E-02	CTSG	
RANK Signaling in Osteoclasts	1.09E00		2.22E-02	MAP2K6,TRAF5	
Granzyme B Signaling	1.09E00		6.25E-02	GZMB	
Signal regulatory protein family interactions	1.09E00		6.25E-02	SKAP2	
Leukocyte Extravasation Signaling	1.11E00		1.58E-02	CD44,CLDN3,MMP12	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	1.11E00		1.59E-02	CCN2,CCR7,COL28A1	
Fatty Acid Activation	1.12E00		6.67E-02	SLC27A3	
Phosphorylation and nuclear translocation of the CRY:PER:kinase complex	1.12E00		6.67E-02	PER1	
YAP1- and WWTR1 (TAZ)-stimulated gene expression	1.12E00		6.67E-02	CCN2	
TP53 Regulates Metabolic Genes	1.13E00		2.35E-02	PRDX5,RRAGB	
Leukotriene Biosynthesis	1.15E00		7.14E-02	GGT5	
The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex	1.15E00		7.14E-02	PER1	
Tumor Microenvironment Pathway	1.17E00		1.69E-02	CD44,MMP12,PDCD1LG2	
G alpha (q) signalling events	1.19E00		1.71E-02	P2RY10,RGS18,XCR1	
Butyrophilin (BTN) family interactions	1.21E00		8.33E-02	BTNL8	
Phenylalanine Degradation IV (Mammalian, via Side Chain)	1.21E00		8.33E-02	SLC27A3	
Th1 and Th2 Activation Pathway	1.23E00		1.79E-02	CCR3,MAP2K6,PTGDR2	
ISG15 antiviral mechanism	1.24E00		2.70E-02	IFIT1,ISG15	
NAD biosynthesis II (from tryptophan)	1.25E00		9.09E-02	NMNAT2	
Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters	1.25E00		9.09E-02	PER1	
Serine metabolism	1.25E00		9.09E-02	PHGDH	
Phagosome Maturation	1.29E00		1.89E-02	CTSG,PRDX5,TUBB4B	
Prednisone ADME	1.29E00		1.00E-01	HSD11B2	
γ-glutamyl Cycle	1.29E00		1.00E-01	GGT5	
CD40 Signaling	1.33E00		3.03E-02	MAP2K6,TRAF5	
Interleukin-1 processing	1.34E00		1.11E-01	CTSG	
OAS antiviral response	1.34E00		1.11E-01	OASL	
IL-4 Signaling	1.34E00	-1.3416407864998738	1.35E-02	ANO1,COL28A1,IRF4,MMP12,PTGDR2	
Activation of IRF by Cytosolic Pattern Recognition Receptors	1.36E00		3.17E-02	IFIT2,ISG15	
Stearate Biosynthesis I (Animals)	1.36E00		3.17E-02	HSD11B2,SLC27A3	
Gαi Signaling	1.41E00		2.11E-02	CNR2,P2RY13,XCR1	
Reelin Signaling in Neurons	1.44E00		2.16E-02	CNR2,MAP2K6,PDK4	
Fructose metabolism	1.44E00		1.43E-01	SORD	
cAMP-mediated signaling	1.46E00	-1.0	1.71E-02	CNR2,P2RY13,RGS18,XCR1	
Pancreatic Secretion Signaling Pathway	1.47E00		1.72E-02	ANO1,CLCA1,RASGRP3,SLC9A3	
CD27 Signaling in Lymphocytes	1.47E00		3.64E-02	MAP2K6,TRAF5	
SLC15A4:TASL-dependent IRF5 activation	1.51E00		1.67E-01	TASL	
Zymosterol Biosynthesis	1.51E00		1.67E-01	CYP51A1	
Antimicrobial peptides	1.56E00		4.08E-02	CTSG,ITLN1	
IL-13 Signaling Pathway	1.58E00		2.46E-02	ANO1,CLCA1,POSTN	
Formation of xylulose-5-phosphate	1.59E00		2.00E-01	SORD	
NAD Biosynthesis from 2-amino-3-carboxymuconate Semialdehyde	1.59E00		2.00E-01	NMNAT2	
NAD Salvage Pathway III	1.59E00		2.00E-01	NMNAT2	
Superpathway of Serine and Glycine Biosynthesis I	1.59E00		2.00E-01	PHGDH	
NAD Biosynthesis III	1.68E00		2.50E-01	NMNAT2	
Transport of inorganic cations/anions and amino acids/oligopeptides	1.73E00		2.80E-02	SLC1A7,SLC26A4,SLC9A3	
MAP kinase activation	1.75E00		5.13E-02	MAP2K6,MAPKAPK3	
Zn Homeostasis Signaling Pathway	1.8E00	-3.162277660168379	1.15E-02	CCR3,CCR7,CNR2,HRH4,MMP12,P2RY10,P2RY13,PTGDR2,SLC9A3,XCR1	
Serine Biosynthesis	1.81E00		3.33E-01	PHGDH	
Interferon gamma signaling	1.83E00		3.06E-02	CD44,IRF4,OASL	
Acetone Degradation I (to Methylglyoxal)	1.84E00		5.71E-02	CYP51A1,HSD11B2	
CREB Signaling in Neurons	1.86E00	-2.6457513110645903	1.33E-02	CCR3,CCR7,CNR2,HRH4,P2RY10,P2RY13,PTGDR2,XCR1	
IL-33 Signaling Pathway	1.87E00		2.29E-02	CTSG,MMP12,PRSS33,TPSAB1	
Activation of Matrix Metalloproteinases	1.89E00		6.06E-02	CTSG,TPSAB1	
PKR-mediated signaling	1.9E00		3.26E-02	ISG15,MAP2K6,TUBB4B	
FAK Signaling	1.94E00	-3.0	1.22E-02	CCR3,CCR7,CNR2,HRH4,IL22RA2,IL31RA,P2RY10,P2RY13,PTGDR2,XCR1	
Regulation of TP53 Activity through Acetylation	1.97E00		6.67E-02	MAP2K6,PIP4K2A	
Degradation of the extracellular matrix	2.05E00		3.70E-02	CD44,CTSG,MMP12	
Cellular Effects of Sildenafil (Viagra)	2.08E00	2.82842712474619	1.35E-02	CCR3,CCR7,CNR2,HRH4,MAP2K6,P2RY10,P2RY13,PTGDR2,XCR1	
NF1 RAS Signaling Pathway	2.18E00	-2.82842712474619	1.52E-02	CCR3,CCR7,CNR2,HRH4,P2RY10,P2RY13,PTGDR2,XCR1	
S100 Family Signaling Pathway	2.2E00	-3.0	1.33E-02	CCR3,CCR7,CNR2,HRH4,MAP2K6,MMP12,P2RY10,P2RY13,PTGDR2,XCR1	
STAT3 Pathway	2.21E00		2.88E-02	CISH,IL22RA2,IL31RA,MAP2K6	
Sorbitol Degradation I	2.28E00		1.00E00	SORD	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	2.33E00	-0.4472135954999579	2.03E-02	ADAM19,COL28A1,MAP2K6,MMP12,SFRP1,TRAF5	
Breast Cancer Regulation by Stathmin1	2.41E00	-2.82842712474619	1.53E-02	CCR3,CCR7,CNR2,HRH4,P2RY10,P2RY13,PTGDR2,TUBB4B,XCR1	
Agranulocyte Adhesion and Diapedesis	2.42E00		2.54E-02	CCL18,CCR3,CCR7,CLDN3,MMP12	
G-Protein Coupled Receptor Signaling	2.44E00	-2.3333333333333335	1.44E-02	CCR3,CCR7,CNR2,HRH4,MAP2K6,P2RY10,P2RY13,PTGDR2,RGS18,XCR1	
Neuroprotective Role of THOP1 in Alzheimer's Disease	2.51E00		3.51E-02	CTSG,GZMB,PRSS33,TPSAB1	
Phagosome Formation	2.52E00	-3.0	1.48E-02	CCR3,CCR7,CNR2,HRH4,MAP2K6,P2RY10,P2RY13,PIP4K2A,PTGDR2,XCR1	
Molecular Mechanisms of Cancer	2.81E00	-3.3166247903554	1.43E-02	CCR3,CCR7,CNR2,HRH4,IL22RA2,IL31RA,MAP2K6,MMP12,P2RY10,P2RY13,PTGDR2,XCR1	
Activation of gene expression by SREBF (SREBP)	2.86E00		7.14E-02	CYP51A1,FDFT1,SQLE	
BBSome Signaling Pathway	3E00	-2.1213203435596424	1.87E-02	CCR3,CCR7,CNR2,HRH4,IFT74,P2RY10,P2RY13,PTGDR2,XCR1	
Interferon Signaling	3.02E00		8.11E-02	IFIT1,IFIT3,ISG15	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	3.1E00		5.06E-02	IFIT2,IFIT3,ISG15,RSAD2	
G alpha (i) signalling events	3.36E00	-2.6457513110645903	2.70E-02	CCR3,CCR7,CNR2,HRH4,P2RY13,PTGDR2,RGS18	
Superpathway of Cholesterol Biosynthesis	3.38E00		1.07E-01	CYP51A1,FDFT1,SQLE	
Ion channel transport	3.38E00	-0.8164965809277261	3.28E-02	ANO1,CLCA1,CLCNKB,MCOLN2,SCNN1B,SLC9B2	
Cholesterol biosynthesis	3.43E00		1.11E-01	CYP51A1,FDFT1,SQLE	
Class A/1 (Rhodopsin-like receptors)	3.43E00	-2.82842712474619	2.41E-02	CCR3,CCR7,CNR2,HRH4,P2RY10,P2RY13,PTGDR2,XCR1	
Granulocyte Adhesion and Diapedesis	3.45E00		3.37E-02	CCL18,CCR3,CCR7,CLDN3,HRH4,MMP12	
Lung Ionic Balance Signaling Pathway	3.47E00	-3.0	1.98E-02	CCR3,CCR7,CLCA1,CNR2,HRH4,P2RY10,P2RY13,PTGDR2,SCNN1B,XCR1	
Sheddase Signaling Pathway	4.13E00	-0.3779644730092272	3.61E-02	CCN2,CCR3,CCR7,CD44,MMP12,POSTN,ZBTB16	
Cholesterol Biosynthesis I	4.41E00		2.31E-01	CYP51A1,FDFT1,SQLE	
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)	4.41E00		2.31E-01	CYP51A1,FDFT1,SQLE	
Cholesterol Biosynthesis III (via Desmosterol)	4.41E00		2.31E-01	CYP51A1,FDFT1,SQLE	
Epoxysqualene Biosynthesis	4.57E00		1.00E00	FDFT1,SQLE	
Interferon alpha/beta signaling	6.79E00	-2.6457513110645903	9.09E-02	IFIT1,IFIT2,IFIT3,IRF4,ISG15,OASL,RSAD2	

Upstream Regulators for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Analysis	ID	Upstream Regulator	Expr Log Ratio	Molecule Type	Predicted Activation State	Activation z-score	Notes	Bias Term	Bias-corrected z-score	p-value of overlap	Target molecules in dataset	Mechanistic Network	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNY3	 	other	Inhibited	-2.449	bias	-0.431	-1.394	5.79E-09	IFIT1,IFIT3,ISG15,OASL,OTOF,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BTK	-1.268	kinase	Inhibited	-2.621	bias	-0.431	-1.492	1.20E-08	CCR7,CD69,CISH,IFIT1,IFIT3,IRF4,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FAM222A	 	other	Inhibited	-2.000	bias	-0.431	-1.138	2.76E-08	IFIT2,ISG15,OASL,RSAD2	FAM222A,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TREX1	 	enzyme	Activated	2.800	bias	0.431	1.593	3.88E-08	CD44,IFIT1,IFIT2,IFIT3,IRF4,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TCR (complex)	 	complex	 	 	 	 	 	4.63E-08	CCR7,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IRF4,ISG15,OASL,RSAD2	IFNG,IRF1,IRF9,SPI1,STAT1,STAT2,TCR (complex)	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	JAK	 	group	Inhibited	-2.236	bias	-0.295	-1.577	1.02E-07	IFIT1,IFIT2,IFIT3,ISG15,RSAD2	JAK,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RC3H1	-0.209	enzyme	Activated	2.449	bias	0.431	1.394	1.28E-07	CD44,IFIT1,IFIT2,IFIT3,ISG15,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SPI1	-1.051	transcription regulator	Inhibited	-2.449	 	-0.213	-1.929	1.67E-07	CCR7,IFIT1,IFIT2,IFIT3,ISG15,MS4A1,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CGAS	-0.642	enzyme	Inhibited	-2.423	bias	-0.431	-1.379	1.69E-07	IFIT1,IFIT2,IFIT3,ISG15,MMP12,RSAD2	CGAS,IFN TYPE 1 (family),IRF3,STAT1,STAT2,STING1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF750	 	transcription regulator	Activated	2.630	bias	0.431	1.496	1.77E-07	IFIT1,IFIT2,IFIT3,IRF4,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RPSA	 	translation regulator	Activated	2.236	bias	0.327	1.504	2.03E-07	IFIT1,IFIT2,IFIT3,ISG15,OASL	CASP3,IRF3,RPSA,STAT1,TERT	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL27	-1.148	cytokine	Inhibited	-2.785	bias	-0.314	-1.911	2.84E-07	CD69,GZMB,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	IFNG,IFNL1,IL27,IRF1,IRF9,SPI1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LINC00624	 	other	 	1.969	bias	0.431	1.121	5.50E-07	IFIT1,IFIT2,IFIT3,ISG15	IRF3,LINC00624,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ATXN3	-0.149	peptidase	 	 	 	 	 	6.06E-07	IFIT1,IFIT2,ISG15	ATXN3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNA2	 	cytokine	Inhibited	-2.437	bias	-0.330	-1.634	6.60E-07	CISH,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	EZH2,IFNA2,IFNAR1,IRF3,IRF9,MYC,RACK1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IRF1	-0.629	transcription regulator	Inhibited	-2.611	bias	-0.398	-1.571	9.47E-07	IFIT1,IFIT2,IFIT3,ISG15,OASL,PDCD1LG2,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RACK1	 	enzyme	 	1.982	 	0.123	1.738	1.04E-06	IFIT2,IFIT3,ISG15,RSAD2	IRF3,RACK1,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TLR9	 	transmembrane receptor	Inhibited	-2.433	bias	-0.404	-1.449	1.50E-06	CCR7,CD69,IFIT1,IFIT3,IRF4,ISG15	IRF1,IRF3,STAT1,STAT2,TLR9,interferon alpha	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFIH1	-0.950	enzyme	 	 	 	 	 	1.80E-06	IFIT1,IFIT3,ISG15,RSAD2	IFIH1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TAFAZZIN	-0.256	enzyme	 	1.000	bias	-0.279	1.558	1.80E-06	CCN2,CD44,IFIT1,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STAG2	 	other	Activated	2.233	bias	0.431	1.271	2.07E-06	IFIT2,IFIT3,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BANF1	0.205	other	Activated	2.390	bias	0.431	1.360	2.31E-06	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	BANF1,IRF3,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNL1	 	cytokine	Inhibited	-2.404	bias	-0.431	-1.368	2.31E-06	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	IFNL1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RIPK2	-0.495	kinase	Inhibited	-2.449	bias	-0.395	-1.482	2.51E-06	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IRF9	-0.834	transcription regulator	Inhibited	-2.000	bias	-0.431	-1.138	2.91E-06	IFIT1,IFIT2,IFIT3,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SOCS1	-1.072	other	Activated	2.236	bias	0.280	1.610	3.40E-06	IFIT1,IFIT2,ISG15,MMP12,RSAD2	SOCS1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PGR	-0.931	ligand-dependent nuclear receptor	 	1.908	 	-0.164	2.364	3.47E-06	CD44,HSD11B2,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	IRF9,PGR,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STING1	 	ion channel	Inhibited	-2.581	bias	-0.431	-1.469	3.74E-06	IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,RSAD2	IFNG,IRF1,IRF3,IRF9,SPI1,STAT1,STAT2,STING1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL2	 	cytokine	 	-0.918	bias	-0.291	-0.285	4.40E-06	CD44,CD69,CISH,GZMB,LGALS12,LRRC32,MAP2K6,MS4A1,RFTN1	IL2,STAT5A/B	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TLR7	 	transmembrane receptor	Inhibited	-2.387	bias	-0.411	-1.406	7.11E-06	CCR7,CD44,CD69,IFIT1,IFIT3,ISG15	IL27,STAT1,STAT2,TLR7	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	POLE	-0.179	enzyme	 	 	 	 	 	8.35E-06	IFIT1,IFIT2,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MAVS	 	other	Inhibited	-2.411	bias	-0.421	-1.395	8.67E-06	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	IFIH1,IFNB1,IRF3,MAVS,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ETV3	 	transcription regulator	Activated	2.236	bias	0.431	1.273	8.83E-06	IFIT1,IFIT2,IFIT3,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SLC15A4	-0.587	transporter	Inhibited	-2.000	bias	-0.431	-1.138	9.25E-06	IFIT1,IFIT2,IFIT3,OASL	SLC15A4,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TASL	-1.630	enzyme	Inhibited	-2.000	bias	-0.431	-1.138	9.25E-06	IFIT1,IFIT2,IFIT3,OASL	STAT1,STAT2,TASL	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TLR3	 	transmembrane receptor	 	 	 	 	 	1.12E-05	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	IFNA1/IFNA13,IFNB1,IFNL1,IRF3,STAT1,STAT2,TICAM1,TLR3	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RTCB	 	enzyme	 	 	 	 	 	1.25E-05	IFIT1,IFIT2,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IRGM	 	enzyme	Activated	2.449	bias	0.413	1.438	1.34E-05	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	CASP3,IRGM,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL4	-0.801	cytokine	 	-1.860	 	-0.225	-1.276	1.37E-05	ANO1,CCL18,CD1B,CD69,CISH,IRF4,PHGDH	IL4,STAT6	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ETV6	-0.233	transcription regulator	Activated	2.236	bias	0.383	1.380	1.39E-05	IFIT1,IFIT3,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PIK3CA	-0.149	kinase	 	 	 	 	 	1.57E-05	CCL18,GAS1,HOXA3,IFIT2,OASL,POSTN,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STAT2	-0.619	transcription regulator	 	1.982	 	0.196	1.594	1.71E-05	IFIT1,IFIT2,ISG15,RSAD2	STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ATAD3A	 	enzyme	 	 	 	 	 	1.78E-05	IFIT1,ISG15,RSAD2	ATAD3A,IRF3,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNA1/IFNA13	 	cytokine	 	 	 	 	 	1.78E-05	IFIT2,ISG15,RSAD2	IFNA1/IFNA13,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CHROMR	 	other	Inhibited	-2.621	 	-0.217	-2.053	1.95E-05	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRKCA	 	kinase	Inhibited	-2.197	 	-0.192	-1.776	2.12E-05	CST1,IFIT1,IFIT3,ISG15,OASL,RSAD2	CASP3,IRF3,IRF9,MYC,PGR,PRKCA,STAT1,STAT2,TP53	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ARFGAP2	 	other	 	 	 	 	 	2.87E-05	IFIT1,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CASP7	 	peptidase	 	 	 	 	 	2.87E-05	IFIT3,ISG15	CASP7,IFNB1,IRF3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MSR1	 	transmembrane receptor	 	 	 	 	 	2.87E-05	IFIT1,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNL4	-2.273	cytokine	 	 	 	 	 	3.23E-05	IFIT1,ISG15,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BCL6	 	transcription regulator	 	 	 	 	 	3.31E-05	CCR7,CD44,CD69,CISH,PDCD1LG2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TEAD	 	group	 	 	 	 	 	4.12E-05	CCN2,CD44,ISG15,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRL	 	cytokine	Inhibited	-2.425	bias	-0.307	-1.681	4.33E-05	CD69,CISH,IFIT1,IFIT3,ISG15,RSAD2	IRF1,PRL	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	USP8	 	peptidase	Activated	2.000	bias	0.291	1.418	4.60E-05	IFIT1,IFIT2,IFIT3,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	interferon alpha	 	group	Inhibited	-2.744	bias	-0.301	-1.918	5.09E-05	ADAM19,GZMB,IFIT1,IFIT2,IFIT3,IRF4,ISG15,RSAD2	IL27,IRF1,IRF3,STAT1,STAT2,interferon alpha	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	INS	 	other	 	-0.447	 	0.042	-0.542	5.66E-05	ANO1,CCN2,CD44,GAS1,POSTN	INS,TEAD	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GPR15LG	 	cytokine	Activated	2.000	 	-0.129	2.259	6.28E-05	CCN2,IFIT1,IFIT2,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PKA	 	complex	 	 	 	 	 	6.60E-05	CCN2,CCR7,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNB1	 	cytokine	 	-1.957	bias	-0.280	-1.409	6.93E-05	IFIT1,IFIT2,IFIT3,ISG15	IFNB1,IRF3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TWIST1	 	transcription regulator	Inhibited	-2.219	bias	-0.293	-1.569	7.24E-05	CD44,IFIT2,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FBXO45	 	other	 	 	 	 	 	8.59E-05	IFIT3,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SPSB3	 	other	 	 	 	 	 	8.59E-05	IFIT1,ISG15	CGAS,IRF3,SPSB3,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NONO	 	transcription regulator	Inhibited	-2.425	bias	-0.334	-1.614	9.16E-05	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IRF3	-0.187	transcription regulator	 	-1.960	 	-0.249	-1.471	9.18E-05	IFIT1,IFIT2,ISG15,RSAD2	IFNB1,IRF3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNF	-0.748	cytokine	 	-0.576	bias	-0.256	0.305	9.56E-05	CCL18,CCN2,CCR7,CD44,CLDN3,IFIT1,IFIT3,MMP12,OASL,PHGDH,RFTN1,SCNN1B,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BCOR	 	transcription regulator	 	 	 	 	 	1.00E-04	CD44,GAS1,ISG15,MS4A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MAP3K7	 	kinase	 	-1.387	 	-0.041	-1.307	1.00E-04	IFIT1,IFIT2,IFIT3,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STAT1	 	transcription regulator	Inhibited	-2.414	bias	-0.408	-1.429	1.12E-04	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2	STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PBRM1	 	other	Inhibited	-2.236	bias	-0.298	-1.571	1.14E-04	IFIT2,IFIT3,ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNASEH2B	 	other	Activated	2.213	bias	0.431	1.260	1.27E-04	IFIT1,IFIT2,IFIT3,IRF4,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	INSIG1	0.345	other	 	 	 	 	 	1.38E-04	CYP51A1,FDFT1,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TGM2	 	enzyme	 	-1.890	 	-0.189	-1.389	1.62E-04	CLC,IFIT1,IFIT2,IFIT3,OASL,PPP1R16B,SLC9B2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ADAR	-0.360	enzyme	 	 	 	 	 	1.62E-04	IFIT1,IFIT2,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NLRP11	 	other	 	 	 	 	 	1.71E-04	IFIT1,IFIT2	IRF3,NLRP11,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM9	 	other	 	 	 	 	 	1.71E-04	CD44,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AKT	 	group	 	-1.980	 	-0.135	-1.713	2.08E-04	CCN2,CCR7,CD44,MMP12,PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	YTHDC2	 	enzyme	 	 	 	 	 	2.83E-04	IFIT2,IFIT3,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MTORC2 (complex)	 	complex	 	 	 	 	 	2.84E-04	IFIT2,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NGLY1	-0.199	enzyme	 	 	 	 	 	2.84E-04	IFIT1,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PELI2	 	enzyme	 	 	 	 	 	2.84E-04	IFIT2,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PLA2G2A	 	enzyme	 	 	 	 	 	2.84E-04	CD44,CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF598	 	enzyme	 	 	 	 	 	2.84E-04	IFIT2,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TREM1	-1.731	transmembrane receptor	 	0.816	 	-0.229	1.378	3.42E-04	CCL18,CCR7,IFIT2,ISG15,MCOLN2,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNAR1	 	transmembrane receptor	Inhibited	-2.000	bias	-0.375	-1.249	3.72E-04	IFIT1,IFIT3,ISG15,RSAD2	IFNAR1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BCR (complex)	 	complex	 	-1.461	bias	-0.387	-0.612	3.86E-04	CCR7,CD44,CD69,GZMB,SORD,ZBTB16	BCL6,BCR (complex)	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FOXC1	0.549	transcription regulator	Inhibited	-2.236	 	-0.144	-1.915	3.98E-04	IFIT1,IFIT2,IFIT3,ISG15,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TERT	 	enzyme	 	 	 	 	 	4.20E-04	IFIT1,IFIT2,ISG15,OASL	IRF3,STAT1,TERT	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	KLF7	 	transcription regulator	 	 	 	 	 	4.25E-04	IFIT1,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF395	 	transcription regulator	 	 	 	 	 	4.25E-04	IFIT1,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFNG	-0.975	cytokine	Inhibited	-2.162	bias	-0.292	-1.301	4.64E-04	CCL18,CISH,IFIT1,IFIT2,IFIT3,ISG15,OASL,PDCD1LG2,RSAD2	IFNG,IRF1,MUC1,MYC,NONO,SPI1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	F3	 	transmembrane receptor	 	1.987	bias	0.285	1.420	4.71E-04	IFIT1,IFIT3,ISG15,RSAD2	F3,IRF3,STAT1,STAT2,STING1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL21	 	cytokine	 	 	 	 	 	4.71E-04	CCR7,CD69,GZMB,MS4A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-15 (includes others)	 	microrna	 	 	 	 	 	5.55E-04	IFIT1,ISG15,WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CAND1	 	transcription regulator	 	 	 	 	 	5.93E-04	IFIT1,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CASP3	 	peptidase	 	 	 	 	 	5.93E-04	IFIT3,ISG15	CASP3,CASP7,IFNB1,IRF3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFN TYPE 1 (family)	 	group	 	 	 	 	 	5.93E-04	IFIT1,ISG15	IFN TYPE 1 (family),STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	KPNA2	 	other	 	 	 	 	 	5.93E-04	IFIT1,ISG15	IRF3,KPNA2,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIP12	 	enzyme	 	 	 	 	 	5.93E-04	ADAM19,CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FGFR2	 	kinase	 	 	 	 	 	6.12E-04	ISG15,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HBB	 	enzyme	 	 	 	 	 	6.19E-04	CCR7,IFIT2,IFIT3,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SOX11	 	transcription regulator	 	-1.446	bias	-0.259	-0.877	6.72E-04	CDH26,MS4A1,POSTN,SKAP2,SPIB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MYC	 	transcription regulator	 	1.723	bias	-0.256	2.478	7.35E-04	CD44,HSD11B2,IFIT1,IFIT2,IFIT3,IRF4,OASL,RSAD2,WEE1	EZH2,MYC	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL1RN	 	cytokine	 	1.982	bias	0.396	1.197	7.60E-04	CD44,IFIT3,OASL,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	THEM6	 	other	 	 	 	 	 	8.06E-04	CYP51A1,FDFT1,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNF216	 	enzyme	 	 	 	 	 	1.01E-03	IFIT1,ISG15	IRF3,RNF216,STAT1,TLR3	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TP53	 	transcription regulator	 	-1.422	 	-0.074	-1.205	1.03E-03	CCN2,CD44,CYP51A1,FDFT1,IFIT1,IFIT2,IFIT3,ISG15,MAP2K6,OASL,PHGDH,RSAD2,SQLE	EZH2,IRF3,MYC,STAT1,STING1,TP53	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STAT6	 	transcription regulator	 	 	 	 	 	1.12E-03	ANO1,CISH,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FEN1	 	enzyme	 	 	 	 	 	1.26E-03	IFIT1,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRRAP	 	transcription regulator	 	 	 	 	 	1.26E-03	CD44,IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CCL5	-0.429	cytokine	 	 	 	 	 	1.40E-03	CD44,SQLE,TUBB4B	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ASCC3	 	enzyme	 	 	 	 	 	1.53E-03	IFIT1,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ETS1	 	transcription regulator	 	 	 	 	 	1.61E-03	CCN2,CD44,CD69,CST1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STAT5A/B	 	group	 	 	 	 	 	1.71E-03	CD69,CISH,RFTN1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IKBKE	 	kinase	 	 	 	 	 	1.83E-03	IFIT1,PDK4,PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	COPA	 	transporter	 	 	 	 	 	1.83E-03	ISG15,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MAP2K5	 	kinase	 	 	 	 	 	1.83E-03	CYP51A1,FDFT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRMT7	 	enzyme	 	 	 	 	 	1.83E-03	ISG15,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IFN beta	 	group	 	 	 	 	 	1.95E-03	IFIT1,IFIT3,RSAD2	IFN beta,IFNG,IRF1,IRF9,SPI1,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	WNT3A	 	cytokine	 	 	 	 	 	1.95E-03	CD44,GGT5,RASGRP3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ADAP1	-0.325	other	 	 	 	 	 	2.16E-03	CD69,GZMB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LTA	 	cytokine	 	 	 	 	 	2.16E-03	CD44,PDCD1LG2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NT5E	 	phosphatase	 	 	 	 	 	2.16E-03	CD69,ZNF366	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TICAM1	 	other	 	 	 	 	 	2.16E-03	IFIT1,IFIT2	IRF3,STAT1,TICAM1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MUC1	 	transmembrane receptor	Inhibited	-2.219	 	-0.229	-1.711	2.41E-03	IFIT2,IFIT3,ISG15,OASL,RSAD2	EZH2,MUC1,MYC,NONO	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PAF1	 	other	 	 	 	 	 	2.48E-03	IFIT3,ISG15,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL11	0.829	cytokine	 	 	 	 	 	2.51E-03	CCN2,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRDM1	 	transcription regulator	 	 	 	 	 	2.62E-03	IFIT1,IFIT2,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CD46	 	transmembrane receptor	 	 	 	 	 	2.88E-03	CD69,GZMB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SHH	-1.768	peptidase	 	 	 	 	 	2.88E-03	CD69,HSD11B2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CSF2	 	cytokine	 	-1.963	bias	-0.390	-1.198	3.17E-03	CCL18,CD1B,CD69,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CFLAR	 	other	 	 	 	 	 	3.28E-03	IFIT2,ISG15	CFLAR,IFNB1,IRF3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TBX21	 	transcription regulator	 	 	 	 	 	3.28E-03	GZMB,PTGDR2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-122 (includes others)	 	microrna	 	 	 	 	 	3.28E-03	FDFT1,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MAPK1	 	kinase	Activated	2.236	 	0.005	2.225	3.45E-03	IFIT1,IFIT2,IFIT3,ISG15,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ERK	 	group	 	-0.068	bias	-0.298	0.518	3.49E-03	CCN2,MS4A1,PDK4,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	YOD1	 	enzyme	 	 	 	 	 	3.71E-03	CCN2,IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FABP5	 	transporter	 	 	 	 	 	3.97E-03	ADAM19,ANO1,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TFAP4	 	transcription regulator	 	 	 	 	 	4.15E-03	CD44,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TP53BP2	 	other	 	 	 	 	 	4.15E-03	CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IMMT	 	other	 	 	 	 	 	4.36E-03	IFIT1,IFIT2,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AMFR	 	transmembrane receptor	 	 	 	 	 	4.63E-03	FDFT1,SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HDAC4	-0.604	transcription regulator	 	 	 	 	 	4.63E-03	ISG15,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ETV6-RUNX1	 	fusion gene/product	 	1.287	bias	0.331	0.552	5.08E-03	ANO1,EMP3,GZMB,MS4A1,SPIB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CALCA	 	other	 	 	 	 	 	5.38E-03	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CCR8	 	g-protein coupled receptor	 	 	 	 	 	5.38E-03	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CDKL2	0.688	kinase	 	 	 	 	 	5.38E-03	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CKAP4	 	other	 	 	 	 	 	5.38E-03	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	COPS6	0.141	other	 	 	 	 	 	5.38E-03	PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	EIF3F	 	translation regulator	 	 	 	 	 	5.38E-03	PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ISGF3 (complex)	 	complex	 	 	 	 	 	5.38E-03	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LINC01013	 	other	 	 	 	 	 	5.38E-03	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LINC01564	 	other	 	 	 	 	 	5.38E-03	PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LOC105374041	 	other	 	 	 	 	 	5.38E-03	RASGRP3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MDC1	 	other	 	 	 	 	 	5.38E-03	WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PABIR1	 	other	 	 	 	 	 	5.38E-03	WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PAK2	-0.252	kinase	 	 	 	 	 	5.38E-03	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	POU2AF1	 	transcription regulator	 	 	 	 	 	5.38E-03	IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SLA2	-0.494	other	 	 	 	 	 	5.38E-03	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SRRM1	 	other	 	 	 	 	 	5.38E-03	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNFRSF14	 	transmembrane receptor	 	 	 	 	 	5.38E-03	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	VEGFB	 	growth factor	 	 	 	 	 	5.38E-03	MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZMAT3	 	other	 	 	 	 	 	5.38E-03	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-136	 	microrna	 	 	 	 	 	5.38E-03	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TYROSINE KINASE (family)	 	group	 	 	 	 	 	5.38E-03	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	EGOT	 	other	 	 	 	 	 	5.64E-03	ISG15,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL12 (family)	 	group	 	 	 	 	 	5.64E-03	CD69,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IRF8	-0.470	transcription regulator	 	 	 	 	 	5.64E-03	ISG15,MS4A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF281	 	transcription regulator	 	 	 	 	 	5.64E-03	ADAM19,CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	POU2F2	 	transcription regulator	 	 	 	 	 	5.67E-03	CD69,LRRC32,MS4A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NF2	 	other	 	 	 	 	 	6.18E-03	IFIT1,IFIT2	IRF3,NF2,STAT1	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NCOR2	 	transcription regulator	 	 	 	 	 	6.75E-03	CD69,CEBPE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FOXP1	 	transcription regulator	 	 	 	 	 	7.34E-03	GAS1,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LYN	 	kinase	 	 	 	 	 	7.34E-03	IFIT1,IFIT2	LYN,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNF138	 	enzyme	 	 	 	 	 	7.34E-03	CCR7,LRRC32	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FCER1 (complex)	 	complex	 	 	 	 	 	7.95E-03	CCL18,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SOCS3	-1.430	phosphatase	 	 	 	 	 	7.95E-03	IFIT1,IFIT2	SOCS3,STAT1,STAT2	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CTLA4	-0.681	transmembrane receptor	 	 	 	 	 	8.58E-03	GZMB,HRH4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	EWSR1-FLI1	 	fusion gene/product	 	 	 	 	 	8.63E-03	CCN2,CD44,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	EZH2	-0.278	transcription regulator	 	-1.698	 	-0.189	-1.240	8.85E-03	HSD11B2,IFIT1,IFIT3,ISG15,RSAD2,SQLE	EZH2,MYC	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SYK	-0.585	kinase	 	 	 	 	 	8.93E-03	CCR7,CD44,CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SETX	-0.277	enzyme	 	 	 	 	 	9.23E-03	IFIT2,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TWIST2	 	transcription regulator	 	 	 	 	 	9.23E-03	CD44,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	p38 MAPK	 	group	 	 	 	 	 	9.47E-03	CCN2,CCR7,CD44,MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GLI2	0.445	transcription regulator	 	 	 	 	 	9.91E-03	ANO1,HSD11B2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CDKN2A	 	enzyme	 	 	 	 	 	1.02E-02	CCL18,PDCD1LG2,PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NFkB (complex)	 	complex	 	 	 	 	 	1.04E-02	CCR7,CD44,FABP6,RFTN1,SPIB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL10	-1.107	cytokine	 	 	 	 	 	1.06E-02	CCL18,CD44,PDCD1LG2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	APOD	 	transporter	 	 	 	 	 	1.07E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CDC14A	0.318	phosphatase	 	 	 	 	 	1.07E-02	WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CSNK1E	 	kinase	 	 	 	 	 	1.07E-02	PER1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GAB3	-0.534	other	 	 	 	 	 	1.07E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GRAMD1A	 	transporter	 	 	 	 	 	1.07E-02	SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GRAMD1B	 	transporter	 	 	 	 	 	1.07E-02	SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GRAMD1C	0.466	transporter	 	 	 	 	 	1.07E-02	SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	H3-3A/3B (family)	 	group	 	 	 	 	 	1.07E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MARK4	 	kinase	 	 	 	 	 	1.07E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MBNL3	 	other	 	 	 	 	 	1.07E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MED6	 	transcription regulator	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MID2	 	enzyme	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	OSBPL9	 	other	 	 	 	 	 	1.07E-02	SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PECAM1	-0.861	other	 	 	 	 	 	1.07E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	POLDIP3	 	other	 	 	 	 	 	1.07E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PTTG3P	 	other	 	 	 	 	 	1.07E-02	MAP2K6	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNF139	 	enzyme	 	 	 	 	 	1.07E-02	FDFT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SOS1	 	other	 	 	 	 	 	1.07E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TMEM259	-0.213	other	 	 	 	 	 	1.07E-02	CYP51A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM13	 	enzyme	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM32	 	transcription regulator	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM36	0.490	enzyme	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM66	 	transcription regulator	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM8	0.165	enzyme	 	 	 	 	 	1.07E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	U2AF1	-0.708	other	 	 	 	 	 	1.07E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	COLLAGEN ALPHA1 (family)	 	group	 	 	 	 	 	1.07E-02	CCL18	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-451 (includes others)	 	microrna	 	 	 	 	 	1.07E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GATA2	-1.104	transcription regulator	 	 	 	 	 	1.21E-02	CCR3,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LACTB	-0.358	peptidase	 	 	 	 	 	1.21E-02	CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RPS6KA3	 	kinase	 	 	 	 	 	1.28E-02	IRF4,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	JNK	 	group	 	 	 	 	 	1.31E-02	CCN2,CCR7,MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SRF	-0.404	transcription regulator	 	 	 	 	 	1.35E-02	ANO1,CCN2,TUBB4B	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FAT1	 	other	 	 	 	 	 	1.36E-02	CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PDGF-BB	 	complex	 	 	 	 	 	1.43E-02	CCN2,CD44,MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SGPL1	 	enzyme	 	 	 	 	 	1.44E-02	IFIT1,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DICER1	 	enzyme	 	 	 	 	 	1.47E-02	CD44,GZMB,RFTN1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CD40LG	0.447	cytokine	 	 	 	 	 	1.51E-02	CCL18,CD69,TRAF5	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BLM	 	enzyme	 	 	 	 	 	1.52E-02	IFIT1,RFTN1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-155	 	microrna	 	 	 	 	 	1.52E-02	CCL18,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ADGRF5	0.918	g-protein coupled receptor	 	 	 	 	 	1.61E-02	GZMB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AMBP	-0.663	transporter	 	 	 	 	 	1.61E-02	ITIH5	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AMOT	 	other	 	 	 	 	 	1.61E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AMOTL1	 	other	 	 	 	 	 	1.61E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CAMK2G	-0.262	kinase	 	 	 	 	 	1.61E-02	CEBPE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CLCA1	-2.300	ion channel	 	 	 	 	 	1.61E-02	ANO1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CNDP2	 	peptidase	 	 	 	 	 	1.61E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	COL3A1	 	other	 	 	 	 	 	1.61E-02	CCL18	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CRLF1	1.164	cytokine	 	 	 	 	 	1.61E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CSNK1D	 	kinase	 	 	 	 	 	1.61E-02	PER1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	G PROTEIN BETA GAMMA CORE (complex)	 	complex	 	 	 	 	 	1.61E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GALNT2	 	enzyme	 	 	 	 	 	1.61E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GGTASE I (complex)	 	complex	 	 	 	 	 	1.61E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HMGN2	 	other	 	 	 	 	 	1.61E-02	CISH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	OASL	-1.666	enzyme	 	 	 	 	 	1.61E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	OXTR	1.179	g-protein coupled receptor	 	 	 	 	 	1.61E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PAN2	 	peptidase	 	 	 	 	 	1.61E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PCBP1	 	translation regulator	 	 	 	 	 	1.61E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRR7	 	other	 	 	 	 	 	1.61E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNF185	-0.234	enzyme	 	 	 	 	 	1.61E-02	CYP51A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TELO2	 	other	 	 	 	 	 	1.61E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TMEM120A	 	ion channel	 	 	 	 	 	1.61E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TMEM43	 	other	 	 	 	 	 	1.61E-02	FDFT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM58	 	enzyme	 	 	 	 	 	1.61E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TSG101	 	transcription regulator	 	 	 	 	 	1.61E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-103 (includes others)	 	microrna	 	 	 	 	 	1.61E-02	PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IgM	 	complex	 	 	 	 	 	1.61E-02	CD44,TRAF5	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM37	0.227	enzyme	 	 	 	 	 	1.61E-02	IFIT2,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RIGI	-1.064	enzyme	 	 	 	 	 	1.64E-02	IFIT1,IFIT3,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	QKI	-0.379	transcription regulator	 	 	 	 	 	1.69E-02	IFIT3,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RBPJ	 	transcription regulator	 	 	 	 	 	1.69E-02	CCR7,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HISTONE H2A (family)	 	group	 	 	 	 	 	1.69E-02	CD44,GAS1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IGF2BP3	-0.872	translation regulator	 	 	 	 	 	1.78E-02	CD44,PIP4K2A	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PI3K (family)	 	group	 	 	 	 	 	1.82E-02	IFIT1,ISG15,MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SMARCA4	 	transcription regulator	 	0.152	bias	-0.354	0.855	1.83E-02	ANO1,CCN2,CD44,EMP3,FABP6,HEPH,IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CCN5	1.046	growth factor	 	 	 	 	 	1.87E-02	CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CD3E	 	transmembrane receptor	 	 	 	 	 	1.87E-02	CD69,WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CDK6	 	kinase	 	 	 	 	 	1.92E-02	ISG15,MAP2K6,SLC27A3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GSE1	 	other	 	 	 	 	 	1.96E-02	IFIT3,IL31RA	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TEAD2	-0.552	transcription regulator	 	 	 	 	 	1.96E-02	CCN2,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PDX1	 	transcription regulator	 	 	 	 	 	2.05E-02	CD44,PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	USP18	-0.766	peptidase	 	 	 	 	 	2.05E-02	IFIT1,OASL	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	YAP/TAZ (family)	 	group	 	 	 	 	 	2.05E-02	CCN2,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CD3 (complex)	 	complex	 	 	 	 	 	2.06E-02	CD44,CD69,GZMB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NTRK1	-0.799	kinase	 	1.342	 	0.028	1.279	2.13E-02	CD44,LRRC61,PHGDH,POSTN,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AJUBA	 	transcription regulator	 	 	 	 	 	2.14E-02	WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AMOTL2	 	other	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CBLB	 	enzyme	 	 	 	 	 	2.14E-02	GZMB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CLK1	-0.395	kinase	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CREBZF	 	transcription regulator	 	 	 	 	 	2.14E-02	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CYRIB	-0.677	other	 	 	 	 	 	2.14E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DUX4-IGH	 	fusion gene/product	 	 	 	 	 	2.14E-02	CLEC12A	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FA2H	 	enzyme	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GNA15	 	enzyme	 	 	 	 	 	2.14E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL13RA2	-2.287	transmembrane receptor	 	 	 	 	 	2.14E-02	MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LNCAROD	 	other	 	 	 	 	 	2.14E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MTCL2	 	other	 	 	 	 	 	2.14E-02	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MYL9	-0.401	other	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NUP205	 	other	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ROCK1	-0.332	kinase	 	 	 	 	 	2.14E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RP11_770J14	 	other	 	 	 	 	 	2.14E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RUNX1T1	 	transcription regulator	 	 	 	 	 	2.14E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SFTPC	 	other	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SLC39A6	 	transporter	 	 	 	 	 	2.14E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TCRB V3 (family)	 	group	 	 	 	 	 	2.14E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	USP26	 	peptidase	 	 	 	 	 	2.14E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	VEGFD	 	growth factor	 	 	 	 	 	2.14E-02	MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	WDR77	 	transcription regulator	 	 	 	 	 	2.14E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-144	 	microrna	 	 	 	 	 	2.14E-02	SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ISG15	-1.868	other	 	 	 	 	 	2.25E-02	IFIT1,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PDCD1	 	transmembrane receptor	 	 	 	 	 	2.25E-02	GZMB,HRH4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TGFB1	-0.696	growth factor	 	0.310	 	-0.235	0.786	2.29E-02	ADAM19,CCN2,CCR7,CD44,MMP12,POSTN,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL12 (complex)	 	complex	 	 	 	 	 	2.35E-02	CD44,CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	YAP1	 	transcription regulator	 	1.448	 	-0.147	1.798	2.37E-02	ADAM19,CCN2,CD44,IFIT1,IFIT2,PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CLIC1	 	ion channel	 	 	 	 	 	2.37E-02	ISG15,MAPKAPK3,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TEAD3	 	transcription regulator	 	 	 	 	 	2.45E-02	CCN2,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	VEGFA	 	growth factor	 	 	 	 	 	2.45E-02	CD44,MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HIF1A	-0.535	transcription regulator	 	0.574	bias	-0.304	1.242	2.50E-02	CCN2,CD44,FHL3,PHGDH,RRAGB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RBM5	-0.262	other	 	 	 	 	 	2.55E-02	CD69,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ABHD5	 	enzyme	 	 	 	 	 	2.66E-02	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CRBN	 	enzyme	 	 	 	 	 	2.66E-02	IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CRTC1	 	transcription regulator	 	 	 	 	 	2.66E-02	PER1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DDOST	 	enzyme	 	 	 	 	 	2.66E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ESRP1	 	other	 	 	 	 	 	2.66E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FBXL8	 	other	 	 	 	 	 	2.66E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FOXL1	0.758	transcription regulator	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GPR37	 	g-protein coupled receptor	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HAS1	-2.120	enzyme	 	 	 	 	 	2.66E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HERC5	-1.501	enzyme	 	 	 	 	 	2.66E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HOXA4	 	transcription regulator	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL31RA	-1.543	transmembrane receptor	 	 	 	 	 	2.66E-02	CISH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	KIRREL1	 	other	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LBP	 	transporter	 	 	 	 	 	2.66E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LINC02159	 	other	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	LOC124902114	 	other	 	 	 	 	 	2.66E-02	PDCD1LG2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MIR4270	 	microrna	 	 	 	 	 	2.66E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PSMD4	 	other	 	 	 	 	 	2.66E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PTPRB	 	transmembrane receptor	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PYCR2	 	enzyme	 	 	 	 	 	2.66E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RAD51AP1	 	other	 	 	 	 	 	2.66E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNF5	 	enzyme	 	 	 	 	 	2.66E-02	FDFT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	S100A16	-0.332	other	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STK39	0.246	kinase	 	 	 	 	 	2.66E-02	CLDN3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNKS/TNKS2 (family)	 	group	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TOLLIP	 	other	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	VASN	 	other	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	VGLL4	 	other	 	 	 	 	 	2.66E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IL13	-1.903	cytokine	Inhibited	-2.000	 	-0.110	-1.780	2.70E-02	CCL18,CD1B,CISH,RFTN1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	STK11	 	kinase	 	 	 	 	 	2.97E-02	CCN2,IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ARF6	 	transporter	 	 	 	 	 	3.19E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CNIH4	 	other	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CWF19L1	-0.145	other	 	 	 	 	 	3.19E-02	GZMB	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DBT	 	enzyme	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DLX6-AS1	 	other	 	 	 	 	 	3.19E-02	WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ETV7	-0.479	transcription regulator	 	 	 	 	 	3.19E-02	IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	F10	 	peptidase	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HADHA	 	enzyme	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HADHB	 	enzyme	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HMGCR	0.287	enzyme	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	KHDRBS1	 	transcription regulator	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	KLF13	-0.138	transcription regulator	 	 	 	 	 	3.19E-02	IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MAP2K4/7 (family)	 	group	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NODAL	 	growth factor	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PLK2	 	kinase	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRKCZ	 	kinase	 	 	 	 	 	3.19E-02	PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PRPF19	 	enzyme	 	 	 	 	 	3.19E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RARS1	 	enzyme	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SPIB	-1.902	transcription regulator	 	 	 	 	 	3.19E-02	IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TGFBR (family)	 	group	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNFRSF8	-1.246	transmembrane receptor	 	 	 	 	 	3.19E-02	IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRAF3IP2	 	enzyme	 	 	 	 	 	3.19E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM29	 	transcription regulator	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	USP51	0.975	peptidase	 	 	 	 	 	3.19E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	WAC	 	other	 	 	 	 	 	3.19E-02	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	USP7	 	peptidase	 	 	 	 	 	3.20E-02	IFIT3,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GATA3	 	transcription regulator	 	 	 	 	 	3.43E-02	CCN2,CCR3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NCOA3	 	transcription regulator	 	 	 	 	 	3.54E-02	CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TEAD1	 	transcription regulator	 	 	 	 	 	3.54E-02	CCN2,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	NFKB1	 	transcription regulator	 	 	 	 	 	3.65E-02	CCN2,CD44,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	histone H3	 	group	 	 	 	 	 	3.69E-02	CCR3,CD69,PCDHA12,RSAD2,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AKR1B10	 	enzyme	 	 	 	 	 	3.71E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ASB14	0.563	other	 	 	 	 	 	3.71E-02	PIP4K2A	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ATP6V1C2	0.486	transporter	 	 	 	 	 	3.71E-02	SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BACC1	 	other	 	 	 	 	 	3.71E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CCN3	 	growth factor	 	 	 	 	 	3.71E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DEK	-0.233	transcription regulator	 	 	 	 	 	3.71E-02	CEBPE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GRB10	 	other	 	 	 	 	 	3.71E-02	MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HOXC-AS3	 	other	 	 	 	 	 	3.71E-02	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IGF2R	-0.362	transmembrane receptor	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ISG20L2	-0.356	enzyme	 	 	 	 	 	3.71E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ITGA5	-1.088	transmembrane receptor	 	 	 	 	 	3.71E-02	GAS1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	KLF1	 	transcription regulator	 	 	 	 	 	3.71E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PSEN1	 	peptidase	 	 	 	 	 	3.71E-02	FDFT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PTGER2	 	g-protein coupled receptor	 	 	 	 	 	3.71E-02	CCR7	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RAB27B	 	enzyme	 	 	 	 	 	3.71E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RARG	 	ligand-dependent nuclear receptor	 	 	 	 	 	3.71E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RASGRP1	-0.266	other	 	 	 	 	 	3.71E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RASSF8	0.498	other	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RBCK1	-0.592	transcription regulator	 	 	 	 	 	3.71E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SIRT2	 	transcription regulator	 	 	 	 	 	3.71E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TCTN1	0.787	other	 	 	 	 	 	3.71E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ULBP1	 	transmembrane receptor	 	 	 	 	 	3.71E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	XRCC6	 	enzyme	 	 	 	 	 	3.71E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF100	 	transcription regulator	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF254	 	transcription regulator	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF429	 	transcription regulator	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF43	0.176	other	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF431	 	transcription regulator	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF528	 	other	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF665	 	other	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF708	 	other	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF85	0.313	transcription regulator	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF91	 	transcription regulator	 	 	 	 	 	3.71E-02	POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	mir-205 (includes others)	 	microrna	 	 	 	 	 	3.71E-02	SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	WWTR1	 	transcription regulator	 	 	 	 	 	3.72E-02	ADAM19,CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CD274	-1.438	transmembrane receptor	 	 	 	 	 	3.78E-02	IFIT1,IFIT3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNKS1BP1	 	other	 	 	 	 	 	3.78E-02	CCN2,CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RRAS2	 	enzyme	 	 	 	 	 	3.79E-02	OASL,POSTN,RSAD2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ERK1/2	 	group	 	 	 	 	 	3.86E-02	CCR7,CD44,IFIT1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GROWTH HORMONE (family)	 	group	 	 	 	 	 	3.90E-02	CISH,PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PIWIL4	 	other	 	 	 	 	 	3.93E-02	GAPT,LRRC61,MCOLN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SMARCAL1	 	enzyme	 	 	 	 	 	4.07E-02	CYP51A1,FDFT1,PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RELA	 	transcription regulator	 	 	 	 	 	4.20E-02	CCR7,CD44,HSD11B2,IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BACH2	0.353	transcription regulator	 	 	 	 	 	4.23E-02	IRF4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DPYSL2	 	enzyme	 	 	 	 	 	4.23E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	DVL3	-0.121	other	 	 	 	 	 	4.23E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FAM210A	 	other	 	 	 	 	 	4.23E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FC GAMMA RECEPTOR (family)	 	group	 	 	 	 	 	4.23E-02	CCL18	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GAPVD1	0.212	other	 	 	 	 	 	4.23E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	GAST	 	other	 	 	 	 	 	4.23E-02	SLC9A3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HDAC11	 	transcription regulator	 	 	 	 	 	4.23E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HERC3	 	enzyme	 	 	 	 	 	4.23E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HTRA4	-0.495	peptidase	 	 	 	 	 	4.23E-02	MAP2K6	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ITCH	 	enzyme	 	 	 	 	 	4.23E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ITGAL	-0.705	transmembrane receptor	 	 	 	 	 	4.23E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PCM1-JAK2	 	fusion gene/product	 	 	 	 	 	4.23E-02	SLC26A4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PLAAT4	 	enzyme	 	 	 	 	 	4.23E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RNF40	 	enzyme	 	 	 	 	 	4.23E-02	PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SLC4A7	 	transporter	 	 	 	 	 	4.23E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TFCP2	 	transcription regulator	 	 	 	 	 	4.23E-02	HS3ST3A1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNFSF9	 	cytokine	 	 	 	 	 	4.23E-02	CCR7	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TNIP1	 	other	 	 	 	 	 	4.23E-02	ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM25	-0.874	enzyme	 	 	 	 	 	4.23E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	XIST	 	other	 	 	 	 	 	4.23E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	EIF2AK2	-0.342	kinase	 	 	 	 	 	4.28E-02	IFIT1,ISG15	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	RXRA	 	ligand-dependent nuclear receptor	 	 	 	 	 	4.28E-02	FABP6,HSD11B2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	BACH1	-0.506	transcription regulator	 	 	 	 	 	4.40E-02	CD44,PDK4	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	FTO	0.365	enzyme	 	 	 	 	 	4.44E-02	CD44,ISG15,LRRC61	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IgG	 	complex	 	 	 	 	 	4.51E-02	CD1B,ISG15,MMP12	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CDX2	 	transcription regulator	 	 	 	 	 	4.53E-02	HEPH,HOXA3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HSP90 (family)	 	group	 	 	 	 	 	4.66E-02	CD44,CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TARDBP	 	transcription regulator	 	 	 	 	 	4.66E-02	CEBPE,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	AAMDC	 	other	 	 	 	 	 	4.74E-02	PHGDH	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ADORA2B	 	g-protein coupled receptor	 	 	 	 	 	4.74E-02	HSD11B2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CDCP1	 	other	 	 	 	 	 	4.74E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	CLPP	-0.157	peptidase	 	 	 	 	 	4.74E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HDAC7	-0.260	transcription regulator	 	 	 	 	 	4.74E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HJURP	 	other	 	 	 	 	 	4.74E-02	WEE1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	IRX3	0.523	transcription regulator	 	 	 	 	 	4.74E-02	HOXA3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	L1CAM	 	other	 	 	 	 	 	4.74E-02	SQLE	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PGK1	-0.285	kinase	 	 	 	 	 	4.74E-02	MAP2K6	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PIEZO1	 	ion channel	 	 	 	 	 	4.74E-02	CD69	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PIP5K1C	-0.155	kinase	 	 	 	 	 	4.74E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PPP2R5D	 	phosphatase	 	 	 	 	 	4.74E-02	FABP6	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	PTGER4	 	g-protein coupled receptor	 	 	 	 	 	4.74E-02	CCR7	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	S1PR3	 	g-protein coupled receptor	 	 	 	 	 	4.74E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	SETD2	 	enzyme	 	 	 	 	 	4.74E-02	CCN2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TREM2	 	transmembrane receptor	 	 	 	 	 	4.74E-02	P2RY13	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TRIM38	-0.689	enzyme	 	 	 	 	 	4.74E-02	IFIT2	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZAP70	-0.454	kinase	 	 	 	 	 	4.74E-02	CCR7	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZMYND8	 	transcription regulator	 	 	 	 	 	4.74E-02	HOXA3	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	ZNF567-DT	 	other	 	 	 	 	 	4.74E-02	CD44	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MRTFB	 	transcription regulator	 	 	 	 	 	4.93E-02	CCN2,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	MYOC	 	other	 	 	 	 	 	4.93E-02	CD44,SFRP1	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	TEAD4	-0.331	transcription regulator	 	 	 	 	 	4.93E-02	CCN2,POSTN	 	
nasal_5k_ipa - 2025-12-01 12:15 PM	 	HISTONE H4 (family)	 	group	 	 	 	 	 	4.93E-02	CD69,SFRP1	 	

Causal Networks for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Master Regulator	Molecule Type	Expr Log Ratio	Depth	Predicted Activation State	Notes	Activation z-score	p-value of overlap	Network bias-corrected p-value	Participating regulators	Target molecules in dataset	Causal network	Target-connected regulators	Relationships Between Master Regulators(Increases/Downstream)	Relationships Between Master Regulators(Decreases/Downstream)	Relationships Between Master Regulators(Affects/Downstream)	Relationships Between Master Regulators(Increases/Upstream)	Relationships Between Master Regulators(Decreases/Upstream)	Relationships Between Master Regulators(Affects/Upstream)	Relationships Between Master Regulators(Increases/Both)	Relationships Between Master Regulators(Decreases/Both)	Relationships Between Master Regulators(Affects/Both)	
AHI1	other	 	3	Activated	biased	3.153	1.31E-09	3.00E-03	AHI1,BTK,ERK (family),ERK1/2 (family),HCK,P38 MAPK (family),PRKCD,RIPK2	CCN2,CCR7,CD44,CD69,CISH,IFIT1,IFIT2,IFIT3,IRF4,ISG15,MMP12,MS4A1,OASL,PDK4,POSTN,RSAD2,SPIB	17 (8)	7	 	 	 	 	HCK	 	 	 	 	
PELI2	enzyme	 	2	 	 	0.905	4.28E-09	6.00E-04	ERK (family),IRF3,JNK (family),PELI2	CCN2,CCR7,IFIT1,IFIT2,IFIT3,ISG15,MMP12,MS4A1,PDK4,POSTN,RSAD2	11 (4)	4	 	IFN BETA (family)	 	 	IRF3	 	 	 	 	
RNY3	other	 	1	Inhibited	biased	-2.449	5.79E-09	1.00E-04	RNY3	IFIT1,IFIT3,ISG15,OASL,OTOF,RSAD2	6 (1)	1	 	 	 	 	 	 	 	 	 	
HCK	kinase	-1.128	2	Inhibited	biased	-3.000	5.80E-09	7.10E-03	BTK,ERK (family),ERK1/2 (family),HCK,P38 MAPK (family),PRKCD,RIPK2	CCN2,CCR7,CD44,CD69,CISH,IFIT1,IFIT2,IFIT3,IRF4,ISG15,MMP12,MS4A1,OASL,PDK4,POSTN,RSAD2	16 (7)	6	PRKCA	AHI1	 	BCR-ABL1,BTK,RIPK2	 	 	 	 	 	
BTK	kinase	-1.268	1	Inhibited	biased	-2.646	9.07E-09	2.00E-04	BTK	CCR7,CD69,CISH,IFIT1,IFIT3,IRF4,ISG15	7 (1)	1	GAST,HCK,MAVS,STING1	 	 	INTERFERON ALPHA (family),IRF1,IRF9,STAT1	 	 	 	 	 	
IFNL1	cytokine	 	2	Inhibited	biased	-3.207	9.87E-09	1.60E-03	IFNL1,PABIR1,STAT1,STAT3,STAT5A/B (family)	CCN2,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,OASL,PDCD1LG2,RFTN1,RSAD2,WEE1	14 (5)	5	IL27,INTERFERON ALPHA (family),IRF1,IRF3,LINC02574,MAVS,NONO,SOCS1,STING1,TICAM1,TLR9	PRMT7,ZNF750	 	IFIH1,IRF9,PABIR1,STAT1,STAT2,STAT5A/B (family),USP18	 	 	 	 	 	
MARCHF5	enzyme	 	3	Activated	biased	3.357	1.58E-08	4.80E-03	IL2RG,MARCHF5,NFKB1,STAT1,STAT3,STAT5A/B (family),STING1	CCN2,CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,OASL,PDCD1LG2,RFTN1,RSAD2	15 (7)	5	 	 	 	 	IL2RG,STING1	 	 	 	 	
FAM222A	other	 	1	Inhibited	biased	-2.000	2.76E-08	1.00E-04	FAM222A	IFIT2,ISG15,OASL,RSAD2	4 (1)	1	 	 	 	IFNB1,STAT1,STAT2	 	 	 	 	 	
MAPK15	kinase	0.835	3	 	 	-0.728	2.78E-08	1.82E-02	CASP3,ERK (family),HIF1A,IRF3,JNK (family),JUN,MAPK15,MEK (family),RB1,TBK1,TERT	CCN2,CCR7,CD44,FHL3,IFIT1,IFIT2,IFIT3,ISG15,MMP12,MS4A1,OASL,PDK4,PER1,PHGDH,POSTN,RRAGB,RSAD2	17 (11)	10	 	 	 	TERT	 	 	 	 	 	
GAST	other	 	2	Inhibited	 	-2.530	3.60E-08	1.90E-03	AKT (family),CASP3,GAST,PRKCA	CCN2,CD44,IFIT1,IFIT3,ISG15,MMP12,OASL,PDK4,RSAD2,SLC9A3	10 (4)	4	 	 	 	BTK,PRKCA	CASP3	 	 	 	 	
TREX1	enzyme	 	1	Activated	biased	2.828	3.88E-08	2.00E-04	TREX1	CD44,IFIT1,IFIT2,IFIT3,IRF4,ISG15,OASL,RSAD2	8 (1)	1	CHROMR,F3,IFNA2	 	 	PARP1	CCL5,IFIH1,IL5,MAVS,USP18	 	 	 	 	
interferon alpha	group	 	2	Inhibited	biased	-2.357	4.48E-08	3.47E-02	INTERFERON ALPHA (family),JNK (family),NFKB (complex),P38 MAPK (family),RB1,STAT1,STAT3,STAT5A/B (family)	ADAM19,CCN2,CCR7,CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,IRF4,ISG15,MMP12,PDCD1LG2,PER1,RFTN1,RSAD2	18 (8)	8	BTK,MAVS,TLR9	PRMT7,RNF216,RTCB,SOCS1	 	CASP3,CGAS,IFIH1,IFN BETA (family),IFNB1,IFNL1,IL27,IRF1,IRF3,LBP,SPRY2,STAT1,STAT2,TICAM1	FOS,IFNAR1,STAT5A/B (family)	 	 	 	 	
JAK	group	 	1	Inhibited	biased	-2.236	4.55E-08	1.00E-04	JAK (family)	IFIT1,IFIT2,IFIT3,ISG15,RSAD2	5 (1)	1	 	 	 	IFIH1,IFNA1/IFNA13,STAT1	 	 	 	 	 	
LIFR	transmembrane receptor	-0.336	3	Inhibited	 	-2.236	5.01E-08	2.76E-02	AKT (family),ERK1/2 (family),JAK1,LIFR,MAPK1,STAT1,STAT2,STAT3,STAT5A/B (family),TP63	CCN2,CCR7,CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,OASL,PDCD1LG2,PDK4,PHGDH,POSTN,RFTN1,RSAD2,WEE1	20 (10)	9	 	 	 	STAT1	 	 	 	 	 	
CTLA4	transmembrane receptor	-0.681	2	 	 	0.577	7.95E-08	2.90E-03	AKT (family),CTLA4,MAPK1,ZAP70	CCN2,CCR7,CD44,GZMB,HRH4,IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,PDK4	12 (4)	4	USP8	PARP1	 	 	IL3RA,KPNA2	 	 	 	 	
ETV6-RUNX1	fusion gene/product	 	3	Activated	biased	2.887	1.02E-07	1.40E-03	ETV6-RUNX1,IRF3,STAT1	ANO1,EMP3,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MS4A1,PDCD1LG2,RSAD2,SPIB	12 (3)	3	 	 	 	 	ALOX5,CCL5,IRF1,IRF3,TNFRSF14	 	 	 	 	
PDCD4	other	 	3	 	biased	1.000	1.23E-07	2.53E-02	CASP3,ERK (family),HIF1A,JNK (family),JUN,MEK (family),PDCD4,STAT1	CCN2,CCR7,CD44,FHL3,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,MS4A1,PDCD1LG2,PDK4,PHGDH,POSTN,RRAGB	16 (8)	7	IFNA2,IFNB1	 	 	CASP3,COL3A1	 	 	 	 	 	
RC3H1	enzyme	-0.209	1	Activated	biased	2.449	1.28E-07	9.00E-04	RC3H1	CD44,IFIT1,IFIT2,IFIT3,ISG15,RSAD2	6 (1)	1	 	 	 	 	IRF1,IRF9,STAT1,STAT2,STING1	 	 	 	 	
CGAS	enzyme	-0.642	1	Inhibited	biased	-2.449	1.47E-07	3.00E-04	CGAS	IFIT1,IFIT2,IFIT3,ISG15,MMP12,RSAD2	6 (1)	1	INTERFERON ALPHA (family)	BANF1,FGFR2,IRGM,SPSB3,ZNF750	 	IFN BETA (family),IFNB1,IRF1,IRF3,STAT1,STAT2,STING1	 	 	 	 	 	
IL5	cytokine	1.076	2	 	 	-1.069	1.51E-07	1.52E-02	AKT (family),ERK1/2 (family),IL5,MAPK (family),MAPK1,STAT5A/B (family)	CCN2,CCR7,CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,PDK4,RFTN1	14 (6)	6	IL2,IL4	IFNA2,TREX1	 	CSF2RB,DUSP6,FCGR2B,IL3RA,STAT5A/B (family)	 	 	 	 	 	
IRS2	enzyme	 	2	Inhibited	biased	-3.162	1.68E-07	3.20E-03	AKT (family),IRS2,STAT1	CCN2,CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4	10 (3)	2	IL2,IL4	SOCS1	 	STAT1	 	 	 	 	 	
EIF2AK4	kinase	 	2	 	 	0.632	1.76E-07	2.90E-03	AKT (family),EIF2AK4,STAT1	CCN2,CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4	10 (3)	2	 	 	 	PARP1,PRDM1,PSEN1	STAT1	 	 	 	 	
ZNF750	transcription regulator	 	1	Activated	biased	2.646	1.77E-07	6.00E-04	ZNF750	IFIT1,IFIT2,IFIT3,IRF4,ISG15,OASL,RSAD2	7 (1)	1	SETX	FOXC1	 	 	CCL5,CGAS,IFIH1,IFNB1,IFNL1,IRF1,STAT1,STAT2	 	 	 	 	
DUSP6	phosphatase	 	2	Activated	 	2.309	1.77E-07	1.55E-02	DUSP6,ERK (family),ERK1/2 (family),PGR	CCN2,CCR7,HSD11B2,IFIT1,IFIT2,IFIT3,ISG15,MS4A1,OASL,PDK4,POSTN,RSAD2	12 (4)	3	CCL5,IL5	 	 	PGR	 	 	 	 	 	
IL2RG	transmembrane receptor	-0.822	2	Inhibited	biased	-2.887	1.83E-07	5.70E-03	IL2RG,JAK1,STAT1,STAT3,STAT5A/B (family)	CCN2,CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,RFTN1	12 (5)	4	 	MARCHF5	 	STAT1,STAT5A/B (family)	 	 	 	 	 	
RPSA	translation regulator	 	1	Activated	biased	2.236	2.03E-07	3.00E-04	RPSA	IFIT1,IFIT2,IFIT3,ISG15,OASL	5 (1)	1	 	 	 	TERT	CASP3,STAT1	 	 	 	 	
IL22	cytokine	 	2	Inhibited	biased	-3.606	2.16E-07	1.15E-02	AKT (family),IL22,STAT1,STAT3,STAT5A/B (family)	CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4,RFTN1	13 (5)	4	IL2,STING1	RNASEH2B	 	LBP,STAT1,STAT5A/B (family)	 	 	 	 	 	
IRF1	transcription regulator	-0.629	1	Inhibited	biased	-2.646	2.31E-07	9.00E-04	IRF1	IFIT1,IFIT2,IFIT3,ISG15,OASL,PDCD1LG2,RSAD2	7 (1)	1	BTK,CGAS,FEN1,FOXC1,IFNA2,IFNB1,INTERFERON ALPHA (family),PBRM1,PRL,STAT1,TLR7,TLR9	BANF1,CHROMR,ETV6-RUNX1,RC3H1,RNASEH2B,TREM1,UBE2I,ZNF750	 	CASP3,CCL5,IFIH1,IFNA1/IFNA13,IFNL1,IRF9	 	 	 	 	 	
IL27	cytokine	-1.148	1	Inhibited	biased	-2.828	2.34E-07	2.00E-03	IL27	CD69,GZMB,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	8 (1)	1	IFN BETA (family),IFNB1,INTERFERON ALPHA (family)	RNASEH2B	 	ADAR,CCL5,IFNA2,IFNL1,IL27RA,IRF9,SOCS1,STAT1,STAT2	FOS	 	 	 	 	
OSBPL9	other	 	2	Inhibited	biased	-2.828	2.49E-07	3.10E-03	OSBPL9,STING1	IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,RSAD2,SQLE	8 (2)	2	 	 	 	STING1	 	 	 	 	 	
FES	kinase	-0.651	2	Activated	biased	2.887	3.08E-07	7.30E-03	FES,SRRM1,STAT1,STAT3,STAT5A/B (family)	CCN2,CD44,CD69,CISH,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,RFTN1	12 (5)	4	 	 	 	 	STAT1,STAT5A/B (family)	 	 	 	 	
USP37	peptidase	 	3	Activated	 	2.668	3.51E-07	2.73E-02	BLM,ERK (family),JNK (family),MYC,P38 MAPK (family),RB1,USP37	CCR7,CD44,HSD11B2,IFIT1,IFIT2,IFIT3,IRF4,MMP12,MS4A1,OASL,PDK4,PER1,POSTN,RFTN1,RSAD2,WEE1,ZBTB16	17 (7)	7	 	 	 	 	 	 	 	 	 	
IRF9	transcription regulator	-0.834	1	Inhibited	biased	-2.000	3.82E-07	7.00E-04	IRF9	IFIT1,IFIT2,IFIT3,ISG15	4 (1)	1	BTK,IFNA2,IFNB1,IFNL1,IL27,IRF1,PBRM1,PRL,RIPK2,STING1,TGM2,TLR7,TLR9,TWIST1	BANF1,ETV3,IRGM,RC3H1,STAG2	 	STAT2	 	 	 	 	 	
STAT2	transcription regulator	-0.619	1	Activated	 	2.000	3.82E-07	2.00E-04	STAT2	IFIT1,IFIT2,ISG15,RSAD2	4 (1)	1	CGAS,CHROMR,FAM222A,FEN1,FOXC1,IFN BETA (family),IFNA1/IFNA13,IFNA2,IFNAR1,IFNB1,IFNL1,IFNL4,IL27,INTERFERON ALPHA (family),IRF9,MAVS,NONO,PRL,RIPK2,STING1	BANF1,ETV3,ETV6,F3,FGFR2,IRGM,RC3H1,SOCS1,USP8,ZNF750	 	 	USP18	 	 	 	 	
interferon alpha	group	 	1	Inhibited	biased	-2.828	3.89E-07	1.60E-03	INTERFERON ALPHA (family)	ADAM19,GZMB,IFIT1,IFIT2,IFIT3,IRF4,ISG15,RSAD2	8 (1)	1	BTK,MAVS,TLR9	PRMT7,RNF216,RTCB,SOCS1	 	CASP3,CGAS,IFIH1,IFN BETA (family),IFNB1,IFNL1,IL27,IRF1,IRF3,LBP,SPRY2,STAT1,STAT2,TICAM1	FOS,IFNAR1,STAT5A/B (family)	 	 	 	 	
CK2	complex	 	2	 	 	0.905	4.04E-07	1.55E-02	CD5,CK2 (complex),PGR,PTEN,SERPINF1,TBK1	CCN2,CD44,GZMB,HSD11B2,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2,SQLE	11 (6)	5	 	 	 	PGR	 	 	 	 	 	
PHLPP2	enzyme	 	2	Activated	 	3.000	4.37E-07	7.60E-03	AKT (family),PHLPP2,PRKCA	CCN2,CD44,IFIT1,IFIT3,ISG15,MMP12,OASL,PDK4,RSAD2	9 (3)	2	 	 	 	 	PRKCA	 	 	 	 	
ALOX5	enzyme	-0.983	3	Activated	 	2.065	4.56E-07	3.41E-02	ALOX5,EIF2A,ERK (family),IFNAR1,JNK (family),MYC,P38 MAPK (family),RB1	CCR7,CD44,HSD11B2,IFIT1,IFIT2,IFIT3,IRF4,ISG15,MAP2K6,MMP12,MS4A1,OASL,PCDHA12,PDK4,PER1,POSTN,PRSS33,RSAD2,WEE1	19 (8)	7	 	ETV6-RUNX1	 	 	 	 	 	 	 	
LHPP	phosphatase	 	2	Activated	biased	3.162	5.27E-07	8.50E-03	AKT (family),LHPP,STAT1	CCN2,CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4	10 (3)	2	 	 	 	 	STAT1	 	 	 	 	
LINC00624	other	 	1	Activated	biased	2.000	5.50E-07	6.00E-04	LINC00624	IFIT1,IFIT2,IFIT3,ISG15	4 (1)	1	 	 	 	ADAR	IRF3,STAT1	 	 	 	 	
PPT1	enzyme	-0.267	2	 	 	-0.707	5.56E-07	4.60E-03	AKT (family),CASP3,IRF3,PPT1	CCN2,CD44,IFIT1,IFIT2,IFIT3,MMP12,PDK4,RSAD2	8 (4)	3	 	 	 	 	CASP3,IRF3,STING1	 	 	 	 	
ATXN3	peptidase	-0.149	1	 	biased	-1.732	6.06E-07	3.00E-04	ATXN3	IFIT1,IFIT2,ISG15	3 (1)	1	 	 	 	STAT1	 	 	 	 	 	
MAPKAP1	other	 	2	Inhibited	biased	-3.162	6.40E-07	1.17E-02	AKT (family),MAPKAP1,STAT1	CCN2,CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4	10 (3)	2	 	 	 	STAT1	 	 	 	 	 	
IL11	cytokine	0.829	2	 	 	-1.941	6.63E-07	2.90E-02	ERK (family),GSK3B,IL11,STAT1,STAT3	ADAM19,CCN2,CD44,GZMB,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MS4A1,PDCD1LG2,PDK4,POSTN	13 (5)	5	FOS,MAVS,PBRM1,STING1	RNASEH2B	 	STAT1	 	 	 	 	 	
CIP2A	other	-0.260	3	 	 	1.732	7.39E-07	3.87E-02	ATRX,CIP2A,CTNNB1,ERK (family),ESTROGEN RECEPTOR (family),GSK3B,HMGA1,IRF3,LMNA,MTORC1 (complex),MYC,NELFE,PP2A (complex),PSEN1,RELA,SREBF1,SRRM1,STAT1,STAT3,STAT5A/B (family),TP53	ADAM19,CD44,CD69,CISH,CLDN3,CYP51A1,FDFT1,GZMB,HSD11B2,IFIT1,IFIT2,IL31RA,IRF4,ISG15,LXN,MAP2K6,MS4A1,OASL,PDCD1LG2,PDK4,PHGDH,POSTN,RFTN1,RSAD2,SCNN1B,SQLE,WEE1	27 (21)	17	 	 	 	ATRX	CDKN2B	 	 	 	 	
RACK1	enzyme	 	1	Activated	 	2.000	7.67E-07	1.00E-04	RACK1	IFIT2,IFIT3,ISG15,RSAD2	4 (1)	1	 	 	 	 	CCL5,IFNB1,IRF3	 	 	 	 	
UBE2I	enzyme	 	2	 	 	0.632	8.04E-07	1.12E-02	AKT (family),STAT1,UBE2I	CCN2,CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4	10 (3)	3	 	 	 	 	IRF1,STAT1	 	 	 	 	
FCGR2B	transmembrane receptor	-0.686	2	Activated	 	3.162	8.35E-07	1.07E-02	AKT (family),FCGR2B,STAT1	CCN2,CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4	10 (3)	2	IL5,SPI1	IL4	 	 	CCL5,STAT1	 	 	 	 	
CDKN1B	other	-0.295	3	 	 	-1.091	9.04E-07	2.64E-02	AKT (family),CASP3,CCNA2,CDK2,CDKN1B,CTNNB1,CYCLIN E (family),EGFR,ERK (family),LMNA,MEK (family),MYC,NPM1,RB1,SMARCA4,SNAI1,SNAI2,STAT1	ANO1,CCN2,EMP3,FABP6,GZMB,HEPH,HSD11B2,IFIT2,IFIT3,IL31RA,IRF4,ISG15,MMP12,MS4A1,PDCD1LG2,PDK4,PER1,POSTN,SCNN1B,TNNC2,WEE1	21 (18)	13	BCR-ABL1,PRKCA,STAT5A/B (family)	BANF1,IL4,PRL	 	TWIST1	CASP3	 	 	 	 	
TAFAZZIN	enzyme	-0.256	2	 	 	1.633	9.36E-07	2.20E-03	IRF3,TAFAZZIN	CCN2,CD44,IFIT1,IFIT2,ISG15,RSAD2	6 (2)	2	 	 	 	 	IRF3	 	 	 	 	
SPRY2	other	0.228	2	 	 	-0.775	9.66E-07	4.74E-02	AKT (family),ERK (family),ERK1/2 (family),HIF1A,MAPK1,PTEN,SPRY2	CCR7,CD44,FHL3,IFIT1,IFIT2,IFIT3,ISG15,MMP12,MS4A1,OASL,PDK4,PHGDH,POSTN,RRAGB,SQLE	15 (7)	6	IFN BETA (family),INTERFERON ALPHA (family),TREM1	 	 	IL4	 	 	 	 	 	
PGR	ligand-dependent nuclear receptor	-0.931	1	Activated	 	2.121	1.03E-06	2.10E-03	PGR	CD44,HSD11B2,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	8 (1)	1	CK2 (complex),DUSP6,PRKCA	 	 	F3	STAT1	 	 	 	 	
PCBP2	other	 	2	 	biased	1.890	1.25E-06	3.60E-03	MAVS,PCBP2	CCN2,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	7 (2)	2	 	 	 	PARP1	MAVS	 	 	 	 	
USP8	peptidase	 	2	 	 	1.265	1.29E-06	9.80E-03	CTLA4,CTNNB1,ERBB3,F2RL1,USP8	CCN2,CD44,GZMB,HRH4,IFIT1,IFIT2,IFIT3,ISG15,PHGDH,SCNN1B	10 (5)	5	 	PRKCA	 	CTLA4	IRGM,STAT1,STAT2	 	 	 	 	
TLR9	transmembrane receptor	 	1	Inhibited	biased	-2.449	1.37E-06	5.00E-03	TLR9	CCR7,CD69,IFIT1,IFIT3,IRF4,ISG15	6 (1)	1	 	RNF216	 	CCL5,IFN BETA (family),IFNB1,IFNL1,IL4,INTERFERON ALPHA (family),IRF1,IRF9,LTA,PRDM1,STAT1	TLR7	 	 	 	 	
RNF5	enzyme	 	2	Activated	biased	2.646	1.62E-06	3.70E-03	MAVS,RNF5	FDFT1,IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	7 (2)	2	 	 	 	 	MAVS	 	 	 	 	
CDKN2B	transcription regulator	 	3	 	 	1.667	1.72E-06	2.29E-02	ATM,CASP3,CDKN2B,IRF3,RB1,TBK1,TERT	CCN2,IFIT1,IFIT2,IFIT3,ISG15,OASL,PER1,PHGDH,RSAD2	9 (7)	7	 	CIP2A,TREM1	 	 	TERT	 	 	 	 	
TAFAZZIN	enzyme	-0.256	1	 	biased	1.000	1.80E-06	1.80E-03	TAFAZZIN	CCN2,CD44,IFIT1,IFIT2	4 (1)	1	 	 	 	 	IRF3	 	 	 	 	
F3	transmembrane receptor	 	2	Activated	biased	3.162	1.95E-06	1.62E-02	F10,F3,IRF3,STAT1,STING1	CCN2,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,OASL,PDCD1LG2,RSAD2	10 (5)	5	GP6,PGR,TREM1	 	 	TREX1	ADAR,CCL5,IFIH1,IRF3,STAT1,STAT2,STING1,USP18	 	 	 	 	
SOCS1	other	-1.072	1	Activated	biased	2.236	2.07E-06	2.70E-03	SOCS1	IFIT1,IFIT2,ISG15,MMP12,RSAD2	5 (1)	1	IFNA2,IFNAR1,IL27,IL4,MAVS	BANF1	 	IFNL1	IFIH1,IFNB1,INTERFERON ALPHA (family),IRS2,STAT2,STAT6,TGM2	 	 	 	 	
STAG2	other	 	1	Activated	biased	2.236	2.07E-06	1.20E-03	STAG2	IFIT2,IFIT3,ISG15,OASL,RSAD2	5 (1)	1	 	 	 	 	IFIH1,IRF9,USP18	 	 	 	 	
IFNL1	cytokine	 	1	Inhibited	biased	-2.449	2.13E-06	4.10E-03	IFNL1	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	IL27,INTERFERON ALPHA (family),IRF1,IRF3,LINC02574,MAVS,NONO,SOCS1,STING1,TICAM1,TLR9	PRMT7,ZNF750	 	IFIH1,IRF9,PABIR1,STAT1,STAT2,STAT5A/B (family),USP18	 	 	 	 	 	
STING1	ion channel	 	2	Inhibited	biased	-3.162	2.30E-06	2.23E-02	NFKB1,STAT1,STING1	CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,OASL,PDCD1LG2,RSAD2	10 (3)	3	CGAS,OSBPL9	F3,MARCHF5,PPT1,RC3H1	 	BTK,CCL5,IFN BETA (family),IFNA1/IFNA13,IFNA2,IFNB1,IFNL1,IL11,IL22,IRF3,IRF9,STAT2,USP18	 	 	 	 	 	
BANF1	other	0.205	1	Activated	biased	2.449	2.31E-06	4.10E-03	BANF1	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	 	 	 	 	ADAR,CCL5,CDKN1B,CGAS,IFIH1,IFN BETA (family),IFNAR1,IFNB1,IRF1,IRF3,IRF9,SOCS1,STAT1,STAT2,TICAM1	 	 	 	 	
UBB	enzyme	0.223	2	 	 	1.667	2.44E-06	4.88E-02	JNK (family),JUN,MAP3K7,TRAF2,UBB	CCN2,CCR7,CD44,IFIT1,IFIT2,IFIT3,MMP12,OASL,WEE1	9 (5)	4	 	 	 	 	MAP3K7	 	 	 	 	
RIPK2	kinase	-0.495	1	Inhibited	biased	-2.449	2.51E-06	4.10E-03	RIPK2	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	HCK	 	 	IFIH1,IRF9,MAP3K7,STAT1,STAT2,USP18	 	 	 	 	 	
LBP	transporter	 	2	Inhibited	biased	-2.530	2.53E-06	3.45E-02	IRF3,JNK (family),LBP,P38 MAPK (family),STAT1	CCN2,CCR7,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,RSAD2	10 (5)	5	IL2,IL22,INTERFERON ALPHA (family)	 	 	IFN BETA (family),IRF3,STAT1	 	 	 	 	 	
ETV6-RUNX1	fusion gene/product	 	2	Activated	biased	2.333	2.54E-06	3.10E-03	ETV6-RUNX1,IRF3	ANO1,EMP3,GZMB,IFIT1,IFIT2,ISG15,MS4A1,RSAD2,SPIB	9 (2)	2	 	 	 	 	ALOX5,CCL5,IRF1,IRF3,TNFRSF14	 	 	 	 	
SNAPIN	other	 	2	Activated	biased	2.333	2.64E-06	1.60E-02	P38 MAPK (family),SNAPIN,STAT1	CCN2,CCR7,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2	9 (3)	2	 	 	 	 	IFNB1,STAT1	 	 	 	 	
CASP7	peptidase	 	2	 	 	1.667	2.74E-06	1.62E-02	CASP7,P38 MAPK (family),STAT1	CCN2,CCR7,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2	9 (3)	3	CHROMR	MAP3K7	 	 	STAT1	 	 	 	 	
SPI1	transcription regulator	-1.051	1	Inhibited	 	-2.449	2.95E-06	5.10E-03	SPI1	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	ADAR	 	 	FCGR2B,PRDM1,USP18	 	 	 	 	 	
STING1	ion channel	 	1	Inhibited	biased	-2.646	3.16E-06	1.16E-02	STING1	IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,RSAD2	7 (1)	1	CGAS,OSBPL9	F3,MARCHF5,PPT1,RC3H1	 	BTK,CCL5,IFN BETA (family),IFNA1/IFNA13,IFNA2,IFNB1,IFNL1,IL11,IL22,IRF3,IRF9,STAT2,USP18	 	 	 	 	 	
FCAR	transmembrane receptor	 	2	 	 	-1.897	3.27E-06	2.12E-02	ERK (family),FCAR,MAPK (family),MAPK1	CCN2,GZMB,IFIT1,IFIT2,IFIT3,ISG15,MS4A1,OASL,PDK4,POSTN	10 (4)	3	 	 	 	 	 	 	 	 	 	
FOS	transcription regulator	-1.526	3	Inhibited	biased	-2.828	3.31E-06	8.60E-03	CASP3,FOS,STAT1	CD44,IFIT1,IFIT2,IFIT3,IL31RA,IRF4,ISG15,PDCD1LG2	8 (3)	3	ADAP1,FOXC1,PRL	FGFR2,IL27,INTERFERON ALPHA (family)	 	IL11	CASP3,CCL5,CFLAR	 	 	 	 	
STEAP1	enzyme	 	2	 	 	1.414	3.31E-06	1.82E-02	AKT (family),CASP3,ERK (family),STEAP1	CCN2,CD44,IFIT3,ISG15,MMP12,MS4A1,PDK4,POSTN	8 (4)	3	 	 	 	CASP3	 	 	 	 	 	
PARP1	enzyme	 	2	Activated	 	3.162	3.81E-06	2.97E-02	AKT (family),IRF3,PARP1,STAT1	CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,MMP12,PDCD1LG2,PDK4,RSAD2	10 (4)	3	EIF2AK4,PCBP2,TERT,TREX1	 	 	 	CCL5,CTLA4,IFN BETA (family),IRF3,STAT1	 	 	 	 	
UCN	other	 	2	 	 	0.000	3.93E-06	2.45E-02	AKT (family),MAPK (family),MAPK1,UCN	CCN2,CD44,GZMB,IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,PDK4	10 (4)	3	 	 	 	 	 	 	 	 	 	
BCR-ABL1	fusion gene/product	 	2	 	 	0.905	4.17E-06	3.14E-02	BCR-ABL1,GSK3B,NFKB (complex),STAT1,STAT5A/B (family)	ADAM19,CCR7,CD69,CISH,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,RFTN1	11 (5)	4	HCK	 	 	CDKN1B,STAT5A/B (family)	IFNAR1,STAT1	 	 	 	 	
PCBP1	translation regulator	 	3	Activated	biased	2.646	4.18E-06	4.10E-03	CASP3,PCBP1,STAT1	CD44,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2	7 (3)	3	 	 	 	CASP3	 	 	 	 	 	
PSEN1	peptidase	 	3	 	biased	1.890	4.66E-06	4.40E-03	CASP3,PSEN1,STAT1	FDFT1,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2	7 (3)	3	EIF2AK4	 	 	CASP3	 	 	 	 	 	
TERT	enzyme	 	2	Inhibited	 	-2.121	4.90E-06	3.23E-02	ATM,CASP3,IRF3,RB1,TBK1,TERT	CCN2,IFIT1,IFIT2,IFIT3,ISG15,OASL,PER1,RSAD2	8 (6)	6	MAPK15,RPSA,TRRAP	CDKN2B	 	IFIH1,IFNB1,IRF3,PARP1	CASP3,TWIST1	 	 	 	 	
MARCHF8	enzyme	 	2	 	 	-0.378	5.47E-06	8.40E-03	AKT (family),MARCHF8,STAT5A/B (family)	CCN2,CD44,CD69,CISH,MMP12,PDK4,RFTN1	7 (3)	2	 	 	 	 	STAT5A/B (family)	 	 	 	 	
PLA2	group	 	2	Inhibited	biased	-2.121	5.79E-06	3.79E-02	P38 MAPK (family),PLA2 (family),PRKCA	CCN2,CCR7,IFIT1,IFIT3,ISG15,MMP12,OASL,RSAD2	8 (3)	2	 	 	 	PRKCA	 	 	 	 	 	
IFNA2	cytokine	 	1	Inhibited	biased	-2.449	6.20E-06	1.38E-02	IFNA2	CISH,IFIT1,IFIT2,IFIT3,ISG15,RSAD2	6 (1)	1	IL27,STING1	IRF3	 	IFIH1,IFNAR1,IFNB1,IL4,IRF1,IRF9,PABIR1,PDCD4,SOCS1,STAT1,STAT2,STAT5A/B (family),TREX1,USP18	IL5	 	 	 	 	
SLC15A4	transporter	-0.587	2	Inhibited	biased	-2.646	6.72E-06	7.00E-03	SLC15A4,STAT1	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,OASL,PDCD1LG2	7 (2)	2	 	 	 	CCL5,IFN BETA (family),STAT1,USP18	 	 	 	 	 	
TASL	enzyme	-1.630	2	Inhibited	biased	-2.646	6.72E-06	7.00E-03	STAT1,TASL	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,OASL,PDCD1LG2	7 (2)	2	 	 	 	CCL5,IFN BETA (family),STAT1,USP18	 	 	 	 	 	
USP51	peptidase	0.975	2	 	 	-1.414	6.81E-06	4.28E-02	P38 MAPK (family),TWIST1,USP51	CCN2,CCR7,CD44,IFIT2,ISG15,MMP12,OASL,RSAD2	8 (3)	3	 	 	 	TWIST1	 	 	 	 	 	
TLR7	transmembrane receptor	 	1	Inhibited	biased	-2.449	7.11E-06	7.30E-03	TLR7	CCR7,CD44,CD69,IFIT1,IFIT3,ISG15	6 (1)	1	 	TLR9	 	IFN BETA (family),IFNB1,IRF1,IRF9,STAT1	 	 	 	 	 	
IL4	cytokine	-0.801	1	 	 	-1.890	7.81E-06	8.90E-03	IL4	ANO1,CCL18,CD1B,CD69,CISH,IRF4,PHGDH	7 (1)	1	IFNA2,SPRY2,TLR9	 	 	CASP3,COL3A1,COLLAGEN ALPHA1 (family),IL13RA2,IL5,IRS2,LTA,PRDM1,SOCS1,STAT1,STAT6	CDKN1B,FCGR2B,IL2,SFTPC	 	 	 	 	
STAT6	transcription regulator	 	2	 	biased	1.890	7.81E-06	4.90E-03	STAT1,STAT6	IFIT1,IFIT2,IFIT3,IL31RA,IRF4,ISG15,PDCD1LG2	7 (2)	2	IL4,LTA,PRKCA	IFN BETA (family),IL13RA2,SOCS1	 	COLLAGEN ALPHA1 (family)	STAT1	 	 	 	 	
MAVS	other	 	1	Inhibited	biased	-2.449	8.67E-06	7.60E-03	MAVS	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	 	PCBP2,RNF5,TREX1	 	BTK,IFIH1,IFN BETA (family),IFNB1,IFNL1,IL11,INTERFERON ALPHA (family),IRF3,SOCS1,STAT1,STAT2	 	 	 	 	 	
ETV3	transcription regulator	 	1	Activated	biased	2.236	8.83E-06	3.70E-03	ETV3	IFIT1,IFIT2,IFIT3,OASL,RSAD2	5 (1)	1	 	 	 	 	IFIH1,IRF9,STAT2,USP18	 	 	 	 	
SLC15A4	transporter	-0.587	1	Inhibited	biased	-2.000	9.25E-06	1.70E-03	SLC15A4	IFIT1,IFIT2,IFIT3,OASL	4 (1)	1	 	 	 	CCL5,IFN BETA (family),STAT1,USP18	 	 	 	 	 	
TASL	enzyme	-1.630	1	Inhibited	biased	-2.000	9.25E-06	1.70E-03	TASL	IFIT1,IFIT2,IFIT3,OASL	4 (1)	1	 	 	 	CCL5,IFN BETA (family),STAT1,USP18	 	 	 	 	 	
IRF3	transcription regulator	-0.187	2	Inhibited	biased	-2.646	9.49E-06	9.00E-03	IRF3,STAT1	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,RSAD2	7 (2)	2	CGAS,INTERFERON ALPHA (family),LBP,LINC02574,MAP3K7,MAVS,STING1,TERT,TICAM1,TMEM120A	ADAR,ATAD3A,ATRX,BANF1,ETV6-RUNX1,F3,LINC00624,NLRP11,PARP1,PELI2,PPT1,RACK1,RNF216,SETX,TAFAZZIN	 	CCL5,IFIH1,IFN BETA (family),IFNA1/IFNA13,IFNL1,STAT1	IFNA2	 	 	 	 	
CSF2RB	transmembrane receptor	-1.244	2	 	biased	-1.134	9.95E-06	2.05E-02	CSF2RB,ERK (family),STAT5A/B (family)	CCN2,CD69,CISH,MS4A1,PDK4,POSTN,RFTN1	7 (3)	2	IL5	 	 	STAT5A/B (family)	 	 	 	 	 	
IL3RA	transmembrane receptor	 	2	 	biased	-1.134	1.04E-05	2.13E-02	ERK (family),IL3RA,STAT5A/B (family)	CCN2,CD69,CISH,MS4A1,PDK4,POSTN,RFTN1	7 (3)	2	IL5	CTLA4	 	STAT5A/B (family)	 	 	 	 	 	
LINC02574	other	 	2	Inhibited	biased	-2.646	1.04E-05	1.05E-02	IRF3,LINC02574,STAT1	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,RSAD2	7 (3)	3	IFNAR1	 	 	IFIH1,IFNB1,IFNL1,IRF3,STAT1	 	 	 	 	 	
ETV6	transcription regulator	-0.233	1	Activated	biased	2.236	1.06E-05	5.70E-03	ETV6	IFIT1,IFIT3,ISG15,OASL,RSAD2	5 (1)	1	 	 	 	 	COLLAGEN ALPHA1 (family),STAT1,STAT2	 	 	 	 	
RTCB	enzyme	 	1	 	biased	1.732	1.25E-05	6.00E-04	RTCB	IFIT1,IFIT2,ISG15	3 (1)	1	 	 	 	 	IFNB1,INTERFERON ALPHA (family)	 	 	 	 	
IRGM	enzyme	 	1	Activated	biased	2.449	1.34E-05	1.35E-02	IRGM	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	 	USP8	 	 	CGAS,IFIH1,IRF9,STAT1,STAT2,USP18	 	 	 	 	
GP6	transmembrane receptor	 	2	 	 	1.134	1.37E-05	1.27E-02	F3,GP6,SYK	CCR7,CD44,CD69,IFIT1,IFIT3,ISG15,RSAD2	7 (3)	2	 	 	 	F3	 	 	 	 	 	
IL27RA	transmembrane receptor	 	2	 	biased	-1.134	1.37E-05	2.85E-02	ERK (family),IL27RA,STAT5A/B (family)	CCN2,CD69,CISH,MS4A1,PDK4,POSTN,RFTN1	7 (3)	2	IL27	 	 	STAT5A/B (family)	 	 	 	 	 	
ATRX	transcription regulator	 	2	Activated	biased	2.646	1.50E-05	1.34E-02	ATRX,IRF3,STAT1	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,RSAD2	7 (3)	3	CIP2A	 	 	 	IRF3,STAT1	 	 	 	 	
FYB2	other	0.658	2	 	 	0.333	1.60E-05	3.49E-02	AKT (family),FYB2,MAPK1	CCN2,CD44,IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,PDK4	9 (3)	2	 	 	 	 	 	 	 	 	 	
PDGF-DD	complex	 	2	 	 	0.333	1.69E-05	3.63E-02	AKT (family),MAPK1,PDGF-DD (complex)	CCN2,CD44,IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,PDK4	9 (3)	2	 	 	 	 	 	 	 	 	 	
CHKA	kinase	0.285	2	 	 	0.333	1.74E-05	3.85E-02	AKT (family),CHKA,MAPK1	CCN2,CD44,IFIT1,IFIT2,IFIT3,ISG15,MMP12,OASL,PDK4	9 (3)	2	 	 	 	 	 	 	 	 	 	
ATAD3A	enzyme	 	1	 	biased	1.732	1.78E-05	1.10E-03	ATAD3A	IFIT1,ISG15,RSAD2	3 (1)	1	 	 	 	 	IFN BETA (family),IRF3	 	 	 	 	
IFNA1/IFNA13	cytokine	 	1	 	biased	-1.732	1.78E-05	2.90E-03	IFNA1/IFNA13	IFIT2,ISG15,RSAD2	3 (1)	1	IRF1,IRF3,JAK (family),STING1	 	 	STAT1,STAT2	 	 	 	 	 	
PCBP1	translation regulator	 	2	 	 	1.732	1.78E-05	1.60E-03	CASP3,PCBP1	CD44,IFIT3,ISG15	3 (2)	2	 	 	 	CASP3	 	 	 	 	 	
SETX	enzyme	-0.277	2	Activated	 	2.236	1.79E-05	3.10E-03	IRF3,SETX	IFIT1,IFIT2,IFIT3,ISG15,RSAD2	5 (2)	2	 	 	 	ZNF750	IRF3	 	 	 	 	
CHROMR	other	 	1	Inhibited	 	-2.646	1.95E-05	9.30E-03	CHROMR	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2,SQLE	7 (1)	1	 	 	 	ADAR,CASP7,IFIH1,STAT1,STAT2,TREX1,USP18	IRF1	 	 	 	 	
HOMER1	other	-0.352	2	Inhibited	 	-2.449	2.01E-05	1.82E-02	AKT (family),CASP3,HOMER1	CCN2,CD44,IFIT3,ISG15,MMP12,PDK4	6 (3)	2	TREM1	INS	 	 	CASP3	 	 	 	 	
HDAC2	transcription regulator	 	2	Inhibited	 	-2.121	2.27E-05	3.76E-02	CDKN2A,HDAC2,STAT1	CCL18,IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2,PHGDH	8 (3)	2	 	 	 	STAT1	SOX11	 	 	 	 	
LAPTM4B	other	 	2	Inhibited	 	-2.449	2.36E-05	2.20E-02	AKT (family),CASP3,LAPTM4B	CCN2,CD44,IFIT3,ISG15,MMP12,PDK4	6 (3)	2	 	 	 	 	CASP3	 	 	 	 	
SPHK	group	 	2	Inhibited	 	-2.449	2.36E-05	2.08E-02	AKT (family),CASP3,SPHK (family)	CCN2,CD44,IFIT3,ISG15,MMP12,PDK4	6 (3)	2	 	 	 	 	CASP3	 	 	 	 	
GH1	growth factor	 	2	 	biased	-1.134	2.60E-05	4.00E-02	ERK (family),GH1,STAT5A/B (family)	CCN2,CD69,CISH,MS4A1,PDK4,POSTN,RFTN1	7 (3)	2	 	 	 	STAT5A/B (family)	 	 	 	 	 	
STX4	transporter	 	2	Activated	 	2.449	2.77E-05	2.47E-02	AKT (family),CASP3,STX4	CCN2,CD44,IFIT3,ISG15,MMP12,PDK4	6 (3)	2	PRKCA	 	 	CASP3	 	 	 	 	 	
ARFGAP2	other	 	1	 	biased	-1.414	2.87E-05	1.20E-03	ARFGAP2	IFIT1,RSAD2	2 (1)	1	 	 	 	 	 	 	 	 	 	
CASP7	peptidase	 	1	 	biased	1.414	2.87E-05	1.30E-03	CASP7	IFIT3,ISG15	2 (1)	1	CHROMR	MAP3K7	 	 	STAT1	 	 	 	 	
MSR1	transmembrane receptor	 	1	 	biased	-1.414	2.87E-05	1.30E-03	MSR1	IFIT1,ISG15	2 (1)	1	 	 	 	 	 	 	 	 	 	
INSIG1	other	0.345	2	 	biased	0.447	3.08E-05	1.59E-02	HSPA5,INSIG1	CYP51A1,FDFT1,IFIT1,ISG15,SQLE	5 (2)	2	 	 	 	 	 	 	 	 	 	
PAWR	transcription regulator	 	2	Activated	 	2.449	3.23E-05	2.65E-02	AKT (family),CASP3,PAWR	CCN2,CD44,IFIT3,ISG15,MMP12,PDK4	6 (3)	2	 	 	 	CASP3	 	 	 	 	 	
STAT1	transcription regulator	 	1	Inhibited	biased	-2.449	3.23E-05	9.00E-03	STAT1	IFIT1,IFIT2,IFIT3,IL31RA,ISG15,PDCD1LG2	6 (1)	1	ATXN3,BTK,CGAS,CHROMR,FAM222A,FEN1,FOXC1,HDAC2,IFN BETA (family),IFNA1/IFNA13,IFNA2,IFNAR1,IFNB1,IFNL1,IFNL4,IL11,IL2,IL22,IL27,IL2RG,IL4,INTERFERON ALPHA (family),IRF3,IRS2,JAK (family),LBP,LIFR,LINC02574,MAPKAP1,MAVS,NONO,PRKCA,PRL,RIPK2,SLC15A4,TASL,TGM2,TLR7,TLR9	ATRX,BANF1,BCR-ABL1,CASP3,CASP7,EIF2AK4,ETV6,F3,FCGR2B,FES,IRGM,LHPP,LINC00624,PARP1,PGR,PRDM1,RC3H1,RPSA,SNAPIN,SOX11,STAT6,UBE2I,USP18,USP8,ZNF750	 	IRF1	 	 	 	 	 	
IFNL4	cytokine	-2.273	1	 	biased	-1.732	3.23E-05	6.60E-03	IFNL4	IFIT1,ISG15,OASL	3 (1)	1	 	 	 	IFIH1,STAT1,STAT2	 	 	 	 	 	
PSEN1	peptidase	 	2	 	 	0.577	3.23E-05	3.30E-03	CASP3,PSEN1	FDFT1,IFIT3,ISG15	3 (2)	2	EIF2AK4	 	 	CASP3	 	 	 	 	 	
USP18	peptidase	-0.766	2	 	biased	0.378	3.69E-05	4.85E-02	CFLAR,P38 MAPK (family),USP18	CCN2,CCR7,IFIT1,IFIT2,ISG15,MMP12,OASL	7 (3)	3	CHROMR,EGOT,FOXC1,IFNA2,IFNAR1,IFNL1,NONO,PBRM1,PRKCA,PRL,RIPK2,SLC15A4,SPI1,STING1,TASL,TWIST1	ETV3,F3,IRGM,RNASEH2B,STAG2,STAT2,TREX1	 	 	CFLAR,STAT1	 	 	 	 	
INS	other	 	1	 	 	-0.447	4.08E-05	7.10E-03	INS	ANO1,CCN2,CD44,GAS1,POSTN	5 (1)	1	 	 	 	 	COL3A1,HOMER1	 	 	 	 	
PRL	cytokine	 	1	Inhibited	biased	-2.449	4.33E-05	1.46E-02	PRL	CD69,CISH,IFIT1,IFIT3,ISG15,RSAD2	6 (1)	1	TWIST1	 	 	ADAR,FOS,IFIH1,IRF1,IRF9,STAT1,STAT2,STAT5A/B (family),USP18	CDKN1B	 	 	 	 	
PRKCA	kinase	 	1	Inhibited	 	-2.236	4.36E-05	3.25E-02	PRKCA	IFIT1,IFIT3,ISG15,OASL,RSAD2	5 (1)	1	GAST,PLA2 (family)	PHLPP2	 	CDKN1B,HCK,IFNB1,PGR,STAT1,STAT5A/B (family),STAT6,STX4,USP18	CASP3,USP8	 	 	 	 	
USP8	peptidase	 	1	Activated	biased	2.000	4.60E-05	8.60E-03	USP8	IFIT1,IFIT2,IFIT3,ISG15	4 (1)	1	 	PRKCA	 	CTLA4	IRGM,STAT1,STAT2	 	 	 	 	
PCGEM1	other	 	2	 	biased	1.897	4.74E-05	4.96E-02	MYC,PCGEM1	CD44,HSD11B2,IFIT1,IFIT2,IFIT3,IRF4,OASL,PDK4,RSAD2,WEE1	10 (2)	2	 	 	 	 	 	 	 	 	 	
IRF3	transcription regulator	-0.187	1	Inhibited	 	-2.000	5.12E-05	8.30E-03	IRF3	IFIT1,IFIT2,ISG15,RSAD2	4 (1)	1	CGAS,INTERFERON ALPHA (family),LBP,LINC02574,MAP3K7,MAVS,STING1,TERT,TICAM1,TMEM120A	ADAR,ATAD3A,ATRX,BANF1,ETV6-RUNX1,F3,LINC00624,NLRP11,PARP1,PELI2,PPT1,RACK1,RNF216,SETX,TAFAZZIN	 	CCL5,IFIH1,IFN BETA (family),IFNA1/IFNA13,IFNL1,STAT1	IFNA2	 	 	 	 	
USP37	peptidase	 	2	Activated	 	2.111	5.30E-05	3.73E-02	BLM,MYC,USP37	CD44,HSD11B2,IFIT1,IFIT2,IFIT3,IRF4,OASL,RFTN1,RSAD2,WEE1,ZBTB16	11 (3)	3	 	 	 	 	 	 	 	 	 	
TWIST1	transcription regulator	 	1	Inhibited	biased	-2.236	5.31E-05	2.65E-02	TWIST1	CD44,IFIT2,ISG15,OASL,RSAD2	5 (1)	1	CDKN1B,USP51	TERT	 	CASP3,IRF9,PRL,USP18	 	 	 	 	 	
IFNB1	cytokine	 	1	Inhibited	biased	-2.000	5.68E-05	1.78E-02	IFNB1	IFIT1,IFIT2,IFIT3,ISG15	4 (1)	1	CGAS,FAM222A,IFNA2,INTERFERON ALPHA (family),KPNA2,LINC02574,MAVS,mir-15 (includes others),PRKCA,STING1,TERT,TICAM1,TLR7,TLR9	ADAR,BANF1,COPA,NLRP11,RACK1,RNF216,RTCB,SNAPIN,SOCS1,SPSB3,TGM2,ZNF750	 	CASP3,IL27,IRF1,IRF9,PABIR1,PDCD4,STAT1,STAT2,STAT5A/B (family)	IL2	 	 	 	 	
GPR15LG	cytokine	 	1	Activated	 	2.000	6.28E-05	5.80E-03	GPR15LG	CCN2,IFIT1,IFIT2,IFIT3	4 (1)	1	 	 	 	MAP2K5	 	 	 	 	 	
SFTPC	other	 	2	 	 	1.732	6.60E-05	2.50E-03	CASP3,SFTPC	CCN2,IFIT3,ISG15	3 (2)	2	 	IL4	 	CASP3	 	 	 	 	 	
IL2	cytokine	 	1	 	biased	-0.447	7.24E-05	4.20E-03	IL2	CD44,CD69,GZMB,LRRC32,RFTN1	5 (1)	1	 	IFNB1,IL4	 	FGFR2,IL22,IL5,IRS2,LBP,STAT1,STAT5A/B (family)	 	 	 	 	 	
MAP3K7	kinase	 	1	 	 	-1.000	7.63E-05	2.00E-02	MAP3K7	IFIT1,IFIT2,IFIT3,OASL	4 (1)	1	RIPK2,SOX11	UBB	 	IFN BETA (family),IRF3	CASP3,CASP7	 	 	 	 	
FBXO45	other	 	1	 	biased	1.414	8.59E-05	2.30E-03	FBXO45	IFIT3,ISG15	2 (1)	1	 	 	 	 	 	 	 	 	 	
SPSB3	other	 	1	 	biased	1.414	8.59E-05	5.10E-03	SPSB3	IFIT1,ISG15	2 (1)	1	 	 	 	 	CGAS,IFNB1	 	 	 	 	
NONO	transcription regulator	 	1	Inhibited	biased	-2.449	8.79E-05	1.63E-02	NONO	IFIT1,IFIT2,IFIT3,ISG15,OASL,RSAD2	6 (1)	1	PBRM1	 	 	CCL5,IFIH1,IFNL1,STAT1,STAT2,USP18	 	 	 	 	 	
PBRM1	other	 	1	Inhibited	biased	-2.236	9.14E-05	3.10E-02	PBRM1	IFIT2,IFIT3,ISG15,OASL,RSAD2	5 (1)	1	 	 	 	IFIH1,IL11,IRF1,IRF9,NONO,USP18	CCL5,IFN BETA (family)	 	 	 	 	
SOX11	transcription regulator	 	2	 	 	-0.816	9.16E-05	3.40E-03	SOX11,WNT (family)	CD44,CDH26,MS4A1,POSTN,SKAP2,SPIB	6 (2)	2	 	HDAC2	 	CCL5,MAP3K7	IFIH1,PRDM1,STAT1	 	 	 	 	
RNASEH2B	other	 	1	Activated	biased	2.236	1.27E-04	1.96E-02	RNASEH2B	IFIT1,IFIT2,IFIT3,IRF4,ISG15	5 (1)	1	 	 	 	 	CCL5,IL11,IL22,IL27,IRF1,USP18	 	 	 	 	
INSIG1	other	0.345	1	 	biased	1.732	1.38E-04	1.09E-02	INSIG1	CYP51A1,FDFT1,SQLE	3 (1)	1	 	 	 	 	 	 	 	 	 	
TGM2	enzyme	 	1	 	 	-1.890	1.62E-04	1.62E-02	TGM2	CLC,IFIT1,IFIT2,IFIT3,OASL,PPP1R16B,SLC9B2	7 (1)	1	 	SOCS1	 	CASP3,CFLAR,IRF9,STAT1	IFNB1	 	 	 	 	
ADAR	enzyme	-0.360	1	 	biased	1.732	1.62E-04	1.91E-02	ADAR	IFIT1,IFIT2,IFIT3	3 (1)	1	CHROMR,FOXC1,IFNAR1,IL27,LINC00624,PRL	BANF1,F3	 	SPI1	CCL5,IFIH1,IFN BETA (family),IFNB1,IRF3	 	 	 	 	
NLRP11	other	 	1	 	biased	1.414	1.71E-04	6.30E-03	NLRP11	IFIT1,IFIT2	2 (1)	1	 	 	 	 	IFNB1,IRF3	 	 	 	 	
TRIM9	other	 	1	 	 	0.000	1.71E-04	1.08E-02	TRIM9	CD44,IFIT2	2 (1)	1	 	 	 	IFN BETA (family)	 	 	 	 	 	
PRDM1	transcription regulator	 	2	 	biased	1.000	2.36E-04	2.60E-02	CASP3,PRDM1	IFIT1,IFIT2,IFIT3,ISG15	4 (2)	2	EIF2AK4,IL4,SPI1,TLR9	SOX11	 	 	CASP3,IFNAR1,STAT1,TNFRSF14	 	 	 	 	
YTHDC2	enzyme	 	1	 	 	-1.732	2.83E-04	7.60E-03	YTHDC2	IFIT2,IFIT3,RSAD2	3 (1)	1	 	 	 	CCL5	 	 	 	 	 	
MTORC2	complex	 	1	 	biased	-1.414	2.84E-04	1.23E-02	MTORC2 (complex)	IFIT2,ISG15	2 (1)	1	 	 	 	 	 	 	 	 	 	
NGLY1	enzyme	-0.199	1	 	biased	1.414	2.84E-04	1.19E-02	NGLY1	IFIT1,IFIT2	2 (1)	1	 	 	 	 	 	 	 	 	 	
PELI2	enzyme	 	1	 	biased	1.414	2.84E-04	1.11E-02	PELI2	IFIT2,IFIT3	2 (1)	1	 	IFN BETA (family)	 	 	IRF3	 	 	 	 	
PLA2G2A	enzyme	 	1	 	biased	-1.414	2.84E-04	5.30E-03	PLA2G2A	CD44,CD69	2 (1)	1	 	 	 	 	 	 	 	 	 	
ZNF598	enzyme	 	1	 	biased	1.414	2.84E-04	6.00E-03	ZNF598	IFIT2,RSAD2	2 (1)	1	 	 	 	 	 	 	 	 	 	
FOS	transcription regulator	-1.526	2	Inhibited	biased	-2.000	3.08E-04	4.40E-02	CASP3,FOS	CD44,IFIT3,IRF4,ISG15	4 (2)	2	ADAP1,FOXC1,PRL	FGFR2,IL27,INTERFERON ALPHA (family)	 	IL11	CASP3,CCL5,CFLAR	 	 	 	 	
TREM1	transmembrane receptor	-1.731	1	 	 	0.816	3.11E-04	4.57E-02	TREM1	CCL18,CCR7,IFIT2,ISG15,MCOLN2,OASL	6 (1)	1	 	 	 	F3,HOMER1,NT5E,SPRY2	CDKN2B,IRF1	 	 	 	 	
AMFR	transmembrane receptor	 	2	 	 	0.577	3.21E-04	1.00E-02	AMFR,HMGCR	CCN2,FDFT1,SQLE	3 (2)	2	 	 	 	 	 	 	 	 	 	
IFNAR1	transmembrane receptor	 	1	Inhibited	biased	-2.000	3.50E-04	2.35E-02	IFNAR1	IFIT1,IFIT3,ISG15,RSAD2	4 (1)	1	FOXC1,IFNA2	BANF1,BCR-ABL1,INTERFERON ALPHA (family),PRDM1	 	ADAR,IFIH1,IFN BETA (family),LINC02574,SOCS1,STAT1,STAT2,USP18	 	 	 	 	 	
FGFR2	kinase	 	1	 	 	1.732	3.61E-04	1.44E-02	FGFR2	ISG15,OASL,RSAD2	3 (1)	1	IL2	 	 	 	CGAS,FOS,STAT2	 	 	 	 	
FOXC1	transcription regulator	0.549	1	Inhibited	 	-2.236	3.82E-04	4.60E-02	FOXC1	IFIT1,IFIT2,IFIT3,ISG15,OASL	5 (1)	1	 	 	 	ADAR,FOS,IFNAR1,IRF1,STAT1,STAT2,USP18	ZNF750	 	 	 	 	
EGOT	other	 	2	 	biased	0.577	4.05E-04	2.76E-02	CASP3,EGOT	IFIT3,ISG15,RSAD2	3 (2)	2	 	 	 	CASP3,USP18	 	 	 	 	 	
F3	transmembrane receptor	 	1	Activated	biased	2.000	4.20E-04	3.21E-02	F3	IFIT1,IFIT3,ISG15,RSAD2	4 (1)	1	GP6,PGR,TREM1	 	 	TREX1	ADAR,CCL5,IFIH1,IRF3,STAT1,STAT2,STING1,USP18	 	 	 	 	
KLF7	transcription regulator	 	1	 	biased	-1.414	4.25E-04	1.45E-02	KLF7	IFIT1,IFIT3	2 (1)	1	 	 	 	 	 	 	 	 	 	
KPNA2	other	 	1	 	biased	-1.414	4.25E-04	1.64E-02	KPNA2	IFIT1,ISG15	2 (1)	1	 	CTLA4	 	IFNB1	 	 	 	 	 	
TRRAP	transcription regulator	 	1	 	 	0.000	4.25E-04	1.70E-02	TRRAP	CD44,IFIT1	2 (1)	1	 	 	 	TERT	 	 	 	 	 	
ZNF395	transcription regulator	 	1	 	biased	-1.414	4.25E-04	1.10E-02	ZNF395	IFIT1,IFIT2	2 (1)	1	 	 	 	 	 	 	 	 	 	
HOXA-AS2	other	 	2	 	 	-1.732	5.02E-04	1.23E-02	CASP3,HOXA-AS2	HOXA3,IFIT3,ISG15	3 (2)	2	 	 	 	 	CASP3	 	 	 	 	
IFN beta	group	 	1	 	biased	-1.732	5.02E-04	2.95E-02	IFN BETA (family)	IFIT1,IFIT3,RSAD2	3 (1)	1	CGAS,IFNAR1,INTERFERON ALPHA (family),IRF3,LBP,MAP3K7,MAVS,SLC15A4,STING1,TASL,TICAM1,TLR7,TLR9,TRIM9	ADAR,ATAD3A,BANF1,COPA,PARP1,PBRM1,PRMT7	 	IL27,SPRY2,STAT1,STAT2	PELI2,STAT6	 	 	 	 	
TEAD	group	 	1	 	 	0.577	5.55E-04	1.31E-02	TEAD (family)	CCN2,CD44,ISG15	3 (1)	1	 	 	 	 	 	 	 	 	 	
mir-15 (includes others)	microRNA	 	1	 	 	-1.732	5.55E-04	1.99E-02	mir-15 (includes others)	IFIT1,ISG15,WEE1	3 (1)	1	 	 	 	CCL5,IFNB1	 	 	 	 	 	
SOX11	transcription regulator	 	1	 	biased	-1.342	5.83E-04	1.08E-02	SOX11	CDH26,MS4A1,POSTN,SKAP2,SPIB	5 (1)	1	 	HDAC2	 	CCL5,MAP3K7	IFIH1,PRDM1,STAT1	 	 	 	 	
CAND1	transcription regulator	 	1	 	 	1.414	5.93E-04	2.52E-02	CAND1	IFIT1,ISG15	2 (1)	1	 	 	 	 	 	 	 	 	 	
CASP3	peptidase	 	1	 	 	1.414	5.93E-04	1.03E-02	CASP3	IFIT3,ISG15	2 (1)	1	EGOT,IFNB1,IL4,INTERFERON ALPHA (family),IRF1,PAWR,PCBP1,PDCD4,PSEN1,SFTPC,STEAP1,STX4,TGM2,TWIST1	CDKN1B,CFLAR,FOS,GAST,HOMER1,HOXA-AS2,LAPTM4B,MAP3K7,PPT1,PRDM1,PRKCA,RPSA,SPHK (family),TERT	 	 	STAT1	 	 	 	 	
TRIP12	enzyme	 	1	 	biased	0.000	5.93E-04	1.53E-02	TRIP12	ADAM19,CCN2	2 (1)	1	 	 	 	 	 	 	 	 	 	
IL2R	complex	 	2	Inhibited	biased	-2.000	7.60E-04	4.25E-02	IL2R (complex),JAK1,STAT5A/B (family)	CD69,CISH,IFIT2,RFTN1	4 (3)	2	 	 	 	STAT5A/B (family)	 	 	 	 	 	
THEM6	other	 	1	 	biased	1.732	8.06E-04	1.70E-02	THEM6	CYP51A1,FDFT1,SQLE	3 (1)	1	 	 	 	 	 	 	 	 	 	
STAT5A/B	group	 	1	 	biased	-1.732	9.54E-04	1.03E-02	STAT5A/B (family)	CD69,CISH,RFTN1	3 (1)	1	BCR-ABL1,CSF2RB,GH1,IFNA2,IFNB1,IFNL1,IL2,IL22,IL27RA,IL2R (complex),IL2RG,IL3RA,IL5,PRKCA,PRL	FES,INTERFERON ALPHA (family),MARCHF8	 	CDKN1B	 	 	 	 	 	
COPA	transporter	 	1	 	biased	1.414	1.01E-03	1.81E-02	COPA	ISG15,RSAD2	2 (1)	1	 	 	 	 	IFN BETA (family),IFNB1	 	 	 	 	
FEN1	enzyme	 	1	 	 	-1.414	1.01E-03	2.40E-02	FEN1	IFIT1,IRF4	2 (1)	1	 	 	 	IRF1,STAT1,STAT2	 	 	 	 	 	
RNF216	enzyme	 	1	 	biased	1.414	1.01E-03	2.78E-02	RNF216	IFIT1,ISG15	2 (1)	1	 	 	 	 	IFNB1,INTERFERON ALPHA (family),IRF3,TICAM1,TLR9	 	 	 	 	
CCL5	cytokine	-0.429	1	 	biased	0.577	1.40E-03	2.12E-02	CCL5	CD44,SQLE,TUBB4B	3 (1)	1	IFIH1,IL27,IRF1,IRF3,mir-15 (includes others),NONO,SLC15A4,SOX11,STING1,TASL,TICAM1,TLR9,YTHDC2	ADAR,BANF1,ETV6-RUNX1,F3,FCGR2B,FOS,PARP1,PBRM1,RACK1,RNASEH2B,TREX1,ZNF750	 	DUSP6	 	 	 	 	 	
PKA	complex	 	1	 	biased	0.000	1.53E-03	2.41E-02	PKA (complex)	CCN2,CD44	2 (1)	1	 	 	 	CCR8	 	 	 	 	 	
WNT3A	cytokine	 	1	 	biased	-1.732	1.83E-03	2.90E-02	WNT3A	CD44,GGT5,RASGRP3	3 (1)	1	 	 	 	 	 	 	 	 	 	
CFLAR	other	 	1	 	 	1.414	1.83E-03	2.74E-02	CFLAR	IFIT2,ISG15	2 (1)	1	TGM2	FOS,USP18	 	 	CASP3	 	 	 	 	
IFIH1	enzyme	-0.950	1	 	biased	-1.414	1.83E-03	4.74E-02	IFIH1	IFIT3,ISG15	2 (1)	1	CHROMR,IFNA2,IFNAR1,IFNL1,IFNL4,INTERFERON ALPHA (family),IRF1,IRF3,JAK (family),LINC02574,MAVS,NONO,PBRM1,PRL,RIPK2,TERT	ADAR,BANF1,ETV3,F3,IRGM,PRMT7,SOCS1,SOX11,STAG2,TREX1,ZNF750	 	CCL5	 	 	 	 	 	
LTA	cytokine	 	1	 	biased	-1.414	1.83E-03	4.11E-02	LTA	CD44,PDCD1LG2	2 (1)	1	ADAP1,IL4,TLR9	 	 	STAT6	 	 	 	 	 	
MAP2K5	kinase	 	1	 	biased	1.414	1.83E-03	1.44E-02	MAP2K5	CYP51A1,FDFT1	2 (1)	1	GPR15LG	 	 	 	 	 	 	 	 	
PRMT7	enzyme	 	1	 	biased	1.414	1.83E-03	4.03E-02	PRMT7	ISG15,RSAD2	2 (1)	1	 	 	 	 	IFIH1,IFN BETA (family),IFNL1,INTERFERON ALPHA (family)	 	 	 	 	
TICAM1	other	 	1	 	biased	-1.414	1.83E-03	4.39E-02	TICAM1	IFIT1,IFIT2	2 (1)	1	INTERFERON ALPHA (family)	BANF1,RNF216	 	CCL5,IFN BETA (family),IFNB1,IFNL1,IRF3	 	 	 	 	 	
ADAP1	other	-0.325	1	 	biased	-1.414	2.16E-03	2.66E-02	ADAP1	CD69,GZMB	2 (1)	1	 	 	 	FOS,LTA	 	 	 	 	 	
NT5E	phosphatase	 	1	 	 	1.414	2.16E-03	1.61E-02	NT5E	CD69,ZNF366	2 (1)	1	TREM1	 	 	 	 	 	 	 	 	
mir-122 (includes others)	microRNA	 	1	 	 	1.414	3.28E-03	1.80E-02	mir-122 (includes others)	FDFT1,SQLE	2 (1)	1	 	 	 	 	 	 	 	 	 	
AMFR	transmembrane receptor	 	1	 	biased	1.414	4.63E-03	2.89E-02	AMFR	FDFT1,SQLE	2 (1)	1	 	 	 	 	 	 	 	 	 	
CCR8	G-protein coupled receptor	 	1	 	biased	-1.000	5.38E-03	4.41E-02	CCR8	CD69	1 (1)	1	PKA (complex)	 	 	 	 	 	 	 	 	
COPS6	other	0.141	1	 	biased	1.000	5.38E-03	2.32E-02	COPS6	PHGDH	1 (1)	1	 	 	 	 	 	 	 	 	 	
EIF3F	translation regulator	 	1	 	biased	1.000	5.38E-03	2.32E-02	EIF3F	PHGDH	1 (1)	1	 	 	 	 	 	 	 	 	 	
LINC01564	other	 	1	 	biased	1.000	5.38E-03	2.32E-02	LINC01564	PHGDH	1 (1)	1	 	 	 	 	 	 	 	 	 	
LOC105374041	other	 	1	 	biased	-1.000	5.38E-03	8.10E-03	LOC105374041	RASGRP3	1 (1)	1	 	 	 	 	 	 	 	 	 	
MDC1	other	 	1	 	biased	1.000	5.38E-03	1.74E-02	MDC1	WEE1	1 (1)	1	 	 	 	 	 	 	 	 	 	
PABIR1	other	 	1	 	biased	-1.000	5.38E-03	1.74E-02	PABIR1	WEE1	1 (1)	1	IFNA2,IFNB1,IFNL1	 	 	 	 	 	 	 	 	
PAK2	kinase	-0.252	1	 	biased	-1.000	5.38E-03	4.41E-02	PAK2	CD69	1 (1)	1	 	 	 	 	 	 	 	 	 	
POU2AF1	transcription regulator	 	1	 	biased	1.000	5.38E-03	2.29E-02	POU2AF1	IRF4	1 (1)	1	 	 	 	 	 	 	 	 	 	
SLA2	other	-0.494	1	 	biased	1.000	5.38E-03	4.41E-02	SLA2	CD69	1 (1)	1	 	 	 	 	 	 	 	 	 	
TNFRSF14	transmembrane receptor	 	1	 	biased	-1.000	5.38E-03	2.72E-02	TNFRSF14	POSTN	1 (1)	1	 	ETV6-RUNX1,PRDM1	 	 	 	 	 	 	 	
VEGFB	growth factor	 	1	 	biased	-1.000	5.38E-03	1.78E-02	VEGFB	MMP12	1 (1)	1	 	 	 	 	 	 	 	 	 	
mir-136	microRNA	 	1	 	biased	-1.000	5.38E-03	2.24E-02	mir-136	PDK4	1 (1)	1	 	 	 	 	 	 	 	 	 	
SETX	enzyme	-0.277	1	 	biased	1.414	7.34E-03	3.46E-02	SETX	IFIT2,IFIT3	2 (1)	1	 	 	 	ZNF750	IRF3	 	 	 	 	
CDC14A	phosphatase	0.318	1	 	biased	1.000	1.07E-02	1.74E-02	CDC14A	WEE1	1 (1)	1	 	 	 	 	 	 	 	 	 	
GRAMD1A	transporter	 	1	 	biased	-1.000	1.07E-02	3.72E-02	GRAMD1A	SQLE	1 (1)	1	 	 	 	 	 	 	 	 	 	
GRAMD1B	transporter	 	1	 	biased	-1.000	1.07E-02	3.72E-02	GRAMD1B	SQLE	1 (1)	1	 	 	 	 	 	 	 	 	 	
GRAMD1C	transporter	0.466	1	 	biased	-1.000	1.07E-02	3.72E-02	GRAMD1C	SQLE	1 (1)	1	 	 	 	 	 	 	 	 	 	
OSBPL9	other	 	1	 	biased	-1.000	1.07E-02	3.72E-02	OSBPL9	SQLE	1 (1)	1	 	 	 	STING1	 	 	 	 	 	
POLDIP3	other	 	1	 	biased	-1.000	1.07E-02	4.37E-02	POLDIP3	ISG15	1 (1)	1	 	 	 	 	 	 	 	 	 	
PTTG3P	other	 	1	 	biased	-1.000	1.07E-02	4.80E-02	PTTG3P	MAP2K6	1 (1)	1	 	 	 	 	 	 	 	 	 	
TMEM259	other	-0.213	1	 	biased	-1.000	1.07E-02	2.36E-02	TMEM259	CYP51A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
TREM2	transmembrane receptor	 	1	 	biased	1.000	1.07E-02	9.50E-03	TREM2	P2RY13	1 (1)	1	 	 	 	 	 	 	 	 	 	
collagen alpha1	group	 	1	 	biased	-1.000	1.07E-02	3.84E-02	COLLAGEN ALPHA1 (family)	CCL18	1 (1)	1	IL4,STAT6	ETV6	 	 	 	 	 	 	 	
CLCA1	ion channel	-2.300	1	 	biased	-1.000	1.61E-02	4.07E-02	CLCA1	ANO1	1 (1)	1	 	 	 	 	 	 	 	 	 	
COL3A1	other	 	1	 	biased	-1.000	1.61E-02	3.84E-02	COL3A1	CCL18	1 (1)	1	IL4,PDCD4	INS	 	 	 	 	 	 	 	
CSNK1D	kinase	 	1	 	 	-1.000	1.61E-02	1.47E-02	CSNK1D	PER1	1 (1)	1	 	 	 	 	 	 	 	 	 	
IL13RA2	transmembrane receptor	-2.287	1	 	biased	-1.000	1.61E-02	3.93E-02	IL13RA2	MMP12	1 (1)	1	IL4	 	 	 	STAT6	 	 	 	 	
RNF185	enzyme	-0.234	1	 	biased	-1.000	1.61E-02	3.07E-02	RNF185	CYP51A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
TMEM120A	ion channel	 	1	 	biased	-1.000	1.61E-02	4.56E-02	TMEM120A	IFIT2	1 (1)	1	 	 	 	IRF3	 	 	 	 	 	
MTCL2	other	 	1	 	 	1.000	2.14E-02	4.25E-02	MTCL2	PDK4	1 (1)	1	 	 	 	 	 	 	 	 	 	
STK39	kinase	0.246	1	 	 	-1.000	2.66E-02	2.94E-02	STK39	CLDN3	1 (1)	1	 	 	 	 	 	 	 	 	 	

Diseases and Bio Functions for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	immune mediated inflammatory disease	Immune mediated inflammatory disease	8.95E-19	 	 	 	 	TNNC2,CCR7,RSAD2,CCL18,NMNAT2,IFIT1,IL22RA2,CCN2,CTSG,SKAP2,TESPA1,CD69,P2RY13,CLC,OASL,GAS1,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,CDH26,SLC27A3,MAP2K6,CCR3,TASL,MAPKAPK3,PHGDH,SLC26A4,DOK2,MMP12,ZBTB16,ANKRD55,IFIT2,GZMB,ARL15,SQLE,ANO1,TPSAB1,PER1,ISG15,HRH4,CEBPE,RASGRP3,MS4A1,PTGDR2,EMP3,CISH,FDFT1,ENTPD4,PDK4,CD44,POSTN,IFIT3,CYP51A1,ZNF366	56	
Dermatological Diseases and Conditions, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	dermatitis	Dermatitis	1.25E-13	 	 	 	 	CCR7,PHGDH,RSAD2,CCL18,DOK2,MMP12,IFIT1,IL22RA2,ANKRD55,SYT2,GZMB,TESPA1,PER1,ISG15,IRF4,MS4A1,PTGDR2,OASL,ENTPD4,PDK4,CD44,TUBB4B,POSTN,UBXN11,IFIT3,IL31RA,CYP51A1,CCR3	28	
Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of organ	2.41E-12	 	 	 	 	CCR7,MAPKAPK3,PHGDH,RSAD2,CCL18,SLC26A4,DOK2,MMP12,IFIT1,ZBTB16,IL22RA2,CCN2,ANKRD55,IFIT2,PPP1R16B,SYT2,GZMB,TESPA1,CD69,ANO1,TPSAB1,PER1,ISG15,P2RY13,HRH4,IRF4,MS4A1,PTGDR2,CLC,OASL,FDFT1,ENTPD4,CNR2,PDK4,CD44,TUBB4B,POSTN,UBXN11,IFIT3,IL31RA,CDH26,CYP51A1,CCR3	43	
Connective Tissue Disorders, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	rheumatic disease	Rheumatic disease	3.22E-11	 	 	 	 	TNNC2,CCR7,MAPKAPK3,PDCD1LG2,RSAD2,CCL18,IFIT1,ZBTB16,CCN2,ANKRD55,IFIT2,GZMB,ARL15,CD69,SQLE,PER1,ISG15,P2RY13,MS4A1,EMP3,OASL,GAS1,CISH,PDK4,CD44,PIP4K2A,POSTN,IFIT3,PRDX5,IL31RA,CDH26,ZNF366,MAP2K6,CCR3	34	
Cancer, Organismal Injury and Abnormalities	abdominal neoplasm	Abdominal neoplasm	7.84E-11	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	124	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	abnormality of skin morphology	Abnormality of skin morphology	1.84E-10	 	 	 	 	MAPKAPK3,RSAD2,CCL18,MMP12,IFIT1,ZBTB16,CCN2,IFIT2,CD69,PER1,ISG15,IRF4,MS4A1,EMP3,OASL,GAS1,CISH,PDK4,CD44,POSTN,IFIT3,SLC9A3,IL31RA,CYP51A1,MAP2K6,CCR3	26	
Cancer, Organismal Injury and Abnormalities	abdominal carcinoma	Abdominal carcinoma	2.00E-10	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	121	
Cardiovascular Disease, Connective Tissue Disorders, Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	systemic sclerosis	Systemic sclerosis	2.04E-10	 	 	 	 	MS4A1,MAPKAPK3,EMP3,RSAD2,OASL,GAS1,IFIT1,ZBTB16,CCN2,CISH,IFIT2,PDK4,POSTN,CD69,IFIT3,IL31RA,PER1,ISG15,MAP2K6,CCR3	20	
Cancer, Organismal Injury and Abnormalities	abdominal cancer	Abdominal cancer	2.84E-10	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	123	
Immunological Disease, Organismal Injury and Abnormalities	allergy	Allergy	2.88E-10	 	 	 	 	PDCD1LG2,PHGDH,CCL18,DOK2,MMP12,IL22RA2,ANKRD55,GZMB,TESPA1,CD69,SQLE,PER1,HRH4,IRF4,PTGDR2,ADAM19,FDFT1,ENTPD4,PDK4,CD44,UBXN11,IL31RA,CYP51A1,CCR3	24	
Immunological Disease, Organismal Injury and Abnormalities	hypersensitive reaction	Hypersensitive reaction	3.92E-10	 	 	 	 	MAPKAPK3,PTGDR2,PHGDH,CCL18,DOK2,MMP12,IL22RA2,ENTPD4,ANKRD55,SORD,PDK4,CD44,GZMB,TESPA1,UBXN11,SQLE,IL31RA,PER1,HRH4,CCR3	20	
Hereditary Disorder, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	familial autoinflammatory disease	Familial autoinflammatory disease	8.81E-10	 	 	 	 	CCR7,RSAD2,OASL,IFIT1,ADAM19,IFIT2,TUBB4B,CD69,IFIT3,IRF4,CEBPE,ZNF366	12	
Cancer, Organismal Injury and Abnormalities	nonhematologic malignant neoplasm	Nonhematologic malignant neoplasm	1.61E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	125	
Cancer, Organismal Injury and Abnormalities	formation	Formation of solid tumor	2.18E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	119	
Cancer, Organismal Injury and Abnormalities	extrapancreatic malignant tumor	Extrapancreatic malignant tumor	2.19E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	125	
Developmental Disorder, Hereditary Disorder, Inflammatory Disease, Inflammatory Response, Metabolic Disease, Organismal Injury and Abnormalities	hyperzincemia and hypercalprotectinemia autoinflammatory syndrome	Hyperzincemia and hypercalprotectinemia autoinflammatory syndrome	2.45E-09	 	 	 	 	CCR7,CD69,RSAD2,IFIT3,OASL,IFIT1,IRF4,ADAM19,IFIT2,ZNF366	10	
Cancer, Organismal Injury and Abnormalities	abdominal adenocarcinoma	Abdominal adenocarcinoma	2.55E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	115	
Cancer, Organismal Injury and Abnormalities	adenocarcinoma	Adenocarcinoma	2.78E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	117	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	inflammation	Inflammation of muscle	3.03E-09	 	 	 	 	MS4A1,PDCD1LG2,EMP3,RSAD2,OASL,IFIT1,SFRP1,IFIT2,CNR2,GZMB,TUBB4B,OTOF,IFIT3,ISG15,IRF4	15	
Cancer, Organismal Injury and Abnormalities	non-melanoma solid tumor	Non-melanoma solid tumor	3.46E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	125	
Cancer, Organismal Injury and Abnormalities	melanoma	Melanoma	3.80E-09	 	 	 	 	CCR7,PDCD1LG2,RSAD2,NMNAT2,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,CDH26,SLC27A3,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,SQLE,CLEC12B,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,FHL3,NRROS,GAS1,TUBB4B,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,ENTPD4,CNR2,PDK4,CAPS2,CD44,POSTN,CLCNKB,CRISP2,ZNF366	103	
Cancer, Organismal Injury and Abnormalities	intraabdominal organ tumor	Intraabdominal organ tumor	6.64E-09	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	121	
Inflammatory Response	inflammatory response	Inflammatory response	7.59E-09	 	-1.868	 	-1.443	CCR7,PTGDR2,RSAD2,CCL18,OASL,IFIT1,ADAM19,IFIT2,CTSG,TUBB4B,CLEC12A,CD69,IFIT3,PRDX5,IRF4,CEBPE,ZNF366,CCR3,XCR1	19	
Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	atopic dermatitis	Atopic dermatitis	1.13E-08	 	 	 	 	PTGDR2,PHGDH,CCL18,DOK2,MMP12,IL22RA2,ENTPD4,ANKRD55,PDK4,CD44,GZMB,TESPA1,UBXN11,IL31RA,PER1,CCR3	16	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	idiopathic inflammatory myopathy	Idiopathic inflammatory myopathy	1.14E-08	 	 	 	 	OTOF,RSAD2,IFIT3,OASL,IFIT1,ISG15,IRF4,SFRP1,IFIT2	9	
Cancer, Organismal Injury and Abnormalities	non-colorectal cancer	Non-colorectal cancer	1.35E-08	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	125	
Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	atopic disease	Atopic disease	3.00E-08	 	 	 	 	PTGDR2,PHGDH,CCL18,DOK2,MMP12,IL22RA2,ENTPD4,ANKRD55,PDK4,CD44,GZMB,TESPA1,UBXN11,IL31RA,PER1,HRH4,CCR3	17	
Cancer, Organismal Injury and Abnormalities	carcinoma	Carcinoma	3.33E-08	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	123	
Cancer, Organismal Injury and Abnormalities	extracranial solid tumor	Extracranial solid tumor	6.01E-08	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	125	
Organismal Injury and Abnormalities	non-malignant disorder	Non-malignant disorder	6.24E-08	 	 	 	 	CCR7,PDCD1LG2,CCL18,CLDN3,IFIT1,SFRP1,CCN2,CTSG,SPIB,OTOF,CD69,OASL,GAS1,SORD,TUBB4B,TRAF5,PIP4K2A,PRDX5,CDH26,FETUB,PCDHA12,CCR3,PHGDH,SLC26A4,PRSS33,MMP12,ZBTB16,SAMD3,HS3ST3A1,GZMB,ANO1,COL28A1,TPSAB1,IRF4,RASGRP3,MS4A1,HSD11B2,PTGDR2,ITIH5,FDFT1,PDK4,WEE1,CD44,POSTN,IFIT3,CYP51A1,SCNN1B,XCR1	48	
Cancer, Organismal Injury and Abnormalities	non-central nervous system malignant neoplasm	Non-central nervous system malignant neoplasm	6.37E-08	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	125	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin cancer	Skin cancer	9.20E-08	 	 	 	 	CCR7,PDCD1LG2,RSAD2,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,SLC1A7,BTNL8,LRRC61,CLC,OASL,ADAM19,CDH26,SLC27A3,CCR3,ZNF157,TASL,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,ITIH5,GGT5,IFIT3,SLC9A3,GAPT,SCNN1B,DYDC1,XCR1,CASS4,PPP1R16B,CTSG,P2RY10,CEACAM21,SIGLEC6,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,CD44,POSTN,CLCNKB,CRISP2,ZNF366	99	
Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	ATAD3A-related type I interferonopathy	ATAD3A-related type I interferonopathy	1.43E-07	 	 	 	 	OTOF,RSAD2,OASL,IFIT1,ISG15	5	
Cardiovascular Disease, Connective Tissue Disorders, Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	1.91E-07	 	 	 	 	POSTN,MAPKAPK3,RSAD2,IFIT3,IFIT1,ISG15,IFIT2,MAP2K6	8	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	cutaneous melanoma cancer	Cutaneous melanoma	2.23E-07	 	 	 	 	CCR7,PDCD1LG2,RSAD2,NMNAT2,IL22RA2,SFRP1,CASS4,CCN2,CLCA1,OR52M1,DMRTC2,PPP1R16B,CTSG,SYT2,TESPA1,P2RY10,OTOF,SLC1A7,CEACAM21,SIGLEC6,FHL3,NRROS,BTNL8,LRRC61,CLC,OASL,ADAM19,TUBB4B,UBXN11,IL31RA,CDH26,FETUB,PCDHA12,SLC27A3,MAP2K6,CCR3,ZNF157,TASL,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,VSTM1,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,PTGDR2,RGS18,EMP3,ITIH5,LGALS12,HOXA3,CISH,ENTPD4,CNR2,PDK4,CAPS2,CD44,POSTN,GGT5,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2,ZNF366,DYDC1,XCR1	94	
Immunological Disease, Organismal Injury and Abnormalities	systemic autoimmune syndrome	Systemic autoimmune syndrome	2.90E-07	 	 	 	 	TNNC2,CCR7,RSAD2,CCL18,NMNAT2,IFIT1,ANKRD55,IFIT2,CTSG,GZMB,SKAP2,ARL15,CD69,SQLE,ISG15,P2RY13,IRF4,RASGRP3,MS4A1,OASL,FDFT1,CD44,TRAF5,PIP4K2A,IFIT3,PRDX5,CDH26,SLC27A3,ZNF366,MAP2K6,CCR3,TASL,RFTN1	33	
Hematological Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	eosinophilic inflammation	Eosinophilic inflammation	3.86E-07	 	 	 	 	POSTN,MS4A1,CCL18,SLC26A4,ANO1,CLC,MMP12,TPSAB1,CDH26	9	
Cardiovascular Disease, Connective Tissue Disorders, Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	diffuse systemic sclerosis	Diffuse systemic sclerosis	4.05E-07	 	 	 	 	POSTN,MAPKAPK3,RSAD2,IFIT3,IFIT1,ISG15,CCN2,IFIT2,MAP2K6	9	
Cancer, Organismal Injury and Abnormalities	incidence	Incidence of tumor	4.27E-07	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SPIB,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,PTGDR2,RGS18,EMP3,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	106	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	antineutrophil cytoplasmic antibody-associated vasculitis	Antineutrophil cytoplasmic antibody-associated vasculitis	4.30E-07	 	 	 	 	MS4A1,RSAD2,IFIT3,OASL,IFIT1,ISG15	6	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	peripheral T-cell lymphoma	Peripheral T-cell lymphoma	4.97E-07	 	 	 	 	MS4A1,CCR7,MMP12,ADAM19,IFIT2,GZMB,TUBB4B,SPIB,CD69,IFIT3,PER1,ISG15	12	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	respiratory system tumor	Respiratory system tumor	6.28E-07	 	 	 	 	CCR7,PDCD1LG2,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,P2RY13,BTNL8,LRRC61,OASL,GAS1,ADAM19,TUBB4B,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CRYBA1,ZNF157,TASL,PHGDH,WDR93,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,HS3ST3A1,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,ITIH5,HOXA3,CISH,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,GAPT,SCNN1B,CRISP2,XCR1	77	
Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of absolute anatomical region	6.69E-07	 	 	 	 	TNNC2,CCR7,MAPKAPK3,PHGDH,RSAD2,CCL18,SLC26A4,MMP12,ZBTB16,ITLN1,CCN2,ANKRD55,IFIT2,PPP1R16B,CTSG,GZMB,ARL15,CD69,SLC1A7,SQLE,ANO1,TPSAB1,PER1,ISG15,P2RY13,BTNL8,MS4A1,CLC,FDFT1,CNR2,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,IFIT3,PRDX5,CDH26,CYP51A1,ZNF366,MAP2K6,CCR3	42	
Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	systemic lupus erythematosus	Systemic lupus erythematosus	8.15E-07	 	 	 	 	MS4A1,RSAD2,NMNAT2,OASL,IFIT1,FDFT1,ANKRD55,IFIT2,CD44,CTSG,GZMB,TRAF5,SKAP2,CD69,IFIT3,ISG15,SLC27A3,RASGRP3,TASL	19	
Dermatological Diseases and Conditions, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	dermatomyositis	Dermatomyositis	9.48E-07	 	 	 	 	MS4A1,EMP3,RSAD2,IFIT3,OASL,IFIT1,ISG15,IFIT2,CNR2,GZMB	10	
Cancer, Organismal Injury and Abnormalities	head and neck neoplasia	Head and neck tumor	9.86E-07	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	112	
Gastrointestinal Disease, Hematological Disease, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	eosinophilia	Eosinophilia of esophagus	1.15E-06	 	 	 	 	POSTN,CCL18,SLC26A4,ANO1,CLC,MMP12,TPSAB1,CDH26	8	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	malignant neoplasm of respiratory system	Malignant neoplasm of respiratory system	1.22E-06	 	 	 	 	CCR7,PDCD1LG2,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,P2RY13,BTNL8,LRRC61,OASL,GAS1,ADAM19,TUBB4B,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CRYBA1,ZNF157,TASL,PHGDH,WDR93,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,HS3ST3A1,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,ITIH5,HOXA3,CISH,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,GAPT,SCNN1B,CRISP2,XCR1	76	
Cardiovascular Disease, Inflammatory Disease, Organismal Injury and Abnormalities	vasculitis	Vasculitis	1.44E-06	 	 	 	 	MS4A1,CCR7,RSAD2,IFIT3,OASL,IFIT1,ISG15,CCR3,TUBB4B	9	
Organismal Injury and Abnormalities	soft tissue lesion	Soft tissue lesion	1.47E-06	 	 	 	 	PDCD1LG2,FABP6,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,CLC,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,SQLE,CLEC12B,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,IFIT3,SLC9A3,CYP51A1,SCNN1B,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,EMP3,LGALS12,HOXA3,CISH,FDFT1,ENTPD4,CNR2,PDK4,WEE1,CD44,POSTN,CLCNKB,CRISP2	97	
Gastrointestinal Disease, Organismal Injury and Abnormalities	benign oral disorder	Benign oral disorder	1.57E-06	 	 	 	 	MS4A1,CCR7,PTGDR2,PHGDH,CCL18,PRSS33,MMP12,CD44,GZMB,TUBB4B,TRAF5,CD69,IFIT3,CYP51A1,IRF4,RASGRP3,CCR3,XCR1	18	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	T-cell non-Hodgkin disease	T-cell non-Hodgkin lymphoma	1.69E-06	 	 	 	 	MS4A1,CCR7,RSAD2,CCL18,CLC,OASL,MMP12,ZBTB16,ADAM19,IFIT2,GZMB,TUBB4B,SPIB,P2RY10,CD69,IFIT3,PER1,ISG15,IRF4,CCR3	20	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	pruritus	Pruritus	2.17E-06	 	 	 	 	CCL18,SQLE,IL31RA,TPSAB1,HRH4,CYP51A1,CNR2,CTSG	8	
Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	non-traumatic arthropathy	Non-traumatic arthropathy	2.54E-06	 	 	 	 	TNNC2,CCR7,PHGDH,RSAD2,CCL18,MMP12,ITLN1,SFRP1,ANKRD55,CTSG,GZMB,ARL15,CD69,SLC1A7,SQLE,P2RY13,BTNL8,MS4A1,FDFT1,CNR2,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,PRDX5,CDH26,ZNF366,MAP2K6,CCR3	30	
Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	inflammation	Inflammation of respiratory system component	3.13E-06	 	 	 	 	MS4A1,PTGDR2,SLC26A4,MMP12,ZBTB16,ADAM19,FDFT1,CD44,GZMB,TUBB4B,TESPA1,POSTN,GGT5,ANO1,IL31RA,PER1,HRH4,CYP51A1,IRF4,CCR3	20	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	digestive organ tumor	Digestive organ tumor	3.25E-06	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,CRISP2,ZNF366	114	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	familial autoimmune disease	Familial autoimmune disease	4.73E-06	 	 	 	 	CCR7,SLC1A7,LGALS12,OASL,IFIT1,TPSAB1,CEBPE,RASGRP3,CTSG,RFTN1	10	
Cancer, Organismal Injury and Abnormalities	non rhabdoid tumor	Non rhabdoid tumor	5.14E-06	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,IFIT1,IL22RA2,SFRP1,CASS4,CCN2,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,SPIB,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,FHL3,BTNL8,LRRC61,CLC,OASL,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CRYBA1,CCR3,ZNF157,RFTN1,PHGDH,DOK2,MMP12,ZBTB16,ITLN1,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,GZMB,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,ITIH5,IFT74,HOXA3,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,CRISP2,XCR1	88	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	endocrine gland tumor	Endocrine gland tumor	7.11E-06	 	 	 	 	PDCD1LG2,FABP6,RSAD2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,WDR93,DOK2,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,SLC9A3,GAPT,CYP51A1,SCNN1B,XCR1,CASS4,PPP1R16B,CTSG,SKAP2,P2RY10,SIGLEC6,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	103	
Cancer, Organismal Injury and Abnormalities	anogenital cancer	Anogenital cancer	7.16E-06	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,SYT2,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,OASL,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,SLC26A4,WDR93,DOK2,MMP12,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,MS4A1,HSD11B2,EMP3,ITIH5,LGALS12,IFT74,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	88	
Cancer, Organismal Injury and Abnormalities	cancer	Cancer of cells	7.23E-06	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,NMNAT2,IFIT1,SFRP1,CCN2,CLCA1,OR52M1,PPP1R16B,CTSG,TESPA1,SPIB,P2RY10,OTOF,CD69,SIGLEC6,FHL3,NRROS,BTNL8,LRRC61,CLC,OASL,GAS1,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,CDH26,PCDHA12,CCR3,TASL,RFTN1,PHGDH,WDR93,DOK2,MMP12,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,ITIH5,FDFT1,ENTPD4,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,ZNF366,DYDC1,XCR1	78	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	genital tumor	Genital tumor	7.35E-06	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CCN2,CLCA1,SYT2,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,OASL,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,SLC26A4,WDR93,DOK2,MMP12,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,MS4A1,HSD11B2,EMP3,ITIH5,LGALS12,IFT74,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	89	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	diabetic nephropathy	Diabetic nephropathy	7.59E-06	 	 	 	 	MS4A1,HSD11B2,CCL18,SLC26A4,GAS1,IFIT1,ZBTB16,SFRP1,CNR2,PDK4,CTSG,TESPA1,SPIB,POSTN,CLCNKB,SIGLEC6,TPSAB1,PER1,IRF4	19	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by mycobacteria	7.63E-06	 	 	 	 	CCR7,MAPKAPK3,PHGDH,IFIT3,IFIT1,CYP51A1,CISH,FDFT1,IFIT2,CTSG	10	
Cancer, Organismal Injury and Abnormalities	connective or soft tissue tumor	Connective or soft tissue tumor	8.17E-06	 	 	 	 	TNNC2,PDCD1LG2,CLDN3,IFIT1,SFRP1,CCN2,CLCA1,OR52M1,TESPA1,SPIB,P2RY10,OTOF,CEACAM21,SIGLEC6,P2RY13,NRROS,BTNL8,LRRC61,CLC,OASL,GAS1,ADAM19,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,CDH26,FETUB,PCDHA12,RFTN1,WDR93,PRSS33,MMP12,CST1,ITLN1,BAIAP3,IFIT2,HS3ST3A1,VSTM1,GZMB,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,SLC9B2,HRH4,HEPH,MS4A1,HSD11B2,PTGDR2,ITIH5,IFT74,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,XCR1	67	
Cancer, Organismal Injury and Abnormalities	generation	Generation of tumor	8.30E-06	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CLCA1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,LGALS12,HOXA3,CISH,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	110	
Inflammatory Disease, Organismal Injury and Abnormalities	chronic inflammatory disorder	Chronic inflammatory disorder	8.47E-06	 	 	 	 	TNNC2,CCR7,MAPKAPK3,PDCD1LG2,CCL18,DOK2,ZBTB16,ITLN1,CCN2,LRRC32,ANKRD55,GZMB,SKAP2,ARL15,CD69,SQLE,PER1,P2RY13,MS4A1,FDFT1,CD44,TUBB4B,PIP4K2A,POSTN,GGT5,PRDX5,IL31RA,CDH26,CYP51A1,ZNF366,CCR3	31	
Cancer, Organismal Injury and Abnormalities	malignant genitourinary solid tumor	Malignant genitourinary solid tumor	8.55E-06	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,OASL,ADAM19,SORD,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,SKAP2,SPIB,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,MCOLN2,PHGDH,DENND2D,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,EMP3,LGALS12,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,WEE1,CD44,POSTN,CLCNKB,LXN,ZNF366	104	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	lung cancer	Lung cancer	9.79E-06	 	 	 	 	PDCD1LG2,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,P2RY13,BTNL8,LRRC61,OASL,GAS1,ADAM19,TUBB4B,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CRYBA1,ZNF157,TASL,PHGDH,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,HRH4,IRF4,CEBPE,CD1B,HEPH,MS4A1,NAIF1,HSD11B2,ITIH5,HOXA3,CISH,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,GAPT,SCNN1B,CRISP2,XCR1	71	
Cancer, Organismal Injury and Abnormalities	frequency	Frequency of tumor	9.82E-06	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,CASS4,PPP1R16B,CTSG,SPIB,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,PTGDR2,RGS18,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	101	
Cancer, Organismal Injury and Abnormalities	malignant neoplasm of retroperitoneum	Malignant neoplasm of retroperitoneum	1.00E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,SFRP1,CASS4,CCN2,CLCA1,OR52M1,DMRTC2,PPP1R16B,SYT2,TESPA1,OTOF,SLC1A7,CEACAM21,FHL3,ADAM19,TUBB4B,PIP4K2A,CDH26,PCDHA12,MAP2K6,CCR3,MAPKAPK3,PHGDH,SLC26A4,DOK2,CST1,ZBTB16,SAMD3,BAIAP3,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,RASGRP3,HEPH,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,CYP51A1,LXN,CRISP2,XCR1	56	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	digestive system cancer	Digestive system cancer	1.05E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,P2RY10,CEACAM21,SIGLEC6,P2RY13,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,CRISP2,ZNF366	112	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	hepato-pancreato-biliary cancer	Hepato-pancreato-biliary cancer	1.05E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OR52M1,DMRTC2,PPP1R16B,SYT2,TESPA1,OTOF,CD69,SLC1A7,CEACAM21,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,GZMB,ARL15,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,CRISP2,ZNF366,XCR1	80	
Organismal Injury and Abnormalities, Respiratory Disease	lung lesion	Lung lesion	1.09E-05	 	 	 	 	PDCD1LG2,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,P2RY13,BTNL8,LRRC61,OASL,GAS1,ADAM19,TUBB4B,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CRYBA1,ZNF157,TASL,PHGDH,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,HRH4,IRF4,CEBPE,CD1B,HEPH,MS4A1,NAIF1,HSD11B2,ITIH5,HOXA3,CISH,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,CRISP2,XCR1	73	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	migration	T cell migration	1.21E-05	 	-1.980	bias	-1.316	CCR7,CD69,PTGDR2,CCL18,CD44,CTSG,P2RY10	7	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities	diabetes mellitus	Diabetes mellitus	1.24E-05	 	 	 	 	RSAD2,CCL18,SLC26A4,NMNAT2,DOK2,IFIT1,ZBTB16,ITLN1,SFRP1,CCN2,ANKRD55,IFIT2,PPP1R16B,CTSG,SKAP2,TESPA1,SPIB,ARL15,CD69,SIGLEC6,TPSAB1,PER1,ISG15,SLC9B2,IRF4,HEPH,MS4A1,HSD11B2,OASL,GAS1,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,PRDX5,SCNN1B	41	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	endocrine carcinoma	Endocrine carcinoma	1.42E-05	 	 	 	 	PDCD1LG2,FABP6,RSAD2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,SLC1A7,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,WDR93,DOK2,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,SLC9A3,GAPT,CYP51A1,SCNN1B,XCR1,CASS4,PPP1R16B,CTSG,SKAP2,P2RY10,SIGLEC6,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	101	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	genital tract cancer	Genital tract cancer	1.48E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,SYT2,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,OASL,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,SLC26A4,WDR93,DOK2,MMP12,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,MS4A1,HSD11B2,EMP3,ITIH5,LGALS12,IFT74,HOXA3,FDFT1,CNR2,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	87	
Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	autoimmune bullous skin disease	Autoimmune bullous skin disease	1.51E-05	 	 	 	 	MS4A1,RSAD2,IFIT3,OASL,IFIT1,ISG15,GZMB	7	
Digestive System Development and Function, Gastrointestinal Disease, Hepatic System Development and Function, Hepatic System Disease, Inflammatory Disease, Inflammatory Response, Metabolic Disease, Organ Development, Organismal Injury and Abnormalities, Psychological Disorders	alcoholic steatohepatitis	Alcoholic steatohepatitis	1.64E-05	 	 	 	 	IFIT3,ISG15,IFIT2	3	
Gastrointestinal Disease, Immunological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities	Sjögren syndrome	Sjögren syndrome	1.64E-05	 	 	 	 	MS4A1,CCR7,CD69,CCL18,IFIT3,RASGRP3,TRAF5	7	
Cancer, Organismal Injury and Abnormalities	cancer	Cancer of secretory structure	1.67E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,CLDN3,SFRP1,CCN2,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,SLC9A3,CYP51A1,SCNN1B,XCR1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,CEACAM21,SIGLEC6,P2RY13,FHL3,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	105	
Cancer, Organismal Injury and Abnormalities	breast or pancreatic cancer	Breast or pancreatic cancer	1.77E-05	 	 	 	 	TNNC2,CCR7,PDCD1LG2,RSAD2,CCL18,CLDN3,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,SKAP2,TESPA1,SPIB,OTOF,CD69,SLC1A7,CEACAM21,SIGLEC6,OASL,GAS1,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,CDH26,PCDHA12,MAP2K6,CCR3,MCOLN2,MAPKAPK3,PHGDH,DENND2D,DOK2,MMP12,CST1,ZBTB16,LRRC32,SAMD3,BAIAP3,HS3ST3A1,GZMB,ARL15,SQLE,ANO1,TPSAB1,HRH4,IRF4,RASGRP3,HEPH,MS4A1,HSD11B2,EMP3,ITIH5,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,POSTN,CLCNKB,CYP51A1,CRISP2,XCR1	69	
Cancer, Organismal Injury and Abnormalities	neoplasia	Neoplasia of cells	1.84E-05	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,NMNAT2,IFIT1,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,TESPA1,SPIB,P2RY10,OTOF,CD69,SIGLEC6,FHL3,NRROS,BTNL8,LRRC61,CLC,OASL,GAS1,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,CDH26,FETUB,PCDHA12,CCR3,TASL,RFTN1,PHGDH,WDR93,DOK2,MMP12,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,ITIH5,IFT74,FDFT1,ENTPD4,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,CRISP2,ZNF366,DYDC1,XCR1	85	
Dermatological Diseases and Conditions, Immunological Disease, Organismal Injury and Abnormalities	pemphigus	Pemphigus	1.86E-05	 	 	 	 	MS4A1,RSAD2,IFIT3,OASL,IFIT1,ISG15,GZMB	7	
Cancer, Organismal Injury and Abnormalities	head and neck cancer	Head and neck cancer	1.95E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,CD69,SLC1A7,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,PPP1R16B,CTSG,SKAP2,SIGLEC6,P2RY13,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,PCDHA12,MAP2K6,RFTN1,MCOLN2,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,EMP3,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	104	
Cancer, Organismal Injury and Abnormalities	extraadrenal retroperitoneal tumor	Extraadrenal retroperitoneal tumor	2.01E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,SFRP1,CASS4,CCN2,CLCA1,OR52M1,DMRTC2,PPP1R16B,SYT2,TESPA1,OTOF,SLC1A7,CEACAM21,FHL3,BTNL8,ADAM19,TUBB4B,PIP4K2A,CDH26,PCDHA12,MAP2K6,CCR3,MAPKAPK3,PHGDH,SLC26A4,DOK2,CST1,ZBTB16,SAMD3,BAIAP3,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,RASGRP3,HEPH,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,CYP51A1,LXN,CRISP2,XCR1	58	
Gastrointestinal Disease, Immunological Disease, Organismal Injury and Abnormalities	celiac disease	Celiac disease	2.11E-05	 	 	 	 	CD69,SQLE,CYP51A1,IRF4,ADAM19,FDFT1,CCR3	7	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	inflammation	Inflammation of joint	2.20E-05	 	 	 	 	TNNC2,CCR7,PHGDH,RSAD2,CCL18,MMP12,ITLN1,ANKRD55,CTSG,GZMB,ARL15,CD69,SLC1A7,SQLE,P2RY13,BTNL8,MS4A1,FDFT1,CNR2,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,PRDX5,CDH26,ZNF366,MAP2K6,CCR3	29	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of lymphocytes	2.28E-05	Decreased	-2.012	bias	-1.341	CCR7,CD69,PTGDR2,CCL18,CCR3,CD44,CTSG,P2RY10	8	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities	interdigital tinea pedis	Interdigital tinea pedis	2.72E-05	 	 	 	 	SQLE,CYP51A1	2	
Hematological Disease, Hereditary Disorder, Infectious Diseases, Organismal Injury and Abnormalities	susceptibility to bacteremia type 2	Susceptibility to bacteremia type 2	2.72E-05	 	 	 	 	MAPKAPK3,CISH	2	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities	tinea capitis	Tinea capitis	2.72E-05	 	 	 	 	SQLE,CYP51A1	2	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	migration	Migration of mononuclear leukocytes	3.53E-05	Decreased	-2.207	bias	-1.500	POSTN,CCR7,CD69,PTGDR2,CCL18,CD44,CTSG,P2RY10	8	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	carcinoma	Lung carcinoma	3.68E-05	 	 	 	 	PDCD1LG2,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,SLC1A7,P2RY13,BTNL8,LRRC61,GAS1,ADAM19,TUBB4B,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CRYBA1,ZNF157,TASL,PHGDH,DOK2,MMP12,CST1,ZBTB16,ITLN1,SAMD3,BAIAP3,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,HRH4,IRF4,CEBPE,CD1B,HEPH,MS4A1,NAIF1,HSD11B2,ITIH5,HOXA3,CISH,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,GAPT,SCNN1B,CRISP2,XCR1	68	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	cutaneous T-cell lymphoma	Cutaneous T-cell lymphoma	4.04E-05	 	 	 	 	MS4A1,CCR7,RSAD2,OASL,ISG15,IRF4,TUBB4B	7	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of mononuclear leukocytes	4.56E-05	Decreased	-2.246	bias	-1.545	POSTN,CCR7,CD69,PTGDR2,CCL18,CCR3,CD44,CTSG,P2RY10	9	
Infectious Diseases, Organismal Injury and Abnormalities	tuberculosis	Tuberculosis	4.56E-05	 	 	 	 	CCR7,MAPKAPK3,PHGDH,IFIT3,IFIT1,CISH,FDFT1,IFIT2,CTSG	9	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Respiratory Disease	neuroendocrine lung tumor	Neuroendocrine lung tumor	4.74E-05	 	 	 	 	PHGDH,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,IRF4,CEBPE,CD1B,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,HOXA3,ADAM19,FDFT1,PDK4,CD44,TUBB4B,POSTN,RRAGB,FETUB,PCDHA12,GAPT,CRYBA1,CRISP2,ZNF157,XCR1	39	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	thoracic neuroendocrine neoplasm	Thoracic neuroendocrine neoplasm	4.74E-05	 	 	 	 	PHGDH,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,IRF4,CEBPE,CD1B,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,HOXA3,ADAM19,FDFT1,PDK4,CD44,TUBB4B,POSTN,RRAGB,FETUB,PCDHA12,GAPT,CRYBA1,CRISP2,ZNF157,XCR1	39	
Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	childhood-onset systemic lupus erythematosus	Childhood-onset systemic lupus erythematosus	4.89E-05	 	 	 	 	RSAD2,IFIT1,ISG15	3	
Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	pemphigus foliaceus	Pemphigus foliaceus	4.99E-05	 	 	 	 	RSAD2,IFIT3,OASL,IFIT1,ISG15	5	
Cancer, Organismal Injury and Abnormalities	pelvic tumor	Pelvic tumor	5.12E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,SYT2,OTOF,CD69,SLC1A7,BTNL8,OASL,ADAM19,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,SPIB,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,MCOLN2,PHGDH,DENND2D,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,EMP3,LGALS12,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,WEE1,CD44,POSTN,CLCNKB,ZNF366	96	
Cancer, Organismal Injury and Abnormalities	formation	Formation of epithelial neoplasm	5.62E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CLCA1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,CASS4,PPP1R16B,CTSG,SPIB,P2RY10,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,PTGDR2,RGS18,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	98	
Cancer, Organismal Injury and Abnormalities	tumorigenesis	Tumorigenesis of epithelial neoplasm	5.62E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CLCA1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,CASS4,PPP1R16B,CTSG,SPIB,P2RY10,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,PTGDR2,RGS18,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	98	
Dermatological Diseases and Conditions, Endocrine System Disorders, Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	polyglandular autoimmune syndrome type 1	Polyglandular autoimmune syndrome type 1	5.65E-05	 	 	 	 	CCR7,OASL,IFIT1,RASGRP3,RFTN1	5	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin carcinoma	Skin carcinoma	6.21E-05	 	 	 	 	CCR7,PHGDH,RSAD2,SLC26A4,DOK2,MMP12,ITLN1,CASS4,LRRC32,SAMD3,BAIAP3,OR52M1,VSTM1,TESPA1,P2RY10,OTOF,SLC1A7,ANO1,COL28A1,CEACAM21,CLEC12B,SIGLEC6,ISG15,HRH4,IRF4,CD1B,RASGRP3,BTNL8,HEPH,MS4A1,ITIH5,LGALS12,OASL,ADAM19,CNR2,CAPS2,CD44,TUBB4B,PIP4K2A,POSTN,CLCNKB,FETUB,PCDHA12,GAPT,CRISP2,ZNF366	46	
Cancer, Organismal Injury and Abnormalities	upper abdominal cancer	Upper abdominal cancer	6.25E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OR52M1,DMRTC2,PPP1R16B,SYT2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,CEACAM21,SIGLEC6,FHL3,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,SLC27A3,MAP2K6,CCR3,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,PDK4,CAPS2,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,LXN,CRISP2,ZNF366,XCR1	91	
Cellular Movement	invasion	Invasion of squamous cell carcinoma cell lines	6.77E-05	 	-1.133	bias	-0.547	POSTN,ANO1,CCN2,IFIT2,CD44	5	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin fissure	Skin fissure	8.13E-05	 	 	 	 	SQLE,CYP51A1	2	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Respiratory Disease	small cell lung cancer	Small cell lung carcinoma	8.30E-05	 	 	 	 	PHGDH,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,IRF4,CEBPE,CD1B,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,HOXA3,ADAM19,FDFT1,PDK4,TUBB4B,POSTN,RRAGB,FETUB,PCDHA12,GAPT,CRYBA1,CRISP2,ZNF157,XCR1	38	
Cancer, Organismal Injury and Abnormalities	genitourinary carcinoma	Genitourinary carcinoma	8.37E-05	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,SYT2,TESPA1,OTOF,SLC1A7,BTNL8,OASL,ADAM19,SLC27A3,CRYBA1,CCR3,ZNF157,TASL,SLC26A4,WDR93,DOK2,CST1,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,MS4A1,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,SKAP2,SPIB,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,MAP2K6,MCOLN2,PHGDH,DENND2D,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,WEE1,CD44,POSTN,CLCNKB,LXN,ZNF366	97	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoma	Lymphoma	8.38E-05	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,BAIAP3,IFIT2,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,IRF4,FHL3,MS4A1,ITIH5,CLC,OASL,ADAM19,FDFT1,SORD,CD44,TUBB4B,POSTN,IFIT3,PCDHA12,CYP51A1,CCR3,RFTN1	34	
Cancer, Organismal Injury and Abnormalities	solid tumor	Primary solid tumor	8.72E-05	 	 	 	 	MS4A1,PDCD1LG2,LGALS12,DOK2,CLDN3,ADAM19,SFRP1,SAMD3,SORD,CD44,TUBB4B,POSTN,IRF4	13	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	9.04E-05	 	 	 	 	MS4A1,CCR7,CD69,TUBB4B	4	
Cellular Movement	cell movement	Cell movement of blood cells	9.22E-05	 	-1.927	bias	-1.097	POSTN,MS4A1,CCR7,CD69,PTGDR2,CCL18,CCR3,CD44,CTSG,GZMB,P2RY10	11	
Inflammatory Disease, Organismal Injury and Abnormalities	inflammatory disorder	Severe inflammatory disorder	1.04E-04	 	 	 	 	MS4A1,CCR7,IFIT3,IL31RA,CLC,ISG15,CEBPE,IFIT2,CD44,TUBB4B	10	
Cancer, Organismal Injury and Abnormalities	pelvic cancer	Pelvic cancer	1.13E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,SYT2,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,OASL,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,SLC27A3,CRYBA1,MAP2K6,CCR3,ZNF157,TASL,MCOLN2,PHGDH,DENND2D,SLC26A4,WDR93,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,MS4A1,HSD11B2,EMP3,ITIH5,LGALS12,IFT74,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,ZNF366,DYDC1,XCR1	94	
Cancer, Organismal Injury and Abnormalities	genitourinary adenocarcinoma	Genitourinary adenocarcinoma	1.14E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,CCL18,NMNAT2,CLDN3,SFRP1,CASS4,CLCA1,PPP1R16B,SYT2,SKAP2,SPIB,OTOF,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,OASL,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,SLC26A4,WDR93,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,ITIH5,IFT74,HOXA3,FDFT1,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,LXN,ZNF366,DYDC1,XCR1	83	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Respiratory Disease	cystic fibrosis	Cystic fibrosis	1.18E-04	 	 	 	 	SLC9A3,PER1,CYP51A1,FDFT1,CTSG	5	
Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoproliferative disorder of the skin	Lymphoproliferative disorder of the skin	1.22E-04	 	 	 	 	MS4A1,CCR7,RSAD2,CLC,OASL,ISG15,ZBTB16,IRF4,CCR3,TUBB4B,P2RY10	11	
Cancer, Organismal Injury and Abnormalities	head and neck carcinoma	Head and neck carcinoma	1.23E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CCN2,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,SLC1A7,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,ZBTB16,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,PPP1R16B,CTSG,SKAP2,SIGLEC6,NRROS,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,PCDHA12,MAP2K6,RFTN1,MCOLN2,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	99	
Cancer, Organismal Injury and Abnormalities	development	Development of malignant tumor	1.29E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CLCA1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,CDH26,SLC27A3,CRYBA1,CCR3,ZNF157,MAPKAPK3,SLC26A4,DOK2,CST1,ZBTB16,ITLN1,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,GAPT,CYP51A1,SCNN1B,DYDC1,XCR1,CASS4,PPP1R16B,CTSG,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,GAS1,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,MAP2K6,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,ANO1,COL28A1,HEPH,PTGDR2,RGS18,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	97	
Cellular Movement	migration	Migration of tumor cells	1.31E-04	 	 	 	 	CCR7,ZBTB16,SFRP1,CD44,GZMB	5	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast or gynecological cancer	Breast or gynecological cancer	1.36E-04	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,RSAD2,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OR52M1,SKAP2,TESPA1,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,NRROS,BTNL8,OASL,GAS1,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,DENND2D,WDR93,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,MS4A1,HSD11B2,EMP3,ITIH5,IFT74,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	84	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Viral Infection	1.37E-04	 	0.644	bias	1.661	CCR7,MAPKAPK3,PHGDH,RSAD2,CLDN3,IFIT1,ITLN1,CASS4,CCN2,LRRC32,BAIAP3,IFIT2,CTSG,GZMB,P2RY10,CD69,ANO1,ISG15,HRH4,IRF4,CEBPE,FHL3,LRRC61,MS4A1,PTGDR2,CLC,OASL,FDFT1,CD44,TUBB4B,GGT5,IFIT3,SLC9A3,RRAGB,CYP51A1,SLC27A3,CCR3,RFTN1,XCR1	39	
Infectious Diseases, Organismal Injury and Abnormalities	septic shock	Septic shock	1.37E-04	 	 	 	 	MS4A1,CCR7,PDCD1LG2,IFIT1,IFIT2,MAP2K6,CCR3,CTSG,GZMB,P2RY10	10	
Cancer, Organismal Injury and Abnormalities	primary neoplasm	Primary neoplasm	1.50E-04	 	 	 	 	MS4A1,PDCD1LG2,LGALS12,DOK2,CLDN3,ADAM19,SFRP1,FDFT1,SAMD3,SORD,CD44,TUBB4B,POSTN,IRF4	14	
Cellular Movement	chemotaxis	Chemotaxis of lung cancer cell lines	1.62E-04	 	 	 	 	CCL18,CD44	2	
Infectious Diseases, Organismal Injury and Abnormalities	systemic inflammatory response syndrome and/or sepsis	Systemic inflammatory response syndrome and/or sepsis	1.66E-04	 	 	 	 	CCR7,IFIT3,ISG15,IL22RA2,CYP51A1,IFIT2,CNR2,MAP2K6,CCR3,CD44,P2RY10	11	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	non-small cell lung cancer	Non-small cell lung carcinoma	1.71E-04	 	 	 	 	PDCD1LG2,RSAD2,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,CTSG,SYT2,TESPA1,P2RY10,OTOF,P2RY13,BTNL8,GAS1,ADAM19,TUBB4B,UBXN11,CDH26,PCDHA12,TASL,PHGDH,DOK2,MMP12,CST1,ZBTB16,ITLN1,SAMD3,BAIAP3,VSTM1,SQLE,PER1,HRH4,IRF4,HEPH,ITIH5,HOXA3,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,SCNN1B,CRISP2,XCR1	49	
Cancer, Organismal Injury and Abnormalities	breast or gastric cancer	Breast or gastric cancer	1.76E-04	 	 	 	 	TNNC2,CCR7,PDCD1LG2,RSAD2,CCL18,CLDN3,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OR52M1,SKAP2,TESPA1,SPIB,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,FHL3,OASL,GAS1,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,CDH26,FETUB,PCDHA12,SLC27A3,MAP2K6,CCR3,MCOLN2,MAPKAPK3,PHGDH,DENND2D,DOK2,MMP12,CST1,ZBTB16,LRRC32,BAIAP3,HS3ST3A1,GZMB,SQLE,ANO1,COL28A1,TPSAB1,PER1,HRH4,IRF4,CEBPE,RASGRP3,MS4A1,HSD11B2,RGS18,EMP3,ITIH5,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,CYP51A1,SCNN1B,ZNF366,XCR1	74	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin tumor	Primary skin tumor	1.85E-04	 	 	 	 	MS4A1,IRF4,CD44,TUBB4B	4	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	nonpituitary endocrine tumor	Nonpituitary endocrine tumor	1.94E-04	 	 	 	 	PDCD1LG2,FABP6,RSAD2,CLDN3,SFRP1,CCN2,CLCA1,OR52M1,DMRTC2,SYT2,TESPA1,OTOF,SLC1A7,BTNL8,LRRC61,OASL,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,ITLN1,IFIT2,HS3ST3A1,ARL15,SQLE,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,GGT5,SLC9A3,CYP51A1,SCNN1B,XCR1,PPP1R16B,CTSG,SKAP2,SIGLEC6,GAS1,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,PCDHA12,MAP2K6,RFTN1,MCOLN2,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,LGALS12,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,LXN,CRISP2,ZNF366	96	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	castration refractory prostate cancer	Androgen-independent prostate tumor	2.31E-04	 	 	 	 	RSAD2,CYP51A1,FDFT1,RASGRP3,TUBB4B	5	
Cancer, Organismal Injury and Abnormalities	soft tissue neoplasm	Soft tissue neoplasm	2.36E-04	 	 	 	 	PDCD1LG2,SFRP1,CCN2,CLCA1,OR52M1,TESPA1,P2RY10,OTOF,CEACAM21,SIGLEC6,P2RY13,NRROS,BTNL8,LRRC61,CLC,GAS1,ADAM19,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,CDH26,FETUB,PCDHA12,PRSS33,CST1,ITLN1,BAIAP3,IFIT2,VSTM1,GZMB,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,SLC9B2,HRH4,HEPH,PTGDR2,ITIH5,IFT74,HOXA3,FDFT1,CNR2,PDK4,CD44,CLEC12A,POSTN,CLCNKB,SLC9A3,SCNN1B	53	
Organismal Injury and Abnormalities, Respiratory Disease	lower respiratory tract disorder	Lower respiratory tract disorder	2.37E-04	 	 	 	 	PHGDH,DENND2D,CCL18,ITIH5,MMP12,ADAM19,CCN2,SAMD3,CNR2,CD44,CTSG,GZMB,POSTN,CD69,ANO1,P2RY13,PCDHA12,CYP51A1,SCNN1B,RASGRP3	20	
Cancer, Organismal Injury and Abnormalities	stromal neoplasm	Stromal neoplasm	2.45E-04	 	 	 	 	PDCD1LG2,CST1,ITLN1,SFRP1,CCN2,BAIAP3,IFIT2,CLCA1,OR52M1,VSTM1,GZMB,TESPA1,P2RY10,OTOF,ANO1,COL28A1,CEACAM21,CLEC12B,SIGLEC6,TPSAB1,PER1,SLC9B2,P2RY13,HRH4,NRROS,BTNL8,LRRC61,HEPH,PTGDR2,ITIH5,CLC,IFT74,HOXA3,ADAM19,FDFT1,CNR2,CD44,TUBB4B,PIP4K2A,CLEC12A,UBXN11,CLCNKB,PRDX5,SLC9A3,IL31RA,PCDHA12	46	
Cell Signaling	replication	Replication of viral replicon	2.61E-04	 	1.987	 	1.684	RSAD2,OASL,IFIT1,ISG15	4	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	lung adenocarcinoma	Lung adenocarcinoma	2.66E-04	 	 	 	 	PDCD1LG2,RSAD2,NMNAT2,DOK2,CLDN3,MMP12,CST1,ITLN1,SFRP1,CASS4,BAIAP3,CLCA1,VSTM1,CTSG,SYT2,P2RY10,OTOF,PER1,P2RY13,HRH4,IRF4,BTNL8,ITIH5,GAS1,HOXA3,ADAM19,PDK4,WEE1,CD44,TUBB4B,POSTN,UBXN11,IFIT3,CLCNKB,CDH26,PCDHA12,SCNN1B,CRISP2,XCR1	39	
Infectious Diseases, Ophthalmic Disease, Organismal Injury and Abnormalities	follicular trachoma	Follicular trachoma	2.69E-04	 	 	 	 	CCL18,CCN2	2	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Epidermophyton floccosum	2.69E-04	 	 	 	 	SQLE,CYP51A1	2	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infetion by Trichophyton mentagrophytes	2.69E-04	 	 	 	 	SQLE,CYP51A1	2	
Cellular Movement	migration	Migration of melanoma cells	2.69E-04	 	 	 	 	CCR7,ZBTB16	2	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities	tinea versicolor	Tinea versicolor	2.69E-04	 	 	 	 	SQLE,CYP51A1	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	neoplasia	Gastrointestinal tumor	3.00E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,SORD,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,IFIT2,HS3ST3A1,SQLE,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,TNNC2,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,SPIB,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,ZNF366	103	
Cancer, Organismal Injury and Abnormalities	gastrointestinal stromal tumor	Gastrointestinal stromal tumor in fibrous tissue	3.05E-04	 	 	 	 	PDCD1LG2,CST1,ITLN1,SFRP1,CCN2,BAIAP3,IFIT2,CLCA1,OR52M1,VSTM1,GZMB,TESPA1,P2RY10,OTOF,ANO1,COL28A1,CEACAM21,CLEC12B,SIGLEC6,TPSAB1,PER1,SLC9B2,P2RY13,HRH4,NRROS,BTNL8,LRRC61,HEPH,PTGDR2,ITIH5,CLC,IFT74,HOXA3,ADAM19,FDFT1,CNR2,CD44,PIP4K2A,CLEC12A,UBXN11,CLCNKB,PRDX5,SLC9A3,IL31RA,PCDHA12	45	
Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of body cavity	3.11E-04	 	 	 	 	MS4A1,CCR7,MAPKAPK3,PHGDH,CCL18,ZBTB16,CCN2,FDFT1,ANKRD55,IFIT2,CD44,PPP1R16B,GZMB,TUBB4B,CD69,IFIT3,PER1,ISG15,P2RY13,CYP51A1,CCR3	21	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	inflammation	Inflammation of airway	3.19E-04	 	 	 	 	PTGDR2,SLC26A4,MMP12,ZBTB16,ADAM19,CD44,TUBB4B,TESPA1,POSTN,GGT5,ANO1,IL31RA,HRH4,IRF4,CCR3	15	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	asthma	Asthma	3.22E-04	 	 	 	 	PTGDR2,SLC26A4,MMP12,ZBTB16,ADAM19,CD44,TUBB4B,TESPA1,POSTN,ANO1,IL31RA,IRF4,CCR3	13	
Cancer, Organismal Injury and Abnormalities	development	Development of carcinoma	3.26E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CASS4,CLCA1,PPP1R16B,CTSG,SYT2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,P2RY13,FHL3,NRROS,BTNL8,LRRC61,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,CDH26,FETUB,PCDHA12,SLC27A3,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,PRSS33,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,LXN,CRISP2,ZNF366,DYDC1,XCR1	95	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	childhood diffuse large B-cell lymphoma	Childhood diffuse large B-cell lymphoma	3.34E-04	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Digestive System Development and Function, Gastrointestinal Disease, Hepatic System Development and Function, Hepatic System Disease, Inflammatory Disease, Inflammatory Response, Organ Development, Organismal Injury and Abnormalities, Psychological Disorders	alcoholic hepatitis	Severe alcoholic hepatitis	3.34E-04	 	 	 	 	IFIT3,ISG15,IFIT2	3	
Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	systemic lupus erythematosus	Active stage systemic lupus erythematosus	3.38E-04	 	 	 	 	MS4A1,RSAD2,IFIT3,IFIT1,ISG15	5	
Cancer, Organismal Injury and Abnormalities	infiltrating ductal carcinoma	Infiltrating ductal carcinoma	3.38E-04	 	 	 	 	POSTN,SQLE,OASL,SFRP1,PDK4,CD44,TUBB4B	7	
Cellular Movement, Immune Cell Trafficking	migration	Leukocyte migration	3.43E-04	Decreased	-2.181	bias	-1.366	POSTN,MS4A1,CCR7,CD69,PTGDR2,CCL18,CCR3,CD44,CTSG,P2RY10	10	
Cancer, Immunological Disease, Organismal Injury and Abnormalities	lymphatic node solid neoplasm	Lymphatic node solid neoplasm	3.63E-04	 	 	 	 	MS4A1,CCR7,MMP12,IRF4,ADAM19,CD44,TUBB4B,SPIB	8	
Cancer, Organismal Injury and Abnormalities	primary tumor	Primary tumor	3.64E-04	 	 	 	 	MS4A1,PDCD1LG2,LGALS12,DOK2,CLDN3,SFRP1,SAMD3,SORD,CD44,TUBB4B,POSTN,IRF4	12	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	cancer	Liver cancer	3.69E-04	 	 	 	 	FABP6,NMNAT2,IFIT1,SFRP1,CLCA1,PPP1R16B,TESPA1,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,GZMB,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	62	
Hematological Disease, Infectious Diseases, Organismal Injury and Abnormalities	bacteremia	Bacteremia	3.74E-04	 	 	 	 	MAPKAPK3,PER1,CISH	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	metastatic castration-recurrent prostate cancer	Metastatic castration-recurrent prostate cancer	3.74E-04	 	 	 	 	CYP51A1,FDFT1,TUBB4B	3	
Immunological Disease, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	neuromuscular and immunological disorder	Neuromuscular and immunological disorder	3.93E-04	 	 	 	 	MS4A1,PHGDH,RSAD2,IFIT1,FDFT1,ANKRD55,CD44,SKAP2,SPIB,CD69,ISG15,IRF4	12	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities	diabetic complication	Diabetic complication	3.99E-04	 	 	 	 	MS4A1,HSD11B2,CCL18,SLC26A4,GAS1,IFIT1,ZBTB16,SFRP1,CNR2,PDK4,PPP1R16B,CTSG,TESPA1,SPIB,POSTN,CLCNKB,SIGLEC6,TPSAB1,PER1,SCNN1B,IRF4	21	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of Th2 cells	4.02E-04	 	 	 	 	PTGDR2,CCL18	2	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Trichophyton rubrum	4.02E-04	 	 	 	 	SQLE,CYP51A1	2	
Molecular Transport	transport	Transport of iodide	4.02E-04	 	 	 	 	SLC26A4,ANO1	2	
Gastrointestinal Disease, Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of gastrointestinal tract	4.12E-04	 	 	 	 	CCL18,SLC26A4,CLC,MMP12,ZBTB16,CCN2,CD44,POSTN,CD69,ANO1,TPSAB1,PER1,P2RY13,CDH26	14	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of T lymphocytes	4.28E-04	Decreased	-2.182	bias	-1.603	CCR7,PTGDR2,CCL18,CTSG,P2RY10	5	
Cancer, Organismal Injury and Abnormalities	epithelial basal cell carcinoma	Epithelial basal cell carcinoma	4.50E-04	 	 	 	 	CCR7,PHGDH,RSAD2,SLC26A4,MMP12,ITLN1,CASS4,SAMD3,BAIAP3,OR52M1,VSTM1,TESPA1,SLC1A7,ANO1,COL28A1,CEACAM21,CLEC12B,SIGLEC6,ISG15,HRH4,IRF4,CD1B,RASGRP3,BTNL8,HEPH,MS4A1,ITIH5,LGALS12,OASL,ADAM19,CNR2,CAPS2,PIP4K2A,POSTN,CLCNKB,FETUB,PCDHA12,GAPT,CRISP2,ZNF366	40	
Cancer, Organismal Injury and Abnormalities	ductal carcinoma	Ductal carcinoma	4.56E-04	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,CCL18,CST1,ZBTB16,SFRP1,CASS4,CCN2,BAIAP3,IFIT2,HS3ST3A1,OR52M1,DMRTC2,SYT2,GZMB,SKAP2,TESPA1,ARL15,OTOF,SLC1A7,SQLE,CEACAM21,SIGLEC6,PER1,IRF4,RASGRP3,HEPH,ITIH5,OASL,ADAM19,PDK4,WEE1,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,CDH26,FETUB,PCDHA12,CYP51A1,CRISP2,MAP2K6,CCR3	47	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	childhood nodular lymphocyte-predominant Hodgkin lymphoma	Childhood nodular lymphocyte-predominant Hodgkin lymphoma	4.64E-04	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Cancer, Immunological Disease, Organismal Injury and Abnormalities	neoplasia	Neoplasia of lymphoid organ	4.65E-04	 	 	 	 	MS4A1,CCR7,PDCD1LG2,MMP12,IRF4,ADAM19,CD44,GZMB,TUBB4B,SPIB	10	
Immunological Disease, Neurological Disease, Organismal Injury and Abnormalities	autoimmune neurological disorder	Autoimmune neurological disorder	4.67E-04	 	 	 	 	MS4A1,PHGDH,RSAD2,IFIT1,FDFT1,ANKRD55,CD44,SKAP2,SPIB,CD69,ISG15,IRF4	12	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	astrocytoma	Grade 4 astrocytoma	4.74E-04	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2	67	
Infectious Diseases, Organismal Injury and Abnormalities	sepsis	Sepsis	4.93E-04	 	 	 	 	CCR7,IFIT3,ISG15,CYP51A1,IFIT2,CNR2,MAP2K6,CCR3,CD44,P2RY10	10	
Cancer, Organismal Injury and Abnormalities	ductal adenocarcinoma	Ductal adenocarcinoma	5.04E-04	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,CCL18,CST1,ZBTB16,CASS4,CCN2,BAIAP3,IFIT2,HS3ST3A1,OR52M1,DMRTC2,SYT2,GZMB,SKAP2,TESPA1,ARL15,OTOF,SLC1A7,SQLE,CEACAM21,SIGLEC6,IRF4,RASGRP3,HEPH,ITIH5,OASL,ADAM19,PDK4,WEE1,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,CDH26,PCDHA12,CYP51A1,CRISP2,MAP2K6,CCR3	44	
Cancer, Immunological Disease, Organismal Injury and Abnormalities	lymph node cancer	Lymph node cancer	5.05E-04	 	 	 	 	MS4A1,CCR7,MMP12,IRF4,ADAM19,CD44,TUBB4B,SPIB	8	
Cancer, Dermatological Diseases and Conditions, Endocrine System Disorders, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Reproductive System Disease	primary cutaneous follicle center lymphoma	Primary cutaneous follicle center lymphoma	5.13E-04	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	brain astrocytoma	Brain astrocytoma	5.17E-04	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2	67	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	Non-Hodgkin lymphoma	5.18E-04	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,IFIT2,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,IRF4,MS4A1,ITIH5,CLC,OASL,ADAM19,FDFT1,CD44,TUBB4B,POSTN,IFIT3,PCDHA12,CCR3,RFTN1	30	
Cancer, Organismal Injury and Abnormalities	pelvic carcinoma	Pelvic carcinoma	5.19E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,SYT2,SPIB,OTOF,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,SLC27A3,CRYBA1,MAP2K6,CCR3,ZNF157,TASL,MCOLN2,PHGDH,DENND2D,SLC26A4,WDR93,DOK2,MMP12,CST1,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,MS4A1,ITIH5,IFT74,HOXA3,FDFT1,ENTPD4,CNR2,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,SCNN1B,ZNF366,DYDC1,XCR1	88	
Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver lesion	Liver lesion	5.32E-04	 	 	 	 	CCR7,FABP6,NMNAT2,IFIT1,SFRP1,CCN2,CLCA1,PPP1R16B,TESPA1,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,GZMB,SHISA2,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	69	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	mammary tumor	Stage I-III mammary tumor	5.35E-04	 	 	 	 	SQLE,MMP12,FDFT1,CD44,TUBB4B	5	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	thyroid gland tumor	Thyroid gland tumor	5.46E-04	 	 	 	 	PDCD1LG2,FABP6,RSAD2,CLDN3,SFRP1,CCN2,OR52M1,DMRTC2,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,OTOF,SLC1A7,SIGLEC6,LRRC61,OASL,GAS1,ADAM19,SORD,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,CDH26,PCDHA12,SLC27A3,MAP2K6,CCR3,RFTN1,MCOLN2,MAPKAPK3,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,VSTM1,GZMB,ARL15,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,ITIH5,LGALS12,IFT74,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,GGT5,CLCNKB,SLC9A3,CYP51A1,SCNN1B,LXN,CRISP2,ZNF366,XCR1	93	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast or ovarian cancer	Breast or ovarian cancer	5.58E-04	 	 	 	 	TNNC2,CCR7,PDCD1LG2,RSAD2,NMNAT2,CLDN3,IFIT1,SFRP1,CCN2,CLCA1,OR52M1,SKAP2,TESPA1,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,NRROS,OASL,GAS1,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,PCDHA12,CRYBA1,MAP2K6,MCOLN2,PHGDH,DENND2D,DOK2,MMP12,CST1,ITLN1,LRRC32,ANKRD55,SQLE,COL28A1,TPSAB1,HRH4,IRF4,RASGRP3,MS4A1,HSD11B2,EMP3,ITIH5,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,CLCNKB,CYP51A1,XCR1	61	
Auditory Disease, Developmental Disorder, Endocrine System Disorders, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	Pendred syndrome	Pendred syndrome	5.62E-04	 	 	 	 	OTOF,SLC26A4	2	
Developmental Disorder, Organismal Injury and Abnormalities, Renal and Urological Disease	renal osteodystrophy	Renal osteodystrophy	5.62E-04	 	 	 	 	TNNC2,FDFT1	2	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	chronic skin disorder	Chronic skin disorder	5.65E-04	 	 	 	 	POSTN,MAPKAPK3,PHGDH,SQLE,IL31RA,MMP12,IFIT1,CYP51A1	8	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin basal cell carcinoma	Basal cell carcinoma	6.08E-04	 	 	 	 	CCR7,PHGDH,RSAD2,SLC26A4,MMP12,ITLN1,CASS4,SAMD3,BAIAP3,OR52M1,VSTM1,TESPA1,SLC1A7,ANO1,COL28A1,CEACAM21,CLEC12B,SIGLEC6,ISG15,HRH4,CD1B,RASGRP3,BTNL8,HEPH,MS4A1,ITIH5,LGALS12,OASL,ADAM19,CNR2,CAPS2,PIP4K2A,POSTN,CLCNKB,FETUB,PCDHA12,GAPT,CRISP2,ZNF366	39	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	hematologic cancer	Hematologic cancer of cells	6.17E-04	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,BAIAP3,IFIT2,CLCA1,OR52M1,CTSG,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,HRH4,IRF4,CEBPE,FHL3,BTNL8,MS4A1,ITIH5,CLC,OASL,ADAM19,FDFT1,SORD,PDK4,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,IFIT3,PCDHA12,CYP51A1,CCR3,RFTN1	44	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Stage II-III breast cancer	6.39E-04	 	 	 	 	SQLE,MMP12,FDFT1,CD44,TUBB4B	5	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	high grade astrocytoma	High grade astrocytoma	6.52E-04	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2,XCR1	70	
Cellular Movement	cell movement	Cell movement of cancer cells	6.54E-04	 	 	 	 	CCR7,ZBTB16,SFRP1,CD44	4	
Developmental Disorder, Immunological Disease, Inflammatory Disease, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	multiple sclerosis	Multiple sclerosis	6.54E-04	 	 	 	 	MS4A1,CD69,PHGDH,RSAD2,IFIT1,ISG15,IRF4,FDFT1,ANKRD55,CD44,SKAP2	11	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatic ductal adenocarcinoma	Pancreatic ductal adenocarcinoma	6.56E-04	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,CCL18,CST1,ZBTB16,CASS4,CCN2,BAIAP3,HS3ST3A1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,CEACAM21,RASGRP3,HEPH,ITIH5,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,PCDHA12,CYP51A1,CRISP2,CCR3	33	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	epithelial thyroid cancer	Thyroid carcinoma	6.80E-04	 	 	 	 	PDCD1LG2,FABP6,RSAD2,CLDN3,SFRP1,CCN2,OR52M1,DMRTC2,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,OTOF,SLC1A7,SIGLEC6,LRRC61,OASL,GAS1,ADAM19,SORD,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,CDH26,PCDHA12,SLC27A3,MAP2K6,CCR3,RFTN1,MCOLN2,MAPKAPK3,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,GZMB,ARL15,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,ITIH5,LGALS12,IFT74,HOXA3,CISH,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,GGT5,CLCNKB,SLC9A3,CYP51A1,SCNN1B,LXN,CRISP2,ZNF366,XCR1	92	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	plasmablastic lymphoma	Plasmablastic lymphoma	6.82E-04	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	T-cell malignant neoplasm	T-cell malignant neoplasm	6.85E-04	 	 	 	 	CCR7,RSAD2,CCL18,MMP12,ZBTB16,IFIT2,PPP1R16B,GZMB,SPIB,P2RY10,OTOF,CD69,PER1,ISG15,IRF4,BTNL8,MS4A1,CLC,OASL,IFT74,ADAM19,FDFT1,TUBB4B,IFIT3,PCDHA12,CCR3	26	
Organismal Injury and Abnormalities, Reproductive System Disease	benign pelvic disease	Benign pelvic disease	6.87E-04	 	 	 	 	PDCD1LG2,CCL18,OASL,CLDN3,GAS1,IFIT1,ZBTB16,SFRP1,CCN2,SAMD3,PDK4,WEE1,CD44,CTSG,SPIB,POSTN,IFIT3,COL28A1,PCDHA12,IRF4,XCR1	21	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	dermatofibrosarcoma	Dermatofibrosarcoma	7.45E-04	 	 	 	 	PRSS33,IFIT2,CD44	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	Grade 2 non-Hodgkin disease	7.45E-04	 	 	 	 	MS4A1,CD44,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities	development	Development of adenocarcinoma	7.54E-04	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,NMNAT2,CLDN3,SFRP1,CASS4,CLCA1,PPP1R16B,CTSG,SYT2,P2RY10,OTOF,SLC1A7,P2RY13,FHL3,NRROS,BTNL8,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,CDH26,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,SLC26A4,DOK2,MMP12,CST1,ITLN1,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,ITIH5,IFT74,HOXA3,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,SCNN1B,LXN,CRISP2,ZNF366,DYDC1,XCR1	75	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Breast cancer	7.63E-04	 	 	 	 	TNNC2,CCR7,PDCD1LG2,RSAD2,CLDN3,IFIT1,SFRP1,CCN2,CLCA1,OR52M1,SKAP2,TESPA1,SPIB,OTOF,CD69,SLC1A7,SIGLEC6,OASL,GAS1,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,PCDHA12,MAP2K6,MCOLN2,PHGDH,DENND2D,DOK2,MMP12,CST1,LRRC32,SQLE,TPSAB1,HRH4,IRF4,RASGRP3,MS4A1,HSD11B2,EMP3,ITIH5,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,POSTN,CLCNKB,XCR1	51	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	early stage breast adenocarcinoma	Early stage breast adenocarcinoma	8.12E-04	 	 	 	 	FDFT1,CD44,TUBB4B	3	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	high grade glioma	Grade 4 high grade glioma	8.53E-04	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2	66	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	musculoskeletal lesion	Musculoskeletal lesion	8.66E-04	 	 	 	 	TNNC2,CCR7,PHGDH,RSAD2,CCL18,MMP12,IFIT1,ITLN1,SFRP1,CCN2,ANKRD55,CTSG,GZMB,ARL15,CD69,SLC1A7,SQLE,P2RY13,BTNL8,MS4A1,ITIH5,IFT74,FDFT1,CNR2,PDK4,WEE1,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,IFIT3,PRDX5,CDH26,PCDHA12,ZNF366,MAP2K6,CCR3	38	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	renal cancer	Renal cancer	8.67E-04	 	 	 	 	PDCD1LG2,FABP6,CCL18,SLC26A4,CST1,SFRP1,BAIAP3,CLCA1,VSTM1,PPP1R16B,COL28A1,TPSAB1,FHL3,ITIH5,IFT74,ADAM19,FDFT1,PDK4,CD44,TUBB4B,PIP4K2A,POSTN,GGT5,IFIT3,CLCNKB,PCDHA12,CYP51A1,LXN,MAP2K6,XCR1	30	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	tumorigenesis	Tumorigenesis of lymphocytes	8.81E-04	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,BAIAP3,IFIT2,OR52M1,CTSG,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,HRH4,IRF4,CEBPE,FHL3,MS4A1,ITIH5,CLC,OASL,ADAM19,FDFT1,SORD,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,IFIT3,IL31RA,PCDHA12,CYP51A1,CCR3,RFTN1	42	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	colony formation	Colony formation of cancer cells	8.82E-04	 	 	 	 	ANO1,SFRP1,TESPA1	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	mature T-cell neoplasm	Mature T-cell neoplasm	9.45E-04	 	 	 	 	MS4A1,CCR7,RSAD2,CCL18,CLC,OASL,MMP12,ZBTB16,ADAM19,IFIT2,GZMB,TUBB4B,SPIB,P2RY10,CD69,IFIT3,PER1,ISG15,IRF4,CCR3,BTNL8	21	
Cellular Movement, Renal and Urological System Development and Function	migration	Migration of mesangial cells	9.56E-04	 	 	 	 	CCR7,CCN2	2	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	onychomycosis	Onychomycosis	9.56E-04	 	 	 	 	SQLE,CYP51A1	2	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities	tinea corporis	Tinea corporis	9.56E-04	 	 	 	 	SQLE,CYP51A1	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	metastatic breast or ovarian malignant neoplasm	Metastatic breast or ovarian malignant neoplasm	9.60E-04	 	 	 	 	TNNC2,CCR7,CLDN3,FDFT1,CD44,TUBB4B	6	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	rheumatoid arthritis	Rheumatoid arthritis	9.95E-04	 	 	 	 	TNNC2,MS4A1,CCR7,CCL18,ANKRD55,CD44,GZMB,PIP4K2A,ARL15,CD69,SQLE,PRDX5,P2RY13,CDH26,ZNF366,CCR3	16	
Molecular Transport	transport	Transport of ion	1.02E-03	 	 	 	 	SLC1A7,SLC26A4,CLCNKB,ANO1,SLC9A3,CLDN3,SLC9B2,SCNN1B,CLCA1,MCOLN2	10	
Organismal Injury and Abnormalities, Respiratory Disease	chronic respiratory disorder	Chronic respiratory disorder	1.02E-03	 	 	 	 	PDCD1LG2,DENND2D,ITIH5,MMP12,ADAM19,CNR2,CTSG,GZMB,POSTN,CD69,GGT5,ANO1,CYP51A1,RASGRP3	14	
Cell Death and Survival, Organismal Injury and Abnormalities	cell death	Cell death of immune cells	1.04E-03	 	-0.536	 	-0.379	MS4A1,CCR7,CD69,CLC,ZBTB16,IRF4,CD44,GZMB	8	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	large intestine neoplasm	Large intestine neoplasm	1.07E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,CLDN3,IFIT1,IL22RA2,SFRP1,CASS4,CCN2,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,SPIB,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,NRROS,BTNL8,LRRC61,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,CDH26,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,CST1,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,IFT74,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,ZNF366,XCR1	95	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	neoplasia	Neoplasia of leukocytes	1.09E-03	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,IL22RA2,BAIAP3,IFIT2,CLCA1,OR52M1,CTSG,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,HRH4,IRF4,CEBPE,FHL3,BTNL8,MS4A1,ITIH5,CLC,OASL,ADAM19,FDFT1,SORD,PDK4,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,IFIT3,IL31RA,PCDHA12,CYP51A1,CCR3,RFTN1	46	
Molecular Transport	transport	Transport of inorganic anion	1.09E-03	 	 	 	 	SLC26A4,CLCNKB,ANO1,CLDN3	4	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver carcinoma	Liver carcinoma	1.11E-03	 	 	 	 	FABP6,NMNAT2,IFIT1,SFRP1,CLCA1,PPP1R16B,TESPA1,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,SLC9B2,CEBPE,HEPH,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	59	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	germinal center B-cell-like diffuse large B-cell lymphoma	Germinal center B-cell-like diffuse large B-cell lymphoma	1.12E-03	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities	development	Development of head and neck tumor	1.15E-03	 	 	 	 	POSTN,ANO1,FETUB,CYP51A1,SCNN1B,CCN2,HS3ST3A1,TUBB4B	8	
Organismal Injury and Abnormalities	calcinosis	Calcinosis	1.16E-03	 	 	 	 	CCR7,MMP12,ISG15,ITLN1,FETUB,CYP51A1,PDK4,WEE1,NRROS	9	
Organismal Injury and Abnormalities	medical complication	Medical complication	1.17E-03	 	 	 	 	MS4A1,PER1,CDH26,CYP51A1,IRF4,CNR2,TUBB4B	7	
Cancer, Organismal Injury and Abnormalities	adenocarcinoma	Primary adenocarcinoma	1.17E-03	 	 	 	 	DOK2,CLDN3,SFRP1,CD44,TUBB4B	5	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	colony formation	Colony formation of glioma cells	1.19E-03	 	 	 	 	ANO1,SFRP1	2	
Cell Morphology	morphology	Morphology of lymphoma cell lines	1.19E-03	 	 	 	 	ZBTB16,CEBPE	2	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	primary brain tumor	Primary brain tumor	1.19E-03	 	 	 	 	ADAM19,SAMD3	2	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities	tinea cruris	Tinea cruris	1.19E-03	 	 	 	 	SQLE,CYP51A1	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	genital carcinoma	Genital carcinoma	1.20E-03	 	 	 	 	CCR7,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,CLCA1,SYT2,SPIB,OTOF,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,SLC26A4,WDR93,DOK2,MMP12,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,ITIH5,IFT74,HOXA3,FDFT1,CNR2,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	76	
Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities	demyelination	Demyelination	1.20E-03	 	 	 	 	MS4A1,PHGDH,RSAD2,IFIT1,FDFT1,ANKRD55,SORD,CD44,SKAP2,CD69,ISG15,IRF4	12	
Cancer, Gastrointestinal Disease, Hematological Disease, Hepatic System Disease, Immunological Disease, Organismal Injury and Abnormalities	hepatosplenic T-cell lymphoma	Hepatosplenic T-cell lymphoma	1.20E-03	 	 	 	 	MS4A1,GZMB,TUBB4B	3	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Severe infection by virus	1.22E-03	 	-0.684	bias	0.323	CCR7,MAPKAPK3,RSAD2,IFIT1,CASS4,CCN2,LRRC32,IFIT2,CTSG,GZMB,P2RY10,ANO1,ISG15,IRF4,FHL3,LRRC61,MS4A1,PTGDR2,FDFT1,CD44,TUBB4B,GGT5,IFIT3,SLC9A3,RRAGB,CYP51A1,SLC27A3,CCR3,RFTN1,XCR1	30	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	kidney carcinoma	Kidney carcinoma	1.23E-03	 	 	 	 	PDCD1LG2,FABP6,CCL18,SLC26A4,CST1,SFRP1,BAIAP3,CLCA1,VSTM1,PPP1R16B,COL28A1,TPSAB1,FHL3,ITIH5,IFT74,ADAM19,FDFT1,PDK4,CD44,TUBB4B,PIP4K2A,POSTN,GGT5,IFIT3,PCDHA12,LXN,MAP2K6,XCR1	28	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	hip or knee osteoarthritis	Hip or knee osteoarthritis	1.25E-03	 	 	 	 	POSTN,FDFT1,CNR2,MAP2K6,TUBB4B	5	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	post-transplant lymphoproliferative disorder	Post-transplant lymphoproliferative disorder	1.29E-03	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Ullrich congenital muscular dystrophy	Ullrich congenital muscular dystrophy	1.29E-03	 	 	 	 	SLC1A7,LGALS12,TPSAB1,CTSG	4	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	psoriasis	Psoriasis	1.30E-03	 	 	 	 	MAPKAPK3,DENND2D,RSAD2,OASL,MMP12,IFIT1,ZBTB16,IL22RA2,ADAM19,GZMB,POSTN,IFIT3,SQLE,ISG15,IRF4	15	
Gastrointestinal Disease, Inflammatory Disease, Organismal Injury and Abnormalities	inflammatory bowel disease	Inflammatory bowel disease	1.32E-03	 	 	 	 	PDCD1LG2,CCL18,DOK2,ZBTB16,ITLN1,CCN2,FDFT1,LRRC32,ANKRD55,CD44,SKAP2,CD69,PER1,P2RY13,CYP51A1	15	
Molecular Transport	transmembrane transport	Transmembrane transport of ion	1.35E-03	 	 	 	 	SLC26A4,ANO1,CLDN3,SLC9B2,SCNN1B,CLCA1,MCOLN2	7	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	psoriasis	Chronic psoriasis	1.36E-03	 	 	 	 	POSTN,MAPKAPK3,SQLE,MMP12,IFIT1	5	
Auditory Disease, Neurological Disease, Organismal Injury and Abnormalities	syndromic sensorineural hearing loss	Syndromic sensorineural hearing loss	1.39E-03	 	 	 	 	OTOF,SLC26A4,CLCNKB	3	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatic cancer	Pancreatic cancer	1.39E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,CCL18,DOK2,CST1,ZBTB16,CASS4,CCN2,SAMD3,BAIAP3,HS3ST3A1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,SQLE,ANO1,CEACAM21,RASGRP3,HEPH,ITIH5,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,PCDHA12,CYP51A1,CRISP2,CCR3	37	
Hematological Disease, Hereditary Disorder, Infectious Diseases, Organismal Injury and Abnormalities	susceptibility to malaria	Susceptibility to malaria	1.45E-03	 	 	 	 	MAPKAPK3,CISH	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	uterine serous carcinoma	Uterine serous carcinoma	1.46E-03	 	 	 	 	HEPH,CLDN3,GAS1,ISG15,ZBTB16,SFRP1,TUBB4B	7	
Cancer, Organismal Injury and Abnormalities	pelvic adenocarcinoma	Pelvic adenocarcinoma	1.47E-03	 	 	 	 	CCR7,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,SYT2,SPIB,OTOF,SLC1A7,SIGLEC6,P2RY13,FHL3,NRROS,BTNL8,GAS1,ADAM19,LGALS7B,TUBB4B,TRAF5,PIP4K2A,PRDX5,IL31RA,RRAGB,FETUB,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,SLC26A4,WDR93,DOK2,MMP12,ZBTB16,ITLN1,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,PER1,ISG15,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,HEPH,ITIH5,IFT74,HOXA3,FDFT1,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	73	
Auditory Disease, Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities	congenital sensorineural hearing loss	Congenital sensorineural hearing loss	1.48E-03	 	 	 	 	OTOF,SLC26A4,CLCNKB	3	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	leg type primary cutaneous diffuse large B-cell lymphoma	Leg type primary cutaneous diffuse large B-cell lymphoma	1.48E-03	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	tumorigenesis	Tumorigenesis of reproductive tract	1.49E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OTOF,SLC1A7,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,IL31RA,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,WDR93,DOK2,MMP12,ZBTB16,ITLN1,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	68	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	malignant neuroendocrine neoplasm	Malignant neuroendocrine neoplasm	1.54E-03	 	 	 	 	PHGDH,RSAD2,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,IRF4,CEBPE,CD1B,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,HOXA3,ADAM19,FDFT1,PDK4,TUBB4B,POSTN,RRAGB,FETUB,PCDHA12,GAPT,CRYBA1,CRISP2,ZNF157,XCR1	39	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Lymphoid Tissue Structure and Development	chemotaxis	Chemotaxis of lymphocytes	1.58E-03	 	 	 	 	CCR7,PTGDR2,CCL18,CCR3	4	
Cancer, Organismal Injury and Abnormalities	undifferentiated sarcoma	Undifferentiated sarcoma	1.64E-03	 	 	 	 	PDK4,CD44,TUBB4B,SPIB	4	
Antimicrobial Response, Inflammatory Response	antiviral response	Antiviral response	1.65E-03	 	 	 	 	RSAD2,IFIT3,OASL,IFIT1,ISG15,IFIT2	6	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	extrapancreatic neuroendocrine tumor	Extrapancreatic neuroendocrine tumor	1.69E-03	 	 	 	 	PHGDH,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,IRF4,CEBPE,CD1B,BTNL8,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,HOXA3,ADAM19,FDFT1,PDK4,CD44,TUBB4B,POSTN,CLCNKB,RRAGB,FETUB,PCDHA12,GAPT,CRYBA1,CRISP2,ZNF157,XCR1	41	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of leukocytes	1.69E-03	 	-0.152	 	0.141	MS4A1,PTGDR2,CLC,CDH26,CD1B,CD44,CTSG,CLEC12A	8	
Cancer, Organismal Injury and Abnormalities	primary squamous cell carcinoma	Primary squamous cell carcinoma	1.69E-03	 	 	 	 	SFRP1,CD44,TUBB4B	3	
Organismal Injury and Abnormalities	postoperative complication	Postoperative complication	1.76E-03	 	 	 	 	MS4A1,CDH26,CYP51A1,IRF4,CNR2,TUBB4B	6	
Cancer, Organismal Injury and Abnormalities	blue round small cell tumor	Blue round small cell tumor	1.76E-03	 	 	 	 	PHGDH,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,SIGLEC6,IRF4,CEBPE,CD1B,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,ITIH5,HOXA3,ADAM19,FDFT1,PDK4,CD44,TUBB4B,POSTN,UBXN11,RRAGB,FETUB,PCDHA12,GAPT,CYP51A1,CRYBA1,CRISP2,ZNF157,XCR1	43	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	carcinoma	Pancreatic carcinoma	1.78E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,CCL18,DOK2,CST1,ZBTB16,CASS4,CCN2,SAMD3,BAIAP3,HS3ST3A1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,CEACAM21,RASGRP3,HEPH,ITIH5,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,PCDHA12,CYP51A1,CRISP2,CCR3	35	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastrointestinal tract cancer	Gastrointestinal tract cancer	1.79E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,CLDN3,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,IFIT2,HS3ST3A1,SQLE,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,HSD11B2,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,ZNF366	100	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastrointestinal carcinoma	Gastrointestinal carcinoma	1.81E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,IL22RA2,SFRP1,CCN2,CLCA1,OR52M1,SYT2,TESPA1,OTOF,CD69,SLC1A7,BTNL8,LRRC61,ADAM19,CDH26,SLC27A3,CRYBA1,CCR3,MAPKAPK3,SLC26A4,WDR93,DOK2,CST1,ZBTB16,HS3ST3A1,SQLE,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,MS4A1,ITIH5,IFT74,CLEC12A,GGT5,IFIT3,SLC9A3,CYP51A1,SCNN1B,DYDC1,XCR1,IFIT1,CASS4,PPP1R16B,CTSG,SKAP2,P2RY10,SIGLEC6,P2RY13,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,RFTN1,MCOLN2,PHGDH,DENND2D,PRSS33,MMP12,LRRC32,SAMD3,BAIAP3,ANKRD55,VSTM1,GZMB,SHISA2,ANO1,COL28A1,HEPH,NAIF1,PTGDR2,RGS18,EMP3,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,ZNF366	96	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	brain tumor	Brain tumor	1.81E-03	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,GZMB,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,CRISP2	77	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatobiliary adenocarcinoma	Pancreatobiliary adenocarcinoma	1.83E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,DENND2D,CCL18,CST1,ZBTB16,CASS4,CCN2,BAIAP3,IFIT2,HS3ST3A1,CLCA1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,CEACAM21,RASGRP3,HEPH,ITIH5,ADAM19,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,PCDHA12,CYP51A1,CRISP2,CCR3	37	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	chemotaxis	Chemotaxis of mononuclear leukocytes	1.84E-03	 	-1.968	bias	-1.408	CCR7,PTGDR2,CCL18,CCR3,CTSG	5	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	ductal breast carcinoma	Invasive ductal breast carcinoma	1.87E-03	 	 	 	 	POSTN,SQLE,OASL,PDK4,CD44,TUBB4B	6	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphocytic cancer	Lymphocytic cancer	1.89E-03	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,BAIAP3,IFIT2,CLCA1,OR52M1,PPP1R16B,CTSG,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,HRH4,IRF4,CEBPE,FHL3,BTNL8,MS4A1,ITIH5,CLC,OASL,IFT74,ADAM19,FDFT1,SORD,PDK4,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,IFIT3,IL31RA,PCDHA12,CYP51A1,CCR3,RFTN1	47	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	malignant lymphocytic neoplasm	Malignant lymphocytic neoplasm	1.89E-03	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,BAIAP3,IFIT2,CLCA1,OR52M1,PPP1R16B,CTSG,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,HRH4,IRF4,CEBPE,FHL3,BTNL8,MS4A1,ITIH5,CLC,OASL,IFT74,ADAM19,FDFT1,SORD,PDK4,CD44,TUBB4B,TRAF5,PIP4K2A,POSTN,UBXN11,IFIT3,IL31RA,PCDHA12,CYP51A1,CCR3,RFTN1	47	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	neuroendocrine tumor	Neuroendocrine tumor	1.93E-03	 	 	 	 	PHGDH,RSAD2,DOK2,MMP12,ZBTB16,ITLN1,CASS4,SAMD3,CLCA1,SKAP2,P2RY10,OTOF,SLC1A7,SHISA2,SQLE,ANO1,COL28A1,IRF4,CEBPE,CD1B,BTNL8,LRRC61,HEPH,MS4A1,NAIF1,HSD11B2,HOXA3,ADAM19,FDFT1,PDK4,CD44,TUBB4B,POSTN,CLCNKB,RRAGB,FETUB,PCDHA12,GAPT,CRYBA1,CRISP2,ZNF157,XCR1	42	
Organismal Injury and Abnormalities, Respiratory Disease	bronchopathy	Bronchopathy	1.98E-03	 	 	 	 	DENND2D,ITIH5,MMP12,ADAM19,CNR2,CD44,CTSG,GZMB,CD69,ANO1,PCDHA12,CYP51A1,SCNN1B,RASGRP3	14	
Cancer, Dermatological Diseases and Conditions, Lipid Metabolism, Metabolic Disease, Organismal Injury and Abnormalities, Small Molecule Biochemistry	malignant fibrous histiocytoma	Malignant fibrous histiocytoma	2.04E-03	 	 	 	 	PDK4,CD44,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	renal cell cancer	Renal cell carcinoma	2.09E-03	 	 	 	 	PDCD1LG2,FABP6,CCL18,SLC26A4,CST1,SFRP1,BAIAP3,CLCA1,VSTM1,PPP1R16B,COL28A1,TPSAB1,FHL3,ITIH5,IFT74,ADAM19,FDFT1,PDK4,CD44,PIP4K2A,POSTN,GGT5,IFIT3,PCDHA12,LXN,MAP2K6,XCR1	27	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital neoplasm	Female genital neoplasm	2.10E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CCN2,CLCA1,OTOF,SLC1A7,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,IL31RA,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,WDR93,DOK2,MMP12,ZBTB16,ITLN1,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	68	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	central nervous system solid tumor	Central nervous system solid tumor	2.13E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,SYT2,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,WDR93,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,GZMB,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,CRISP2,XCR1	82	
Cancer, Organismal Injury and Abnormalities	growth	Growth of malignant tumor	2.15E-03	 	-0.946	 	-0.416	MAPKAPK3,ANO1,LGALS12,SFRP1,CD44,TESPA1	6	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver tumor	Liver tumor	2.16E-03	 	 	 	 	FABP6,NMNAT2,IFIT1,SFRP1,CLCA1,PPP1R16B,TESPA1,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,GZMB,SHISA2,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	65	
Cancer, Organismal Injury and Abnormalities	head and neck squamous cell cancer	Head and neck squamous cell carcinoma	2.17E-03	 	 	 	 	PDCD1LG2,RSAD2,CCL18,WDR93,NMNAT2,MMP12,SFRP1,CCN2,LRRC32,BAIAP3,HS3ST3A1,PPP1R16B,GZMB,TESPA1,OTOF,SQLE,ANO1,TPSAB1,ISG15,SLC9B2,IRF4,RASGRP3,NRROS,LRRC61,HEPH,ITIH5,ADAM19,FDFT1,PDK4,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,CLCNKB,CDH26,PCDHA12,SCNN1B,ZNF366,DYDC1,XCR1	41	
Cell Signaling, Molecular Transport, Vitamin and Mineral Metabolism	mobilization	Mobilization of Ca2+	2.24E-03	 	-1.408	 	-0.811	CCR7,CNR2,CCR3,CD44,CTSG,RFTN1	6	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	muscle weakness	Muscle weakness	2.31E-03	 	 	 	 	MS4A1,SLC1A7,IRF4,CD44,SYT2,TUBB4B,SPIB	7	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	inflammation	Inflammation of lung	2.33E-03	 	 	 	 	MS4A1,PER1,CYP51A1,FDFT1,GZMB,TUBB4B	6	
Auditory Disease, Neurological Disease, Organismal Injury and Abnormalities	early onset hearing loss	Early onset hearing loss	2.36E-03	 	 	 	 	OTOF,SLC26A4,CLCNKB,TUBB4B	4	
Cancer, Organismal Injury and Abnormalities	benign connective or soft tissue neoplasm	Benign connective or soft tissue neoplasm	2.36E-03	 	 	 	 	IFIT1,SFRP1,CCN2,FDFT1,HS3ST3A1,PDK4,WEE1,CD44,POSTN,IFIT3,ANO1,FETUB,SCNN1B	13	
Cell Death and Survival	cytolysis	Cytolysis of lymphoma cell lines	2.38E-03	 	 	 	 	MS4A1,ISG15	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital tract cancer	Female genital tract cancer	2.48E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,CCN2,CLCA1,OTOF,SLC1A7,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,IL31RA,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,WDR93,DOK2,MMP12,ZBTB16,ITLN1,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,GAPT,CYP51A1,ZNF366,DYDC1,XCR1	66	
Cancer, Organismal Injury and Abnormalities	squamous-cell carcinoma	Squamous-cell carcinoma	2.50E-03	 	 	 	 	PDCD1LG2,RSAD2,CCL18,NMNAT2,IFIT1,SFRP1,CCN2,PPP1R16B,TESPA1,P2RY10,OTOF,SIGLEC6,NRROS,LRRC61,GAS1,ADAM19,TUBB4B,PIP4K2A,UBXN11,CDH26,PCDHA12,TASL,WDR93,DOK2,MMP12,LRRC32,SAMD3,BAIAP3,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,IRF4,RASGRP3,HEPH,MS4A1,ITIH5,FDFT1,ENTPD4,PDK4,WEE1,CD44,POSTN,GGT5,CLCNKB,GAPT,SCNN1B,ZNF366,DYDC1,XCR1	55	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	activated B-cell-like diffuse large B-cell lymphoma	Activated B-cell-like diffuse large B-cell lymphoma	2.57E-03	 	 	 	 	MS4A1,IRF4,TUBB4B	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	Grade 3 non-Hodgkin disease	2.57E-03	 	 	 	 	MS4A1,CD44,TUBB4B	3	
Molecular Transport	transmembrane transport	Transmembrane transport of anion	2.57E-03	 	 	 	 	SLC26A4,ANO1,CLDN3	3	
Cancer, Organismal Injury and Abnormalities	malignant tumor	Refractory malignant tumor	2.58E-03	 	 	 	 	MS4A1,RSAD2,CYP51A1,IRF4,FDFT1,RASGRP3,TUBB4B	7	
Cellular Function and Maintenance	ion homeostasis	Ion homeostasis of cells	2.59E-03	 	-0.445	 	0.025	MS4A1,CCR7,CCL18,SLC26A4,ANO1,SCNN1B,CCR3,XCR1	8	
Cancer, Organismal Injury and Abnormalities	upper aerodigestive tract carcinoma	Upper aerodigestive tract carcinoma	2.62E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,WDR93,MMP12,CST1,ZBTB16,SFRP1,CCN2,HS3ST3A1,VSTM1,TESPA1,OTOF,SQLE,ANO1,COL28A1,SIGLEC6,ISG15,IRF4,RASGRP3,NRROS,ITIH5,ADAM19,IGFLR1,FDFT1,WEE1,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,CDH26,PCDHA12,SCNN1B,DYDC1,MCOLN2,XCR1	38	
Cancer, Organismal Injury and Abnormalities	grade 3-4 tumor	Grade 3-4 tumor	2.69E-03	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2	69	
Cell Death and Survival	apoptosis	Apoptosis of prostate cell lines	2.73E-03	 	 	 	 	SFRP1,PDK4	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive CD30 positive anaplastic diffuse large B cell lymphoma	CD20 positive CD30 positive anaplastic diffuse large B cell lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive anaplastic large cell lymphoma	CD20 positive anaplastic large cell lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive centroblastic lymphoma	CD20 positive centroblastic lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive immunoblastic diffuse large B-cell lymphoma	CD20 positive immunoblastic diffuse large B-cell lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive plasmablastic lymphoma	CD20 positive plasmablastic lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive primary effusion lymphoma	CD20 positive primary effusion lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	aggressive follicular lymphoma	Grade 3B aggressive follicular lymphoma	2.73E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD30 positive anaplastic large cell lymphoma	Anaplastic large cell lymphoma	2.79E-03	 	 	 	 	MS4A1,IRF4,CCR3,TUBB4B	4	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreaticobiliary cancer	Pancreaticobiliary cancer	2.87E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,DENND2D,CCL18,DOK2,CST1,ZBTB16,CASS4,CCN2,SAMD3,BAIAP3,IFIT2,HS3ST3A1,CLCA1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,SQLE,ANO1,CEACAM21,PER1,RASGRP3,HEPH,ITIH5,ADAM19,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,FETUB,PCDHA12,CYP51A1,CRISP2,CCR3	43	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	uterine serous papillary cancer	Uterine serous papillary cancer	2.92E-03	 	 	 	 	HEPH,CLDN3,GAS1,ISG15,ZBTB16,SFRP1	6	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	central nervous system tumor	Primary central nervous system tumor	2.94E-03	 	 	 	 	MS4A1,ADAM19,SAMD3,SORD,TUBB4B	5	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by RNA virus	2.98E-03	 	-0.684	bias	0.354	CCR7,MAPKAPK3,RSAD2,IFIT1,CASS4,CCN2,IFIT2,CTSG,GZMB,P2RY10,ANO1,ISG15,FHL3,MS4A1,PTGDR2,FDFT1,CD44,TUBB4B,GGT5,IFIT3,SLC9A3,RRAGB,CYP51A1,SLC27A3,CCR3,RFTN1,XCR1	27	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of lymphocytes	3.03E-03	 	 	 	 	MS4A1,CLC,CDH26,CD1B,CD44,CTSG	6	
Gastrointestinal Disease, Organismal Injury and Abnormalities	periodontal disease	Periodontal disease	3.06E-03	 	 	 	 	CD69,PTGDR2,PHGDH,PRSS33,MMP12,GZMB,TUBB4B	7	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	development	Development of genital tumor	3.06E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,OTOF,SLC1A7,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,IL31RA,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,WDR93,DOK2,MMP12,ZBTB16,ITLN1,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,GAPT,ZNF366,DYDC1,XCR1	65	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Stage III breast cancer	3.07E-03	 	 	 	 	SQLE,MMP12,FDFT1,TUBB4B	4	
Cancer, Cell-To-Cell Signaling and Interaction	sphere formation	Sphere formation of pancreatic cancer cell lines	3.11E-03	 	 	 	 	ISG15,CD44	2	
Cancer, Organismal Injury and Abnormalities	development	Development of neuroepithelial tumor	3.18E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,SYT2,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,CRISP2,XCR1	80	
Cell Death and Survival	cytolysis	Cytolysis	3.25E-03	 	-0.985	 	-0.839	MS4A1,CCR7,CD69,ISG15,CD44,GZMB	6	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreaticobiliary carcinoma	Pancreaticobiliary carcinoma	3.30E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,DENND2D,CCL18,DOK2,CST1,ZBTB16,CASS4,CCN2,SAMD3,BAIAP3,IFIT2,HS3ST3A1,CLCA1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,CEACAM21,PER1,RASGRP3,HEPH,ITIH5,ADAM19,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,FETUB,PCDHA12,CYP51A1,CRISP2,CCR3	41	
Cancer, Organismal Injury and Abnormalities	breast or colorectal cancer	Breast or colorectal cancer	3.32E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,RSAD2,CLDN3,IFIT1,SFRP1,CCN2,CLCA1,OR52M1,CTSG,SKAP2,TESPA1,SPIB,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,BTNL8,LRRC61,OASL,GAS1,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,FETUB,PCDHA12,SLC27A3,MAP2K6,CCR3,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,PRSS33,DOK2,MMP12,CST1,ZBTB16,LRRC32,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CD1B,RASGRP3,MS4A1,HSD11B2,PTGDR2,EMP3,ITIH5,HOXA3,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,CLCNKB,CYP51A1,SCNN1B,ZNF366,XCR1	80	
Cancer, Immunological Disease, Organismal Injury and Abnormalities, Reproductive System Disease	lymph node-positive breast cancer	Lymph node-positive breast cancer	3.34E-03	 	 	 	 	CCR7,CD44,TUBB4B	3	
Cancer, Immunological Disease, Organismal Injury and Abnormalities	lymphoreticular neoplasm	Lymphoreticular neoplasm	3.35E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,IFIT1,CTSG,SYT2,TESPA1,SPIB,P2RY10,OTOF,CD69,FHL3,BTNL8,CLC,OASL,ADAM19,SORD,TUBB4B,IL31RA,FETUB,PCDHA12,CCR3,RFTN1,PHGDH,MMP12,ZBTB16,BAIAP3,ANKRD55,IFIT2,GZMB,ANO1,PER1,ISG15,SLC9B2,IRF4,RASGRP3,MS4A1,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CYP51A1,CRISP2	50	
Cancer, Organismal Injury and Abnormalities	malignant neoplasm of aerodigestive tract	Malignant neoplasm of aerodigestive tract	3.38E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,WDR93,MMP12,CST1,ZBTB16,SFRP1,CCN2,IFIT2,HS3ST3A1,VSTM1,TESPA1,OTOF,SQLE,ANO1,COL28A1,SIGLEC6,ISG15,IRF4,RASGRP3,NRROS,ITIH5,ADAM19,IGFLR1,FDFT1,WEE1,CD44,TUBB4B,PIP4K2A,POSTN,UBXN11,CDH26,PCDHA12,SCNN1B,DYDC1,MCOLN2,XCR1	39	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	upper gastrointestinal tract cancer	Upper gastrointestinal tract cancer	3.41E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,SFRP1,CASS4,CCN2,CLCA1,SKAP2,TESPA1,P2RY10,OTOF,SLC1A7,SIGLEC6,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,CDH26,FETUB,PCDHA12,SLC27A3,CCR3,MCOLN2,MAPKAPK3,PHGDH,MMP12,CST1,ZBTB16,LRRC32,BAIAP3,IFIT2,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,PER1,ISG15,IRF4,CEBPE,RASGRP3,MS4A1,RGS18,ITIH5,HOXA3,IGFLR1,FDFT1,ENTPD4,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,CYP51A1,SCNN1B,ZNF366,DYDC1,XCR1	62	
Cancer, Organismal Injury and Abnormalities	malignant solid tumor	Refractory malignant solid tumor	3.43E-03	 	 	 	 	MS4A1,RSAD2,CYP51A1,FDFT1,RASGRP3,TUBB4B	6	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Humoral Immune Response, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of B lymphocytes	3.51E-03	 	 	 	 	MS4A1,SFRP1,SPIB	3	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	immunodeficiency	Autosomal dominant immunodeficiency	3.51E-03	 	 	 	 	IRF4,CEBPE	2	
Cellular Movement	chemotaxis	Chemotaxis of carcinoma cell lines	3.51E-03	 	 	 	 	CCL18,CD44	2	
Cellular Growth and Proliferation	tumorsphere formation	Tumorsphere formation	3.51E-03	 	 	 	 	SFRP1,CD44	2	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatic tumor	Pancreatic tumor	3.63E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,CCL18,DOK2,CST1,ZBTB16,CASS4,CCN2,SAMD3,BAIAP3,HS3ST3A1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,SQLE,ANO1,CEACAM21,PER1,RASGRP3,BTNL8,HEPH,ITIH5,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,PCDHA12,CYP51A1,CRISP2,CCR3	39	
Tissue Development	disassembly	Disassembly of extracellular matrix	3.68E-03	 	 	 	 	MMP12,TPSAB1,CTSG	3	
Cell Signaling, Cellular Function and Maintenance, Vitamin and Mineral Metabolism	elevation	Elevation of Ca2+ in cytosol	3.68E-03	 	 	 	 	CCR7,CCR3,XCR1	3	
Cancer, Organismal Injury and Abnormalities	primary head and neck neoplasia	Primary head and neck neoplasm	3.68E-03	 	 	 	 	ADAM19,SAMD3,TUBB4B	3	
Molecular Transport	transport	Transport of halide	3.68E-03	 	 	 	 	SLC26A4,CLCNKB,ANO1	3	
Molecular Transport	transport	Transport of monovalent inorganic anion	3.68E-03	 	 	 	 	SLC26A4,CLCNKB,ANO1	3	
Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	neuromuscular disease	Neuromuscular disease	3.79E-03	 	 	 	 	TNNC2,MS4A1,MAPKAPK3,PHGDH,RSAD2,IFIT1,ZBTB16,ITLN1,FDFT1,ANKRD55,SORD,CNR2,PDK4,CD44,SKAP2,SPIB,OTOF,CD69,SLC1A7,ISG15,CYP51A1,IRF4	22	
Gastrointestinal Disease, Organismal Injury and Abnormalities	chronic periodontal disease	Chronic periodontal disease	3.80E-03	 	 	 	 	CD69,PTGDR2,PRSS33,GZMB	4	
Cell Signaling, Molecular Transport, Vitamin and Mineral Metabolism	quantity	Quantity of Ca2+	3.81E-03	 	-1.982	bias	-1.439	PTGDR2,IL31RA,TPSAB1,HRH4,RASGRP3,CCR3	6	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	glioma cancer	Grade 3-4 glioma cancer	3.89E-03	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2	68	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	Aggressive diffuse large B-cell lymphoma	3.94E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD30 positive diffuse large cell lymphoma	CD30 positive diffuse large cell lymphoma	3.94E-03	 	 	 	 	MS4A1,TUBB4B	2	
Gastrointestinal Disease, Organismal Injury and Abnormalities	metaplasia	Metaplasia of intestine	3.94E-03	 	 	 	 	CLCA1,CD44	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	uterine tumor	Uterine tumor	3.95E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,IL31RA,PCDHA12,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,WDR93,DOK2,MMP12,ZBTB16,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,PDK4,WEE1,CD44,CLEC12A,POSTN,IFIT3,GAPT,ZNF366,DYDC1,XCR1	59	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary mediastinal large B-cell lymphoma	Primary mediastinal large B-cell lymphoma	4.03E-03	 	 	 	 	MS4A1,PDCD1LG2,IRF4,TUBB4B	4	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	metastasis to bone	Skeletal metastasis	4.04E-03	 	 	 	 	TNNC2,FDFT1,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	metastatic breast cancer	Metastatic breast cancer	4.18E-03	 	 	 	 	CCR7,CLDN3,FDFT1,CD44,TUBB4B	5	
Antimicrobial Response, Inflammatory Response	antimicrobial response	Antimicrobial response	4.22E-03	 	 	 	 	RSAD2,IFIT3,OASL,IFIT1,ISG15,IFIT2,CTSG	7	
Organismal Injury and Abnormalities, Reproductive System Disease	abnormality of endometrium	Abnormality of endometrium	4.23E-03	 	 	 	 	CCR7,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,CTSG,SPIB,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,IL31RA,PCDHA12,MAP2K6,CCR3,ZNF157,MCOLN2,WDR93,DOK2,MMP12,ZBTB16,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,CD44,CLEC12A,IFIT3,GAPT,ZNF366,DYDC1,XCR1	55	
Auditory Disease, Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	hereditary congenital syndromic hearing loss	Hereditary congenital syndromic hearing loss	4.23E-03	 	 	 	 	OTOF,SLC26A4,CLCNKB	3	
Molecular Transport	transport	Transport of molecule	4.24E-03	 	-1.414	 	-0.810	HEPH,RSAD2,SLC26A4,CLDN3,MMP12,ITLN1,BAIAP3,CLCA1,CTSG,SLC1A7,CLCNKB,ANO1,SLC9A3,SLC9B2,SCNN1B,SLC27A3,MCOLN2	17	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	laryngeal squamous cell carcinoma	Laryngeal squamous cell carcinoma	4.33E-03	 	 	 	 	ITIH5,WDR93,CDH26,PCDHA12,SCNN1B,ADAM19,HS3ST3A1,RASGRP3,CD44,TUBB4B,TESPA1	11	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	AIDS-related lymphoma associated with Castleman disease	AIDS-related lymphoma associated with Castleman disease	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	AIDS-related primary effusion lymphoma	AIDS-related primary effusion lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20-positive lymphoma	Advanced CD20-positive lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD30 positive anaplastic large cell lymphoma	Ann Arbor stage I-IV CD30 positive anaplastic large cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	angioimmunoblastic T-cell lymphoma	Ann Arbor stage I-IV angioimmunoblastic T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	cutaneous small/medium T-cell lymphoma	Ann Arbor stage I-IV cutaneous small/medium T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	enteropathy-associated T-cell lymphoma	Ann Arbor stage I-IV enteropathy-associated T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Gastrointestinal Disease, Hematological Disease, Hepatic System Disease, Immunological Disease, Organismal Injury and Abnormalities	hepatosplenic T-cell lymphoma	Ann Arbor stage I-IV hepatosplenic T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous gamma-delta T-cell lymphoma	Ann Arbor stage I-IV primary cutaneous gamma-delta T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Connective Tissue Disorders, Hematological Disease, Hereditary Disorder, Immunological Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	subcutaneous panniculitis-like T-cell lymphoma	Ann Arbor stage I-IV subcutaneous panniculitis-like T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive unclassifiable aggressive B-cell non-Hodgkin lymphoma	CD20 positive unclassifiable aggressive B-cell non-Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Neurological Disease, Organismal Injury and Abnormalities	calcification	Calcification of brain	4.39E-03	 	 	 	 	ISG15,NRROS	2	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	dermatofibrosarcoma protuberans	Dermatofibrosarcoma protuberans in fibrous tissue	4.39E-03	 	 	 	 	PRSS33,IFIT2	2	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities	extraskeletal Ewing sarcoma	Extraskeletal Ewing sarcoma	4.39E-03	 	 	 	 	CD44,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	leg type primary cutaneous diffuse large B-cell lymphoma	Generalized leg type primary cutaneous diffuse large B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	cutaneous B-cell lymphoma	Localized cutaneous B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Endocrine System Disorders, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Reproductive System Disease	primary cutaneous follicle center lymphoma	Multifocal primary cutaneous follicle center lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	New York Heart Association class I-II diffuse large B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Burkitt lymphoma	Non-Burkitt lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Reproductive System Disease	primary breast lymphoma	Primary breast lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous CD4 positive small / medium T-cell lymphoma	Primary cutaneous CD4 positive small / medium T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	leg type primary cutaneous diffuse large B-cell lymphoma	Regional leg type primary cutaneous diffuse large B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	Stage I diffuse large B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	unclassifiable aggressive B-cell non-Hodgkin lymphoma	Stage I unclassifiable aggressive B-cell non-Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Endocrine System Disorders, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Reproductive System Disease	primary testicular lymphoma	Stage I-II primary testicular lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Stage IB nodular lymphocyte predominant Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	Stage II diffuse large B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	unclassifiable aggressive B-cell non-Hodgkin lymphoma	Stage II unclassifiable aggressive B-cell non-Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	de novo diffuse large B-cell lymphoma	Stage II-IV de novo diffuse large B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Stage IIB nodular lymphocyte predominant Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell lymphoma	Stage III-IV untreated follicular B-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Stage IIIA nodular lymphocyte predominant Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Stage IIIB nodular lymphocyte predominant Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Stage IVA nodular lymphocyte predominant Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Stage IVB nodular lymphocyte predominant Hodgkin lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell or T-cell lymphoma	Symptomatic stage follicular B-cell or T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cell Signaling	G-protein signaling, coupled to cyclic nucleotide second messenger	G-protein signaling, coupled to cyclic nucleotide second messenger	4.43E-03	 	 	 	 	CNR2,CCR3,XCR1	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Stage II breast cancer	4.43E-03	 	 	 	 	FDFT1,CD44,TUBB4B	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal lymphoma	Nodal lymphoma	4.44E-03	 	 	 	 	MS4A1,MMP12,IRF4,ADAM19,TUBB4B,SPIB	6	
Developmental Disorder, Immunological Disease, Inflammatory Disease, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	relapsing-remitting multiple sclerosis	Relapsing-remitting multiple sclerosis	4.64E-03	 	 	 	 	MS4A1,RSAD2,IFIT1,ISG15	4	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	malignant neoplasm of male genital organ	Malignant neoplasm of male genital organ	4.82E-03	 	 	 	 	CCR7,RSAD2,SFRP1,SYT2,SPIB,OTOF,CD69,SIGLEC6,P2RY13,FHL3,LGALS7B,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,RRAGB,FETUB,PCDHA12,CCR3,SLC26A4,WDR93,ZBTB16,LRRC32,SAMD3,BAIAP3,IFIT2,HS3ST3A1,GZMB,SQLE,COL28A1,TPSAB1,PER1,ISG15,IRF4,CD1B,RASGRP3,HEPH,MS4A1,ITIH5,LGALS12,HOXA3,FDFT1,PDK4,CD44,GGT5,CLCNKB,CYP51A1,ZNF366	49	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of granulocytes	4.83E-03	 	 	 	 	PTGDR2,CTSG,CLEC12A	3	
Cell Cycle	G2 phase	Arrest in G2 phase of bone cancer cell lines	4.86E-03	 	 	 	 	MAP2K6,WEE1	2	
Cancer, Cardiovascular Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive intravascular diffuse large B-cell lymphoma	CD20 positive intravascular diffuse large B-cell lymphoma	4.86E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive refractory low-grade B-cell non-Hodgkin lymphoma	CD20 positive refractory low-grade B-cell non-Hodgkin lymphoma	4.86E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell lymphoma	Grade 1-3A follicular B-cell lymphoma	4.86E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	IRF4 rearrangement positive diffuse large B-cell lymphoma	IRF4 rearrangement positive diffuse large B-cell lymphoma	4.86E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	T-cell/histiocyte rich large B-cell lymphoma	Stage II-IV T-cell/histiocyte rich large B-cell lymphoma	4.86E-03	 	 	 	 	MS4A1,TUBB4B	2	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	myasthenic syndrome	Myasthenic syndrome	4.90E-03	 	 	 	 	MS4A1,CD44,SYT2,SPIB	4	
Organismal Injury and Abnormalities, Respiratory Disease	chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	4.98E-03	 	 	 	 	CD69,DENND2D,ITIH5,ANO1,MMP12,CYP51A1,ADAM19,CNR2,RASGRP3,CTSG,GZMB	11	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Lymphoid Tissue Structure and Development	chemotaxis	Chemotaxis of T lymphocytes	5.04E-03	 	 	 	 	CCR7,PTGDR2,CCL18	3	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	toe abnormality	Toe abnormality	5.04E-03	 	 	 	 	SQLE,CYP51A1,FDFT1	3	
Cancer, Organismal Injury and Abnormalities	extrapulmonary squamous cell carcinoma	Extrapulmonary squamous cell carcinoma	5.07E-03	 	 	 	 	PDCD1LG2,RSAD2,CCL18,NMNAT2,SFRP1,CCN2,PPP1R16B,TESPA1,P2RY10,OTOF,SIGLEC6,NRROS,LRRC61,ADAM19,TUBB4B,PIP4K2A,UBXN11,CDH26,PCDHA12,WDR93,DOK2,MMP12,LRRC32,BAIAP3,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,IRF4,RASGRP3,HEPH,MS4A1,ITIH5,FDFT1,ENTPD4,PDK4,CD44,POSTN,CLCNKB,GAPT,SCNN1B,ZNF366,DYDC1,XCR1	49	
Infectious Diseases, Organismal Injury and Abnormalities	neonatal late-onset sepsis	Neonatal late-onset sepsis	5.23E-03	 	 	 	 	IFIT3,ISG15,IFIT2,MAP2K6,CD44	5	
Cardiovascular Disease, Hematological Disease, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	ANCA negative Churg-Strauss syndrome	ANCA negative Churg-Strauss syndrome	5.24E-03	 	 	 	 	MS4A1	1	
Cellular Compromise	acidification	Acidification of breast cancer cell lines	5.24E-03	 	 	 	 	CD44	1	
Hematological Disease, Organismal Injury and Abnormalities	acquired factor VIII deficiency	Acquired factor VIII deficiency	5.24E-03	 	 	 	 	MS4A1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function	activation	Activation of B-lymphocyte derived cell lines	5.24E-03	 	 	 	 	MS4A1	1	
Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	pemphigus vulgaris	Active stage pemphigus vulgaris	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Cell-To-Cell Signaling and Interaction, Organismal Injury and Abnormalities	adhesion	Adhesion of hairy cell leukemia cells	5.24E-03	 	 	 	 	CD44	1	
Cell-To-Cell Signaling and Interaction, Skeletal and Muscular System Development and Function	adhesion	Adhesion of smooth muscle cell lines	5.24E-03	 	 	 	 	CD44	1	
Cancer, Organismal Injury and Abnormalities	head and neck squamous cell cancer	Advanced TNM stage head and neck squamous cell cancer	5.24E-03	 	 	 	 	CD44	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	burkitt-like lymphoma	Advanced stage burkitt-like lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Organismal Injury and Abnormalities	sinonasal mucosal melanoma	Advanced stage sinonasal mucosal melanoma	5.24E-03	 	 	 	 	CD44	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal marginal zone lymphoma	Ann Arbor stage II-IV nodal marginal zone lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Ann Arbor stage II-IV small B-cell lymphocytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	splenic marginal zone lymphoma	Ann Arbor stage II-IV splenic marginal zone lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cell Cycle	G0/G1 phase transition	Arrest in G0/G1 phase transition of myeloid cells	5.24E-03	 	 	 	 	CD44	1	
Cellular Function and Maintenance, DNA Replication, Recombination, and Repair	replication	Arrest in replication of DNA	5.24E-03	 	 	 	 	WEE1	1	
Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	autistic spectrum disorder with isolated skills	Autistic spectrum disorder with isolated skills	5.24E-03	 	 	 	 	WDR93	1	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	autosomal dominant specific granule deficiency 1	Autosomal dominant specific granule deficiency 1	5.24E-03	 	 	 	 	CEBPE	1	
Endocrine System Disorders, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	apparent mineralocorticoid excess	Autosomal recessive apparent mineralocorticoid excess	5.24E-03	 	 	 	 	HSD11B2	1	
Hematological Disease, Hereditary Disorder, Immunological Disease, Metabolic Disease, Organismal Injury and Abnormalities	common variable immunodeficiency type 5	Autosomal recessive common variable immunodeficiency type 5	5.24E-03	 	 	 	 	MS4A1	1	
Cardiovascular Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive moyamoya disease type 7	Autosomal recessive moyamoya disease type 7	5.24E-03	 	 	 	 	ANO1	1	
Developmental Disorder, Hereditary Disorder, Immunological Disease, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	autosomal recessive presynaptic congenital myasthenic syndrome type 7B	Autosomal recessive presynaptic congenital myasthenic syndrome type 7B	5.24E-03	 	 	 	 	SYT2	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	autosomal recessive pseudohypoaldosteronism type IB2	Autosomal recessive pseudohypoaldosteronism type IB2	5.24E-03	 	 	 	 	SCNN1B	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BIRC3-MALT1 fusion positive gastric mucosa-associated lymphoid tissue lymphoma	BIRC3-MALT1 fusion positive gastric mucosa-associated lymphoid tissue lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Developmental Disorder, Endocrine System Disorders, Hematological Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	Bartter syndrome type 3 with hypocalciuria	Bartter syndrome type 3 with hypocalciuria	5.24E-03	 	 	 	 	CLCNKB	1	
Cancer, Cell-To-Cell Signaling and Interaction, Organismal Injury and Abnormalities	binding	Binding of melanoma cells	5.24E-03	 	 	 	 	CD44	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive aggressive mantle cell lymphoma	CD20 positive aggressive mantle cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive non-progressing low grade non-Hodgkin lymphoma	CD20 positive non-progressing low grade non-Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
DNA Replication, Recombination, and Repair, Nucleic Acid Metabolism, Small Molecule Biochemistry	catabolism	Catabolism of UDP	5.24E-03	 	 	 	 	ENTPD4	1	
Carbohydrate Metabolism, Small Molecule Biochemistry	catabolism	Catabolism of sorbitol	5.24E-03	 	 	 	 	SORD	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Cellular Compromise, Tumor Morphology	cell-cell adhesion	Cell-cell adhesion of melanoma cells	5.24E-03	 	 	 	 	CD44	1	
Cell-To-Cell Signaling and Interaction, Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Lymphoid Tissue Structure and Development	chemoattraction	Chemoattraction of regulatory T lymphocytes	5.24E-03	 	 	 	 	CCL18	1	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	chemokinesis	Chemokinesis of T lymphocytes	5.24E-03	 	 	 	 	CTSG	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell or T-cell lymphoma	Chemoresistant follicular B-cell or T-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Organismal Injury and Abnormalities	chromophilic cell carcinoma	Chromophilic cell carcinoma	5.24E-03	 	 	 	 	CD44	1	
Infectious Diseases, Organismal Injury and Abnormalities, Respiratory Disease	chronic cavitary pulmonary histoplasmosis	Chronic cavitary pulmonary histoplasmosis	5.24E-03	 	 	 	 	CYP51A1	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Respiratory Disease, Skeletal and Muscular Disorders	congenital myopathy type 15	Congenital myopathy type 15	5.24E-03	 	 	 	 	TNNC2	1	
Developmental Disorder, Gastrointestinal Disease, Hereditary Disorder, Organismal Injury and Abnormalities	congenital secretory sodium diarrhea type 8	Congenital secretory sodium diarrhea type 8	5.24E-03	 	 	 	 	SLC9A3	1	
Developmental Disorder, Hereditary Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities	congenital zonular cataract with sutural opacities 10	Congenital zonular cataract with sutural opacities 10	5.24E-03	 	 	 	 	CRYBA1	1	
Lipid Metabolism, Small Molecule Biochemistry	conversion	Conversion of leukotriene D4	5.24E-03	 	 	 	 	GGT5	1	
Cell-To-Cell Signaling and Interaction	detachment	Detachment of breast cell lines	5.24E-03	 	 	 	 	GZMB	1	
Embryonic Development, Organismal Development, Tissue Development	development	Development of mesonephros	5.24E-03	 	 	 	 	ZBTB16	1	
Cardiovascular Disease, Connective Tissue Disorders, Developmental Disorder, Gastrointestinal Disease, Hereditary Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	developmental delay, cleft palate and proliferative retinopathy	Developmental delay, cleft palate and proliferative retinopathy	5.24E-03	 	 	 	 	LRRC32	1	
Cellular Compromise	disassembly	Disassembly of actin	5.24E-03	 	 	 	 	CCN2	1	
Cellular Movement	dissemination	Dissemination of carcinoma cell lines	5.24E-03	 	 	 	 	CCN2	1	
Cellular Movement	dissemination	Dissemination of hepatoma cell lines	5.24E-03	 	 	 	 	CCN2	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	early-onset seizures with neurodegeneration and brain calcifications	Early-onset seizures with neurodegeneration and brain calcifications	5.24E-03	 	 	 	 	NRROS	1	
Cellular Function and Maintenance, Molecular Transport	efflux	Efflux of iodide	5.24E-03	 	 	 	 	SLC26A4	1	
Cellular Development, Organismal Development	epithelial-mesenchymal transformation	Epithelial-mesenchymal transformation of epithelial cell lines	5.24E-03	 	 	 	 	POSTN	1	
Gastrointestinal Disease, Infectious Diseases, Organismal Injury and Abnormalities	esophageal candidiasis	Esophageal candidiasis	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	extrapulmonary blastomycosis	Extrapulmonary blastomycosis	5.24E-03	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	chronic lymphocytic leukemia	Fludarabine and alemtuzumab-refractory chronic lymphocytic leukemia	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Grade 1 indolent marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Grade 1 lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Grade 1 small B-cell lymphocytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Grade 2 indolent marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Grade 2 lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Grade 2 small B-cell lymphocytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell lymphoma	Grade 3A follicular B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Grade 3A indolent marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Grade 3A lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Grade 3A small B-cell lymphocytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	Grade 4 non-Hodgkin disease	5.24E-03	 	 	 	 	CD44	1	
Cellular Movement	haptotaxis	Haptotaxis of melanoma cell lines	5.24E-03	 	 	 	 	CD44	1	
Organismal Functions	healing	Healing by hepatic stellate cells	5.24E-03	 	 	 	 	CCR7	1	
Hereditary Disorder, Organismal Injury and Abnormalities	hereditary alpha tryptasemia syndrome	Hereditary alpha tryptasemia syndrome	5.24E-03	 	 	 	 	TPSAB1	1	
Digestive System Development and Function, Gastrointestinal Disease, Hepatic System Development and Function, Hepatic System Disease, Infectious Diseases, Inflammatory Disease, Inflammatory Response, Organ Development, Organismal Injury and Abnormalities	chronic hepatitis C	High grade chronic hepatitis C	5.24E-03	 	 	 	 	CCR7	1	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	bladder carcinoma	Highly invasive bladder carcinoma	5.24E-03	 	 	 	 	CD44	1	
Hereditary Disorder, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	immunodeficiency 108 with autoinflammation	Immunodeficiency 108 with autoinflammation	5.24E-03	 	 	 	 	CEBPE	1	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	immunodeficiency 131	Immunodeficiency 131	5.24E-03	 	 	 	 	IRF4	1	
Cardiovascular Disease, Hereditary Disorder, Immunological Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	immunodeficiency 38 with basal ganglia calcification	Immunodeficiency 38 with basal ganglia calcification	5.24E-03	 	 	 	 	ISG15	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Arthroderma otae	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Aspergillus fumigatus	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Fusarium	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Fusarium solani	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Microsporum gypseum	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Pichia kudriavzevii	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Scedosporium	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Scedosporium apiospermum	5.24E-03	 	 	 	 	CYP51A1	1	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	interstitial myopathy	Interstitial myopathy	5.24E-03	 	 	 	 	MS4A1	1	
Cellular Movement	invasion	Invasion by embryonic stem cell lines	5.24E-03	 	 	 	 	HSD11B2	1	
Infectious Diseases, Organismal Injury and Abnormalities, Respiratory Disease	bronchopulmonary aspergillosis	Invasive bronchopulmonary aspergillosis	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	candidiasis	Invasive candidiasis	5.24E-03	 	 	 	 	CYP51A1	1	
Cancer, Organismal Injury and Abnormalities	sinonasal mucosal melanoma	Invasive sinonasal mucosal melanoma	5.24E-03	 	 	 	 	CD44	1	
Post-Translational Modification	isgylation	Isgylation of protein	5.24E-03	 	 	 	 	ISG15	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Renal and Urological Disease, Skeletal and Muscular Disorders	Joubert syndrome type 40	Joubert syndrome type 40	5.24E-03	 	 	 	 	IFT74	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	kyphomelic dysplasia	Kyphomelic dysplasia	5.24E-03	 	 	 	 	CCN2	1	
Auditory Disease, Developmental Disorder, Hereditary Disorder, Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities	Leber congenital amaurosis with early-onset deafness	Leber congenital amaurosis with early-onset deafness	5.24E-03	 	 	 	 	TUBB4B	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Li-Shao-Li type spondyloepimetaphyseal dysplasia	Li-Shao-Li type spondyloepimetaphyseal dysplasia	5.24E-03	 	 	 	 	CCN2	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Localized nodular lymphocyte predominant Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	post-transplant lymphoproliferative disorder	Localized post-transplant lymphoproliferative disorder	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Dermatological Diseases and Conditions, Endocrine System Disorders, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Reproductive System Disease	primary cutaneous follicle center lymphoma	Localized primary cutaneous follicle center lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Dermatological Diseases and Conditions, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous marginal zone B-cell lymphoma	Localized primary cutaneous marginal zone B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	refractory B-cell non-Hodgkin lymphoma	Low grade refractory B-cell non-Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	relapsed B-cell non-Hodgkin lymphoma	Low grade relapsed B-cell non-Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cellular Movement	lymphatic invasion	Lymphatic invasion by lymphoma cell lines	5.24E-03	 	 	 	 	CD44	1	
Cancer, Organismal Injury and Abnormalities	metastasis	Metastasis of embryonic stem cell lines	5.24E-03	 	 	 	 	CD44	1	
Endocrine System Disorders, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	mild apparent mineralocorticoid excess	Mild apparent mineralocorticoid excess	5.24E-03	 	 	 	 	HSD11B2	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	mixed-cell follicular lymphoma	Mixed-cell follicular lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	mucormycosis	Mucormycosis	5.24E-03	 	 	 	 	CYP51A1	1	
Cancer, Dermatological Diseases and Conditions, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous marginal zone B-cell lymphoma	Multifocal primary cutaneous marginal zone B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Immunological Disease, Organismal Injury and Abnormalities	multiple chemical sensitivity	Multiple chemical sensitivity	5.24E-03	 	 	 	 	SORD	1	
Infectious Diseases, Organismal Injury and Abnormalities	mycetoma	Mycetoma	5.24E-03	 	 	 	 	CYP51A1	1	
Organismal Injury and Abnormalities, Renal and Urological Disease	nephrotoxic acute renal failure	Nephrotoxic acute renal failure	5.24E-03	 	 	 	 	SLC9A3	1	
Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities	Neu-Laxova syndrome type 1	Neu-Laxova syndrome type 1	5.24E-03	 	 	 	 	PHGDH	1	
Immunological Disease, Infectious Diseases, Organismal Injury and Abnormalities	non-meningeal disseminated histoplasmosis	Non-meningeal disseminated histoplasmosis	5.24E-03	 	 	 	 	CYP51A1	1	
Immunological Disease, Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	oculobulbar myasthenia gravis	Oculobulbar myasthenia gravis	5.24E-03	 	 	 	 	MS4A1	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities	patterned macular dystrophy type 3	Patterned macular dystrophy type 3	5.24E-03	 	 	 	 	MAPKAPK3	1	
Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	phosphoglycerate dehydrogenase deficiency	Phosphoglycerate dehydrogenase deficiency	5.24E-03	 	 	 	 	PHGDH	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	presynaptic congenital myasthenic syndrome type 7	Presynaptic congenital myasthenic syndrome type 7	5.24E-03	 	 	 	 	SYT2	1	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Hereditary Disorder, Immunological Disease, Metabolic Disease, Organismal Injury and Abnormalities	primary localized cutaneous amyloidosis type 2	Primary localized cutaneous amyloidosis type 2	5.24E-03	 	 	 	 	IL31RA	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Tumor Morphology	follicular B-cell or T-cell lymphoma	Progressed follicular B-cell or T-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	aspergillosis	Progressive aspergillosis	5.24E-03	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Tumor Morphology	lymphoplasmacytic lymphoma	Progressive lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Lymphoid Tissue Structure and Development	proliferation	Proliferation of activated T lymphocyte	5.24E-03	 	 	 	 	CLC	1	
Infectious Diseases, Organismal Injury and Abnormalities, Respiratory Disease	pulmonary blastomycosis	Pulmonary blastomycosis	5.24E-03	 	 	 	 	CYP51A1	1	
Hematological Disease, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Renal and Urological Disease	IgA nephropathy	Recurrent IgA nephropathy	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive Waldenstrom macroglobulinemia	Refractory CD20 positive Waldenstrom macroglobulinemia	5.24E-03	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	extrapulmonary aspergillosis	Refractory extrapulmonary aspergillosis	5.24E-03	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	fusariosis	Refractory fusariosis	5.24E-03	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Refractory nodular lymphocyte predominant Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	oropharyngeal candidiasis	Refractory oropharyngeal candidiasis	5.24E-03	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive mantle cell lymphoma	Relapsed CD20 positive mantle cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	antineutrophil cytoplasmic antibody-associated vasculitis	Relapsed antineutrophil cytoplasmic antibody-associated vasculitis	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodular lymphocyte predominant Hodgkin lymphoma	Relapsed nodular lymphocyte predominant Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Organismal Injury and Abnormalities, Renal and Urological Disease	relapsing nephrotic syndrome	Relapsing nephrotic syndrome	5.24E-03	 	 	 	 	MS4A1	1	
Molecular Transport	secretion	Secretion of bicarbonate	5.24E-03	 	 	 	 	ANO1	1	
Connective Tissue Disorders, Organismal Injury and Abnormalities, Respiratory Disease	interstitial lung disease	Severe interstitial lung disease	5.24E-03	 	 	 	 	MS4A1	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Reproductive System Disease, Skeletal and Muscular Disorders	skeletal defects, genital hypoplasia, and intellectual disability	Skeletal defects, genital hypoplasia, and intellectual disability	5.24E-03	 	 	 	 	ZBTB16	1	
Organismal Injury and Abnormalities, Respiratory Disease	smoking related chronic obstructive pulmonary disease	Smoking related chronic obstructive pulmonary disease	5.24E-03	 	 	 	 	ANO1	1	
Cancer, Dermatological Diseases and Conditions, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous marginal zone B-cell lymphoma	Solitary primary cutaneous marginal zone B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	sorbitol dehydrogenase deficiency with peripheral neuropathy	Sorbitol dehydrogenase deficiency with peripheral neuropathy	5.24E-03	 	 	 	 	SORD	1	
Embryonic Development, Organismal Development	specification	Specification of dorsal-ventral axis	5.24E-03	 	 	 	 	SFRP1	1	
Hereditary Disorder, Organismal Injury and Abnormalities, Reproductive System Disease	spermatogenic failure 58	Spermatogenic failure 58	5.24E-03	 	 	 	 	IFT74	1	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	sporadic gastric carcinoma	Sporadic gastric carcinoma	5.24E-03	 	 	 	 	CD44	1	
Connective Tissue Disorders, Developmental Disorder, Gastrointestinal Disease, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	squalene synthase deficiency	Squalene synthase deficiency	5.24E-03	 	 	 	 	FDFT1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell or T-cell lymphoma	Stable disease stage follicular B-cell or T-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	low-grade B-cell non-Hodgkin lymphoma	Stable disease stage low-grade B-cell non-Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal adenocarcinoma	Stage 2-3 primary colorectal adenocarcinoma	5.24E-03	 	 	 	 	CD44	1	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal adenocarcinoma	Stage 2-3 sporadic colorectal adenocarcinoma	5.24E-03	 	 	 	 	CD44	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	gastric mucosa-associated lymphoid tissue lymphoma	Stage I-II gastric mucosa-associated lymphoid tissue lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nongastric mucosa associated lymphoid tissue lymphoma	Stage I-II nongastric mucosa associated lymphoid tissue lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	ductal breast carcinoma	Stage II ductal breast carcinoma	5.24E-03	 	 	 	 	CD44	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	extranodal marginal zone cell lymphoma	Stage II extranodal marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 3 follicular lymphoma	Stage II grade 3 follicular lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Stage II indolent marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Stage II lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal marginal zone lymphoma	Stage II nodal marginal zone lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Stage II small B-cell lymphocytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	Stage II untreated diffuse large B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	extranodal marginal zone cell lymphoma	Stage III extranodal marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Stage III indolent marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Stage III lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal marginal zone lymphoma	Stage III nodal marginal zone lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	recurrent non-Hodgkin lymphoma	Stage III recurrent non-Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	refractory non Hodgkin lymphoma	Stage III refractory non Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	Stage III untreated diffuse large B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Stage IV indolent marginal zone cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Stage IV lymphoplasmacytic lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal marginal zone lymphoma	Stage IV nodal marginal zone lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	recurrent non-Hodgkin lymphoma	Stage IV recurrent non-Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	refractory non Hodgkin lymphoma	Stage IV refractory non Hodgkin lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Organismal Injury and Abnormalities, Renal and Urological Disease	stenosis of the pyeloureteral joint	Stenosis of the pyeloureteral joint	5.24E-03	 	 	 	 	CCN2	1	
Infectious Diseases, Organismal Injury and Abnormalities	systemic infection	Systemic infection by Candida	5.24E-03	 	 	 	 	CYP51A1	1	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	post-transplant lymphoproliferative disorder	Systemic post-transplant lymphoproliferative disorder	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal carcinoma	TNM stage I colorectal carcinoma	5.24E-03	 	 	 	 	CD44	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	TNM stage T1-3N0M0 t(11;18) positive gastric marginal zone B-cell lymphoma	TNM stage T1-3N0M0 t(11;18) positive gastric marginal zone B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	TNM stage T1-3N1M0 t(11;18) positive gastric marginal zone B-cell lymphoma	TNM stage T1-3N1M0 t(11;18) positive gastric marginal zone B-cell lymphoma	5.24E-03	 	 	 	 	MS4A1	1	
Auditory Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	temperature-sensitive autosomal recessive auditory neuropathy 1	Temperature-sensitive autosomal recessive auditory neuropathy 1	5.24E-03	 	 	 	 	OTOF	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	Wegener granulomatosis and microscopic polyangiitis	Wegener granulomatosis and microscopic polyangiitis	5.24E-03	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	ALK fusion positive CD20 positive diffuse large B-cell non-Hodgkin lymphoma	ALK fusion positive CD20 positive diffuse large B-cell non-Hodgkin lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	advanced germinal center B-cell-like diffuse large B-cell lymphoma	Advanced germinal center B-cell-like diffuse large B-cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive indolent follicular lymphoma	CD20 positive indolent follicular lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive mantle cell lymphoma	CD20 positive mantle cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive nodal marginal zone cell lymphoma	CD20 positive nodal marginal zone cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive relapsed low-grade B-cell non-Hodgkin lymphoma	CD20 positive relapsed low-grade B-cell non-Hodgkin lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma transformed from lymphoplasmacytic lymphoma	Diffuse large B-cell lymphoma transformed from lymphoplasmacytic lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma transformed from mucosa-associated lymphoid tissue lymphoma	Diffuse large B-cell lymphoma transformed from mucosa-associated lymphoid tissue lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma transformed from nodular lymphocyte-predominant Hodgkin lymphoma	Diffuse large B-cell lymphoma transformed from nodular lymphocyte-predominant Hodgkin lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma	High grade diffuse large B-cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cellular Movement, Hematological System Development and Function, Hypersensitivity Response, Immune Cell Trafficking	migration	Migration of eosinophils	5.35E-03	 	 	 	 	PTGDR2,CCR3	2	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities	pleomorphic liposarcoma	Pleomorphic liposarcoma	5.35E-03	 	 	 	 	PDK4,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive follicular non Hodgkin lymphoma	Recurrent CD20 positive follicular non Hodgkin lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive marginal zone cell lymphoma	Recurrent CD20 positive marginal zone cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive small B-cell lymphocytic lymphoma	Recurrent CD20 positive small B-cell lymphocytic lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive Waldenstrom macroglobulinemia	Relapsed CD20 positive Waldenstrom macroglobulinemia	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive extranodal marginal zone cell lymphoma	Relapsed CD20 positive extranodal marginal zone cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive small B-cell lymphocytic lymphoma	Relapsed CD20 positive small B-cell lymphocytic lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell or T-cell lymphoma	Stage I follicular B-cell or T-cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 1 follicular lymphoma	Stage II grade 1 follicular lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 2 follicular lymphoma	Stage II grade 2 follicular lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	activated B-cell-like diffuse large B-cell lymphoma	Stage IV activated B-cell-like diffuse large B-cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	extranodal marginal zone cell lymphoma	Symptomatic stage extranodal marginal zone cell lymphoma	5.35E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	glioma formation	Glioma	5.41E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,SYT2,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2,XCR1	79	
Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	progressive supranuclear palsy	Progressive supranuclear palsy	5.48E-03	 	 	 	 	SLC1A7,IRF4,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital tract serous carcinoma	Female genital tract serous carcinoma	5.55E-03	 	 	 	 	POSTN,HEPH,CLDN3,GAS1,ISG15,ZBTB16,ITLN1,SFRP1,PDK4,TUBB4B	10	
Cancer, Organismal Injury and Abnormalities	pelvic serous carcinoma	Pelvic serous carcinoma	5.55E-03	 	 	 	 	POSTN,HEPH,CLDN3,GAS1,ISG15,ZBTB16,ITLN1,SFRP1,PDK4,TUBB4B	10	
Organismal Injury and Abnormalities, Reproductive System Disease	benign uterine disease	Benign uterine disease	5.58E-03	 	 	 	 	IFIT1,SFRP1,SAMD3,PDK4,WEE1,CD44,CTSG,SPIB,POSTN,IFIT3,COL28A1,PCDHA12,IRF4	13	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	malignant neoplasm of large intestine	Malignant neoplasm of large intestine	5.59E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,CLDN3,IFIT1,IL22RA2,SFRP1,CASS4,CCN2,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,NRROS,BTNL8,LRRC61,ADAM19,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,CDH26,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,CST1,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,SHISA2,SQLE,ANO1,COL28A1,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,IFT74,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,ZNF366,XCR1	92	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	angioimmunoblastic T-cell lymphoma	Angioimmunoblastic T-cell lymphoma	5.65E-03	 	 	 	 	MS4A1,MMP12,ADAM19,TUBB4B,SPIB	5	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	androgen-independent prostate tumor	Metastatic androgen-independent prostate tumor	5.71E-03	 	 	 	 	CYP51A1,FDFT1,TUBB4B	3	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	neoplasia	Neoplasia of blood cells	5.75E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,IFIT1,IL22RA2,CLCA1,OR52M1,CTSG,SYT2,TESPA1,SPIB,P2RY10,OTOF,CD69,FHL3,BTNL8,CLC,OASL,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,CCR3,RFTN1,PHGDH,MMP12,ZBTB16,BAIAP3,ANKRD55,IFIT2,GZMB,ANO1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,MS4A1,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CYP51A1,CRISP2	58	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Hodgkin disease	Hodgkin lymphoma	5.82E-03	 	 	 	 	MS4A1,IRF4,BAIAP3,FHL3,CD44,TUBB4B	6	
Cellular Movement	migration	Migration of squamous cell carcinoma cell lines	5.82E-03	 	-0.930	 	-0.380	ISG15,CST1,SFRP1,CCN2,IFIT2,CD44	6	
Cell Cycle	G2 phase	Arrest in G2 phase of sarcoma cell lines	5.87E-03	 	 	 	 	MAP2K6,WEE1	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BCL2 rearrangement negative follicular lymphoma	BCL2 rearrangement negative follicular lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive c-MYC positive lymphoma	CD20 positive c-MYC positive lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	relapsed mantle cell lymphoma	Early stage relapsed mantle cell lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Connective Tissue Disorders, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	primary bone lymphoma	Primary bone lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	primary gastric carcinoma	Primary gastric carcinoma	5.87E-03	 	 	 	 	CD44,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	lung adenocarcinoma	Primary lung adenocarcinoma	5.87E-03	 	 	 	 	DOK2,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive marginal zone cell lymphoma	Refractory CD20 positive marginal zone cell lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	invasive breast adenocarcinoma	Stage I invasive breast adenocarcinoma	5.87E-03	 	 	 	 	CD44,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	transformed diffuse large B-cell lymphoma	Stage II-IV transformed diffuse large B-cell lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 3 follicular lymphoma	Stage III grade 3 follicular lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Stage III small B-cell lymphocytic lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 3 follicular lymphoma	Stage IV grade 3 follicular lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small B-cell lymphocytic lymphoma	Stage IV small B-cell lymphocytic lymphoma	5.87E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	endometrial cancer	Endometrial cancer	6.00E-03	 	 	 	 	CCR7,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,IL31RA,PCDHA12,MAP2K6,CCR3,ZNF157,MCOLN2,WDR93,DOK2,MMP12,ZBTB16,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,CD44,CLEC12A,IFIT3,GAPT,ZNF366,DYDC1,XCR1	53	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cell movement	Cell movement of phagocytes	6.00E-03	 	-1.955	bias	-1.410	POSTN,CCR7,PTGDR2,CCR3,CD44,CTSG	6	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by human herpesvirus 4	6.04E-03	 	 	 	 	MS4A1,IRF4,CCR3,LRRC61	4	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	hepatocellular carcinoma	Hepatocellular carcinoma	6.15E-03	 	 	 	 	PHGDH,SLC26A4,ZBTB16,ITLN1,SFRP1,PPP1R16B,CD69,SQLE,ANO1,COL28A1,CLEC12B,SIGLEC6,TPSAB1,PER1,CEBPE,HEPH,OASL,FDFT1,SORD,PDK4,WEE1,CD44,TUBB4B,POSTN,GGT5,IFIT3,CDH26,FETUB,PCDHA12,XCR1	30	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	transitional cell bladder cancer	Urothelial bladder carcinoma	6.23E-03	 	 	 	 	PDCD1LG2,PHGDH,DENND2D,FABP6,CST1,SFRP1,CCN2,BAIAP3,IFIT2,CLCA1,VSTM1,GZMB,OTOF,SLC1A7,SQLE,ANO1,COL28A1,CLEC12B,P2RY13,FHL3,RASGRP3,NRROS,BTNL8,HEPH,MS4A1,ITIH5,HOXA3,ADAM19,FDFT1,PDK4,CD44,TUBB4B,CLEC12A,POSTN,GGT5,CLCNKB,IL31RA,PCDHA12,SCNN1B,TASL	40	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	upper respiratory tract neoplasm	Upper respiratory tract neoplasm	6.30E-03	 	 	 	 	CCR7,PTGDR2,ITIH5,WDR93,ADAM19,HS3ST3A1,WEE1,CD44,TUBB4B,PIP4K2A,TESPA1,CDH26,PCDHA12,SCNN1B,IRF4,RASGRP3	16	
Cancer, Dental Disease, Gastrointestinal Disease, Organismal Injury and Abnormalities	keratocystic odontogenic tumors	Keratocystic odontogenic tumor	6.37E-03	 	 	 	 	POSTN,ANO1,FETUB,SCNN1B,CCN2,HS3ST3A1	6	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	AIDS-related Burkitt lymphoma	AIDS-related Burkitt lymphoma	6.40E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	AIDS-related diffuse large B cell lymphoma	AIDS-related diffuse large B cell lymphoma	6.40E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive splenic marginal zone cell lymphoma	CD20 positive splenic marginal zone cell lymphoma	6.40E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	high tumor burden follicular lymphoma	High tumor burden follicular lymphoma	6.40E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20-positive B-cell non-Hodgkin lymphoma	Primary CD20-positive B-cell non-Hodgkin lymphoma	6.40E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease	primary epithelial ovarian cancer	Primary ovarian carcinoma	6.40E-03	 	 	 	 	CLDN3,CD44	2	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hair and Skin Development and Function, Organ Development, Tissue Development	proliferation	Proliferation of dermal fibroblasts	6.40E-03	 	 	 	 	PDK4,CD44	2	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	central nervous system cancer	Central nervous system cancer	6.66E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,EMP3,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2,XCR1	77	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	oligo or polyarticular juvenile idiopathic arthritis	Oligo or polyarticular juvenile idiopathic arthritis	6.68E-03	 	 	 	 	CD69,P2RY13,ANKRD55,CCR3	4	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cell movement	Cell movement of dendritic cells	6.68E-03	 	 	 	 	CCR7,CCR3,CD44	3	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	large intestine adenocarcinoma	Large intestine adenocarcinoma	6.70E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,IFIT1,IL22RA2,SFRP1,CASS4,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,NRROS,BTNL8,LRRC61,ADAM19,TUBB4B,PIP4K2A,UBXN11,IL31RA,CDH26,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,CST1,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,SHISA2,SQLE,ANO1,COL28A1,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,PTGDR2,EMP3,ITIH5,IFT74,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,ZNF366,XCR1	87	
Organismal Injury and Abnormalities, Reproductive System Disease	endometriosis	Endometriosis	6.80E-03	 	 	 	 	PDCD1LG2,CCL18,OASL,CLDN3,GAS1,ZBTB16,SFRP1,CCN2,WEE1,CD44,XCR1	11	
Organismal Injury and Abnormalities	lithiasis	Lithiasis	6.94E-03	 	 	 	 	ANO1,CYP51A1,SCNN1B,ADAM19,CD44	5	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BCL2 rearrangement negative MYC rearrangement negative lymphoma	BCL2 rearrangement negative MYC rearrangement negative lymphoma	6.96E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	bulky diffuse large B cell lymphoma	Bulky diffuse large B cell lymphoma	6.96E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	ductal breast carcinoma	Stage I-III ductal breast carcinoma	6.96E-03	 	 	 	 	CD44,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast adenocarcinoma	Stage II breast adenocarcinoma	6.96E-03	 	 	 	 	CD44,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	recurrent non-Hodgkin lymphoma	Stage III-IV recurrent non-Hodgkin lymphoma	6.96E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	stage IV gastric cancer	Stage IV gastric cancer	6.96E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities	refractory solid tumor	Stage IV refractory solid tumor	6.96E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	unresectable pancreatic ductal adenocarcinoma	Unresectable pancreatic ductal adenocarcinoma	6.96E-03	 	 	 	 	CCN2,TUBB4B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	upper gastrointestinal carcinoma	Upper gastrointestinal carcinoma	7.03E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,SFRP1,CASS4,CCN2,SKAP2,TESPA1,P2RY10,OTOF,SLC1A7,SIGLEC6,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,CDH26,FETUB,PCDHA12,SLC27A3,CCR3,MCOLN2,MAPKAPK3,PHGDH,MMP12,CST1,ZBTB16,BAIAP3,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,PER1,ISG15,IRF4,CEBPE,RASGRP3,RGS18,ITIH5,HOXA3,IGFLR1,FDFT1,ENTPD4,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,CYP51A1,SCNN1B,ZNF366,DYDC1,XCR1	58	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	glioma cancer	Glioma cancer	7.13E-03	 	 	 	 	TNNC2,CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,CD44,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2,XCR1	76	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	mature lymphocytic neoplasm	Mature lymphocytic neoplasm	7.26E-03	 	 	 	 	CCR7,PDCD1LG2,PHGDH,RSAD2,CCL18,MMP12,ZBTB16,IFIT2,OR52M1,CTSG,GZMB,SPIB,P2RY10,OTOF,CD69,ANO1,PER1,ISG15,IRF4,BTNL8,MS4A1,ITIH5,CLC,OASL,ADAM19,FDFT1,CD44,TUBB4B,TRAF5,POSTN,UBXN11,IFIT3,IL31RA,PCDHA12,CCR3,RFTN1	36	
Cell-To-Cell Signaling and Interaction	activation	Activation of cells	7.35E-03	 	-0.128	 	0.326	MS4A1,PTGDR2,CLC,CDH26,CCN2,CD1B,CD44,CTSG,CLEC12A	9	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	metastatic gastric cancer	Metastatic gastric cancer	7.35E-03	 	 	 	 	MS4A1,CST1,CD44,TUBB4B	4	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	non-colon gastrointestinal cancer	Non-colon gastrointestinal cancer	7.46E-03	 	 	 	 	CCR7,PDCD1LG2,FABP6,RSAD2,CCL18,SFRP1,CASS4,CCN2,CLCA1,SKAP2,TESPA1,P2RY10,OTOF,SLC1A7,SIGLEC6,FHL3,NRROS,TUBB4B,PIP4K2A,UBXN11,CDH26,FETUB,PCDHA12,SLC27A3,CCR3,MCOLN2,MAPKAPK3,PHGDH,MMP12,CST1,ZBTB16,LRRC32,BAIAP3,IFIT2,HS3ST3A1,VSTM1,GZMB,SQLE,ANO1,COL28A1,PER1,ISG15,IRF4,CEBPE,RASGRP3,MS4A1,RGS18,ITIH5,HOXA3,IGFLR1,FDFT1,ENTPD4,PDK4,CAPS2,WEE1,CD44,POSTN,CLCNKB,CYP51A1,SCNN1B,ZNF366,DYDC1,XCR1	63	
Infectious Diseases, Organismal Injury and Abnormalities	replication	Replication of Flaviviridae	7.46E-03	 	 	 	 	OASL,IFIT1,ISG15	3	
Cancer, Organismal Injury and Abnormalities	metastatic solid tumor	Metastatic solid tumor	7.49E-03	 	 	 	 	TNNC2,MS4A1,CCR7,CLDN3,CST1,SFRP1,CCN2,FDFT1,CD44,TUBB4B,CYP51A1,IRF4	12	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive refractory follicular B-cell non-Hodgkin lymphoma	CD20 positive refractory follicular B-cell non-Hodgkin lymphoma	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	mantle cell lymphoma	Early relapsed mantle cell lymphoma	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive primary mediastinal diffuse large B-cell lymphoma	High-risk CD20 positive primary mediastinal diffuse large B-cell lymphoma	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatic ductal adenocarcinoma	Locally advanced pancreatic ductal adenocarcinoma	7.54E-03	 	 	 	 	CCN2,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	recurrent grade 1 follicular lymphoma	Recurrent grade 1 follicular lymphoma	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	recurrent grade 2 follicular lymphoma	Recurrent grade 2 follicular lymphoma	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	acute lymphocytic leukemia, type L3	Stage III acute lymphocytic leukemia, type L3	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary mediastinal large B-cell lymphoma	Stage III primary mediastinal large B-cell lymphoma	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	acute lymphocytic leukemia, type L3	Stage IV acute lymphocytic leukemia, type L3	7.54E-03	 	 	 	 	MS4A1,TUBB4B	2	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	knee arthritis	Knee arthritis	7.71E-03	 	 	 	 	POSTN,CNR2,CTSG,TUBB4B	4	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	hematological neoplasia	Hematopoietic neoplasm	7.94E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,IFIT1,IL22RA2,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,TESPA1,SPIB,P2RY10,OTOF,CD69,FHL3,BTNL8,CLC,OASL,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,CCR3,RFTN1,PHGDH,MMP12,ZBTB16,BAIAP3,ANKRD55,IFIT2,GZMB,ANO1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,MS4A1,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CYP51A1,CRISP2	59	
Cellular Movement	migration	Migration of cells	7.99E-03	 	-1.836	 	-0.934	CCR7,PHGDH,CCL18,CLDN3,MMP12,IFIT1,CST1,ZBTB16,SFRP1,CASS4,CCN2,IFIT2,CTSG,GZMB,P2RY10,CD69,SQLE,COL28A1,ISG15,HRH4,MS4A1,HSD11B2,PTGDR2,EMP3,FDFT1,CNR2,PDK4,CD44,POSTN,IFIT3,MAP2K6,CCR3	32	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	High grade non-Hodgkin disease	8.01E-03	 	 	 	 	MS4A1,CD44,TUBB4B	3	
Infectious Diseases, Organismal Injury and Abnormalities	severe COVID-19	Severe COVID-19	8.14E-03	 	 	 	 	RSAD2,IFIT3,ISG15,GZMB,TUBB4B	5	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 non-overexpressing IGH/CCND1 negative mantle cell lymphoma	CCND1 non-overexpressing IGH/CCND1 negative mantle cell lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive Burkitt lymphoma	CD20 positive Burkitt lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive primary cutaneous diffuse large B-cell lymphoma	CD20 positive primary cutaneous diffuse large B-cell lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive relapsed follicular B-cell non-Hodgkin lymphoma	CD20 positive relapsed follicular B-cell non-Hodgkin lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease, Tumor Morphology	castration refractory prostate cancer	Progressive castration refractory prostate cancer	8.14E-03	 	 	 	 	CYP51A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	extranodal marginal zone cell lymphoma	Refractory extranodal marginal zone cell lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal marginal zone lymphoma	Refractory nodal marginal zone lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	splenic marginal zone lymphoma	Refractory splenic marginal zone lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nodal marginal zone lymphoma	Relapsed nodal marginal zone lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	splenic marginal zone lymphoma	Relapsed splenic marginal zone lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	stage IB cervical carcinoma	Stage IB cervical carcinoma	8.14E-03	 	 	 	 	CD44,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Burkitt lymphoma	Stage III Burkitt lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Burkitt lymphoma	Stage IV Burkitt lymphoma	8.14E-03	 	 	 	 	MS4A1,TUBB4B	2	
Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	familial congenital myopathy	Familial congenital myopathy	8.15E-03	 	 	 	 	TNNC2,SLC1A7,LGALS12,TPSAB1,CTSG,SYT2	6	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	osteoarthritis	Osteoarthritis	8.17E-03	 	 	 	 	POSTN,SLC1A7,PHGDH,MMP12,ITLN1,FDFT1,CNR2,MAP2K6,BTNL8,TUBB4B,PIP4K2A	11	
Auditory Disease, Neurological Disease, Organismal Injury and Abnormalities	syndromic hearing loss	Syndromic hearing loss	8.26E-03	 	 	 	 	OTOF,SLC26A4,CLCNKB,TUBB4B	4	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreaticobiliary neoplasm	Pancreaticobiliary neoplasm	8.48E-03	 	 	 	 	CCR7,MAPKAPK3,PDCD1LG2,PHGDH,DENND2D,CCL18,DOK2,CST1,ZBTB16,CASS4,CCN2,SAMD3,BAIAP3,IFIT2,HS3ST3A1,CLCA1,OR52M1,DMRTC2,SYT2,GZMB,TESPA1,ARL15,OTOF,SLC1A7,SQLE,ANO1,CEACAM21,PER1,RASGRP3,BTNL8,HEPH,ITIH5,ADAM19,PDK4,WEE1,CD44,TUBB4B,POSTN,CDH26,FETUB,PCDHA12,CYP51A1,CRISP2,CCR3	44	
Gastrointestinal Disease, Organismal Injury and Abnormalities	abnormality	Abnormality of oral mucosa	8.59E-03	 	 	 	 	PHGDH,CD44,TUBB4B	3	
Cellular Movement, Renal and Urological System Development and Function	cell movement	Cell movement of kidney cell lines	8.64E-03	 	 	 	 	POSTN,PTGDR2,COL28A1,CCR3	4	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	squamous cell carcinoma of the vagina or vulva	Squamous cell carcinoma of the vagina or vulva	8.64E-03	 	 	 	 	OTOF,ADAM19,CD44,TUBB4B	4	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	proliferation	Proliferation of cancer cells	8.71E-03	 	-0.625	 	-0.147	ANO1,LGALS12,SFRP1,CD44,TESPA1	5	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 overexpression positive IGH/CCND1 fusion positive mantle cell lymphoma	CCND1 overexpression positive IGH/CCND1 fusion positive mantle cell lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma transformed from marginal zone lymphoma	Diffuse large B-cell lymphoma transformed from marginal zone lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Epstein Barr virus positive diffuse large B-cell lymphoma	Epstein Barr virus positive diffuse large B-cell lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	hormone sensitive malignant neoplasm of prostate	Hormone sensitive malignant neoplasm of prostate	8.76E-03	 	 	 	 	RSAD2,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent transformed lymphoma	Indolent transformed lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	Non-gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 1 follicular lymphoma	Stage III grade 1 follicular lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 2 follicular lymphoma	Stage III grade 2 follicular lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 1 follicular lymphoma	Stage IV grade 1 follicular lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	grade 2 follicular lymphoma	Stage IV grade 2 follicular lymphoma	8.76E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	superficial bladder carcinoma	Superficial bladder carcinoma	8.76E-03	 	 	 	 	CD44,TUBB4B	2	
Dermatological Diseases and Conditions, Infectious Diseases, Organismal Injury and Abnormalities	tuberculoid leprosy	Tuberculoid leprosy	8.76E-03	 	 	 	 	CD1B,CTSG	2	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	disorder of basal ganglia	Disorder of basal ganglia	8.82E-03	 	 	 	 	TNNC2,MAPKAPK3,PHGDH,ZBTB16,ITLN1,FDFT1,CNR2,PDK4,CD44,TUBB4B,OTOF,SLC1A7,ISG15,CYP51A1,IRF4,RASGRP3	16	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	non-melanoma skin cancer	Non-melanoma skin cancer	8.84E-03	 	 	 	 	MS4A1,DOK2,FDFT1,LRRC32,CD44,TESPA1,P2RY10,POSTN,OTOF,SIGLEC6,PCDHA12,GAPT,IRF4,CCR3	14	
Endocrine System Disorders, Organismal Injury and Abnormalities	benign thyroid disease	Benign thyroid disease	9.18E-03	 	 	 	 	MS4A1,OTOF,CD69,SLC26A4,PRDX5,IRF4,PIP4K2A	7	
Cell Death and Survival	cell viability	Cell viability of tumor cell lines	9.27E-03	 	-1.193	 	-0.297	PHGDH,FABP6,CCL18,DOK2,CLDN3,IFIT1,ZBTB16,SFRP1,CCN2,WEE1,CD44,PPP1R16B,CTSG,SPIB,POSTN,SQLE,IRF4,MAP2K6,MCOLN2	19	
Auditory Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive prelingual nonsyndromic sensorineural hearing loss	Autosomal recessive prelingual nonsyndromic sensorineural hearing loss	9.41E-03	 	 	 	 	OTOF,SLC26A4	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BCL2 rearrangement positive c-MYC rearrangement positive diffuse large B-cell lymphoma	BCL2 rearrangement positive c-MYC rearrangement positive diffuse large B-cell lymphoma	9.41E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BCL6 rearrangement positive c-MYC rearrangement positive diffuse large B-cell lymphoma	BCL6 rearrangement positive c-MYC rearrangement positive diffuse large B-cell lymphoma	9.41E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 negative lymphoma	CD20 negative lymphoma	9.41E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	MYC translocation positive diffuse large B-cell lymphoma	MYC translocation positive diffuse large B-cell lymphoma	9.41E-03	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities, Respiratory Disease	nasal polyp	Nasal polyp	9.41E-03	 	 	 	 	PTGDR2,IRF4	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive follicular non Hodgkin lymphoma	Refractory CD20 positive follicular non Hodgkin lymphoma	9.41E-03	 	 	 	 	MS4A1,TUBB4B	2	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin hyperpigmentation	Skin hyperpigmentation	9.41E-03	 	 	 	 	CYP51A1,IRF4	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Stage IIIC breast cancer	9.41E-03	 	 	 	 	FDFT1,TUBB4B	2	
Cell Death and Survival, Cellular Compromise	cytotoxicity	Cytotoxicity of cells	9.44E-03	 	 	 	 	CD69,CLEC12B,CCR3,GZMB	4	
Organismal Injury and Abnormalities, Renal and Urological Disease	kidney disease	Early stage kidney disease	9.44E-03	 	 	 	 	CLCNKB,ZBTB16,PDK4,TUBB4B	4	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nasal type extranodal NK-/T-cell lymphoma	Nasal type extranodal NK-/T-cell lymphoma	9.44E-03	 	 	 	 	MS4A1,CCL18,IRF4,GZMB	4	
Cancer, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	hereditary malignant hematological system tumor	Hereditary malignant hematological system tumor	9.50E-03	 	 	 	 	MS4A1,IL31RA,TUBB4B	3	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	hip osteoarthritis	Hip osteoarthritis	9.50E-03	 	 	 	 	FDFT1,MAP2K6,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities	cancer	Stage IIIA cancer	9.50E-03	 	 	 	 	MS4A1,FDFT1,TUBB4B	3	
Cancer, Organismal Injury and Abnormalities	malignant solid tumor	Advanced malignant solid tumor	9.54E-03	 	 	 	 	TNNC2,MS4A1,CCR7,CLDN3,CST1,ITLN1,SFRP1,CCN2,FDFT1,CD44,TUBB4B,CYP51A1,IRF4	13	
Cellular Development	differentiation	Differentiation of progenitor cells	9.63E-03	 	-0.094	 	0.056	ZBTB16,SFRP1,CEBPE,GZMB,SPIB	5	
Organismal Injury and Abnormalities, Renal and Urological Disease	structural renal abnormality	Structural renal abnormality	9.81E-03	 	 	 	 	TNNC2,FDFT1,XCR1	3	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	hematologic cancer	Hematologic cancer	9.93E-03	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,IFIT1,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,TESPA1,SPIB,P2RY10,OTOF,CD69,FHL3,BTNL8,CLC,OASL,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,CCR3,RFTN1,PHGDH,MMP12,ZBTB16,BAIAP3,ANKRD55,IFIT2,GZMB,ANO1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,MS4A1,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CYP51A1,CRISP2	58	
Cellular Movement	cell movement	Cell movement	1.00E-02	 	-1.688	 	-0.778	CCR7,PHGDH,CCL18,CLDN3,MMP12,IFIT1,CST1,ZBTB16,SFRP1,CASS4,CCN2,IFIT2,CTSG,GZMB,P2RY10,CD69,SQLE,COL28A1,ISG15,HRH4,MS4A1,HSD11B2,PTGDR2,EMP3,FDFT1,CNR2,PDK4,CD44,POSTN,IFIT3,MAP2K6,CCR3,XCR1	33	
Cancer, Organismal Injury and Abnormalities	carcinoma in situ of breast and genitourinary system	Carcinoma in situ of breast and genitourinary system	1.01E-02	 	 	 	 	POSTN,HS3ST3A1,CD44,TUBB4B	4	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of CD4+ T-lymphocytes	1.01E-02	 	 	 	 	CD69,SFRP1	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	double hit type high grade B-cell lymphoma	Double hit type high grade B-cell lymphoma	1.01E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoma	Metastatic lymphoma	1.01E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive follicular non Hodgkin lymphoma	Relapsed CD20 positive follicular non Hodgkin lymphoma	1.01E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	stage I multiple myeloma	Stage I multiple myeloma	1.01E-02	 	 	 	 	FDFT1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Stage IIIB breast cancer	1.01E-02	 	 	 	 	FDFT1,TUBB4B	2	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease	primary ovarian cancer	Primary ovarian cancer	1.01E-02	 	 	 	 	POSTN,CLDN3,CD44	3	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastrointestinal adenocarcinoma	Gastrointestinal adenocarcinoma	1.02E-02	 	 	 	 	CCR7,PDCD1LG2,FABP6,IFIT1,IL22RA2,SFRP1,CASS4,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,SKAP2,TESPA1,P2RY10,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,NRROS,BTNL8,LRRC61,ADAM19,TUBB4B,PIP4K2A,UBXN11,IL31RA,CDH26,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,WDR93,PRSS33,DOK2,MMP12,CST1,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,SHISA2,SQLE,ANO1,COL28A1,PER1,ISG15,SLC9B2,IRF4,CEBPE,CD1B,RASGRP3,HEPH,MS4A1,NAIF1,PTGDR2,RGS18,EMP3,ITIH5,IFT74,HOXA3,IGFLR1,FDFT1,ENTPD4,CNR2,PDK4,CAPS2,CD44,CLEC12A,POSTN,GGT5,IFIT3,CLCNKB,SLC9A3,CYP51A1,SCNN1B,ZNF366,XCR1	89	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	microscopic polyangiitis	Active stage microscopic polyangiitis	1.04E-02	 	 	 	 	MS4A1	1	
Cell-To-Cell Signaling and Interaction, Connective Tissue Development and Function, Hepatic System Development and Function	adhesion	Adhesion of hepatic stellate cells	1.04E-02	 	 	 	 	CCN2	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	aggregation	Aggregation of monocyte-derived dendritic cells	1.04E-02	 	 	 	 	CD44	1	
Cell Death and Survival	antiapoptosis	Antiapoptosis of colorectal cancer cell lines	1.04E-02	 	 	 	 	CD44	1	
Cell Death and Survival, Organismal Injury and Abnormalities	apoptosis	Apoptosis of invariant natural killer T cells	1.04E-02	 	 	 	 	ZBTB16	1	
Cell Morphology, Inflammatory Response	architecture	Architecture of monocyte-derived dendritic cells	1.04E-02	 	 	 	 	CCR7	1	
Cell Cycle	G2/M phase transition	Arrest in G2/M phase transition of bone cancer cell lines	1.04E-02	 	 	 	 	MAP2K6	1	
Cell Cycle	G2/M phase transition	Arrest in G2/M phase transition of colorectal cancer cell lines	1.04E-02	 	 	 	 	MAP2K6	1	
Cardiovascular System Development and Function, Cell Cycle	cell cycle progression	Arrest in cell cycle progression of vascular endothelial cells	1.04E-02	 	 	 	 	CD44	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	chronic lymphocytic leukemia	Asymptomatic stage chronic lymphocytic leukemia	1.04E-02	 	 	 	 	MS4A1	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	autosomal dominant osteopetrosis type 1	Autosomal dominant osteopetrosis type 1	1.04E-02	 	 	 	 	CLCNKB	1	
Auditory Disease, Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive congenital deafness type 3	Autosomal recessive congenital deafness type 3	1.04E-02	 	 	 	 	OTOF	1	
Auditory Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive deafness type 9	Autosomal recessive deafness type 9	1.04E-02	 	 	 	 	OTOF	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BCL2 rearrangement positive BCL6 rearrangement positive CD20 positive MYC rearrangement positive diffuse large B-cell lymphoma	BCL2 rearrangement positive BCL6 rearrangement positive CD20 positive MYC rearrangement positive diffuse large B-cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	Bardet-Biedl syndrome type 22	Bardet-Biedl syndrome type 22	1.04E-02	 	 	 	 	IFT74	1	
Auditory Disease, Developmental Disorder, Endocrine System Disorders, Hematological Disease, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	Bartter syndrome type 4B	Bartter syndrome type 4B	1.04E-02	 	 	 	 	CLCNKB	1	
Dermatological Diseases and Conditions, Immunological Disease, Organismal Injury and Abnormalities	benign mucous membrane pemphigoid	Benign mucous membrane pemphigoid	1.04E-02	 	 	 	 	MS4A1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function	binding	Binding of Th2 cells	1.04E-02	 	 	 	 	CCR3	1	
Carbohydrate Metabolism, Small Molecule Biochemistry	biosynthesis	Biosynthesis of D-fructose	1.04E-02	 	 	 	 	SORD	1	
Hereditary Disorder, Organismal Injury and Abnormalities, Respiratory Disease	bronchiectasis type 1	Bronchiectasis type 1	1.04E-02	 	 	 	 	SCNN1B	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 negative CD5 positive CD23 positive small lymphocytic lymphoma	CCND1 negative CD5 positive CD23 positive small lymphocytic lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive double hit diffuse large B-cell lymphoma	CD20 positive double hit diffuse large B-cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities, Renal and Urological Disease	candiduria	Candiduria	1.04E-02	 	 	 	 	CYP51A1	1	
DNA Replication, Recombination, and Repair, Nucleic Acid Metabolism, Small Molecule Biochemistry	catabolism	Catabolism of GDP	1.04E-02	 	 	 	 	ENTPD4	1	
Drug Metabolism, Protein Synthesis	catabolism	Catabolism of glutathione	1.04E-02	 	 	 	 	GGT5	1	
Cell Cycle	cell cycle progression	Cell cycle progression of myeloid cells	1.04E-02	 	 	 	 	CD44	1	
Cellular Movement	cell movement	Cell movement of hairy cell leukemia cells	1.04E-02	 	 	 	 	CD44	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	cell-cell adhesion	Cell-cell adhesion of melanoma cell lines	1.04E-02	 	 	 	 	CD44	1	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Lymphoid Tissue Structure and Development	chemotaxis	Chemotaxis of Th2 cells	1.04E-02	 	 	 	 	PTGDR2	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	colony formation	Colony formation of glioma stem cells	1.04E-02	 	 	 	 	ANO1	1	
Infectious Diseases, Organismal Injury and Abnormalities	complicated intra-abdominal infection	Complicated intra-abdominal infection	1.04E-02	 	 	 	 	PER1	1	
Skeletal and Muscular System Development and Function	contraction	Contraction of airway smooth muscle	1.04E-02	 	 	 	 	ANO1	1	
Lipid Metabolism, Small Molecule Biochemistry	conversion	Conversion of leukotriene C4	1.04E-02	 	 	 	 	GGT5	1	
Cell Death and Survival, Cellular Compromise	cytotoxicity	Cytotoxicity of keratinocyte cancer cell lines	1.04E-02	 	 	 	 	GZMB	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	differentiation	Differentiation of plasmacytoid dendritic cells	1.04E-02	 	 	 	 	SPIB	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Humoral Immune Response, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of pro-B lymphocytes	1.04E-02	 	 	 	 	SPIB	1	
Infectious Diseases, Organismal Injury and Abnormalities	disseminated candidiasis	Disseminated candidiasis	1.04E-02	 	 	 	 	CYP51A1	1	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal adenoma	Early stage colorectal adenoma	1.04E-02	 	 	 	 	CD44	1	
Developmental Disorder, Immunological Disease, Inflammatory Disease, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	primary progressive multiple sclerosis	Early stage primary progressive multiple sclerosis	1.04E-02	 	 	 	 	MS4A1	1	
Cellular Function and Maintenance	endocytosis	Endocytosis by dendritic cells	1.04E-02	 	 	 	 	CCR7	1	
Carbohydrate Metabolism, Cellular Function and Maintenance, Drug Metabolism, Molecular Transport, Small Molecule Biochemistry	endocytosis	Endocytosis of hyaluronic acid	1.04E-02	 	 	 	 	CD44	1	
Cell Cycle	G2/M phase	Entry into G2/M phase of colorectal cancer cell lines	1.04E-02	 	 	 	 	WEE1	1	
Endocrine System Disorders, Gastrointestinal Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	Fanconi renotubular syndrome with maturity-onset diabetes of the young type 4	Fanconi renotubular syndrome with maturity-onset diabetes of the young type 4	1.04E-02	 	 	 	 	SCNN1B	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Cellular Function and Maintenance, Tissue Development	formation	Formation of cell-associated matrix	1.04E-02	 	 	 	 	CD44	1	
Cardiovascular System Development and Function, Organismal Development	formation	Formation of vasculature	1.04E-02	 	 	 	 	CD44	1	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	growth	Growth of pancreatic ductal adenocarcinoma	1.04E-02	 	 	 	 	MAPKAPK3	1	
Cell Cycle, DNA Replication, Recombination, and Repair	homologous recombination	Homologous recombination of GFP reporter gene	1.04E-02	 	 	 	 	WEE1	1	
Dermatological Diseases and Conditions, Hereditary Disorder, Organismal Injury and Abnormalities	ichthyosis bullosa of Siemens	Ichthyosis bullosa of Siemens	1.04E-02	 	 	 	 	SLC9A3	1	
Cardiovascular Disease, Connective Tissue Disorders, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	immune-mediated thrombotic thrombocytopenic purpura	Immune-mediated thrombotic thrombocytopenic purpura	1.04E-02	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Klebsiella oxytoca	1.04E-02	 	 	 	 	PER1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by arthrodermataceae	1.04E-02	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by hookworm	1.04E-02	 	 	 	 	TUBB4B	1	
Gastrointestinal Disease, Hereditary Disorder, Organismal Injury and Abnormalities	intestinal dysmotility syndrome	Intestinal dysmotility syndrome	1.04E-02	 	 	 	 	ANO1	1	
Cellular Movement	invasion	Invasion by glioma stem cells	1.04E-02	 	 	 	 	ANO1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	follicular B-cell or T-cell lymphoma	Late relapsed follicular B-cell or T-cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	leptomeningitis	Leptomeningitis	1.04E-02	 	 	 	 	MS4A1	1	
Cardiovascular Disease, Developmental Disorder, Endocrine System Disorders, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	Liddle syndrome type 1	Liddle syndrome type 1	1.04E-02	 	 	 	 	SCNN1B	1	
Digestive System Development and Function, Gastrointestinal Disease, Hepatic System Development and Function, Hepatic System Disease, Infectious Diseases, Inflammatory Disease, Inflammatory Response, Organ Development, Organismal Injury and Abnormalities	chronic hepatitis C	Low grade chronic hepatitis C	1.04E-02	 	 	 	 	CCR7	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin lymphoma	Low grade scattered non-Hodgkin lymphoma	1.04E-02	 	 	 	 	CD44	1	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Respiratory Disease	lung typical carcinoid tumor	Lung typical carcinoid tumor	1.04E-02	 	 	 	 	CD44	1	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	malignant schwannoma	Malignant schwannoma	1.04E-02	 	 	 	 	CD44	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	metabolism	Metabolism of CTP	1.04E-02	 	 	 	 	ENTPD4	1	
Cell-To-Cell Signaling and Interaction	mitogenic response	Mitogenic response of tumor cell lines	1.04E-02	 	 	 	 	EMP3	1	
Cellular Assembly and Organization, Tissue Development	morphogenesis	Morphogenesis of tubules	1.04E-02	 	 	 	 	MAP2K6	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Organismal Development, Tissue Development	neurogenesis	Neurogenesis of neuronal progenitor cells	1.04E-02	 	 	 	 	GZMB	1	
Organismal Injury and Abnormalities	non-cardiac chest pain	Non-cardiac chest pain	1.04E-02	 	 	 	 	CNR2	1	
Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities	opsoclonus-myoclonus syndrome	Opsoclonus-myoclonus syndrome	1.04E-02	 	 	 	 	SCNN1B	1	
Gastrointestinal Disease, Infectious Diseases, Organismal Injury and Abnormalities	oral candidiasis	Oral candidiasis	1.04E-02	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	paracoccidioidomycosis	Paracoccidioidomycosis	1.04E-02	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	pleomorphic mantle cell lymphoma	Pleomorphic mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	primary skin squamous cell carcinoma	Primary skin squamous cell carcinoma	1.04E-02	 	 	 	 	CD44	1	
Infectious Diseases, Organismal Injury and Abnormalities	quantity	Quantity of Theiler's encephalomyelitis virus	1.04E-02	 	 	 	 	IFIT3	1	
Infectious Diseases, Organismal Injury and Abnormalities	quantity	Quantity of Vesicular stomatitis Indiana virus	1.04E-02	 	 	 	 	IFIT3	1	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	rectosigmoid adenocarcinoma	Rectosigmoid adenocarcinoma	1.04E-02	 	 	 	 	PDK4	1	
Connective Tissue Disorders, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	recurrent immune thrombocytopenic purpura	Recurrent immune thrombocytopenic purpura	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive Burkitt lymphoma	Refractory CD20 positive Burkitt lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive primary mediastinal diffuse large B-cell lymphoma	Refractory CD20 positive primary mediastinal diffuse large B-cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	chromoblastomycosis	Refractory chromoblastomycosis	1.04E-02	 	 	 	 	CYP51A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	coccidioidomycosis	Refractory coccidioidomycosis	1.04E-02	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive Burkitt lymphoma	Relapsed CD20 positive Burkitt lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive primary mediastinal diffuse large B-cell lymphoma	Relapsed CD20 positive primary mediastinal diffuse large B-cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Dermatological Diseases and Conditions, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities	Setleis syndrome	Setleis syndrome	1.04E-02	 	 	 	 	POSTN	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	microscopic polyangiitis	Severe microscopic polyangiitis	1.04E-02	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	mycosis	Severe mycosis	1.04E-02	 	 	 	 	CYP51A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	small cleaved-cell follicular lymphoma	Small cleaved-cell follicular lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	invasive ductal breast cancer	Stage I invasive ductal breast cancer	1.04E-02	 	 	 	 	CD44	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD19 positive mantle cell lymphoma	Stage II CCND1 positive CD19 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD20 positive mantle cell lymphoma	Stage II CCND1 positive CD20 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD5 positive mantle cell lymphoma	Stage II CCND1 positive CD5 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	PAX5 positive cyclin D1 positive mantle cell lymphoma	Stage II PAX5 positive cyclin D1 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD19 positive mantle cell lymphoma	Stage III CCND1 positive CD19 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD20 positive mantle cell lymphoma	Stage III CCND1 positive CD20 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD5 positive mantle cell lymphoma	Stage III CCND1 positive CD5 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	PAX5 positive cyclin D1 positive mantle cell lymphoma	Stage III PAX5 positive cyclin D1 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD19 positive mantle cell lymphoma	Stage IV CCND1 positive CD19 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD20 positive mantle cell lymphoma	Stage IV CCND1 positive CD20 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CCND1 positive CD5 positive mantle cell lymphoma	Stage IV CCND1 positive CD5 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	PAX5 positive cyclin D1 positive mantle cell lymphoma	Stage IV PAX5 positive cyclin D1 positive mantle cell lymphoma	1.04E-02	 	 	 	 	MS4A1	1	
Lipid Metabolism, Small Molecule Biochemistry	synthesis	Synthesis of leukotriene D4	1.04E-02	 	 	 	 	GGT5	1	
Molecular Transport	translocation	Translocation of chloride	1.04E-02	 	 	 	 	ANO1	1	
Neurological Disease, Organismal Injury and Abnormalities	neurological disorder	Progressive neurological disorder	1.05E-02	 	 	 	 	PDCD1LG2,PHGDH,RSAD2,IFIT1,ZBTB16,ITLN1,CASS4,CCN2,ANKRD55,GZMB,SKAP2,OTOF,CD69,SLC1A7,SQLE,ANO1,COL28A1,ISG15,P2RY13,IRF4,FHL3,MS4A1,OASL,FDFT1,SORD,CNR2,PDK4,CD44,TUBB4B,UBXN11,ZNF366	31	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	adult leukemia	Adult leukemia	1.05E-02	 	 	 	 	MS4A1,CCR7,IRF4,TUBB4B	4	
Cancer, Organismal Injury and Abnormalities	osteogenic neoplasm	Osteogenic neoplasm	1.05E-02	 	 	 	 	POSTN,ANO1,FETUB,SCNN1B,CCN2,FDFT1,HS3ST3A1,PDK4,CD44,TUBB4B,RFTN1	11	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	brain glioma formation	Brain glioma	1.05E-02	 	 	 	 	TNNC2,PDCD1LG2,FABP6,NMNAT2,CLDN3,IFIT1,SFRP1,CASS4,CLCA1,DMRTC2,PPP1R16B,CTSG,OTOF,CD69,SLC1A7,SIGLEC6,P2RY13,FHL3,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,PRDX5,IL31RA,FETUB,PCDHA12,SLC27A3,CRYBA1,CCR3,RFTN1,MCOLN2,MAPKAPK3,PHGDH,DENND2D,SLC26A4,DOK2,ZBTB16,LRRC32,SAMD3,BAIAP3,ANKRD55,IFIT2,HS3ST3A1,SHISA2,SQLE,ANO1,COL28A1,TPSAB1,PER1,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,HEPH,MS4A1,NAIF1,HSD11B2,PTGDR2,ITIH5,LGALS12,IFT74,CISH,ENTPD4,PDK4,WEE1,POSTN,IFIT3,CLCNKB,SLC9A3,SCNN1B,CRISP2	73	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive T-cell/histiocyte rich diffuse large B-cell lymphoma	CD20 positive T-cell/histiocyte rich diffuse large B-cell lymphoma	1.08E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD274 positive non-Hodgkin lymphoma	CD274 positive non-Hodgkin lymphoma	1.08E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cellular Assembly and Organization, Cellular Function and Maintenance	depolarization	Depolarization of mitochondrial membrane	1.08E-02	 	 	 	 	ITLN1,GZMB	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma transformed from follicular lymphoma	Diffuse large B-cell lymphoma transformed from follicular lymphoma	1.08E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	gastric mucosa-associated lymphoid tissue lymphoma	Gastric mucosa-associated lymphoid tissue lymphoma	1.08E-02	 	 	 	 	MS4A1,TUBB4B	2	
Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	abnormal bone density	Abnormal bone density	1.08E-02	 	 	 	 	TNNC2,SLC1A7,CLCNKB,ANO1,CCN2,FDFT1,CNR2	7	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking	binding	Binding of granulocytes	1.08E-02	 	 	 	 	CCR3,CD44,CTSG	3	
Organismal Injury and Abnormalities, Respiratory Disease	respiratory distress	Respiratory distress	1.11E-02	 	 	 	 	CCR7,CLC,CYP51A1,CEBPE,CTSG,TUBB4B	6	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Philadelphia-positive acute lymphoblastic leukemia	Philadelphia-positive acute lymphoblastic leukemia	1.11E-02	 	 	 	 	MS4A1,PDK4,TUBB4B	3	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	myeloid or lymphoid neoplasm	Myeloid or lymphoid neoplasm	1.14E-02	 	 	 	 	CCR7,PDCD1LG2,RSAD2,CCL18,IFIT1,CLCA1,OR52M1,PPP1R16B,CTSG,SYT2,TESPA1,SPIB,P2RY10,OTOF,CD69,FHL3,BTNL8,CLC,OASL,ADAM19,SORD,TUBB4B,TRAF5,PIP4K2A,UBXN11,IL31RA,FETUB,PCDHA12,CCR3,RFTN1,PHGDH,MMP12,ZBTB16,BAIAP3,ANKRD55,IFIT2,GZMB,ANO1,PER1,ISG15,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,MS4A1,ITIH5,IFT74,FDFT1,PDK4,WEE1,CD44,CLEC12A,POSTN,GGT5,IFIT3,CYP51A1,CRISP2	58	
Inflammatory Disease, Organismal Injury and Abnormalities, Respiratory Disease	vasomotor rhinitis	Vasomotor rhinitis	1.15E-02	 	 	 	 	PTGDR2,HRH4	2	
Cell-To-Cell Signaling and Interaction, Renal and Urological System Development and Function	binding	Binding of kidney cell lines	1.15E-02	 	 	 	 	POSTN,HRH4,CD44	3	
Endocrine System Disorders, Gastrointestinal Disease, Immunological Disease, Metabolic Disease, Organismal Injury and Abnormalities	insulin-dependent diabetes mellitus	Insulin-dependent diabetes mellitus	1.15E-02	 	 	 	 	MS4A1,CD69,NMNAT2,IRF4,ANKRD55,SKAP2	6	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	invasive breast cancer	Invasive breast cancer	1.16E-02	 	 	 	 	POSTN,CCR7,SQLE,DOK2,OASL,CLDN3,SFRP1,FDFT1,PDK4,CD44,TUBB4B	11	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	uterine cancer	Uterine cancer	1.16E-02	 	 	 	 	CCR7,PDCD1LG2,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,NRROS,BTNL8,OASL,GAS1,ADAM19,TUBB4B,TRAF5,IL31RA,PCDHA12,MAP2K6,CCR3,ZNF157,MCOLN2,PHGDH,WDR93,DOK2,MMP12,ZBTB16,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,VSTM1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,HSD11B2,EMP3,ITIH5,IFT74,FDFT1,CNR2,CD44,CLEC12A,IFIT3,GAPT,ZNF366,DYDC1,XCR1	55	
Carbohydrate Metabolism	catabolism	Catabolism of carbohydrate	1.18E-02	 	 	 	 	POSTN,SORD,CD44	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	HER2 negative hormone receptor negative breast cancer	HER2 negative hormone receptor negative breast cancer	1.19E-02	 	 	 	 	POSTN,RSAD2,GAS1,SFRP1,CCN2,SORD,PDK4,WEE1,TUBB4B	9	
Neurological Disease, Organismal Injury and Abnormalities	progressive motor neuropathy	Progressive motor neuropathy	1.20E-02	 	 	 	 	MS4A1,PHGDH,RSAD2,IFIT1,ITLN1,FDFT1,ANKRD55,CNR2,PDK4,CD44,GZMB,SKAP2,CD69,SLC1A7,SQLE,ISG15,IRF4,FHL3	18	
Digestive System Development and Function, Gastrointestinal Disease, Hepatic System Development and Function, Hepatic System Disease, Inflammatory Disease, Inflammatory Response, Metabolic Disease, Organ Development, Organismal Injury and Abnormalities	steatohepatitis	Steatohepatitis	1.21E-02	 	 	 	 	IFIT3,ISG15,IFIT2,CCR3	4	
Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	bullous pemphigoid	Bullous pemphigoid	1.22E-02	 	 	 	 	MS4A1,GZMB	2	
Inflammatory Disease, Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities	Devic syndrome	Devic syndrome	1.22E-02	 	 	 	 	MS4A1,CD69	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Hodgkin lymphoma	Relapsed Hodgkin lymphoma	1.22E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	metastatic renal cancer	Metastatic renal cancer	1.22E-02	 	 	 	 	SFRP1,FDFT1,TUBB4B	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	Indolent non-Hodgkin lymphoma	1.25E-02	 	 	 	 	POSTN,MS4A1,ITIH5,ANO1,PER1,PCDHA12,IRF4,CD44,TUBB4B,RFTN1	10	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	inborn error of metabolism	Autosomal recessive inborn error of metabolism	1.26E-02	 	 	 	 	SLC9A3,PER1,CYP51A1,SCNN1B,FDFT1,CTSG	6	
Organismal Injury and Abnormalities	acute disease	Acute disease	1.27E-02	 	 	 	 	CCR7,PDCD1LG2,PHGDH,IFIT1,CCN2,ANKRD55,IFIT2,CLCA1,CTSG,SYT2,GZMB,TESPA1,P2RY10,OTOF,SLC9B2,HRH4,IRF4,CEBPE,RASGRP3,BTNL8,MS4A1,ITIH5,CLC,IFT74,FDFT1,PDK4,WEE1,CD44,TUBB4B,TRAF5,PIP4K2A,CLEC12A,POSTN,GGT5,SLC9A3,IL31RA,CDH26,FETUB,PCDHA12,CYP51A1,CRISP2,MAP2K6,CCR3	43	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease	testicular cancer	Testicular cancer	1.29E-02	 	 	 	 	MS4A1,IRF4,HS3ST3A1,TUBB4B	4	
Organismal Injury and Abnormalities, Respiratory Disease	bronchiectasis	Bronchiectasis	1.29E-02	 	 	 	 	CYP51A1,SCNN1B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	Stage IIIA breast cancer	1.29E-02	 	 	 	 	FDFT1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities	metastasis	Metastasis	1.30E-02	 	 	 	 	TNNC2,MS4A1,CCR7,CLDN3,CST1,SFRP1,CCN2,FDFT1,CD44,TUBB4B,HRH4,CYP51A1,IRF4	13	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	primary central nervous system cancer	Primary central nervous system cancer	1.31E-02	 	 	 	 	MS4A1,SAMD3,SORD,TUBB4B	4	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of blood cells	1.32E-02	 	1.330	 	1.756	MS4A1,CCR3,CD44,CTSG,GZMB	5	
Cell Death and Survival, Organismal Injury and Abnormalities	apoptosis	Apoptosis of leukocyte cell lines	1.33E-02	 	 	 	 	MS4A1,CD69,IRF4	3	
Cancer, Organismal Injury and Abnormalities	subcutaneous tumor	Subcutaneous tumor	1.33E-02	 	 	 	 	POSTN,MS4A1,IFIT3,IFIT1,SFRP1,PDK4,WEE1,CD44,TUBB4B	9	
Gastrointestinal Disease, Inflammatory Disease, Organismal Injury and Abnormalities	Crohn disease	Crohn disease	1.37E-02	 	 	 	 	DOK2,ITLN1,CYP51A1,FDFT1,LRRC32,ANKRD55,CD44,SKAP2	8	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of chronic lymphocytic leukemia cells	1.37E-02	 	 	 	 	MS4A1,CD44	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	differentiation	Differentiation of CD34+ cells	1.37E-02	 	 	 	 	CEBPE,SPIB	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	TP53 mutation positive lymphoma	TP53 mutation positive lymphoma	1.37E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	HER2-positive carcinoma of breast	HER2-positive carcinoma of breast	1.37E-02	 	 	 	 	CLCNKB,LRRC32,OR52M1,TUBB4B,PIP4K2A	5	
Cancer, Organismal Injury and Abnormalities	cancer	Stage III cancer	1.37E-02	 	 	 	 	MS4A1,SQLE,MMP12,FDFT1,TUBB4B	5	
Cell Death and Survival, Organismal Injury and Abnormalities	cell death	Cell death of lymphocytes	1.39E-02	 	 	 	 	MS4A1,CLC,ZBTB16,GZMB	4	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	histiocytosis	Histiocytosis	1.39E-02	 	 	 	 	MS4A1,MMP12,IL22RA2,TUBB4B	4	
Cancer, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	leiomyosarcoma	Leiomyosarcoma	1.41E-02	 	 	 	 	POSTN,CD44,TUBB4B	3	
Organismal Injury and Abnormalities	pulmonary fibrosis or aplastic anemia	Pulmonary fibrosis or aplastic anemia	1.44E-02	 	 	 	 	POSTN,MS4A1,PHGDH,CCL18,P2RY13,CYP51A1,CCN2,SAMD3,CD44	9	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	plasma cell myeloma	Plasma cell myeloma	1.44E-02	 	 	 	 	MS4A1,PDCD1LG2,UBXN11,IFIT3,IRF4,FDFT1,IFIT2,CD44,CTSG,TUBB4B,TRAF5	11	
Cellular Movement, Embryonic Development	cell movement	Cell movement of embryonic cell lines	1.44E-02	 	 	 	 	POSTN,HSD11B2,PTGDR2,CCR3	4	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	diffuse large B-cell lymphoma associated with chronic inflammation	Diffuse large B-cell lymphoma associated with chronic inflammation	1.45E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities, Tumor Morphology	upper gastrointestinal tract tumor	Progressive upper gastrointestinal tract tumor	1.45E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cellular Development, Cellular Growth and Proliferation, Reproductive System Development and Function	proliferation	Proliferation of prostate cell lines	1.45E-02	 	 	 	 	SFRP1,PDK4	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	TP53 mutation negative lymphoma	TP53 mutation negative lymphoma	1.45E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	TP53 mutation negative malignant hematological tumor	TP53 mutation negative malignant hematological tumor	1.45E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	metastatic skin cancer	Metastatic skin cancer	1.45E-02	 	 	 	 	CLDN3,CD44,TUBB4B	3	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Metabolic Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	gout	Gout	1.48E-02	 	 	 	 	PHGDH,RSAD2,CCL18,UBXN11,CTSG,TUBB4B,ARL15	7	
Immunological Disease, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	myasthenia gravis	Myasthenia gravis	1.49E-02	 	 	 	 	MS4A1,CD44,SPIB	3	
Organismal Injury and Abnormalities	pathological cyst	Pathological cyst	1.49E-02	 	 	 	 	ANO1,IRF4,CD44	3	
Cancer, Ophthalmic Disease, Organismal Injury and Abnormalities	malignant neoplasm of eye	Malignant neoplasm of eye	1.50E-02	 	 	 	 	PDCD1LG2,CYP51A1,IRF4,TUBB4B	4	
Cancer, Organismal Injury and Abnormalities	advanced malignant tumor	Advanced malignant tumor	1.50E-02	 	 	 	 	TNNC2,MS4A1,CCR7,CLDN3,CST1,ITLN1,SFRP1,CCN2,FDFT1,CD44,TUBB4B,HRH4,CYP51A1,IRF4	14	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	bladder carcinoma	Bladder carcinoma	1.51E-02	 	 	 	 	PDCD1LG2,PHGDH,DENND2D,FABP6,DOK2,CST1,SFRP1,CCN2,BAIAP3,IFIT2,CLCA1,VSTM1,GZMB,OTOF,SLC1A7,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,P2RY13,FHL3,RASGRP3,NRROS,BTNL8,HEPH,MS4A1,ITIH5,HOXA3,ADAM19,FDFT1,ENTPD4,PDK4,CD44,TUBB4B,CLEC12A,POSTN,GGT5,CLCNKB,IL31RA,FETUB,PCDHA12,SCNN1B,SLC27A3,CRYBA1,MAP2K6,TASL	47	
Cellular Movement	chemotaxis	Chemotaxis	1.52E-02	Decreased	-2.369	bias	-1.696	CCR7,PTGDR2,CCL18,CCR3,CD44,CTSG,XCR1	7	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	invasive breast adenocarcinoma	Invasive breast adenocarcinoma	1.52E-02	 	 	 	 	POSTN,SQLE,DOK2,OASL,PDK4,CD44,TUBB4B	7	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	ALK fusion negative T-cell lymphoma	ALK fusion negative T-cell lymphoma	1.53E-02	 	 	 	 	MS4A1,TUBB4B	2	
Nutritional Disease, Organismal Injury and Abnormalities, Psychological Disorders	anorexia	Anorexia	1.53E-02	 	 	 	 	CNR2,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive B-cell acute lymphocytic leukemia	CD20 positive B-cell acute lymphocytic leukemia	1.53E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive precursor B-cell acute lymphoblastic leukemia	CD20 positive precursor B-cell acute lymphoblastic leukemia	1.53E-02	 	 	 	 	MS4A1,TUBB4B	2	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	oligoarticular juvenile idiopathic arthritis	Oligoarticular juvenile idiopathic arthritis	1.53E-02	 	 	 	 	ANKRD55,CCR3	2	
Cell Death and Survival, Cellular Compromise	cytotoxicity	Cytotoxicity of lymphocytes	1.53E-02	 	 	 	 	CD69,CLEC12B,CCR3	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital tract adenocarcinoma	Female genital tract adenocarcinoma	1.54E-02	 	 	 	 	CCR7,FABP6,NMNAT2,CLDN3,SFRP1,CASS4,OTOF,SLC1A7,NRROS,BTNL8,GAS1,ADAM19,TUBB4B,TRAF5,PIP4K2A,IL31RA,PCDHA12,CRYBA1,MAP2K6,CCR3,ZNF157,MCOLN2,DOK2,MMP12,ZBTB16,ITLN1,SAMD3,BAIAP3,ANKRD55,HS3ST3A1,GZMB,ARL15,SQLE,ANO1,COL28A1,TPSAB1,ISG15,SLC9B2,HRH4,IRF4,RASGRP3,HEPH,ITIH5,IFT74,FDFT1,PDK4,CD44,CLEC12A,POSTN,GGT5,IFIT3,GAPT,ZNF366,DYDC1,XCR1	55	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	17p deletion negative small B cell lymphocytic lymphoma	17p deletion negative small B cell lymphocytic lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	17p deletion positive CD20 positive chronic lymphocytic leukemia	17p deletion positive CD20 positive chronic lymphocytic leukemia	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	17p deletion positive small lymphocytic lymphoma	17p deletion positive small lymphocytic lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Connective Tissue Disorders, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Charcot neuroarthropathy of foot	Active stage Charcot neuroarthropathy of foot	1.56E-02	 	 	 	 	FDFT1	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	Wegener granulomatosis	Active stage Wegener granulomatosis	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Cell-To-Cell Signaling and Interaction, Organismal Injury and Abnormalities	adhesion	Adhesion of chronic lymphocytic leukemia cells	1.56E-02	 	 	 	 	CD44	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of monocyte-derived dendritic cells	1.56E-02	 	 	 	 	CD44	1	
Gastrointestinal Disease, Hepatic System Disease, Metabolic Disease, Organismal Injury and Abnormalities	hepatic steatosis	Advanced stage hepatic steatosis	1.56E-02	 	 	 	 	CD44	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	relapsed chronic lymphocytic leukemia	Advanced stage relapsed chronic lymphocytic leukemia	1.56E-02	 	 	 	 	MS4A1	1	
Cell Death and Survival	antiapoptosis	Antiapoptosis of stomach cancer cell lines	1.56E-02	 	 	 	 	CD44	1	
Cell Death and Survival, Organismal Injury and Abnormalities	apoptosis	Apoptosis of mucosal-associated invariant T lymphocytes	1.56E-02	 	 	 	 	ZBTB16	1	
Cell Cycle	G2/M phase transition	Arrest in G2/M phase transition of cervical cancer cell lines	1.56E-02	 	 	 	 	MAP2K6	1	
Cell Cycle	G2/M phase transition	Arrest in G2/M phase transition of sarcoma cell lines	1.56E-02	 	 	 	 	MAP2K6	1	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	combined immunodeficiency	Autosomal dominant combined immunodeficiency	1.56E-02	 	 	 	 	IRF4	1	
Auditory Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive deafness type 4	Autosomal recessive deafness type 4	1.56E-02	 	 	 	 	SLC26A4	1	
Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	neurometabolic disorder due to serine deficiency	Autosomal recessive neurometabolic disorder due to serine deficiency	1.56E-02	 	 	 	 	PHGDH	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	autosomal recessive pseudohypoaldosteronism type IB1	Autosomal recessive pseudohypoaldosteronism type IB1	1.56E-02	 	 	 	 	SCNN1B	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities	avellino corneal dystrophy	Avellino corneal dystrophy	1.56E-02	 	 	 	 	POSTN	1	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	B- and T-/NK-cell type monomorphic post-transplant lymphoproliferative disorder	B- and T-/NK-cell type monomorphic post-transplant lymphoproliferative disorder	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Cell-To-Cell Signaling and Interaction, Organismal Injury and Abnormalities	binding	Binding of chronic B-cell lymphocytic leukemia cells	1.56E-02	 	 	 	 	CD44	1	
Cardiovascular System Development and Function, Cell-To-Cell Signaling and Interaction	binding	Binding of high endothelial postcapillary venule	1.56E-02	 	 	 	 	CD44	1	
Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	bone resorption disorder	Bone resorption disorder	1.56E-02	 	 	 	 	FDFT1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive indolent marginal zone cell lymphoma	CD20 positive indolent marginal zone cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD20 positive lymphoplasmacytoid lymphoma	CD20 positive lymphoplasmacytoid lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD5 positive CD19 positive CD20 positive chronic lymphocytic leukemia	CD5 positive CD19 positive CD20 positive chronic lymphocytic leukemia	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	CD5 positive CD20 positive small B-cell lymphocytic lymphoma	CD5 positive CD20 positive small B-cell lymphocytic lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Infectious Diseases, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Reproductive System Disease	candidal vulvovaginitis	Candidal vulvovaginitis	1.56E-02	 	 	 	 	CYP51A1	1	
Cellular Movement, Hematological System Development and Function, Hematopoiesis	cell rolling	Cell rolling of hematopoietic cells	1.56E-02	 	 	 	 	CD44	1	
Cell Morphology, Cellular Movement	cell spreading	Cell spreading of lung cancer cell lines	1.56E-02	 	 	 	 	CASS4	1	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	chemotaxis	Chemotaxis by myeloid dendritic cells	1.56E-02	 	 	 	 	CCR7	1	
Carbohydrate Metabolism, Drug Metabolism, Small Molecule Biochemistry	cleavage	Cleavage of hyaluronic acid	1.56E-02	 	 	 	 	CD44	1	
Dermatological Diseases and Conditions, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	dandruff	Dandruff	1.56E-02	 	 	 	 	CYP51A1	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	depletion	Depletion of acetyl-coenzyme A	1.56E-02	 	 	 	 	PDK4	1	
Cellular Growth and Proliferation	doubling time	Doubling time of tumor cell lines	1.56E-02	 	 	 	 	PIP4K2A	1	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities, Reproductive System Disease	external vulvar pruritus	External vulvar pruritus	1.56E-02	 	 	 	 	CYP51A1	1	
Cellular Assembly and Organization, Organismal Development, Skeletal and Muscular System Development and Function, Tissue Development	formation	Formation of myosin stress fibers	1.56E-02	 	 	 	 	POSTN	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	indolent marginal zone cell lymphoma	Grade 1-3A indolent marginal zone cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Organ Development, Reproductive System Development and Function	growth	Growth of prostate gland	1.56E-02	 	 	 	 	SFRP1	1	
Connective Tissue Disorders, Developmental Disorder, Gastrointestinal Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	holoprosencephaly-1	Holoprosencephaly-1	1.56E-02	 	 	 	 	GAS1	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection by Giardia	1.56E-02	 	 	 	 	TUBB4B	1	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Invasive infection	1.56E-02	 	 	 	 	CYP51A1	1	
Organismal Injury and Abnormalities	irritation	Irritation	1.56E-02	 	 	 	 	CYP51A1	1	
Cell Death and Survival	killing	Killing of pancreatic cancer cell lines	1.56E-02	 	 	 	 	PDK4	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	low-grade CD19 positive B-cell lymphoma	Low-grade CD19 positive B-cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Developmental Disorder, Organismal Injury and Abnormalities	low-grade squamous intraepithelial lesion	Low-grade squamous intraepithelial lesion	1.56E-02	 	 	 	 	MMP12	1	
Cellular Development, Hematological System Development and Function, Lymphoid Tissue Structure and Development	maturation	Maturation of Langerhans cells	1.56E-02	 	 	 	 	MAP2K6	1	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	metastatic skin squamous cell carcinoma	Metastatic skin squamous cell carcinoma	1.56E-02	 	 	 	 	CD44	1	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	migration	Migration of Th2 cells	1.56E-02	 	 	 	 	CCL18	1	
Cellular Movement, Connective Tissue Development and Function, Hepatic System Development and Function	migration	Migration of hepatic stellate cells	1.56E-02	 	 	 	 	CCR7	1	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	migration	Migration of naive T lymphocytes	1.56E-02	 	 	 	 	CCR7	1	
Organismal Injury and Abnormalities, Renal and Urological Disease	obstructive nephropathy	Obstructive nephropathy	1.56E-02	 	 	 	 	COL28A1	1	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	osteoid osteoma	Osteoid osteoma	1.56E-02	 	 	 	 	FDFT1	1	
Hematological Disease, Immunological Disease, Infectious Diseases, Organismal Injury and Abnormalities	plasmacytic hyperplasia post-transplant lymphoproliferative disorder	Plasmacytic hyperplasia post-transplant lymphoproliferative disorder	1.56E-02	 	 	 	 	IRF4	1	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous anaplastic large cell lymphoma	Primary cutaneous anaplastic large cell lymphoma	1.56E-02	 	 	 	 	IRF4	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Tumor Morphology	gastric marginal zone B cell lymphoma	Progressive gastric marginal zone B cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Refractory lymphoplasmacytic lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	17p deletion negative chronic lymphocytic leukemia	Relapsed 17p deletion negative chronic lymphocytic leukemia	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoplasmacytic lymphoma	Relapsed lymphoplasmacytic lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Connective Tissue Disorders, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	secondary hypertrophic osteoarthropathy	Secondary hypertrophic osteoarthropathy	1.56E-02	 	 	 	 	IRF4	1	
Cell Death and Survival, Cellular Development, Cellular Function and Maintenance	self-renewal	Self-renewal of squamous cell carcinoma cell lines	1.56E-02	 	 	 	 	CD44	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	Wegener granulomatosis	Severe Wegener granulomatosis	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Organismal Injury and Abnormalities	small cell adenocarcinoma	Small cell adenocarcinoma	1.56E-02	 	 	 	 	CLCNKB	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	gastric marginal zone B cell lymphoma	Stage I-IIE gastric marginal zone B cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	chronic lymphocytic leukemia	Stage III-IV chronic lymphocytic leukemia	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	gastric marginal zone B cell lymphoma	Stage IV gastric marginal zone B cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-gastric extranodal marginal zone lymphoma	Stage IV non-gastric extranodal marginal zone lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	superficial papillary bladder carcinoma	Superficial papillary bladder carcinoma	1.56E-02	 	 	 	 	CD44	1	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	gastric marginal zone B cell lymphoma	Symptomatic stage gastric marginal zone B cell lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-gastric extranodal marginal zone lymphoma	Symptomatic stage non-gastric extranodal marginal zone lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	refractory chronic lymphocytic leukemia	Symptomatic stage refractory chronic lymphocytic leukemia	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	splenic marginal zone lymphoma	Symptomatic stage splenic marginal zone lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	TP53 mutation negative small B-cell lymphocytic lymphoma	TP53 mutation negative small B-cell lymphocytic lymphoma	1.56E-02	 	 	 	 	MS4A1	1	
Infectious Diseases, Organismal Injury and Abnormalities	trichuriasis	Trichuriasis	1.56E-02	 	 	 	 	TUBB4B	1	
Endocrine System Disorders, Hematological Disease, Organismal Injury and Abnormalities	tumor-induced hypercalcemia	Tumor-induced hypercalcemia	1.56E-02	 	 	 	 	FDFT1	1	
Hair and Skin Development and Function, Hereditary Disorder, Organismal Injury and Abnormalities	variation in skin/hair/eye pigmentation 1	Variation in skin/hair/eye pigmentation 1	1.56E-02	 	 	 	 	IRF4	1	
Cancer, Organismal Injury and Abnormalities	squamous cell carcinoma of the non-oropharynx	Squamous cell carcinoma of the non-oropharynx	1.57E-02	 	 	 	 	PDCD1LG2,RSAD2,CCL18,WDR93,MMP12,SFRP1,CCN2,HS3ST3A1,TESPA1,OTOF,ISG15,IRF4,RASGRP3,NRROS,ITIH5,ADAM19,FDFT1,CD44,TUBB4B,UBXN11,CDH26,PCDHA12,SCNN1B,DYDC1	24	
Gastrointestinal Disease, Hepatic System Disease, Metabolic Disease, Organismal Injury and Abnormalities	hepatic steatosis	Hepatic steatosis	1.59E-02	 	 	 	 	IFIT3,ISG15,FDFT1,IFIT2,CCR3,CD44,ARL15	7	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	dysglobulinemia	Dysglobulinemia	1.59E-02	 	 	 	 	MS4A1,IL31RA,CYP51A1,IRF4,ANKRD55	5	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	prostate cancer	Prostate cancer	1.59E-02	 	 	 	 	CCR7,RSAD2,SLC26A4,WDR93,ZBTB16,SFRP1,LRRC32,SAMD3,BAIAP3,IFIT2,SYT2,GZMB,SPIB,OTOF,CD69,SQLE,COL28A1,SIGLEC6,TPSAB1,PER1,ISG15,P2RY13,FHL3,CD1B,RASGRP3,HEPH,ITIH5,LGALS12,HOXA3,FDFT1,PDK4,LGALS7B,CD44,TUBB4B,TRAF5,PIP4K2A,GGT5,UBXN11,CLCNKB,PRDX5,RRAGB,FETUB,PCDHA12,CYP51A1,ZNF366,CCR3	46	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	ALK fusion negative large cell lymphoma	ALK fusion negative large cell lymphoma	1.61E-02	 	 	 	 	MS4A1,TUBB4B	2	
Endocrine System Disorders, Organismal Injury and Abnormalities, Renal and Urological Disease	hypercalciuria	Hypercalciuria	1.61E-02	 	 	 	 	CYP51A1,CD44	2	
Cellular Movement	migration	Migration of lymphoma cell lines	1.61E-02	 	 	 	 	MS4A1,CCR7	2	
Cancer, Organismal Injury and Abnormalities	serous papillary carcinoma	Serous papillary carcinoma	1.61E-02	 	 	 	 	PDK4,TUBB4B	2	
Cell Signaling, Cellular Function and Maintenance, Molecular Transport, Vitamin and Mineral Metabolism	store-operated calcium influx	Store-operated calcium influx	1.61E-02	 	 	 	 	MS4A1,ANO1	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Tissue Development	differentiation	Differentiation of hematopoietic progenitor cells	1.61E-02	 	 	 	 	ZBTB16,SFRP1,CEBPE,SPIB	4	
Organismal Injury and Abnormalities, Renal and Urological Disease	kidney stones	Kidney stones	1.61E-02	 	 	 	 	CYP51A1,SCNN1B,CD44	3	
Cancer, Organismal Injury and Abnormalities	invasive cancer	Invasive cancer	1.61E-02	 	 	 	 	TNNC2,MS4A1,CCR7,DOK2,OASL,CLDN3,CST1,SFRP1,CCN2,FDFT1,PDK4,CD44,TUBB4B,POSTN,SQLE,HRH4,CYP51A1,IRF4	18	
Cell Cycle	interphase	Entry into interphase	1.65E-02	 	 	 	 	EMP3,ZBTB16,WEE1	3	
Organismal Injury and Abnormalities, Reproductive System Disease	abortion	Abortion	1.65E-02	 	 	 	 	CCR7,HSD11B2,P2RY13,IRF4,IFIT2,CD44	6	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of granulocytes	1.67E-02	 	-1.964	bias	-1.395	CCR7,PTGDR2,CCR3,CTSG	4	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Huntington disease	Huntington Disease	1.69E-02	 	 	 	 	TNNC2,OTOF,MAPKAPK3,SLC1A7,ZBTB16,CYP51A1,FDFT1,CNR2,CD44	9	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	BCL2 rearrangement positive BCL6 rearrangement positive MYC rearrangement positive B-cell lymphoma	BCL2 rearrangement positive BCL6 rearrangement positive MYC rearrangement positive B-cell lymphoma	1.69E-02	 	 	 	 	MS4A1,TUBB4B	2	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease	platinum-resistant recurrent ovarian cancer	Platinum-resistant recurrent ovarian cancer	1.69E-02	 	 	 	 	CYP51A1,TUBB4B	2	
Cancer, Ophthalmic Disease, Organismal Injury and Abnormalities	retinoblastoma formation	Retinoblastoma	1.69E-02	 	 	 	 	CYP51A1,TUBB4B	2	
Dermatological Diseases and Conditions, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	seborrheic dermatitis	Seborrheic dermatitis	1.69E-02	 	 	 	 	CYP51A1,IRF4	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	tongue squamous cell carcinoma	Tongue squamous cell carcinoma	1.69E-02	 	 	 	 	SFRP1,TUBB4B	2	

Tox Functions for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Liver Inflammation/Hepatitis, Liver Steatosis	alcoholic steatohepatitis	Alcoholic steatohepatitis	1.64E-05	 	 	 	 	IFIT3,ISG15,IFIT2	3	
Liver Inflammation/Hepatitis	alcoholic hepatitis	Severe alcoholic hepatitis	3.34E-04	 	 	 	 	IFIT3,ISG15,IFIT2	3	
Liver Hyperplasia/Hyperproliferation	cancer	Liver cancer	3.69E-04	 	 	 	 	FABP6,NMNAT2,IFIT1,SFRP1,CLCA1,PPP1R16B,TESPA1,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,GZMB,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	62	
Liver Hyperplasia/Hyperproliferation	liver carcinoma	Liver carcinoma	1.11E-03	 	 	 	 	FABP6,NMNAT2,IFIT1,SFRP1,CLCA1,PPP1R16B,TESPA1,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,SLC9B2,CEBPE,HEPH,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	59	
Liver Hyperplasia/Hyperproliferation	hepatosplenic T-cell lymphoma	Hepatosplenic T-cell lymphoma	1.20E-03	 	 	 	 	MS4A1,GZMB,TUBB4B	3	
Liver Hyperplasia/Hyperproliferation	liver tumor	Liver tumor	2.16E-03	 	 	 	 	FABP6,NMNAT2,IFIT1,SFRP1,CLCA1,PPP1R16B,TESPA1,OTOF,CD69,SLC1A7,SIGLEC6,BTNL8,OASL,ADAM19,SORD,TUBB4B,PIP4K2A,UBXN11,IL31RA,RRAGB,CDH26,FETUB,PCDHA12,CCR3,MCOLN2,PHGDH,DENND2D,SLC26A4,ZBTB16,ITLN1,LRRC32,IFIT2,GZMB,SHISA2,SQLE,ANO1,COL28A1,CLEC12B,TPSAB1,PER1,ISG15,SLC9B2,CEBPE,RASGRP3,HEPH,MS4A1,HSD11B2,PTGDR2,RGS18,ITIH5,IFT74,HOXA3,CISH,IGFLR1,FDFT1,PDK4,WEE1,CD44,POSTN,GGT5,IFIT3,SLC9A3,CYP51A1,ZNF366,XCR1	65	
Liver Hyperplasia/Hyperproliferation	hepatosplenic T-cell lymphoma	Ann Arbor stage I-IV hepatosplenic T-cell lymphoma	4.39E-03	 	 	 	 	MS4A1,TUBB4B	2	
Liver Inflammation/Hepatitis	chronic hepatitis C	High grade chronic hepatitis C	5.24E-03	 	 	 	 	CCR7	1	
Kidney Failure	nephrotoxic acute renal failure	Nephrotoxic acute renal failure	5.24E-03	 	 	 	 	SLC9A3	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	IgA nephropathy	Recurrent IgA nephropathy	5.24E-03	 	 	 	 	MS4A1	1	
Nephrosis	relapsing nephrotic syndrome	Relapsing nephrotic syndrome	5.24E-03	 	 	 	 	MS4A1	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Hepatocellular carcinoma	6.15E-03	 	 	 	 	PHGDH,SLC26A4,ZBTB16,ITLN1,SFRP1,PPP1R16B,CD69,SQLE,ANO1,COL28A1,CLEC12B,SIGLEC6,TPSAB1,PER1,CEBPE,HEPH,OASL,FDFT1,SORD,PDK4,WEE1,CD44,TUBB4B,POSTN,GGT5,IFIT3,CDH26,FETUB,PCDHA12,XCR1	30	
Liver Adhesion	adhesion	Adhesion of hepatic stellate cells	1.04E-02	 	 	 	 	CCN2	1	
Glomerular Injury	Fanconi renotubular syndrome with maturity-onset diabetes of the young type 4	Fanconi renotubular syndrome with maturity-onset diabetes of the young type 4	1.04E-02	 	 	 	 	SCNN1B	1	
Liver Inflammation/Hepatitis	chronic hepatitis C	Low grade chronic hepatitis C	1.04E-02	 	 	 	 	CCR7	1	
Liver Inflammation/Hepatitis, Liver Steatosis	steatohepatitis	Steatohepatitis	1.21E-02	 	 	 	 	IFIT3,ISG15,IFIT2,CCR3	4	
Liver Steatosis	hepatic steatosis	Advanced stage hepatic steatosis	1.56E-02	 	 	 	 	CD44	1	
Liver Fibrosis	migration	Migration of hepatic stellate cells	1.56E-02	 	 	 	 	CCR7	1	
Liver Steatosis	hepatic steatosis	Hepatic steatosis	1.59E-02	 	 	 	 	IFIT3,ISG15,FDFT1,IFIT2,CCR3,CD44,ARL15	7	
Kidney Failure, Renal Damage	ischemic acute renal failure	Ischemic acute renal failure	2.08E-02	 	 	 	 	SLC9A3	1	
Pulmonary Hypertension	pulmonary hypertensive arterial disease	Pulmonary hypertensive arterial disease	2.36E-02	 	 	 	 	POSTN,MS4A1,PTGDR2,GZMB	4	
Renal Damage	post-operative acute kidney injury	Post-operative acute kidney injury	2.59E-02	 	 	 	 	CDH26	1	
Cardiac Dysfunction	calcification	Calcification of aortic valve	2.88E-02	 	 	 	 	CCR7,MMP12,ITLN1,FETUB,PDK4,WEE1	6	
Renal Necrosis/Cell Death	cell death	Cell death of kidney cells	2.90E-02	 	-1.432	 	-1.166	EMP3,LGALS12,CCN2,FDFT1,MAP2K6,CD44	6	
Cardiac Dysfunction	ventricular dysfunction	Ventricular dysfunction	2.96E-02	 	 	 	 	CCR7,MMP12,ITLN1,FETUB,PDK4,WEE1,TUBB4B	7	
Glomerular Injury, Renal Inflammation, Renal Nephritis	membranoproliferative glomerulonephritis	Membranoproliferative glomerulonephritis	3.10E-02	 	 	 	 	MS4A1	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	4.00E-02	 	 	 	 	GGT5,SQLE,ANO1,FETUB,WEE1	5	
Renal Inflammation, Renal Nephritis	pyelonephritis	Pyelonephritis	4.11E-02	 	 	 	 	PER1	1	
Cardiac Dysfunction, Heart Failure	diastolic heart failure	Diastolic heart failure	4.62E-02	 	 	 	 	CCN2	1	
Liver Inflammation/Hepatitis	inflammation	Inflammation of liver	4.73E-02	 	 	 	 	CCR7,MAPKAPK3,IFIT3,ISG15,IFIT2,CCR3	6	
Nephrosis	childhood nephrotic syndrome	Childhood nephrotic syndrome	5.61E-02	 	 	 	 	MS4A1	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	IgA nephropathy	Primary IgA nephropathy	5.61E-02	 	 	 	 	MS4A1	1	
Kidney Failure	chronic renal failure	Chronic renal failure	5.85E-02	 	 	 	 	TNNC2,SLC9A3,CYP51A1	3	
Glomerular Injury, Renal Inflammation, Renal Nephritis	systemic lupus erythematosus nephritis class V	Active stage systemic lupus erythematosus nephritis class V	6.11E-02	 	 	 	 	MS4A1	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	lupus nephritis WHO class III/IV	Lupus nephritis WHO class III/IV	6.11E-02	 	 	 	 	MS4A1	1	
Nephrosis	steroid-resistant nephrotic syndrome	Steroid-resistant nephrotic syndrome	6.11E-02	 	 	 	 	MS4A1	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	diffuse proliferative lupus nephritis	Active stage diffuse proliferative lupus nephritis	6.60E-02	 	 	 	 	MS4A1	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	systemic lupus erythematosus nephritis class III	Active stage systemic lupus erythematosus nephritis class III	6.60E-02	 	 	 	 	MS4A1	1	
Kidney Failure	stage V chronic kidney disease	Stage V chronic kidney disease	6.60E-02	 	 	 	 	TNNC2	1	
Nephrosis	steroid dependent nephrotic syndrome	Steroid dependent nephrotic syndrome	6.60E-02	 	 	 	 	MS4A1	1	
Renal Necrosis/Cell Death	cell death	Cell death of kidney cell lines	7.02E-02	 	-1.980	 	-1.730	EMP3,LGALS12,FDFT1,MAP2K6,CD44	5	
Glomerular Injury, Renal Necrosis/Cell Death	apoptosis	Apoptosis of mesangial cells	7.09E-02	 	 	 	 	CCN2	1	
Cardiac Dysfunction	ventricular remodeling	Ventricular remodeling	7.58E-02	 	 	 	 	TUBB4B	1	
Liver Hyperplasia/Hyperproliferation	liver tumor	Child-Pugh class A liver tumor	7.63E-02	 	 	 	 	FDFT1,TUBB4B	2	
Liver Cirrhosis, Liver Fibrosis	primary biliary cirrhosis	Primary biliary cirrhosis	7.72E-02	 	 	 	 	CCR7,CCN2,SPIB	3	
Nephrosis	nephrosis	Idiopathic nephrosis	8.06E-02	 	 	 	 	MS4A1	1	
Liver Inflammation/Hepatitis	chronic hepatitis C	Chronic hepatitis C	8.40E-02	 	 	 	 	CCR7,MAPKAPK3	2	
Renal Damage	acute kidney injury	Acute kidney injury	9.35E-02	 	 	 	 	SLC9A3,CDH26	2	
Liver Hyperplasia/Hyperproliferation	small cell undifferentiated hepatoblastoma	Small cell undifferentiated hepatoblastoma	9.50E-02	 	 	 	 	TUBB4B	1	
Cardiac Necrosis/Cell Death	apoptosis	Apoptosis of cardiomyocytes	1.04E-01	 	 	 	 	MAP2K6	1	
Cardiac Arteriopathy	multi vessel coronary artery disease	Multi vessel coronary artery disease	1.04E-01	 	 	 	 	TUBB4B	1	
Cardiac Inflammation	inflammatory cardiomyopathy	Inflammatory cardiomyopathy	1.09E-01	 	 	 	 	TUBB4B	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	advanced hepatocellular carcinoma	BCLC stage C advanced hepatocellular carcinoma	1.14E-01	 	 	 	 	FDFT1	1	
Congenital Heart Anomaly	single ventricle defect	Single ventricle defect	1.14E-01	 	 	 	 	TUBB4B	1	
Cardiac Inflammation	acute myocarditis	Acute myocarditis	1.18E-01	 	 	 	 	TUBB4B	1	
Renal Proliferation	proliferation	Proliferation of mesangial cells	1.32E-01	 	 	 	 	CCR7	1	
Cardiac Arrythmia	paroxysmal atrial fibrillation	Paroxysmal atrial fibrillation	1.37E-01	 	 	 	 	TUBB4B	1	
Liver Hyperplasia/Hyperproliferation	advanced liver tumor	Advanced liver tumor	1.47E-01	 	 	 	 	FDFT1,TUBB4B	2	
Cardiac Inflammation	pericarditis	Pericarditis	1.50E-01	 	 	 	 	TUBB4B	1	
Pulmonary Hypertension	primary pulmonary hypertension	Primary pulmonary hypertension	1.52E-01	 	 	 	 	POSTN,PTGDR2	2	
Kidney Failure	end stage renal disease	End stage renal disease	1.54E-01	 	 	 	 	TNNC2,SLC9A3	2	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	advanced hepatocellular carcinoma	Child-Pugh class A advanced hepatocellular carcinoma	1.55E-01	 	 	 	 	FDFT1	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	idiopathic membranous nephropathy	Idiopathic membranous nephropathy	1.55E-01	 	 	 	 	MS4A1	1	
Liver Hyperplasia/Hyperproliferation	liver cholangiocarcinoma	Resectable liver cholangiocarcinoma	1.59E-01	 	 	 	 	TUBB4B	1	
Renal Hydronephrosis	hydronephrosis	Hydronephrosis	1.64E-01	 	 	 	 	XCR1	1	
Liver Hyperplasia/Hyperproliferation	liver cholangiocarcinoma	Child-Pugh class A liver cholangiocarcinoma	1.77E-01	 	 	 	 	TUBB4B	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	IgA nephropathy	IgA nephropathy	1.78E-01	 	 	 	 	MS4A1,ANKRD55	2	
Liver Fibrosis	fibrosis	Fibrosis of liver	1.90E-01	 	 	 	 	POSTN,CCR7,CCN2,SPIB	4	
Heart Failure	heart failure with preserved ejection fraction	Heart failure with preserved ejection fraction	1.94E-01	 	 	 	 	TUBB4B	1	
Renal Necrosis/Cell Death	apoptosis	Apoptosis of kidney cell lines	2.08E-01	 	 	 	 	LGALS12,MAP2K6,CD44	3	
Liver Hyperplasia/Hyperproliferation	liver metastasis	Liver metastasis	2.23E-01	 	 	 	 	CD44	1	
Liver Hyperplasia/Hyperproliferation	liver cholangiocarcinoma	Locally advanced liver cholangiocarcinoma	2.23E-01	 	 	 	 	TUBB4B	1	
Heart Failure	acute decompensated heart failure	Acute decompensated heart failure	2.27E-01	 	 	 	 	TUBB4B	1	
Cardiac Arrythmia	hereditary Wolff-Parkinson-White syndrome	Hereditary Wolff-Parkinson-White syndrome	2.27E-01	 	 	 	 	SLC26A4	1	
Cardiac Infarction	acute myocardial infarction	Acute myocardial infarction	2.39E-01	 	 	 	 	POSTN,TUBB4B	2	
Cardiac Arrythmia	persistent atrial fibrillation	Persistent atrial fibrillation	2.43E-01	 	 	 	 	TUBB4B	1	
Congenital Heart Anomaly	conotruncal heart malformations	Conotruncal heart malformations	2.47E-01	 	 	 	 	CTSG	1	
Cardiac Damage	cardiotoxicity	Cardiotoxicity	2.67E-01	 	 	 	 	TUBB4B	1	
Heart Failure	failure	Failure of heart	2.81E-01	 	 	 	 	ZBTB16,SCNN1B,CCN2,TUBB4B	4	
Liver Hyperplasia/Hyperproliferation	liver cholangiocarcinoma	Unresectable liver cholangiocarcinoma	3.15E-01	 	 	 	 	TUBB4B	1	
Liver Hyperplasia/Hyperproliferation	liver cholangiocarcinoma	Metastatic liver cholangiocarcinoma	3.19E-01	 	 	 	 	TUBB4B	1	
Cardiac Arteriopathy	disorder of coronary artery	Disorder of coronary artery	3.24E-01	 	 	 	 	OASL,SCNN1B,ADAM19,ANKRD55,CAPS2,TUBB4B,ARL15	7	
Liver Hyperplasia/Hyperproliferation	liver cholangiocarcinoma	Liver cholangiocarcinoma	3.60E-01	 	 	 	 	IFIT2,TUBB4B	2	
Cardiac Arrythmia	atrial flutter	Atrial flutter	3.71E-01	 	 	 	 	TUBB4B	1	
Cardiac Infarction	ST-elevation myocardial infarction	ST-elevation myocardial infarction	3.74E-01	 	 	 	 	TUBB4B	1	
Cardiac Infarction	myocardial infarction	Myocardial infarction	3.77E-01	 	 	 	 	POSTN,SCNN1B,CCR3,TUBB4B	4	
Cardiac Arteriopathy	coronary artery disease	Coronary artery disease	3.80E-01	 	 	 	 	OASL,ADAM19,ANKRD55,CAPS2,TUBB4B,ARL15	6	
Nephrosis	nephrosis	Nephrosis	3.90E-01	 	 	 	 	MS4A1,SCNN1B	2	
Liver Steatosis	nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	4.24E-01	 	 	 	 	FDFT1,CCR3,ARL15	3	
Renal Inflammation, Renal Nephritis	nephritis	Nephritis	4.63E-01	 	 	 	 	MS4A1,PER1,ANKRD55	3	
Cardiac Congestive Cardiac Failure, Heart Failure	congestive heart failure	Congestive heart failure	5.11E-01	 	 	 	 	SCNN1B	1	
Liver Inflammation/Hepatitis, Liver Steatosis	nonalcoholic steatohepatitis	Nonalcoholic steatohepatitis	5.63E-01	 	 	 	 	CCR3	1	
Cardiac Arrythmia	arrhythmia	Arrhythmia	1.00E00	 	 	 	 	SLC26A4,TUBB4B	2	
Renal Proliferation	cell proliferation	Cell proliferation of kidney cell lines	1.00E00	 	 	 	 	COL28A1	1	
Congenital Heart Anomaly	congenital heart disease	Congenital heart disease	1.00E00	 	 	 	 	CTSG,TUBB4B	2	
Cardiac Dilation, Cardiac Enlargement	dilated cardiomyopathy	Dilated cardiomyopathy	1.00E00	 	 	 	 	CD69	1	

Regulator Effects for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM

Networks for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
ID	Analysis	Molecules in Network	Score	Focus Molecules	Top Diseases and Functions	
1	nasal_5k_ipa - 2025-12-01 12:15 PM	ADAM19,CCR3,CISH,CLDN3,CNR2,ERK1/2,FABP6,HSP90 (family),IFIT1,IFIT2,IFIT3,IFN beta,IL31RA,IRF4,ISG15,ITLN1,MAP2K6,MID2,NFkB (complex),OASL,PCDHA12,PHGDH,PPP1R16B,RASGRP3,RFTN1,RSAD2,SFRP1,STAT5A/B,TASL,TCR (complex),TRIM66,WEE1,estrogen receptor,histone H3,interferon alpha	46	24	Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	
2	nasal_5k_ipa - 2025-12-01 12:15 PM	AKT,BCR (complex),CCN2,CCR7,CD1B,CD3 (complex),CD44,CD69,CTSG,EMP3,ERK,GZMB,IL12 (family),IgG,IgM,JAK,JNK,MMP12,MS4A1,PDGF-BB,PDK4,PI3K (family),PI3K p85,PIP4K2A,PKA,POSTN,RAB7,SORD,SPIB,SQLE,TEAD,TRAF5,ZBTB16,caspase 3/7,p38 MAPK	31	18	Connective Tissue Disorders, Inflammatory Disease, Organismal Injury and Abnormalities	
3	nasal_5k_ipa - 2025-12-01 12:15 PM	ACTA2,AMBP,ANO1,CAP1,CCR6,CLCA1,CST1,EOMES,FHL3,FOXA2,GAST,GLI1,GPX4,HAMP,HEPH,HIF1A,IFT74,IFT88,IL22RA2,ITIH5,MZF1,P2RY10,PER1,PRKCA,PTGDR2,RB1,RRAGB,SLC9A3,SMARCA4,SPRED1,SRF,TREM2,TRIM36,TUBB4B,USP48	22	14	Cellular Movement, Inflammatory Response, Organismal Injury and Abnormalities	
4	nasal_5k_ipa - 2025-12-01 12:15 PM	AGAP2-AS1,APOD,APOE,BAX,CACYBP,CAMK2G,CCND1,CDH26,CLC,CTHRC1,CTNNB1,CYP51A1,DDR2,ENTPD4,FOXL1,GNA15,LOX,MAPKAPK3,MAPT,NFIX,NMNAT2,P2RY13,PDCD1LG2,PYCR2,RNF213,SHISA2,SKAP2,SLC9B2,SNAI2,SOX11,STAT3,SULF2,TGM2,TNNC2,TWIST2	18	12	Organismal Injury and Abnormalities, Tissue Morphology, Cellular Development	
5	nasal_5k_ipa - 2025-12-01 12:15 PM	CCL18,CD2,CD5,DNMT3B,DOK1,DOK2,ERBB2,FGFR2,GGT5,HOXA5,HRH4,HSD11B2,IL16,IL17A,IL2,KLRB1,KLRG1,LGALS12,LGALS9,LRRC32,LXN,PDCD1,PGR,PPP1R9B,PTPN6,RGS18,SCNN1B,SERPINB9,SHH,SLC26A4,TNFRSF8,TNFSF14,TNFSF9,XCL1,ZNF366	18	12	Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function	
6	nasal_5k_ipa - 2025-12-01 12:15 PM	ALOX5AP,ARID1A,CDH1,CDX2,CEBPE,COL28A1,COL7A1,CSF3R,Collagen type VI,DEK,FDFT1,GAPT,GAS1,GPX4,HOXA3,KLF7,LRRC32,LRRC61,LTBP1,LTF,LYST,MCOLN2,NRROS,PIEZO1,PIWIL4,PRDX5,PRG2,RASSF8,RELA,RFX1,SMAP2,TGFB1,TP53,USP48,mir-130 (includes others)	16	11	Inflammatory Disease, Organismal Injury and Abnormalities, Gastrointestinal Disease	
7	nasal_5k_ipa - 2025-12-01 12:15 PM	LGALS7B,PELP1	2	1	Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	
8	nasal_5k_ipa - 2025-12-01 12:15 PM	HS3ST3A1,TFCP2	2	1	Nucleic Acid Metabolism, Small Molecule Biochemistry, Cancer	
9	nasal_5k_ipa - 2025-12-01 12:15 PM	BTNL8,HNF4A	2	1	Cellular Development, Embryonic Development, Endocrine System Disorders	
10	nasal_5k_ipa - 2025-12-01 12:15 PM	ALOX5,PRSS33	2	1	Cardiovascular Disease, Hereditary Disorder, Lipid Metabolism	
11	nasal_5k_ipa - 2025-12-01 12:15 PM	DYDC1,ERG	2	1	Carbohydrate Metabolism, Cellular Function and Maintenance, Hereditary Disorder	
12	nasal_5k_ipa - 2025-12-01 12:15 PM	IGFL1,IGFLR1	2	1	Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	
13	nasal_5k_ipa - 2025-12-01 12:15 PM	SALL4,XCR1	2	1	Gastrointestinal Disease, Hereditary Disorder, Organismal Injury and Abnormalities	
14	nasal_5k_ipa - 2025-12-01 12:15 PM	PTPN11,VSTM1	2	1	Cancer, Cardiovascular System Development and Function, Cell Death and Survival	
15	nasal_5k_ipa - 2025-12-01 12:15 PM	CREB1,OTOF,RNY3	2	1	Auditory Disease, Hereditary Disorder, Neurological Disease	
16	nasal_5k_ipa - 2025-12-01 12:15 PM	CLEC12A,DUX4-IGH,TCF12	2	1	Cellular Development, Cellular Growth and Proliferation, Connective Tissue Disorders	
17	nasal_5k_ipa - 2025-12-01 12:15 PM	CDK6,FGF8,SLC27A3,SYVN1	2	1	Cancer, Cardiovascular System Development and Function, Cell Death and Survival	

My Lists for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
My Lists	 -log(p-value)	Molecules 

Tox Lists for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
Ingenuity Toxicity Lists	 -log(p-value)	Molecules 
Cholesterol Biosynthesis	2.51E00	1.25E-01	SQLE,FDFT1
Increases Liver Steatosis	1.83E00	2.23E-02	IRF4,LXN,CNR2,CD44
Cardiac Fibrosis	1.81E00	1.57E-02	POSTN,PTGDR2,ZBTB16,CCN2,CNR2,MAP2K6
Acute Renal Failure Panel (Rat)	1.47E00	3.64E-02	SLC9A3,CD44
Renal Necrosis/Cell Death	1.46E00	1.12E-02	EMP3,LGALS12,SFRP1,IRF4,CCN2,FDFT1,MAP2K6,CD44
Hormone Receptor Regulated Cholesterol Metabolism	1.39E00	1.25E-01	FABP6
Cytochrome P450 Panel - Substrate is a Sterol (Rat)	1.21E00	8.33E-02	CYP51A1
Cytochrome P450 Panel - Substrate is a Sterol (Mouse)	1.18E00	7.69E-02	CYP51A1
Cytochrome P450 Panel - Substrate is a Sterol (Human)	1.15E00	7.14E-02	CYP51A1
Increases Depolarization of Mitochondria and Mitochondrial Membrane	1.09E00	6.25E-02	GZMB
Fatty Acid Metabolism	1.08E00	2.2E-02	CYP51A1,SLC27A3
Reversible Glomerulonephritis Biomarker Panel (Rat)	1E00	5E-02	SQLE
Increases Liver Hyperplasia/Hyperproliferation	9.5E-01	1.35E-02	PHGDH,SQLE,CCN2
LPS/IL-1 Mediated Inhibition of RXR Function	9.29E-01	1.32E-02	FABP6,HS3ST3A1,SLC27A3
LXR/RXR Activation	8.67E-01	1.63E-02	CYP51A1,FDFT1
Decreases Depolarization of Mitochondria and Mitochondrial Membrane	7.03E-01	2.38E-02	ITLN1
Increases Transmembrane Potential of Mitochondria and Mitochondrial Membrane	6.44E-01	2.04E-02	ZBTB16
Hepatic Fibrosis	6.4E-01	8.57E-03	CCR7,ISG15,CCN2,SPIB
Xenobiotic Metabolism Signaling	6.36E-01	9.46E-03	CYP51A1,HS3ST3A1,MAP2K6
FXR/RXR Activation	6.21E-01	1.12E-02	FABP6,FETUB
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	6.21E-01	1.92E-02	WEE1
Oxidative Stress	5.94E-01	1.79E-02	PRDX5
Cardiac Necrosis/Cell Death	5.39E-01	8.38E-03	CNR2,MAP2K6,CTSG
Increases Glomerular Injury	5.38E-01	9.8E-03	ADAM19,CCN2
Cardiac Hypertrophy	4.48E-01	7.41E-03	ADAM19,CCN2,MAP2K6
TGF-β Signaling	3.88E-01	1E-02	MAP2K6
Liver Proliferation	3.45E-01	6.87E-03	CCN2,MAP2K6
Increases Renal Damage	3.12E-01	7.87E-03	CD44
TR/RXR Activation	3.05E-01	7.69E-03	SYT2
Increases Liver Hepatitis	3.03E-01	7.63E-03	CNR2
Decreases Transmembrane Potential of Mitochondria and Mitochondrial Membrane	2.41E-01	6.17E-03	GZMB
NF-κB Signaling	2.35E-01	5.38E-03	MAP2K6,TRAF5
PPARα/RXRα Activation	2.08E-01	5.46E-03	MAP2K6
NRF2-mediated Oxidative Stress Response	0E00	4.63E-03	MAP2K6
Hepatic Cholestasis	0E00	4.63E-03	FABP6
RAR Activation	0E00	4.36E-03	ZBTB16,HOXA3
Mitochondrial Dysfunction	0E00	2.96E-03	PRDX5
Increases Renal Proliferation	0E00	5.1E-03	COL28A1

My Pathways for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
My Pathways	 -log(p-value)	Molecules 

Analysis Ready Molecules for My Projects->Nasal_TB->nasal_5k_ipa - 2025-12-01 12:15 PM
ID	Symbol	Expr Log Ratio	Expr p-value	Expr False Discovery Rate (q-value)
ADAM19	ADAM19	-1.21990634426745	2.48117057691109E-5	0.018620067328535
ANKRD55	ANKRD55	-1.12296808433204	7.43823907513648E-4	0.0997019204285555
ANO1	ANO1	-1.21770484233022	6.38757400534867E-4	0.0967175609828012
ARL15	ARL15	-0.358025938130385	4.15937829286822E-4	0.0783765991729665
BAIAP3	BAIAP3	1.27048539558906	7.24846643556029E-4	0.0989326608141475
BTNL8	BTNL8	-2.41998923890576	4.51757976642101E-5	0.0254324682250281
CAPS2	CAPS2	0.909771183187936	7.02227920047735E-4	0.0989326608141475
CASS4	CASS4	-2.13839960883795	8.16352476006834E-5	0.0344684424181986
CCDC194	CCDC194	-1.54934937078116	2.65084703488142E-4	0.0581430591845614
CCL18	CCL18	-1.99710005340056	2.51497861064036E-4	0.0578771459557654
CCN2	CCN2	1.23803767075301	6.42059217109306E-4	0.0967175609828012
CCR3	CCR3	-2.81894701936973	7.85722090959673E-6	0.008703959200993
CCR7	CCR7	-1.19778167204691	8.00820089491246E-5	0.0344684424181986
CD1B	CD1B	-2.57309518009725	2.21525227510808E-5	0.0178159027020478
CD44	CD44	-0.867641452334028	3.76085608246153E-4	0.0727812672188869
CD69	CD69	-2.41635405091362	1.04708603472326E-6	0.00221052950505515
CDH26	CDH26	-1.24874860769962	1.17838013538903E-4	0.043264482840403
CEACAM21	CEACAM21	-2.00291318952695	8.22520487399548E-7	0.00198450693024157
CEBPE	CEBPE	-2.73627071750916	5.31485211719455E-6	0.00690481056979221
CISH	CISH	-1.38362856604567	2.11866769416098E-5	0.0178159027020478
CLC	CLC	-4.31983379668735	5.61624415470214E-9	4.74263737643822E-5
CLCA1	CLCA1	-2.30002697876805	2.59931806602641E-4	0.0578771459557654
CLCNKB	CLCNKB	1.3436485258612	2.17061090318004E-4	0.0578771459557654
CLDN3	CLDN3	0.918243692077083	3.42262581277144E-4	0.0672147992463917
CLEC12A	CLEC12A	-2.7522147170074	4.01901875552254E-6	0.00565643398016835
CLEC12B	CLEC12B	-2.26361934246689	4.26831541656259E-5	0.0254324682250281
CNR2	CNR2	-2.16070945997484	1.09725206191331E-4	0.0411810890525642
COL28A1	COL28A1	1.92475410064816	1.3264971103063E-4	0.0466733535332565
CRISP2	CRISP2	2.84060319447694	3.93989477938463E-6	0.00565643398016835
CRYBA1	CRYBA1	-1.64775151606906	7.17368766934404E-4	0.0989326608141475
CST1	CST1	-6.47833824686422	4.19647374137468E-15	7.0874245018077E-11
CTSG	CTSG	-3.03418120217086	2.93833711917946E-4	0.0617162353676996
CYP51A1	CYP51A1	0.490565327812251	7.13843597156629E-4	0.0989326608141475
DENND2D	DENND2D	-0.407605440379002	6.0279181588977E-4	0.0931005657707941
DMRTC2	DMRTC2	-2.58015535790605	5.06643391620959E-4	0.0881269692333288
DOK2	DOK2	-0.748298619775385	6.47112581624521E-4	0.0967175609828012
DYDC1	DYDC1	2.01786622054926	8.71381010486999E-5	0.0350398902050355
EMP3	EMP3	-1.18522597113503	7.36445627387721E-4	0.0995026416076098
ENTPD4	ENTPD4	-0.269274881144137	4.78408673544521E-4	0.0841650425780563
FABP6	FABP6	1.81167446867097	7.32985867803856E-5	0.0334578333009171
FDFT1	FDFT1	0.497345395667866	2.36663385532543E-4	0.0578771459557654
FETUB	FETUB	-4.3980954935573	5.58483795775566E-7	0.00157203880447559
FHL3	FHL3	-1.15119798022212	5.39434659442851E-5	0.0284703498854072
GAPT	GAPT	-1.95759474047517	9.10751390080909E-5	0.0357713493652941
GAS1	GAS1	1.12697298335927	4.50526563403208E-5	0.0254324682250281
GGT5	GGT5	-1.85361104922918	6.00658938664543E-4	0.0931005657707941
GZMB	GZMB	-0.93527492722191	6.8811462129232E-4	0.0989326608141475
HEPH	HEPH	-0.942307247659859	5.85548914260267E-4	0.0931005657707941
HOXA3	HOXA3	-2.19400778202097	4.2230271328912E-4	0.0783765991729665
HRH4	HRH4	-2.28054075639826	1.37809996300571E-4	0.0474994495412316
HS3ST3A1	HS3ST3A1	-1.28325980274344	1.32253446591101E-4	0.0466733535332565
HSD11B2	HSD11B2	0.951339685609898	1.86757721901234E-4	0.0573482030034536
IFIT1	IFIT1	-1.70874522164243	4.21932003830675E-4	0.0783765991729665
IFIT2	IFIT2	-2.05044523917434	6.2897171648188E-5	0.0303505809133213
IFIT3	IFIT3	-1.61268253330126	2.32426835590428E-4	0.0578771459557654
IFT74	IFT74	0.77576886467223	4.61867448295871E-4	0.0829838227049891
IGFLR1	IGFLR1	-1.2140435451294	1.81580936696188E-4	0.05684342873772
IL22RA2	IL22RA2	-1.50546974588498	2.56205783484623E-4	0.0578771459557654
IL31RA	IL31RA	-1.54251219322294	1.09301112647986E-4	0.0411810890525642
IRF4	IRF4	-0.992614559314485	2.43312786896962E-4	0.0578771459557654
ISG15	ISG15	-1.8682648407588	2.12488960189428E-4	0.0578771459557654
ITIH5	ITIH5	1.39024456302797	3.41245265315852E-4	0.0672147992463917
ITLN1	ITLN1	-4.58435560671569	3.76424752687704E-7	0.00157203880447559
LGALS12	LGALS12	-4.48891659007711	2.67922440731021E-8	1.50831403383541E-4
LGALS7B	LGALS7B	-1.52749386247846	2.37955569092718E-4	0.0578771459557654
LRRC32	LRRC32	1.94529312335857	1.70728312579836E-4	0.0554505859838625
LRRC61	LRRC61	0.909457615508322	7.12099997944585E-4	0.0989326608141475
LXN	LXN	0.681236350761242	2.46238267471573E-4	0.0578771459557654
MAP2K6	MAP2K6	-0.62886817819342	1.81748188278577E-4	0.05684342873772
MAPKAPK3	MAPKAPK3	-0.492924095531238	6.00734180634213E-4	0.0931005657707941
MCOLN2	MCOLN2	-0.702711236465586	2.98478606812943E-4	0.0617162353676996
MMP12	MMP12	-1.39160291734701	5.52653173812746E-4	0.0906190238109074
MS4A1	MS4A1	-1.58117092673537	2.39156786508613E-4	0.0578771459557654
NAIF1	NAIF1	-0.282363488232247	5.64308268370227E-4	0.0916404071586997
NMNAT2	NMNAT2	0.86686865413807	5.88275618654644E-5	0.02989392946233
NRROS	NRROS	-0.933522142259089	3.00754440329037E-4	0.0617162353676996
OASL	OASL	-1.66626366551568	3.03300819202977E-4	0.0617162353676996
OR52M1	OR52M1	-3.33642727405966	2.12052186629855E-4	0.0578771459557654
OTOF	OTOF	-2.34343559737911	4.11565874730448E-5	0.0254324682250281
P2RY10	P2RY10	-0.897880662073769	3.79226213231218E-4	0.0727812672188869
P2RY13	P2RY13	-1.84309624523114	5.3011876679224E-4	0.0886453054688528
PCDHA12	PCDHA12	1.06273844942012	5.16511651784235E-4	0.0881269692333288
PDCD1LG2	PDCD1LG2	-1.38816498089191	2.55578951298189E-4	0.0578771459557654
PDK4	PDK4	1.00717940110968	2.02163438763645E-4	0.0578771459557654
PER1	PER1	0.646468059754473	8.39865001779405E-5	0.0345962927196399
PHGDH	PHGDH	0.971380552606511	5.92648229879738E-4	0.0931005657707941
PIP4K2A	PIP4K2A	-0.346444891305134	6.06374695647306E-4	0.0931005657707941
POSTN	POSTN	-2.47402246798315	6.01808041754527E-5	0.02989392946233
PPP1R16B	PPP1R16B	-0.953630195557354	1.63998583836426E-5	0.0153876226800744
PRDX5	PRDX5	0.688153095285438	2.50580348586987E-4	0.0578771459557654
PRSS33	PRSS33	-2.48710510827275	3.56176971702938E-5	0.0250644703128788
PTGDR2	PTGDR2	-2.38623377053605	2.16725713061751E-6	0.00406697840877767
RASGRP3	RASGRP3	-0.499564030329626	1.48022173446454E-4	0.0499989297467431
RFTN1	RFTN1	-0.515528905358666	5.28495206524614E-5	0.0284703498854072
RGS18	RGS18	-1.86432890834208	5.49938787762686E-4	0.0906190238109074
RRAGB	RRAGB	0.321904706863434	3.40257828734174E-4	0.0672147992463917
RSAD2	RSAD2	-2.1618307721724	7.56316494500687E-5	0.0336142875674266
SAMD3	SAMD3	-0.942269171378473	2.05794430400447E-4	0.0578771459557654
SCNN1B	SCNN1B	0.615618817658972	7.26369230916827E-4	0.0989326608141475
SFRP1	SFRP1	-1.14881645389981	2.38809505305907E-4	0.0578771459557654
SHISA2	SHISA2	1.31188577318699	7.90081839675549E-6	0.008703959200993
SIGLEC6	SIGLEC6	-1.34486556130828	2.53574248656703E-5	0.018620067328535
SKAP2	SKAP2	-1.73039543540399	4.46977888677544E-4	0.0811721458266133
SLC1A7	SLC1A7	-3.59808563359929	1.63028531778011E-4	0.0539880171215456
SLC26A4	SLC26A4	-1.77094765930631	2.52817882053753E-4	0.0578771459557654
SLC27A3	SLC27A3	-0.480736360128158	4.70916010920515E-4	0.083718952720385
SLC9A3	SLC9A3	-2.30461434161838	3.81801334276396E-5	0.0254324682250281
SLC9B2	SLC9B2	-1.14685977381306	2.96416464553081E-4	0.0617162353676996
SORD	SORD	1.54270969621224	3.97598411770004E-5	0.0254324682250281
SPIB	SPIB	-1.90249811290628	4.838358165063E-7	0.00157203880447559
SQLE	SQLE	0.837886616378273	6.92571599444109E-4	0.0989326608141475
SYT2	SYT2	-0.573046071853789	2.77319922803758E-4	0.060046874054265
TASL	TASL	-1.63038664982454	7.10351596136426E-4	0.0989326608141475
TESPA1	TESPA1	-1.02091939133632	1.92994269303454E-5	0.0171551590224528
TNNC2	TNNC2	1.17008004493652	6.71411124319247E-4	0.0986040215532849
TPSAB1	TPSAB1	-2.49099140456287	1.52997698321328E-5	0.0151998713349935
TRAF5	TRAF5	-0.45835827318786	5.21800990190827E-4	0.0881269692333288
TUBB4B	TUBB4B	0.913427517675833	4.43564120750755E-4	0.0811721458266133
UBXN11	UBXN11	0.812807446058046	2.6044544334408E-4	0.0578771459557654
VSTM1	VSTM1	-3.65819760768088	3.64255605949015E-6	0.00565643398016835
WDR93	WDR93	1.15373959691933	6.67409419432485E-4	0.0986040215532849
WEE1	WEE1	0.469429873618097	2.44403737165145E-4	0.0578771459557654
XCR1	XCR1	-1.1206030773278	2.32743583683533E-4	0.0578771459557654
ZBTB16	ZBTB16	1.37542309030051	7.24772425041529E-5	0.0334578333009171
ZNF157	ZNF157	1.3534175373188	5.19671355801214E-4	0.0881269692333288
ZNF366	ZNF366	-0.958517870361646	8.24580183645497E-6	0.008703959200993

